var title_f16_60_17344="Acquired methemoglobinemia";
var content_f16_60_17344=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Methemoglobinemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 174px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCACuAlgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiimSyLGrNIwVFGSx4AHqTQBT1XV7DSbX7Tqd3DaW5YJ5k7hFyegya8k8d/GlNK1cWfhuOxv4VA3zu7MrsegTb1x3zXKfG/xw+tSS6TFaxtpVtNkuHBMsik4dWHG3B6V5HHesFRQEJQfK+wblHt715lfGPmcIaeZ9zk3DUJU1XxSu/wCXp5X/AMj1+f49eIFlWJtK0uB8jO8uQw9iDxWxoXx4kEjN4l0cJbOdsL2B3HI65DHnt0rwy5vTdwKLieQbRlEwrc9s8cVVtpzHdxTBQHXowO39a5frVVP4j3J8O4CpCypWfzPtTwd4w0fxbYtc6PcMxjIEkMi7ZEOO4/rXRBgT1r4b0DXrzw/rceq6Vdsl3GSeRkMP7pz1B719e/DnxTB4v8MWupxYWYjZOgGNsg64HpnpXpYbE+192W58XneRSy5qrTd4P70+z/RnUUE460UjdMcV1nzwhYAE9hXmfiT4yeG9B1q40yaO/uZoDteS2RWTdjoCWGa8o+L/AMTdQ1rVLzRtMlktdLtpWhcJw1wQQDu7gAhsAHnvXlqyqoG2EBgOoYivMr47lfLT6H3GUcJqrTVbGPdaJfq/0Pd9a+PF4bxn8PaIJdOCgeZdqVk39xhWxjpVuw+NOpWc0cviTQ4xp8i5Eli2XT3ILdPyr55Ls7fvCzjOSCTSxHyw4jVPnGMnkiuX67Uve57/APqxgeTkVP53d/zPsjwH8QdE8Zm4TSjcRzwLvkinTaQpOAcgkH867HNfBVvJLbEmOWRCRglHKk/lXuHwi+JWvNrthoevbry1um8qK4ddskbYJXnuvGOea7MPjlNqM1qfN5vwlUw0JV8M7xWtnuvn1/rc+hgc0U1fenV6J8YBrJ8T69YeHdEutT1SQpbQLubAyzc4AA7nJFHijX9P8NaPLqWrT+TbR4GQMszHoqjuT6V8mfEbxNeeMNdN5qexLaIMtvEi/NDHngH1Y9z/AIVz4jEKktNz2MoymePqXlpBbv8ARf1odD4i+Lfii61i4utL1A6dphkxDA8Slgo6Z4PJ6mshvi940890/toquOG8hP8ACuPRrZIUjUucnHzDB+pHaqOohkjMbDJRuo715LrVb35j76OXYOMVFUo6eSPTtN+KXjk5ZtVjZRwTJbofyGMV6l4B+KkmpammneJY7W2ln2pbTW4ba7nqrZ+6T19K+ZNK1MxKsLKCnU5610MFytwHgQjdKpwPb0z2rWOIqQd7/I58Rk2ExVNx5FF9GlY+1UYMMqQR2Ip1eTfs/wDiT7boL6BdKVu9LUbCST5kZJ5GfQ8fiK9Zr1aVRVIKaPzrGYWeErSoz3X9JhSE4pTXmXxm8eTeFba2tNMnjh1KceaWkj3AQjIJHbdnFVOaguZk4bDzxNRUqe7GfFP4qWPhErYac9tc62WQmGbcI0Q9SzDv7V5befFnxnqMszRahYWEC4VktoQwUeoZ8kk15Tdwme8Z2V55p3MjsGzvLHO7HalayvILd2MiRQxHGTJ8x+ma86pXm3dbH22EybD0IpOKlLq2rnb/APCx/F8FxPcQ+JL0vNk7ZlRo/wDgK4+X8K3vBXx01jS71ofFp/tOwYE74IgJ1J6YxhSPXPNeT2RmmmEbR28w52vNx+tON5d2AMQiiRtuFZVzsB9KyVeUXozsqZXh60XCVNa9kkz7l8P6zY67pVvqGmXCTW86B1KnkexHYjpWmCM18efDvx6/hXXIrmOIrbMAl4gjyZU9ueCDzx9K+sPDmr22vaJZ6pYB/st3GJY/MXa2D6jsa9KjW9qvM+KzTLJYGatrB7P9P63NOkJA60tch8VfEsvhTwXealabTeZWKDcuV3sep+gya1bSV2edTpyqzUI7vQPiH490nwPYQz6p5sss7FIoIQCzEDJzzwOnNeA6z8evFdyWawXT7CJWIAji81yOwO44/EV5ne315rGs3eo6hKZ7yc/POx++cdx0H4AUt1FHDKmxWEkgGR6GvNq4icn7uiPtMDk2HoxXtVzS89vuO8j+NfjyWJit/ahoxufNpHyPyqxp3xz8a28zS3T2F5FtwI5YAqgnvlcGvOLyIQW6uyKTIhU4cjPv71Hb2ayKFYlW27hJnkcdKy9pVWvMzteBwkk17JfcfWPwc+J8Xji1nttRWC11qA5aFOFkTsUBJJx3/CvTgcivgi3nn0m9t7rT3NvexMksdxG5LRsO+Oh9wa+y/hj4o/4S/wAI2mpOjJcjMNwCuB5q43Eex6/jXfh6rmrS3Pls4y6OGl7Wl8D6dn/kdZSEgdaWuL+Lniqfwb4LudUs445LsukEW/orOcbsd8dce1dEmoq7PHp05VZqEd2SfED4g6J4Hgt31Z5pJ7gkRW9uoeRgOrYyMAepryG+/aC1UXFxJY6Fa/YRMVh852ErJjjIBxn9K8Svpri8uZry5kaa4kcvLOxJLljn8Oew4qSRZHgUABgRnBOPxrhniJSvy6H1WHyehTS9r7zPRIfjV40uZ52+32sQySsa2qEKP7oJ5OPetbwl8dNettXjg8SLb6hYyPl5YoRHJEuOigYB5x1rySwiyGkTcZADwORiokTNyjEEn1H9KSqyutTqlgMNKLTgvut+J9w+EfE2neKdHh1DS5t0bjLRMR5kR/uuATg1uA5r4Q0TVrnw3rlnqWmT3EFxE43FW2+YufmT6EcV9qeEPEdh4p0ODVNLctBLkFWGGRhwVIrqo1vaI+bzHLng3eLvF/h5G3RRSE4rY8wCcVyvi3x/4Z8KCMa1qsMUsgykKfO7e+B24xk8V5x8dfitcaDdv4b8OyPb6pgG6uin+oQqGXZngkg9e38vmhYo3Z3XcN7/ADSuO55Nc9Suo6Lc9fBZW6yVSrpE+hvEX7QypPbL4b0ZpISheVr47G9lUKT+tYqftF67g50LTJNy5UxyPwfRq8Xt28u4kFuS8bnJ3ptBA7//AFqbHzKZGEhTfuy64w3biuf21R7s9lZbhYpJRv63PrH4b/GbR/F+oxaTdQS6fqzISA+DFIQMttbPseDXqikV+fIRhJwpL9AzHBHrgV9Nfsy+LdS13SdT0fUWEsWkeUlvMc7yjbvlY98betb0a/M+WR5OY5bGjH2tLbqj26igUhNdJ4ojMBnJxxmvLvGXxp8P+GNXv9MktdQvLy0Kq3kIvlliobbuJ9COcVyf7QvxGu7K8l8JaKVXzbfN9OMlwGyBGvocck9eRXz9e+f9mMMhUFWUksef84rGdWz5Uevg8uVSPtKuz2R9GD9obTixX/hH77hd5PmrwPyqxa/tAaVJIwuND1GOJULbo2R2J7ADj+dfN0c00pTbjcVO7aeqioZ5XaTcVB2+nfjpWXtZHf8A2bhuz+8+5vCXirSPFWmR3ujXkcyMoLx7h5kRIztdeoNboORX5+WWr32nanZ6pp8r293AwZJI+oYeo7j619bfBz4mQ+NbNrLUDFDr9uu6WGMELInZ1z+o7Gt41E9GeTisC6K54O6/I9NoJoHNMlkWON3kYKigszHoAOprQ88wfHHizTPB2hSaprDuIVYIkcY3PI56Kor5y8Q/HbxTeapLLoj22macBhIZIVlb6sT39hxXM/GLxXH4v8bXV7G5fT7b/RbMqcgop5f/AIEcmuKAxjfwCcHA5rKUmz28LhIQipTV2+56T/wu3x2VYnVLYAfxfYo+Peui0X9oPXY7q3XWNM0+6s14me2DpKw/vDJxn2xXiryDcyqMp0zikSRwmFCnrnFRr3OmVGlJawX3W/I+6fBXizSvGGiR6no0zNCSVeOQbZImHVWHY8iugFfB/hfxHqnhXUbfU9Hm23cRPynlJAeqsO4P/wCqvs/wF4ltvFvhWx1a1aMtKgEyJnEcoHzrzzwf0xW0ZXPGxWF9i+aOx0NFFFUcgV538cfEFzoXguUafLCl5dsIAHXcTGQd5UeuPyzXoleI/tHQ37nSZVjU6aiSKXCnKyHsT2BGMe+axxDapux6uSUIV8dThU2vf1trb5ngMdsLgAvO0eeVjwT8vr7U+2tLS5kVE84bh98sAAfpVeI5Z/8AWqFPAXG78/SpMRRuoZpzJ1KKRz+deEopLU/Xp6bFz+x7cyOizFXXIAOCcjqSKhk0dFkVftOMjODGaptJvuN4BjbPLZ6U97qWSVVJO4cAoxBx/Wj3R2dty0mkxSqXiuhge2T9a9z/AGZENvH4ht/M3oGhbG0jBw2fz4rwI/vA7biuDjeMbfpgc17v+y/LNKfEIlZmCeSPmHI+/wD4V1YSyrJI8HiXXLKj9P8A0pHvIqtqDvFZTyRnDpGzA4zggVZHSobuMzW0sQbbvQrn0yMZr2T8qVr6nw9qF3a3ri5kSRLmZmeeQHIZyck47c+lUy9p8/EpbHynOMmjxNp97oms3ekXu0TWMrRnAxvGchvxBBHsaygz55GfbNfOcrT1P2yliYOCcFp09C/PJHvJiz5Z5wRyPapP7Q5JZBnGPlAUEe9Lp01nLdJHdQwwoOfNkdiPoQOtSXz6dIJfs0ILAHDqSoPvt6Yp+ztrcPrUm7JDE1KAE74lIPQplT+PWpZbpI3EltcZj/5ZylyHVseg5rJaIMFPTjmm/ZuEIIKt0b1pLl6jlUrbXPvjRSzaRYs5y5gjyT3O0VeqnpB/4ldnn/ngn/oIq5X0S2PxKW7PJ/2k8/8ACB2m0ZP9oxcf8BevnLYiXKL54dXUIwMZ49s/1r69+JOgxeIvB9/aSI8kqIZ4FQ4YyqCVx+PH418d3EhYZuE8rnoDg5715GPvGopNaNH33C9VTwrprdN3+e35CalbxWlwGtJlZn3Z8znA/GssOvlMpbc7cHqTmtTU2W4t08uPcyj74wOPes+0t2kl3bDtT7xzjFcjWp9LFe4AskaMSK5fjPHGfwrV00RQr8oIyeuc81lQSGIGFoyjLksSf0q9C7BtyFY1YZO8Z/Kt7aXOZSfNY9L+El9NY/EDSktJCPtWYJv4t0fUj65AOa+o1r5l+BmnyX3jixu4E3xWccksr9FAYFR+OTX00vSvQwSag/U+G4mcfraS3sr/AI/oB7V8rfHh7z/hPdUdpN8ccKRxxSfOoU9f90Zr6pNfMn7QGnX+l+Kp9UvI410rUAsUU3UeYATtPocAnpirxUW4r1MeH5xhinzW1Ttf5HksOpXsQKiGAxquCuzoPUHqfpS3mpxSReU5J+UAh4zk+/tUTXFkZFQFpVxzuOQT/jVhbaG4cRACHd8zO+WJH4dPpXnSkz7dQvqVd6yMWi2lUxgluQPp3pz6fC0Yna8BikPyLggt+vFSwWVorbSZJS+Qm3gkj2qE28UMuZJo4jjJRlJC56VDbbL5Y2K8VuVlWTzVWJiQrH5uR7d6+nP2YfOXwxrEdxLJIUvsLvzhR5a8AHoK+fNP1G1SOQSTW7ZOFUQ8/UHHFfXPwkgji+HuiSRxKjzWyyOduGYnu3qcV1YOD579jwuIq0VhOS2ra/zOxrxr9qKTyvBOntk5+3Lhc8Mdp617LXjX7UURfwNYPtyqXyZJ6A7Wxmu6u7U2z5XK1fF0/U+Y44pBLL8u10GMA8KfT3qZWWR2AdtygAP1GcdKYiuifaZ8lJuQAOc+xptrIsUMkG1iQQ/+PNeRKVtD7+ML6hKd8IUEt5XVicbSeKmsnkt2Cbc92cnOfpVZWEYMUKHdN1U85PX8qkn3MgQSCNt3K+gx0pqdlcXJrYa7mZgIj84O0OTjOOtfTP7K4ceBtTWQk41KTGTnHyr3r5oLK8jCBA0akSEjnA6Gvqb9mnTbmw+HrzXcLQi8u5LiIN/EhAAb6HBrrwr948TPklhvmj1mvFv2pv8AkTNKG/Yv9oKTxnPyNxivaa8p/aQ0afVfAAntlZ/7PuFuZFXH3ACGPPYZyfpXZWTcGkfNZdJRxUHLa58q8uixjdkKSD2NOadnt0iK7vLG0YBGRTYyEb5txiI6qf5U0bhwWYSLzx3rzdErH3F+pLBM8UDc5hcnI6Z9qSLd5r8FFxnOc8Um9TCSznfxtUjgjNPt2jZ8uyorAqWIyB709G0R6iXDpLKcDj+97V9E/stI6aX4lJ3eUbuLZxgf6vnFfODOB8xPIPzY6fjX1Z+zhpklp4C+3SHjUJmmRcdFHyg/jjNb4fWZ5Wcu2Gd+rR6uKzvENxLaaFqNzbuEmhtpZEYjOGCEg4+orRqpqtouoabd2UjsiXMLwsy9VDAjI9+a7WfJxaTTZ8DXmp3eqyy3t/O93PIctNKx3OT/AEpkK7YpEYkKMFsnueAa1/F/hweGPEF/o7SG4FhLsEx+USL159+lZUm9bd1LIyuqlmHRRnjH415LunqffRanBSjtZMfBbPCAWUKA4Gd2cjpUaoEuFChmjOSN56EHH4061MW2XbITOQoVTzznqKiR13pu5XzQdw+vTmi72Hy6+oOCSTyxjbaAeuK+gf2UmUaj4tjEZVgYMknk/f7V4BL8ztIdwJf5eMDk9PrivoP9lcJ9q8UEzJJMPIVx/F/Hya2ofxDgzNf7JNvy/NH0IOlNY45NKOlBr0T40+OvjxNs+LOrqo/5ZxjOOrba8/lvRLC8TgvIwycjHIr2L9qSwtoPG2lXEKhLi7sz523jdtY4b9cZryVhCYz5ZVGCY5Gc+tcUtJs+swsufDxa7EUd7mBCnylDtZgOxoF2lw4dsMYlPYrzngU+1ECxxO5DKrnco6njiknEZkUQqpJVsjGCDU9zo1Vhb6WKSGRh8j5B2gZAz2r0r9nYxf8AC1rJ4y+Ws5lIPsB+leYz2PkeacsCuAc8j8K9U/Zr0u8b4gW97DayyWMFvKJbjHyxlx8oJ98dBVw1aOfFStRnfsz6wHSqWtf8gi/yOPs8n/oJq6ORUVzElxBLBJnZIhRsehGDXYfKLc/PjfmIqVAAZsZHbcakYmRQSRtX07/Wt7x54fbwp4p1LSJIJBHBOTBvbcWhY5RifeufKYJyQiE9qwaPpovmimLtPlZUZJ6gdxTowAz424FMkO112A7cYLLwPxoK/KDjBYnmgofuUoV5BY55Gea+q/2Xs/8ACrxnr9um/wDZa+VbOCW5aKC1jae6lkEcMQGTI54Cj3r7V+EvhZfCPgaw04rIlw4+0XCu2SsrgFh+HT8KuC1ODMJL2aj5nY0UUVoeMFZHivRIfEXh++0m5kkiiuo9hdMZXnIIz7iteg0mr6MqE5U5KcXZrVHxp428OXPhfWLixubSZ4lYpbXEkewzIDjcOcVz62w8yN2nAJBbGcHHtX2B8QPBGneNtLhtNTkmiaCTzIpoThkOMHrxg8flXiWq/AfxJZzrHoeqWV1bsmXabMJDZ6Y+bPGOeK8qtg5KV4K6P0TL+J6NWmo4iXLPr/n2PJpZ4gkg3Mzk8qxyD759ars5URsrbWQckPk16PdfAzxsjBkTTpyx58u5xj65A/StTwp8CdduL9o/EksVlY7SS8EgkcnsFHb6msnh6knblsenLPcFGDn7VO33/ceZ6RY3XiPUrew0rT2l1CVtoS3X5QvdmPYDqT0r7J8E+HLTwzotraW1tBFcCFFuZY1wZXA5JPfkn86zPh/8OtE8EiZ9MR5bqbIa5mwZNnHyAjtlc/WuzAwetejhsP7NXlufDZ5nbx7VOlpTX4vz/QWg80UV1Hz55J8aPh5YataXPiO3XytQs4Wlljji3fawoHDd8gDANfN7XFlNMXaHygRt2xRDaR68nrX3SwyK4TxJ8KfCut28ijT47G5d9/2i1G1snrx0IOfSuDEYRzlz09z6zI+Io4OCoYq7itmuiPlCK10o27mZ71JMjY2wYI9etNGmRhFb7TEQzEIuCWfHp6H619C/8KA0jZj+29RJxjJVDx6dKJ/2f9Hm2/8AE4v1wu3hE59zxXL9Uq9UfQf6x5cm3Go9fJ/5Hz9b28K5YXFrGVH3bkYHHr6n6V7L8Gvhw+qzjX/FFkotAhjtrGeHAkBH3yp7enrXqfhT4b+GvDlrbpBp0FxdRIUa6njDyPk5JOeB+FdgqgdK6KGBUJc8/uPCzTiiWIhKjhk0n1628u352EjjWNVVAFVQAAOgAp9FFeifIDWHSvmP4m/Cm70bUXutGjvb3TZmeUokYPkZbOw45I54NfTxGaaUFY1qEa0bSPRyzM62XVXUp6p7rufCv2K5eTbnanCkcjy/c0jbLLO3ZKEO7LDiT1z7V9gap8O/C2p3ZubrSIfOLFiyEpknqTg1Rf4T+DXdWfSFbHYyvj+dcCwE47NH1q4rw0o+9GS+7/M+O9SLxXiy4DBhnb6e1ehfDbwNq3jDZLBA0WnFwr3cg+QY6hQfvEdK+jX+Gng187vDunnPB/d//Xrp7Cxt9Ps4bSyhSC1hQRxxRjCoo6ACtqeDafvPQ87FcTKUf9ng1Lu+hkeDvDNj4Y0eGxslDMq4ecoFeXry2PrXQCkAxS13JJKyPlalSVWTnN3bA1ma9omm69ZG01ezgu4D0WVA204xkZ6HnrWnSEZptX0ZMZOLunZnxX8R/Ad54K8QPDJHc3FgxDW10sZ2spPCs3QOPauWkiVh5tu8yggktuzn8a+7Na0XT9csjZ6vax3dqWD+VIOMjoa59vhh4KbOfDen8+keP61wTwV37r0PrMPxMo01GtFuS6q2p8hafaTmESQrbrkbd0gwT6j696UaXNbyOgZpom5aIjcXI6HFfUt78GvCk01s9nDc2KxS+Y6QTHEq/wBw5zgfStmD4beE4nkc6PBK78FpSzHHoCTwKlYOVzofElC1+Vv5I8J+DfwuPiO8l1LxFp8sWkIv7lG3RNI/quOqjvX09Y2sNlaxW1rEsVvEoSNF6Ko6CnwQRwRRxwqEjjUIigYCgdAKlxXbSpKmrI+Yx+PqY2fNLRdF2CsvxFomn+IdMk0/VraO4tpAflcA7TggMPQjPBrUoIq2r6M4oycWpRdmj5N+Kfwn1HwtNbz6NLeappk58v5kLvAf9raMYPY/WvM1tmVflJjYBg24YViD93619+4ri9W+GHhHVNRlvbzR4muZW3sVZkBb+9gHGa4quDTd4H0uC4g5I8mIV7dV+p8aQXCCVirbWBO3PP0xT3iaWZ5JZQuDhmk4JOM4r3m8/Zxim1KSaHxLKlsz52tahpAPTduA/Suv8LfA/wAM6NLI9+ZtY3rjZeAFAc/eAGOe2awjg6l7PY9OrnuEjHmg236f5njPwW+H83jK6Fzc749DtpAlwx4Mx67EP5Z9M19a2dtDZ2kNtbRrHBCixxovRVAwBVXRNHsND06Ow0i1itLOLJSKJcAZOT+prQFd9GiqUbdT5bMcfLG1OZ6RWy/rqFQ3UEVzBJDcRpLDIpV43UFWB6gg9qmoIrY8/Y+Qviz8Pbvwbq8l5CTNpNzK8sLJGQsILZCP2HXAx6VwCrMZCM5MvUkcg191eINFsdf0m403VIFntJxh0b1HIP1Bwa8mn/Z90NIkNlrGpw3Cc+YzK4bjuMfyrjqYfW8T6XBZxTVNRrvVde581oCFMfymTk7j6elAR0AkClg4I2v049K9xX9nfUgxx4ngC57Wpz/6FW94T+AtpY38Vx4k1FdTihYsltHFsjkyP48kk4Ppis1Qk3sd0s2wsY35r/JnhPhHRbrxB4m02zsLX7VvnjaeNASEjDDdv9Fxmvt3TrO20+yitLCCO3tYRtjijUKqD0AFZXh/whoHh24mn0PSrWxlmUJI0K4LKDkA1vAYrrpU/Zo+dzHH/XJLlVkgpCM0tFannHh3xx+FM2uST6/4bRpdRYA3NnuwJwBgMo/vjHTvXzdKjwCeG7Rra6U7XhkUrtx7HvX6AsMjFY3iDwxo/iCznttWsILiOfb5jFMO20gj5hz29a5quH59Yux7OBzd0IqFVXS69V/mfDNkg3MWQEfKiyJ1bnrTUWI3CxxuZPn3bWGFAHcV9R3nwC8LT3c0sNxqNvDI24QRy/InsMjNWdB+BfhPTNQW6uEuNSwhXyrtgyZJHzYGOR0/Guf6tUueq86wyjo3f0PlrTrS81fUrey06J7+7ldglpHyzYycgegAz+FfX3wj8BWngnQyQrNq18qSX0rHOXA+4OwVcnFdFoXhXQ9AUjRtKs7PLmTdFGA24jBOevTitsV00aHs9XuePmGZvFrkgrR/MBRRRXQeScX8Svh7pPju0tk1Fpbe6tm3RXMAG8DupyOVPpXyt8RvBN94P168hMd9/ZEcgitr24j2rPlQTgjjgkj8K+3CM1Dd2lveQNDdwRTwnqkqBlP4Gs5U1LXqduGxs6HuvWPY/PyJdomBmBA5+U9KlWB7QNJJIMOu4BuMA19nyfCvwQ6Oo8OWMe/gtGpU/mDS2nwv8H20oddEt5CuNomy4XHIwCay9i7no/2rSt8LufJXgXw9q/jfUJdJ0OOJ2Ee6eaZsRxDsWI556DFfXnwu8JN4L8H2mkS3P2m4VmlmkAwC7HJA9h0FdHa6dZWbs1paW8DMMMYolQke+BVutYU1E87F42WI02QDimSp5iMuWG4EZBwRT6K0OI86+Jnwr0rx1JBcz3V1ZX8ERjSaHaQ/p5gI+YA/TrXzxefCDxzbxSMdIM4i3EGOVWZgD2HfPYV9lkZo21LimdVHGVKS5Vqj4I/sPV/KcHSNQBU4KtbOP6Usei6s0v8AyCdQwBhQbdsc/hX3vRS5Do/tF/ynzF8F/hJrZ16w13xBA2m2djOZUtJ0xPI642nHQLk9evFfTopMe9KKpKxxVq0q0ryCiiimZBRRUN5dW9jaTXV7PFb2sKGSWaVwiRqBkszHgADuaAJqKpwapp84sjBfWsgvUMlqUmU+eoGSyYPzDBByM8VcoAKKKKACiqmraha6RpV7qWoS+TZWcL3E8m0tsjRSzHABJwAeACantp47m3ingbdFKgdGxjIIyDzQBJRRRQAUUUUAFFQG8thfLZG4hF40ZmEG8eYYwQC23rtBIGemSKpp4g0Z9aOjpq+nNq4G42IuUM4GM58vO7pz0oA06KKKACiiigAooooAKKR2VEZ3YKijJJOABWZo/iLRNaFwdG1jTdQFvxMbW6SXy/8Ae2k46HrQBqUVm6Lr+j66JzomrafqIgYLKbO5SbyyegbaTg8HrWlQAUUUUAFFFFABRRWXrniHRdASJ9d1fTtMSUkRte3KQhyOoG4jNAGpRWXqviLRNHt7e41bWNNsYLniCS5ukiWXjPyliA3BzxWmjK6K6MGRhkEHIIoAWiiigAooooAKKKKACist/EOippDaq+r6culqxVrw3KCEENtIL525DAjr1GKt6df2mp2UV5pt1b3lnMMxz28gkjcZxkMCQfwoAs0UUUAFFFFABRRVXU9RstKsZb3VLy2srOLBknuZVjjTJAGWYgDkgfjQBaorEs/Fvhy90671Cz8QaRcWFpj7RcxXsbxQ56b2DYX8a0NK1Ow1eyS80m9tb60fIWe2lWVGx1wykg0AW6KKKACiiigAooooAKKytP8AEeial9t/s7WdNu/sP/H15F0kn2fr/rMH5fut1x0PpUui65pOu273Gh6pY6lAjbGks7hJlVvQlSRmgDQooooAKKKKACiiigAornn8b+FE1JtOfxPoS6gs32c2x1CISiTO3Zs3Z3Z4xjOeKvJ4g0Z9aOjpq+nNq4G42IuUM4GM58vO7pz0oA06KKKACiiigAoopssiQxPJK6pGgLM7HAUDqSewoAdRWTpPiTQ9Ytbi60jWdNv7a2/10trdRypFxn5ipIHHPNTaLrmk67bvcaHqljqUCNsaSzuEmVW9CVJGaANCiiigAooooAK4/wCMX/JJ/GH/AGCbr/0U1dhRQB8/mPUvC3jrS/DemwPJHBaajqehttyoWSAn7Pj/AGJc4H911HaoDr0ieF7ybwz4k1XUbk+FL+51lpb6SZrO7WJTG3zH/R5d5kHlqF4XO0bQa9g8TeMtO8NeIdI0/WJrSytL+3uZze3VysKRGJoQFO7g7vO9Rjb3zxIPFds3iq20qIQyWc+lPqq36zgx7FkReOMEEPu3Z7fjQBxFxoAPi3wZpba14kNre6dfXd3jWrpWnkX7KFJIcFQN7EBNo5PGCQcjwhd3mmWPgnVrjVNd1GTUrW9F9FLeSzeescLOmyMttVx5YAKgE5OSc5r1zT/Emh6lp1xqGnazpl3YW+fOuYLpJIo8DJ3MDgYHPNJb+JdCutHm1e21rTJtKhJEl7HdRtAmMZ3SA7R1HU96APn0eJTqeneLbfT7vOl3XgvUbtrX/hIJ9WaKRQgXzDKP3Mm2RgUVm7Zxxn6H8Of8i9pf/XrF/wCgCqHg/wAUWnilNWm05oJbSyvTaR3EE4mScCKN94I4/wCWmMAn7vXsOgoAKKKKACisi88T6DY6kunXuuaXb6g7rGtrLdxpKWYAqoQnOSCMDHepJ/EGjW+sRaTcavp0WqygGOye5RZnz0whO4/lQB5+2o+GLD4/xrBeaNbanc6RLBchJYkmluDNAUR8HLOVHAPOBxxXIWE9uY9J0Hch8XxeNpLye3/5biL7Q7vORnPlmAgbuhBAr2g+LPDgu57U6/pAuYA7TQ/bY98YRirlhuyApBBz0IwaZ/wmHhkaQNVPiLRv7LMnki8+3ReT5nXbv3bd3tnNAG7RWLqPivw7pkMEupa9pNnFPGJonuLyOMSIejKSRkcjkcc1S/4Trw8PGB8NPqVrHqZt4biNXnjAm8wsFRPm3M+FDYA+66nnNAHT0UUUAFFFZGmeJ9B1a9az0vXNLvbxU8xoLa7jkkC/3iqknHvQBY8QNYJoOpPrTKulrbSm7ZyQBDsO8nHONueleI6tLpfinSPFep+FNX0Z72bww+n6bo2m3EbXCQDLkyIpyGOVUKB8nTkk17JbeKfD92L/AOy67pU/2BGkvPLvI2+zKudzSYPyAYOScYxUEnjXwrHayXMniXRFtopfJeU38QRJMZ2E7sBvbrQBxHgi/wBK1r4nWt54Wlgn0u28NJa3L2xBSOQyoYYmI4DqqyfKeRnmvV6yJ/E2gwXllaT63pkd1eqr2sL3cavcK33Sik5YHsRnNIfE+gDVl0o65pY1NnMa2f2uPzi4GSoTO7OO2KANiiub8IeNtB8Wvex6LqFvNcWk8sMsAmjaQCOQp5m1WJ2MRlWPUEV0lABRRVDWNa0vRIUm1nUrLT4nJVHu50iViAWIBYjPAJ+gNAF+uJ+JGtaRpdsY7rWdD0XV5baQW93q1t5ieWcb0UlkyThflDHOAdrYrfuPE+gW2jw6tc65pcOlTkCK8ku41hkJzwrk7T0PQ9qbqHinw/p0UEuoa7pVrHcIJYXnvI0EiHoyknkHI5FAHjHhO90jw/L4VvPFNt/ZOjyeETaW6ag+R5gkBkj3MBl3TYQuASOAOMV6f8HLa9s/hX4Wt9USVLyPT4ldJchkG35VIPQgYGO2K24fEuhT6lc6dBrWmSahahmntkuozLCF6l0zlcd8io7XxZ4du9On1C11/SZrCB1jluY7yNoo2YgKrMDgEkgAHqSKANqiuS1b4i+FdN0u01J9b064sLm9SxFxb3cTxpI3Xc27ACjlucgc4rp7O6t760hurKeK4tZkEkU0Th0kUjIZWHBBHcUATUUVXv721060e61C5gtbaPG+aeQIi5OBljwOSB+NAFiuU+Imm6/q+m21l4faz+zyS/6ek93JavLDj/VpKkbldxwCcZ25AIJyNS08TaDeaZc6laa3pk+nWxInuoruNooiOu5wcL17mmf8JX4d/sqPU/7e0n+zZXMaXf2yPyXcAsVD5wSArHGegPpQB4b4WMmm+FfBtzrFrY2Hh7TfFl8ZminLxQDfdKjPlECIkpAB5GNpO3oPTPg4yT2Pie9s8HSr3Xrm4sHUfJJEVQF09VMiyEEcHOa6VPFvhuS5sraPxBpDXF6A1rEt7GWuAehQbssD2xmprbxJod1fXdlbazpk15ZqzXMEd0jSQAdS6g5UDvnFAGrRXLah4/8AC9poer6pDrenX8Ol2xuriOyu4pZAuMqAN3VjgLkjJIFbGg61puv6bHf6NfW17aPx5lvMsihu6kqSMjPIoA0aKKgvru2sLSa7vriG2tYVLyzTOERFHUsx4A9zQBPXL/EuHR7jwfdQeJNSl0vTZJYd95GVBiZZUZDllZQNyrksMY64rT0/xJoeo215cafrOmXUFnn7TLBdRyLBgEneQcLwD1x0qODxV4en0s6lBr2kyacJPKN0l5GYg/8Ad3g4z7ZoA8e1LXLrUtOae/1X+3fCukeJ7FxrDQxqstuFy5cxhY3SOVky6qBwc9M123wsmhvvEHjvUtLdZdCvNVje0miOYpnFtEs0iEcMC4PzDgkGumHjLwwfsOPEein7dzaYvov9I+Yr+7+b5vmBHGeRircHiDRrjWJdJt9X06XVYgTJZJco0yY65QHcPyoA06K5w+OfC72l9cWviDSbtbO2a7mS2vYpGWIDO4gNwORycDkVb8KeJdJ8V6PDqWh3tvdW8iqWEUqO0LFQ3lvtJCuAwyM8UAbFFFI7KiM7sFRRkknAAoAWuQ+LyajJ8MfEqaKJjftZSBBAMyEY+bb77d2Mc5rY0fxNoOtTyQaNrel6hNGgkeO0u45WVD0YhScA5HPvTbPxV4evbW7ubLXtJuLezwLmWK8jdIM/3yDhfxoA8Q1rUJb7wl4k0Pwzq7+JfDEGj29wXht4R9lImXfbjyEQHMIclCCy7eetd54Kv7DWvivr+qeGZ4LrRDpFlby3FqwaGS4WSYgAjgssbKD6ZANdZJ428Kx2iXUnibQ0tXlaBZmv4gjSKAWQNuxuAIyOoyKtyeI9Ei1WHS5NZ01NTnAaK0a6QTSAjIKpnJB9hQBq0VjReKvD0uptpsWvaS+oqXBtVvIzKChIcbM5+Uq2eOMHPSq3grxpoXjOwa50G/t7gxkiWBZo3li+ZlBdVY7Q20kZ6jmgDoqKKKACisi88T6DY6kunXuuaXb6g7rGtrLdxpKWYAqoQnOSCMDHepJ/EGjW+sRaTcavp0WqygGOye5RZnz0whO4/lQBzWrMfE3j+00lPm0rQtl/fHqJLo828R/3RmU+/lV5rYT25j0nQdyHxfF42kvJ7f8A5biL7Q7vORnPlmAgbuhBAr2g+LPDgu57U6/pAuYA7TQ/bY98YRirlhuyApBBz0IwaZ/wmHhkaQNVPiLRv7LMnki8+3ReT5nXbv3bd3tnNAG7RWLqPivw7pkMEupa9pNnFPGJonuLyOMSIejKSRkcjkcc1S/4Trw8PGB8NPqVrHqZt4biNXnjAm8wsFRPm3M+FDYA+66nnNAHT0UUjsqIzuwVFGSScACgBa5D4vJ5vwx8TR/Y570PYyIYIGIdgRgkYBPHXoelbGj+JtB1qeSDRtb0vUJo0Ejx2l3HKyoejEKTgHI596bZ+KvD17a3dzZa9pNxb2eBcyxXkbpBn++QcL+NAHgGp79VsfGb2OpW3itBoVnG+p6XbiONYY5yz27RoSDIYy7cHIUAbR39M8FX9hrXxX1/VPDM8F1oh0iyt5bi1YNDJcLJMQARwWWNlB9MgGusk8beFY7RLqTxNoaWrytAszX8QRpFALIG3Y3AEZHUZFW5PEeiRarDpcms6ampzgNFaNdIJpARkFUzkg+woA1aKxovFXh6XU202LXtJfUVLg2q3kZlBQkONmc/KVbPHGDnpVbwV400LxnYNc6Df29wYyRLAs0byxfMyguqsdobaSM9RzQB0VFFFABRRRQBwvjSz1JPHfhbW7LQrnWLWxtb6GZbeSBZInlMGwgTSIDkI44PT688FcfDPxA2iJp8NvBzoV1b4eVRGssl8lwtscc7dgKZAK4HWvd6KAPG/EnhXXvE8ms6pFoP9lh4NOjXSrmeEtfm2uTM6uY2aMAqfLXJ+uBU954c1vUddvPEkmg3EEB1Oyuv7GaaAz3CwRSoZCRIYg5aWMgF+kC5IOBXrtFAHIfDqz1K3/4SS61bTH0x9R1Z7uG3eWORhGYYVBYxsVBJRsjJ57kYJ6+iigAooooA8T8U6fqGt698S9C0rQ2u59VW0tft7SQrFa5gX5pNzCQ7fvAIrcjtT77wPrA13U4JotfvbS+1iHURPazadHb4QxlWkeRPtAdNhGEyCAMEbjj2migDyS98Fas3grU7eHToJL0+KJtZNm8iKL6AXplVGYHGWj243dMAHHZfEWja7q2u6Z4itND1fSGtHuo2tbGTTnvJDKkIFwfN3w5xG0Z+cvt24OCy161RQB5X4L8FXOn6hpT3Olypa2+i3VqBezQTSRyy3G/YTGAvKk/dXaB8uT3T4e6Fr/hvU/Dz6hpFxNG/hqw0q5kinhP2SaBpS3mAuCy4kGCm/wC6eOleq0UAFFFFABXgvgrQtV8TeFvB0FlpcmkW2nR3kzaq0kP75pYpYlESozPyZAzb1X7nfiveqKAPBYPAeuv4curFtN1z7bbeGr3Srb7TPpqWxeSIKI4hAquyllBDSlcYyRknHZ6roepaX4n8N6zYaEdWs7HSZtOext5IY5Ld3MZEiCR1jIIQocEHB4yMivR6KAPDdY8D61Pc60h0zWktNaW0f7JpU+mpBaiOGNPIeSZPMXy2RipiBGCCADnO/feENTew1sw6dH9tufFVpqcTh4wzW8c1uxfdnjCrJweeoA559TooA434eWepaRLrmnajpk8MT6peX0F75kTQzJNO0igAOXDAPg7lA44JrsqKKACvPPihNJb+KPh/NDp02pyR6pOy2sJjDuRZz8qZGVcj73LDpxzivQ6KAPEF8E+I7e70/XVt9RtpftmpXJ07SnsnntPtLxlCDcAwk4jYPg5zJ8pI3Z6H4f8Ag+60fXNDuZ9NnhtrTSbiANdzQSywyyXPmbcxgKPlJ+4u0D5c+vp1FAHilt4R1+T4ZyeCp/DojvLe3njGstcW5iuGL7tyfekBlHDb0GMnO6m3ngvV9Vs9WkfTNce4uTpcJXV5dOXzYYLxJGAjtQEwqb+WYkg7QOmfbaKAPLPEvhnWf7e1jUtO0v7TF/aml30UMcsaNcLAMS7dzABgMY3FQcda9Ns5nuLSGaW3ltZJEDNBMVLxkj7rFSy5HTgkehNTUUAFcP8AGsZ+GuqjyRP+8tv3Rx8/+kR/Lzxz05ruKKAPF/EPg/XvEd9rGtJpl1pEck+mmPTlktWuLhbZpGZzkyQb/wB4NgZiD5Y3FeMT6d4N1OfUdNvbjTdUYt4kj1O7/taayaQqllLF5uy3AjB3GMYG5jgMe+PYaKAPNdP0jVtJ8UeIopfDn9qW2sarDfRams0AW3QJGv7xZG37oihZAqsDkcqc1y3hjwJrljbaTp97aa7NJpNldwRzyT6elmzyQshMYjUTuHYg4kIIOCxJHPudFAHj+peBNWn0LS7CysIbdh4NvtHmIdFVLmVIAiHB5G5ZDkZHU5559K8LXF3caHa/2hpl1plzGixtb3DxO2QAMgxu64PbnPqBWtRQAVxXxs/5JF4v/wCwZP8A+gmu1ooA8Z8VeENc8Wz6tew6NLoUIsbO0is3ltmluxDciZh8pkiC7V2IH4yx3ALkU6Hwdqt/cTXV3pusSyXGrabPcf2zNYFpIoC25vLtgEGAQOSzNgccV7JRQB5xNpeq6X468TXf/CNf27Y64bQxTCeFVtxGgRo5RIwbaCDINivyx4BrA8KeCdX07WtFttQg12aLTdSnvRdCbT0s8v5v7wFU+0sWVwGVsck8kKCfZqKAPINB8Data+F/AdidPitrnT9Ku7W9w6YiklgC4JUndlxyVz0zXd/DsX8Pg/S7LVtKudMu7G2itXjmkikEhSNQXQxu3ykg43YPHIFdJRQAVU1j/kE3v/XB/wD0E1booA8A8PeGNZ8YeAvCcNjpbaHBa+FZbSO/mli/0mS4tkRdgjZmCE/OxYK2ccZzVu48E63qGkavGdL103R0YabAmpT6asRAlRvLRbZVyAFOGcjAJGOa90ooA888Q6TqOm+Po9b0/wAPHW9Ok0b+y1tYJYY2tmEjN0lZV8t1YKdpJGwcEVys3gfWBqt/BNY601pfarBqIFhNpyWsQQxlQ7un2gGPYVAQEFVXBG4ge20UAeWWfhDU4bK2/wCJdGlyvjC41aRg8e77O1xMVkJzzmN14+9g4x2rovhha6npWhPo+raXPaPZzzlLkyxPFcq80jgptcuOCMh1XrxmuxooAKKKKAPE/FOn6hrevfEvQtK0NrufVVtLX7e0kKxWuYF+aTcwkO37wCK3I7U++8D6wNd1OCaLX720vtYh1ET2s2nR2+EMZVpHkT7QHTYRhMggDBG449pooA8kvfBWrN4K1O3h06CS9PiibWTZvIii+gF6ZVRmBxlo9uN3TABx2XxFo2u6trumeIrTQ9X0hrR7qNrWxk057yQypCBcHzd8OcRtGfnL7duDgstetUUAeV+C/BVzp+oaU9zpcqWtvot1agXs0E0kcstxv2ExgLypP3V2gfLk90+Huha/4b1Pw8+oaRcTRv4asNKuZIp4T9kmgaUt5gLgsuJBgpv+6eOleq0UAFVNY/5BN7/1wf8A9BNW6KAPAPD3hjWfGHgLwnDY6W2hwWvhWW0jv5pYv9JkuLZEXYI2ZghPzsWCtnHGc1buPBOt6hpGrxnS9dN0dGGmwJqU+mrEQJUby0W2VcgBThnIwCRjmvdKKAPPPEOk6jpvj6PW9P8ADx1vTpNG/stbWCWGNrZhIzdJWVfLdWCnaSRsHBFcrN4H1garfwTWOtNaX2qwaiBYTaclrEEMZUO7p9oBj2FQEBBVVwRuIHttFAHlln4Q1OGytv8AiXRpcr4wuNWkYPHu+ztcTFZCc85jdePvYOMdq6L4YWup6VoT6Pq2lz2j2c85S5MsTxXKvNI4KbXLjgjIdV68ZrsaKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACikdtqM3XAzXgmj/tIabffD7W/ENxopttQ0+aKKPTTd7jciTO1lk2DH3ZM/KcbPegD3yiuC0/4paCfCugavrMjWFxq9obyOyhjlu5VQLuc4jQttUZyxUCqN98XdKi8Z+G9GsLW41Gw1q1e6j1C0imlCgA4CxpGxfkYbB+T+LFAHpdFeP8Agf4x215fa/b+MJbXTltddk0iylhtpvLfBIQSSfMiscHqVBweOK7LU/iP4U0vWJNMvtWWO6imjt5WEErQwyvnYkkwUxoxweGYHigDrqK4m/8Aip4O0+6v4LzV2iawulsrtzaT+XBK2dqvJs2qDg/MTjg81ZT4jeFDBrUsmsRwLo237eLmKSFod33TtdQSGyMEAg5GM5oA62iuStviL4VnsdUuzqot4tLRZLxbuCW2khVhlWMciq+GyMYHORjrWD4i+LOjr4a8QT+Grhp9a07S21NLa9sbiAGPgK5DqhKkkdDkg5HHNAHpdFefWHxR0G28O6Jc+Ir5YNTu9Jg1S5htbWaZYEdFLOwRX8uME4y5A96ydT+K8em/FAaTcPbSeFzoI1cXltbzXEpy+Nw8vdmPb82dvA5JxQB6vRXnl18Qrb/hLNDWz1bRn8OX+lzaiSYrhrqRYwzF4yq+WFAHKthuCAM1paB8TPCWv6hptjpeqtJcalE81kJLWaFbhUJDbGdArEbTkA54PFAHY0UVxGnfFXwbqN1ZwWmrOTeXTWMEj2c8cTzjrF5jIE3dOCecjHWgDt6K5Gb4keE4dcGkyauou/tQsd3kSmEXBGRCZtvliT/Z3Z9qpQfFzwPNq15pkevRm+tDcCeI28wMfkKWlJJTGAFPPQ4OM0Ad3RXHWXxM8J3mkTaqmqPDp0UH2k3F1aT26NFuC70MiLvG4gfLnkgVDJ8VPB0Wk6nqM+rPBb6Y0S3izWc8csBkI8vdEyB8NkYO3FAHb0V534j+Lfh/TvD/AIgvtMaXUL7R4UmlsGgmgkKvjY3zR5CEEHeAVwRzyK6nwZ4gi8UeGrDV4Le5thcwpI0U8MkZVioYgb1UuvPDgYbqKANuiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiivKv+Fyf9U4+JP/AII//s6APVaK8q/4XJ/1Tj4k/wDgj/8As6P+Fyf9U4+JP/gj/wDs6APVaK8q/wCFyf8AVOPiT/4I/wD7Oj/hcn/VOPiT/wCCP/7OgD1WivKv+Fyf9U4+JP8A4I//ALOj/hcn/VOPiT/4I/8A7OgD1WivKv8Ahcn/AFTj4k/+CP8A+zo/4XJ/1Tj4k/8Agj/+zoA9Voryr/hcn/VOPiT/AOCP/wCzo/4XJ/1Tj4k/+CP/AOzoA9Voryr/AIXJ/wBU4+JP/gj/APs6P+Fyf9U4+JP/AII//s6APVaK8q/4XJ/1Tj4k/wDgj/8As6P+Fyf9U4+JP/gj/wDs6APVaK8q/wCFyf8AVOPiT/4I/wD7Oj/hcn/VOPiT/wCCP/7OgD1OQFkZR1IIr578Pfs8rbeBlh1We2fxVb6ffWVvJDMxtGMwkCM+Y9xK+a3IHGTweK7H/hcn/VOPiT/4I/8A7Oj/AIXJ/wBU4+JP/gj/APs6AOdX4N6vbSeEb5J7S7utM0UaPfWY1O5sY5lBZtyTwrvxljlSuCBWjp/wx1fQ9b8DaroVtokA0KG7gn037ZcCILMzHMczo7sRvJO4DJHGAcDR/wCFyf8AVOPiT/4I/wD7Oj/hcn/VOPiT/wCCP/7OgDk7z4L+IZ/DniGwW80nztR8TjW4WMsm1YQT8rfu8h+egyPerepfBi8bV/FA8jT9Z0rW9QOorHe6ve2gt5Gbc26GH5JsE/KSynjr6dD/AMLk/wCqcfEn/wAEf/2dH/C5P+qcfEn/AMEf/wBnQBzHir4N+INW0b4h2lteaUsniHVYb60MksmEjRiSJMIcNz2z9am8ZfBfVfEmveOr3+0bG3i1kWMlicuxWS3RQRKu0DacHoT1B9q6H/hcn/VOPiT/AOCP/wCzo/4XJ/1Tj4k/+CP/AOzoA5fx98KtX8TW3jPXPEN1aWWoajZW1vb22mLPeInkurksFjDuWKgYVCVB74rMsfCvifxx4k8c302mJpaah4ej0iCWeKeCF5vkOVEsSSbRtOT5fGcDPU93/wALk/6px8Sf/BH/APZ0f8Lk/wCqcfEn/wAEf/2dAGDH8KPEulC7fSLnR7iXVPDMGg3q3U0iLBJHCsRljKxtvXCk7SF579qhg+EfiTQNat7nw5PpF7BF4YOgg39xJC3mMxZpcLE4Kgnhcj0z3rpP+Fyf9U4+JP8A4I//ALOj/hcn/VOPiT/4I/8A7OgDAsPgxqml/wDCNQ2d/YzW+l6FfabK8rOjPNcCQ7lAU/IGk7nOB0pmhfC3XfDifDe+uZbC4HhG3v2vYrZpHkn8zcVEI2fMecYOOema6L/hcn/VOPiT/wCCP/7Oj/hcn/VOPiT/AOCP/wCzoA7T4f3mv6j4R0+98W21taaxcp5sttbxughB5VCGYncBjPTnIxxXg3w9+G/iPxD4Y0vTdWtF0jSdP8TS6vMboSx3U23hVSIoAFIJ+fd+HHPov/C5P+qcfEn/AMEf/wBnR/wuT/qnHxJ/8Ef/ANnQBz1h8GLzT7y/tZINP1jSpdW/tS1lu9WvYDbMWBObWP8AdSOBkB9yk5544rW0X4V6jD4J+Iuh6hd2Yk8SX91d2skDsRGsgGwSZUYII5Azx0NW/wDhcn/VOPiT/wCCP/7Oj/hcn/VOPiT/AOCP/wCzoAoa18O/FXij4WW/hDWp9EsGsbaBLa5spppvNlh2hS4ZE2KVBBA3HJBB4xWP4p+D2sa94Z8QW8Flo2n6zqkVtHJdSa1fX7TmKRWJd5lyqhVwqhWP+1iun/4XJ/1Tj4k/+CP/AOzo/wCFyf8AVOPiT/4I/wD7OgDK1r4S6vqet+Mbk3thFb6zoMOmQEM5dJkVOXG3G0lOoJOO1eleAbHVNK8IaVpuuRWUd5Y28drmznaWORURVD5ZEIJx93Bx6muK/wCFyf8AVOPiT/4I/wD7Oj/hcn/VOPiT/wCCP/7OgD1WivKv+Fyf9U4+JP8A4I//ALOj/hcn/VOPiT/4I/8A7OgD1WivKv8Ahcn/AFTj4k/+CP8A+zo/4XJ/1Tj4k/8Agj/+zoA9Voryr/hcn/VOPiT/AOCP/wCzo/4XJ/1Tj4k/+CP/AOzoA9Voryr/AIXJ/wBU4+JP/gj/APs6P+Fyf9U4+JP/AII//s6APVaK8q/4XJ/1Tj4k/wDgj/8As6P+Fyf9U4+JP/gj/wDs6APVaK8q/wCFyf8AVOPiT/4I/wD7Oj/hcn/VOPiT/wCCP/7OgD1WivKv+Fyf9U4+JP8A4I//ALOj/hcn/VOPiT/4I/8A7OgD1WivKv8Ahcn/AFTj4k/+CP8A+zo/4XJ/1Tj4k/8Agj/+zoA9I1fVtP0a2S41a8gs7d5FiEs7hE3N0BY8DPTnvgVcRldVZGDKwyCDkEV4Z4/+Idr4r8F6xol/8OviMkF3bsnmPofEbDlX+/8AwsA34V8qeBfih4u8EOi6DrE62inmzn/ewHnJ+RuFz6rg+9AH6P0V4d8FfjndePrlNPv/AAtfx3QIV72wQy2in1cnmP6ZavcaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOV+J+l61rngnUdI8NSwQX+oJ9mNxOxVYYm4kbgEk7cgY7kV5n4C/Zo8JaD5Vx4heXX71edso8q3B9owcn/gRIPpXu1FAEFhZWun2kdrYW0FraxDCQwRhEUegUcCp6KKACiiigAooooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Samples of blood with varying methemoglobin levels displayed on white absorbent material.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Shihana F, Dissanayake DM, Buckley NA, Dawson AH. A simple quantitative bedside test to determine methemoglobin. Ann Emerg Med 2010 55:184. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17344=[""].join("\n");
var outline_f16_60_17344=null;
var title_f16_60_17345="Patient information: Pityriasis rosea (The Basics)";
var content_f16_60_17345=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17226\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/35/2612\">",
"         Pityriasis rosea",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pityriasis rosea (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pityriasis-rosea-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H26584895\">",
"      <span class=\"h1\">",
"       What is pityriasis rosea?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pityriasis rosea is a harmless skin rash that causes small, itchy spots on the belly, back, chest, arms, and legs. The rash usually lasts about 4 to 6 weeks, but in some people, it can last for months.",
"     </p>",
"     <p>",
"      Pityriasis rosea is most common in older children and young adults.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26584910\">",
"      <span class=\"h1\">",
"       What causes pityriasis rosea?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The cause is not known. But it does not seem to be easily spread from person to person.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26584925\">",
"      <span class=\"h1\">",
"       What are the symptoms of pityriasis rosea?",
"      </span>",
"      &nbsp;&mdash;&nbsp;In many people, the rash starts with 1 round or oval patch. This spot is about the size of a half dollar but might be larger. A day or two later, many smaller spots about the size of a dime appear. But not everyone gets the large spot before the rest of the rash.",
"     </p>",
"     <p>",
"      If you have light skin, the spots are usually pink or salmon-colored. If you have dark skin, the spots can be a red-brown color or darker than your skin (",
"      <a class=\"graphic graphic_picture graphicRef65314 \" href=\"UTD.htm?2/35/2612\">",
"       picture 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      The spots might be:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        On the belly, back, chest, arms, and legs",
"       </li>",
"       <li>",
"        Spread out in a &ldquo;Christmas tree&rdquo; pattern on the back",
"       </li>",
"       <li>",
"        Itchy",
"       </li>",
"       <li>",
"        A little scaly",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In children, the spots sometimes happen on the face and scalp.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26584940\">",
"      <span class=\"h1\">",
"       Is there a test for pityriasis rosea?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. Your doctor or nurse will often be able to tell if you have it by learning about your symptoms and doing an exam. But he or she might gently scrape the rash or do a different test to get a sample of your skin. Tests on the skin sample can help the doctor tell if you have pityriasis rosea or a different disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26584955\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Take a special kind of bath called an oatmeal bath. Use lukewarm, not hot water.",
"       </li>",
"       <li>",
"        Use unscented moisturizing lotion or cream on your skin.",
"       </li>",
"       <li>",
"        Keep your body cool.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H26584970\">",
"      <span class=\"h1\">",
"       How is pityriasis rosea treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people do not need any treatment. If the symptoms bother you, your doctor might prescribe creams or ointments to help with itching. In rare cases, doctors prescribe other medicines or a special type of treatment that uses lights, called &ldquo;phototherapy.&rdquo;",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?16/60/17345?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17226 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-2A3F076F4F-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17345=[""].join("\n");
var outline_f16_60_17345=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26584895\">",
"      What is pityriasis rosea?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26584910\">",
"      What causes pityriasis rosea?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26584925\">",
"      What are the symptoms of pityriasis rosea?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26584940\">",
"      Is there a test for pityriasis rosea?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26584955\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26584970\">",
"      How is pityriasis rosea treated?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17226\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/35/2612\">",
"      Pityriasis rosea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_60_17346="Afferent nerve subtypes";
var content_f16_60_17346=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Afferent nerve subtypes innervating the airways and lungs of rats",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 372px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF0AhcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACis7V9a07R3sE1O6S3a+uVs7YN/y0lYEqo9zg1o0AFecaRqd54g+K3jDRtSurm1s9It7UWVtBK0JkEqFnnJXBbDAKOoGOmTXo9ZGteGtF1ueKfVdNtrqeJSqSunzqp6ruHOD6dKAPNtX+IV54Mu7HRXng19kmtoZ7xpQZX+0TyJlgg2xlAF643cgYxR4U+KuqalrWg2uo6XZJa6rqN7pge3lYvHJb5O/aRjaQPXI6+1d7e+B/DF7P51zoGmSShI4wzW68LGcoOn8PasT4a/Diz8HxyzXf2K/1Q3NxPFerbeW8azNuZBlm+mQRkYoA76iiigAooooAKKKKACiiigAooooAKKK5zU/Gej6d4gbRLh7o6mtqb3yYrWSTMAOC4KqQQDxgHOe1AHR1wfxp8Qah4c8Fi60ub7K897b2k15tDfZYpJAry88ZAOAT0JFddoWr2GvaRa6ppF1Hd2Fym+KZOjDp35HIIwemKs3dtBeWstteQxT28qlJIpVDK6nqCDwRQBxHjC5Pgy3bXYdWke3gtWj/ALOvr35J5C8YEgdyWyo3fKM7twAAJyeO074v6zqms2Gl2Gk2CXFzeapYl7iSRFD2aBw+MZAYMBtPIIPNekjwL4XGn3FidCsGtLgKskTxBgwUgqOegBAIA4BFcxrvwl0e/wDFmianZ22nWmnWTXMl1YracXjToEZmYMMEADsaAOn+HPib/hMvBGkeIPsptDfQ+Y0JbdsIYqQD3GQcH0rpKhsrS3sbOG0soI7e1gQRxRRKFVFAwAAOABU1ABRRRQAUUUUAFFFFABRRRQAUUUUAFFUtY1Sx0XTZr/VbmO1s4QC8shwBk4A9ySQAByScCqtl4i0+71VdMV5otQaA3K288DxsYgVBcbgOMsB9TQBc1e5ms9Jvbm2hM88MDyRxD/lowUkL+JGK868BPd+JfhpoPiG68S3UGo3Lx3d1cibEJ/ejfB5Z+VVwDHwAQec5zn1CsOHwj4fg1NtQh0eyS7ZzKXWIDLnq+Om4/wB7GaAPH9X+O99aWmqzW2kWMxtbCPUIys7NG6td/ZigcDD9Q29eOox3r0vwN4svNc13xRo2p2cEF5odzHC0lvIXjlWRN6kZAIIHBFYvjj4Q6BrnhW60nQrHTdEuZ1SIXcdoGZIhKJSgAK8Fh69zXcaBomn6FaPDptla2vnP5s/2ePYJJCBlj3PTuTxgUAadFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUHpx1oGcDPWgAooooAKKKKAPLfi74Y1PxnpWrW9paPFcafHHLpUzBdxuVYPvjO75eip82MDceld34SvNTvvDlhPr1g+n6q0Si6t2ZW2yAYbBUkFSeRz0Na9FABRRRQBh63rjab4g8O6asAkXVZ5oWkLYMeyB5cgd87MfjW5Xzx8fPh54j1r4j+FtR8OanqkVpf3C2tysNw6rZsFO6ZcHC5iDA4xyvfdX0FawJa2sNvFu8uJAi7mLHAGBknkn3NAEtFFFABRRRQAUUUUAFFFFABRRRQAV5N4w8N6hqXxeGqPpmqS6IPD8unPcWNysMhlaTeFUh1bp36Zr1migDj/hFo2q+H/h3o2la8lul/axsjJAFCou4lAdoClguMkdTk89a7CiigArE8Ea43iXwlpOsyQLbvewLMYlbcEz2z3qv8QvD03ijwhqOlWl7cWF5LHm2uoJWjaKUcqcqQcZ4I9Ca85/Zb8Ka34d8G3lx4lmvftlxcNDFa3ErMtvFESuFUnC5beeOoC0Ae00UUUAFFFFABRRRQAUUUUAFFFFABRRRQBxHxd8Nah4m8M2sWjmJr+wv7fUYoJm2pcGJt3lse2fXpkCtrSb281K+jmuvD8+nCKJl868kiMgLEZRBGzfLwMkkdBwe27RQAUUVDeW8d3aT2027ypkaNtjFWwRg4I5B56igDK8N622sXuvwNAIhpmoGyUhs+YPJik3H0/1mMe1bdfPPwM+HniPw58VfFMuvanqdzp1i2LVpbh2S8aUDErAnDERqAc9Dj0r6GoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKO+KKACiiigAoopkSsN+4k5YkZPagB9FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVyHxY8QXXhjwNe6nY3NvaTrLBD9quIzJHbiSZI2kK5GdoYtj2oA6+ivHfhT8UbbU9XuPDmreJtP1/UzdCKyurO28n7TGYfNZimSAFIZcj0FexUAFFFFABRRSMQqkscAdTQAtFNjkSWNZI2DowyGU5BFKGB6HNAC0Uiur52kHHHFKDkZFAHDfGzWb3w/8ADfVdS0ubyLyEIY3wDg7wDwfbNVfhf4sv/EHhDRtQvyGubsBpCFAHJ7ACq37R5I+D+u4XdxHkf8DWsb4Ft/xbTw/vIxhPmzjaSf5mgD2Wio5J4ov9ZIq4GfmOOKjhvrWZlWG4icsu5QrA5HrQBYooooAKKKKACijPOO9FABRQDnpQSB1oAKKjnmjt4mlmcJGvVj0FcxH8QfDcniS60Fb/AP4mlqHMsJjYYCDLc4oA6uiuLtfib4VuvDV/r0GpbtMsZRDcS+UwKMSABjGe4puofFHwnp+m6Vf3WpFLXU932Z/KY7sEA544wSOtAHbUVy0/j3w7B4sj8Ny323V5ASsPltjpn72MVVi+JnhaZ9bSLUGZ9GLC8URNlNrbTjj5uTjigDs6K89Hxi8Gf8IyuvHUpBpxnNvu+zvu3gKSNuM/xLWxd+PNBtPE2naDcXLpqGoRedbL5bFXXGclsYHHrQB1VFcdZfEfw5ea/quj291K17piyNdJ5LDYI/vYOOfwrNHxi8HN4auddjv5m0+CbyHb7O4bfxwFxk/eHNAHodFcDqnxZ8KaXa6HcX15MkWsxebaEQO25cgHOBxyw61bT4i6G3je68L+bL/aUETSFfLbB2gswzjHAFAHZ0V57D8XvCs2k61qCXM/2fSW2XOYHBB3BeBjnk9qbdfGDwlb+HrPWnu5/sN3K0MTi3fJYbc5GOPvCgD0SiuO1D4h6HY+LLPw7PJMNRu03xDym2kYz97GOlQ2XxO8O3d/4itEmnEuhCVrvMLdI878cc4x2oA7eivOIPjF4XuPC6a7DLcNZtdCz/1LgiQ7eMY/215r0GzuEurOG5j+5KiyLn0IzQBNkc80jOqruYgL615Xouq50r4mb75S8d7diH97koBCMAegz0rF8Y63IvwZ8PSW2oslxJPbLIyy4Zhv5B/KgD2/NGa868Q6t5fxh8MWwu1W1NhePKm/CllMeCfpzWf4Z1KaXxh8RGN4zQ27MIh5nCfuYzx6ck0Aeq5GM5orxUatcP8As8ajePdStdNFcjzTIS+d74O7+tXvFeqXcPjzwHbx3syRTRy+dGrlVfAGCR3oA9corzXStTvG+NOu2LXU/wBjjsd625c7N2IvmA6Z5P5mqfhnW7+68A/EK8lvJXmtb3UEt5C5JiVIlKgHtgmgD1aivIPEmuX8Hwo8L3lvfTrc3FxbLJMjkM4LcgnvW/rWo36fGXw/p0NzOtlJp1xNJCrkI5V48EjoSMn86APQKK8t8OareP4j+I0c13PIlpJJ5Cs5IiAhQ4X05yaoy6zqR+BUepLd3C37byJxIQ4/eNgg9emKAPYKK4bxfq93Y/EjwVZW87rb3iXvnQhiFk2rHtJHfGTiq/h7Uryb4heM7aWeZoLUIIUJJVMxRnj05JNAHoNFeN2muak3wY8a6hJfXP22Br4QzeYS8e2PK4PUYP5Vr+J9Uv7fw94EkjupRLdTQLOwcgyAwknPrzQB6bRRRQAUUUUAFFFFABRRRQAUUUUAFYHjqXTLbwvd3WuafNqOnWxS4lghi81jscMG29wpAY+wrfooA8Q8KanqPjPx1oV/p2h6bomgWeL/AMuREW8nSSOaNCdo+XDBjtzkqwPavb659vB2hDWrfVrbT4LS/iuGumltUERnco6ky4Hz8Oxy2SCeDyc9BQAUUUUAFcz8S9EvfEfgfVdJ0u4FteXKKI5SSNpDqx5HPQEV01FAHycnwQ8fsAn9tFFTAX/SZAMfgalX4I/EGHy2j19SXUlv38mQfTrX1ZRQB8lD4QfEqGN7aLU5TC5AYi4POec5znjpVe1+GnxWsHUWst1nBXd9pDAD6Fq+vaKAPir4heC/iFpnhq4vPEVzO+mwgBlaUEHJ9AfWqXhr4beLdQ8Madqmj6iTa3bIUgSVlKHPy55x19K+lP2kVDfCLWc+sf8A6GKxvgzE3/Cr/DQIIbdA2CO26gDyzUfgd8QIojKmqG7fbkRpcyA8nBHJ60zS/gh8QHt1lbUHs5ACBG9wxYDPHIJFfXtFAHyVJ8KfifFIvl6hcSAZGVuOB+Zplj8Kfie0TyG/uImBOEa4JJ5+tfXFFAHyW3w++LkVvCkd1cuuWJQTJlcYxkk96jsPB3xhjnNzCb1JQCh3yxng+2cV9cUUAfHNj4E+LMOottW/jllBQyPcKy7TweN3FW5vh18V7KJBFcXUx37RtnHfq3Le/wClfXdFAHyQ/wANviskJVLm5YdMCcZPv96rulfDL4lWHiLTpZrq4uLVbuGaZhccBQ43DBb0FfVVFAHP+Po55vCOox2cnlXDKoRyM7TvXmvkeDTPEr/G7WrFNZhGvhJ2mvfKGyQBfmG3bgZHtX2F4rVn0C6VIzIx2YUd/nFfN1lZTv8AtO6/sj6xXJyR1BT9c0Aea6FZa3J8IvF9zbapHHo8F9GLuyMYLTuWQBg2OACR3HSofFVnrEPgbwXc32ppPYTJN9jgCAGDDqGBOOcnHXPSuq8JwOPgJ8R0Ibm/hYLnH/LSKovG1jcXHwi+HvlQuzIbjK4yf9YvNAD9T0jxInxytbC515JNcKkLfiJQANpyNu3HT2rG0zStWfUviGsereXJaef9rcID9pxMoP8ADxk88Yr0zX7OaT9p7T5Y4GZAvzsRwPlPNY2gWFwnif4sb4H8uRrrawXg/wCkLQB5S9hd/wDCrBqH2w/YBqEkf2XA++Fjy2cdwV79q9B1/wAN69Z/E3wfY3GvtJd3VpvtrrYMwrtPy428+nQ1jNouoH4ClTZTiVdWlYKUxwVh/PpXq3jnTro/GT4d3EVvL5YsMMR0Q7TxQB5nofh/V5viX400+DW2ivrRLs3FztGZ9oO7+HAz9BXJWem3TfDTUtRS+xZxXwiktSPvvhPmzj3HftXsXhvTr1Pjh8Q5/s0nkSwagEkxwxIOAK4bTND1Nfgl4hD2c+3+0kOAvXPligDF8X6RfWfh/wAB3NzqD3EN9A7W6HH+jAOoIHHfOec9K6uz8MalH8cNQ0Ya3cC9S3uGN8ApdgIiSDlcc9OlHj/QdTn8D/DE29hO729vMJAFz5eZVPP5V30emXx/aa1C6FrL9m+yXA83b8vMTAfmaAPFtN0e6l8L+OrgahKI7F/3sYxic+aq/Nx754xVfUdOmT4caBem9uHhuLyaL7Odu1Noi5XjOTu7nsK7nRtA1JfCfxQR7C5EszMYl243/wCkJ0/CqeueF9ZT4R+Gbf8Asq8My6hMxjCHJDCEA498HH0oAm8T+ELqy+LugaPLrF7LPcwBluiy70+UnjjHTjpVTRfC803iv4jWf9r3cf8AZkd55kild1zsz9/IxzjnGOtem+NdC1Gf4+eF7uKxuHtktRul2ZVSFPFZ+haDqkXxC+KskmnXCxXcV+YGMf8Ard27GD79qAPKdG0Fv+FZwa19suQq6ukP2bI8o8xfNjGd3zevYV9rabbfbfBtnbF3jM1iibwcEZQc18u6F4T1v/hSL2p0u6NydaSYRbTuK/uecenyn8q+q/DkbxeHtLjkUq6WsSsp6ghBkUAfLFn8Gprq18X3K65coukXE8JHmt+/2RhstxznOKx9c+FF1p3gHTNefWJpY7uaKNbfzGITe2M4IxkV73oW06N8VP7wv738P3C1z/jVj/worw1gLk3NqP8AyJQB57q/wUvrTx7pOhp4imaa+tp7iOZ5XJQRlcqTjvuH5VR0b4QX15r3irTl16dH0hiJHErjzv3atz6/eA59K978U4Pxv8HgsAfsF4ee/MVZfhPA8c/FE4JHmHPH/TvF3oA8Kb4Van/wrGfxGNedbSNZGa0Mj4YoxHTpzg1Z8RfCPVtL8Z+H9Il8QNNJqMbtDN5kn7rb2B6ivXGwf2bL/aQAbe4I9vnarnxGDf8AC1fh9NtIQpOoJPBOF4z3PIoA8btvg94gn8eanokPiQreW1v5rXLSyfOMJxnr/EPyqHSPhPrl34Y8Uaja6+YrfS57qGWEySfvjGgZj6HcDjmveNIB/wCF7+IS3/QO4ye2IqoeEsf8K0+JOP8An+1LPP8A0xWgDw7VfhZr1l4K0jVpNeWSzvZYUjtxJJmNnOAeeOPatS6+D3ii08eaZoT+KI2vbq0nuIrkyS/IiMgK565O4e3FeqeJI93wg8HI/H+k2p54/izW7rRP/DQXh0DBP9j3eOf9uKgDwG0+F3iq71bxTb2/iGNZtKZluXLyA3ACKxIx7EDn0qCf4a+JYPhxDrr+II202Rsi0DSbgQSPp2Ne6+Ggf+En+KJ42+ZKPfPkJWbqwDfs+WATHLY/8eegDy/xD8K/GFh4w8P6ZeeJoZb2/WZrecNIRFsCluozzkdPSmaX8L/Gdx4n8R2Fv4kjS608gXE+58S5jV+OM9CBz6V7t4/Xd8Xvh/14ivm4HXCx03wvk/Ef4i/NxmP5f+3eKgD54g8E+LG+G+qaymuxDSrYzefbHducqoLdsHI9a17j4eeLtKHhC8vvEEVxbXd1CLaIFyYvl355GPugiu/s1J/Z48XL8x2td9uQPLrpPGxI0L4akHn7VByP+vdqAPWoVdYUWRtzhQGPqafRRQAUUUUAFFFFABRRRQAUUUUAFFFISAMkgD3oAWsbxjrR8O+GNR1dbaS6NpEZBFGCS3OOg575q9HqVjLFaSx3cDx3ZAt2VwRKSpYBfXhSeOwNZfj291TTfB+qXmgQPcapDFugjSEyszZHRByxxnigDM+G/ia+8SW1618LSdIGUR3tlFJFDKTnKBZfn3LgZPQ7xjoa7KvG/hha654l8YaprXipNat3smhFj51vLZRyKGuVI8s8MCjRM3H3seldf8UYPEdxp+mr4Ra4S9Fy/mNHIFVUMEoUvkjIEhjOOemccUAdrRXjwtPEUg8FaHrGr6tp0l7dX7TNbXIE/lKrvCjv82SBtzyfrXrdtF9ltIomlklESBTJKcs2BjLHuT1NAE1FRJcwvAsySKYm6Nng0rzxpLHEzgSSZ2r3OKAJKKYksbySRqwLx43D0zyKPOj8ppN42KCS3YYoAq6zpVlrWnSWOpwLcWsmN0bEgHByOlPttOtLW2jt7eBI4Y8bEHQY6VOZowIyXAEhwn+0cZ/kKXzE8zZuG/rigB1FMWWNlZg4Kr1PpTRcRGOKQSLslwEP97PTFAEtFNMiCURlhvIzt74pQykkAjK9fagBaKb5ibA24bT0NKWAIBOCeBQAtFIGUsVBGR1HpQSACcjAoAWim71wpyMN096dQAEZ61GIYhIZBGnmHq20Z/OpKKAIUtbdIzGkEQRuSoQYNKbeEqqmGMqvQbRgVLRQBH5EXm+aY08zGN20Z/OgQxAsREmW+98o5+tSZozQBH5EOzZ5Uezrt2jFKYkLBiill6EjkU+jIoAYIowxYRoGPU4GTSeRFsKeUmw8ldoxUmRjOaKAGGGMgAxoQOg2jil8tN+/Yu71xzTs0ZFADPKjwR5aYPX5etBjQgAopA6DFPzSBhuK55HOKAAopYMVG4dDik2LknauT1OOtKHU7sEfL19qa0qKgcsAp6H1oAUIgGAqgemKdSFlDBSRk9B60tAHGaZ4UubWw8ZwySoX1q5nliIH3FeMKM/iDWb4h8B3mr/DzS/D0d1DDPZywyGWRSVYI2SABXotGaAOU1fwzNffEHQ9fWdFt7C2nhePHzMzlCCD6fKap6N4Su7PXvGF7JPGY9ZctCAOUzEic/iprt6KAPOz4HvB8Jbjwr58JupIpYxKAQvzMxBxn3rR8UeE7nV/E3hTUIZo0i0lpjKGXJfeqgY/75NdnRQBxum+FbiH4jav4iklQQ3FuLeNAOTwmWP4pVbRfCF5aeFPF2lXE6NLq9zdyxuBgBZYwoz+Vd3RQBwOseDry68FaDo8M0fnWEsLu2OCE64q5f8Ahm6n+KOmeJFdPstrYy2rJ/ES7Kc/T5a7KigDz3Q/C2o2mueOLuVEWPVZHNtyCSDEqgnnjkHrVebwdqM/wqtNB+Vb2NtzAkY+8x/rXpVFAHIeIvDd1qXj/wAMazE6i20yK5WUHuZAoGP++araJoF7aeN/Fl5LGRa6mFaJ8ggkRIn4fdNdxRQB5UngTVIvhP4i8Or5bXt21wYRnhg6YXv/AFrT8TeG9TvdN8EwW0YMmmzxvc8jChYWU9/U9q9CooAKKKKACiiigAooooAKKKKACiiigArjvi7eW1l4A1M3llZ30VwY7Tyr1ykG6WRY1aRhyFUuGJGCMcEHmuxrK8T6Bp3ifR5NL1qAXFjI8ckkRPD7HDgH1GVGR3FAHiPwF0PwboWsfZ7q20NfGFjILKO70+/luY7rfD5u+NXJ2kJkMcYyGAIziveNXEh0q98jf5vkPs2fe3bTjHvXOab8N/CGlarZ6lpPh/T7C+tXMkU1tCI25VlIJHUYY8fSurniSeGSKUZjkUqwzjIPBoA8r+AejeJNJ0y5fxLHeBbm1tJI3vJnaUybG80MrTSbcEr2QnJyoxger1y3gXwTpvg2C4i0xpXEoWNd+B5cKFikYAAB2l3+Y5Zt3zE10GqG6GmXZ08KbwQv5AboZNp259s4oA5Lxd/yUfwF/wBdL7/0nNdPrckiadIIeZXIRR65PP6ZryrS7Tx1Na+F9avNMOpahpt3d7oLqdbaVopIdikkjGQ27t0xXr1s0k1rC9zCIpmRWeLcH2NjkZ74PGaAODvptJTRbjSbeeExWTyvLEHy0Xlt0I696uT67pEutWGqLqVoLCANbvOZBsDlc4LZx/EK6oaZZieeX7PFvmGHOwfN659c1BJoOlyWH2JrKH7Lu3eXtwM+tAHO2OraZpV7dXF3eWqXmo7pEQyBWnVDtUqCecAjp60xrqxg0e40aC/he8ic7rdW+dQuGbK9cYrqLvRrC6EHnWsTNANsTFRlB6D8qQaNYDUmv1toxdOCHfHLZGKAOb1DWdNnktbtL+2lsNNQTSOjgrDLwq7m6DhzwfWkk1XSrbVzrU17AvnrLHCTKNkgjA+6ehzmuij8P6XHZXFolnGLa4OZU7Oc55p82i6fLb28LWsRitzmNSuQv+cUAcnZra2dpqGkxXCHUbuUOsTN88gwCePTbmnX17pcelQKtxbpa6Sjs5DZW2eMhRu54xkjmuvbTLNtQS+Nun2pBtWTuB0qEaHpoF4PskZW8JM4PIfPJyKAMCTWNMbX7bUZb+1ihUvbLIZl2yBU3Zz/AMCqGz1TT7C31RY54Y9QmIk2s3MoP3SB3+UjpW/L4Z0iaxgs5LKM28Lb41yeD9evapp9D024vra8ltUNxbjEbcjAxjp0P40Ac60mnDQItIt5oUW13B1V8iERYYhvTj1qxNqNlcaxYXi31ubK2/ds/mDYJChI5z6ZrWj8O6XHfXd2tqBPdgiY7mw2Rg8ZwMg01fDWkrpZ05bRRaFg5Tc2cjvnOaAMm2vLGzvb3UmuYTdXyyNEQwxLHFwuPXhu3rVUQW0OmXOjwypveUkohyUwofB9K6K88O6XeNYtPagmy/1GGZdnT0PI4HBqUaLYDVJNREH+lumxn3HBH0zjv1oA5ya+szHo0rXMRtLJVaaUzDZC+3C7h+JrTtLqz/4SN3lliW7nLW8XzjMiIN2AO+N5OferC+GNIXT72xFoPs14xadC7fMSc9c5HPpTk8OaWiWCrbn/AEEkwMZGLLnGec5PQdaANC+mW3tJJJDhQMH8eP61ylxdxRaBLp8N+kl3BIY5EVwXCg/Nx1HFdiyhgQwBHoazYtC06PUpr9LZRdTAh33H5s9eOlAGNfa5YNqNhMt/atZ2o8ySQTLtRiCg3H/gVNTWbGDXjeS6lCtrdRybAZBtbyyFJX161qW3hfR7axubOKyQW9w26VSxO48dycjoKkfw7pUlvbQPZoYrcERAk/KD15/CgDnILtLXSrjTTdR/2vPLh4A4aQg4DHH+7Tr7VNNksba0hvojHpo8ySZJhmFoz5eG9D83euqTS7JL4Xi26faQu3zMc4/yaZHounRi6CWkQF026bj75680Ac7LrmmPr0GqtqVuNNRWt1mMo8suOTg9/vLVW1vbbTbW/ja5jXVtScShJG+eZchNyjvhfT0rrDoummxWzNnD9mUhhHt4B9f0qSbS7Ka8t7qW2ja4gG2NyOVHpQBx17c6a2k/2HZ3kTtpu9mQSjfGsPQMOvSrNxrujzaxY6p/atqdPt0MZnEoMSyEHgt07iuoj0yyjuprlLWETzDEj7RlvrUY0XTRaPaiygFu53NHsGCfXH4UAc5b6zpOmXl5f3V/arJqm6SLMgHnLH8i7OeeCOnWqbXNrBpF5oNvexSX8cjAwCQBwqqGbjrjGa7I6TYGKCNrOBkgG2MMgOwe2elSfYLT7Ubn7ND9oIwZNg3EfWgDj/7c0lk064e/tpNP0uESTSrKNsEoAjAc9jhiMGpG8R6QmrDVX1O0S0kV4UlaUBJPL5+U5+b7/GK6kaZYiGaIWduIpjmRPLGHPuO9IdKsGgWFrK3MSnKoYwQPoO1AHFw31vZafe6S9zGuq3bbo7ZpR50inGSo6kbc8jpSteaRNo9vp0NzC6aLEZZQsoY28kHChsdO/X0ruGs7VrhJ2toTOgwshQblHsetCWNpH52y1gXzs+ZiMfPnrn1/GgDll1HTLvxJZ6ql7BJbKDaxzLIPL34zjPQ53gD3rrLqZLe2lmkICIpYmmrZ2qxiNbaERqdwURgAH1xUzKGUqwBU9QR1oA8xh8UHT7qTSrye7TWdahS5t7dkJMLSFkIBxgBdoPNVv7fi1LSR4ftb+6bUtMlMmpkId6ojEn5sYOSVPHY16k9pbvOk7wRNMgwshQFlHsetIlnapJLIltCskvEjBAC/1PegDzW68caNfG08Ww6hMNEtnjtUkEbBGaU/PuBGflCr9M1GniuHT9bN5f3s8Y1u1JsbZ0J2SbtoUccfdJ59a9JGmWAtRaiythbA7vKES7c+uMYp8lhaSPG8lrAzR8IWjB2/T0oA80s/EAnsW8Hvfz/8JJvP2xQpMkcbksWU4xgBl57Ul147sdY0201nTdWlTTdNKNftGh53tjawxngLk/WvTFsbRbxrtbaEXTDa0oQbyPQnr2qOPStPjt5II7K2SGQ5dFiUK31GOaAPP18a6bBq6+Ib3Vymh30f2fTiwxFIxx7ddyN1pbfxJDaLNod3fzx+ItWC3EdvIPnh87KjYMfdUr+Heu+m0jTpoYYZbG2aGE5jjMQ2ofYdBUr6fZverePawNdqoVZigLgDsD170AeZzeMbK50aCxtdYdrrTZM6myDLoiOVO4Y4y238DV6bxxo7arB4g/t6JfDaKLRJQf3DzSHPLeo2/hmu3j0XTYzcGOxt1NxnzSIxl89cnvUTeH9LbTVsGsbY2iv5ixeUu0MOhxjr70AcVB4xtrO6ni1HVJIrjWIRcWNtKOYy7eWqJxzyuce+aifxSH0JdFttZVvEFtIy3yoQ00UasdzYHTHy8+9egzaRp891DczWcDzwrtjdkBKDOePSkh0fToby5u4rOBbm54llCDc/1NAHDX3jnS724ttd0/X4F8P2TRw3EqMDG8krbdrnsVwD7bqSLxrYW2ty3d7rcSWGowM2nK7jYxVgmFPcllJH1rsk8N6QuknTP7PtvsRILRCMAMR3OOp96dN4d0iZLRJdPt2S0x5AKDEePSgDhrXxHcNpkugvqm3xVdTbXiLAywI/BkVf7qnJzzjvUk/jO01C3sI9G1lZZLF0+2yIwb+Pyir+hLEGu5GiacNXbVBaRfb2UIZsfNgdv1qG08N6RaJcpbWEEa3Enmy7V++2Qcn8QDQBrKQwBBBB6EUtIoCqFHAAwKWgAooooAKKKKACiiigAooooAKhvbu3sLOe7vJo4LaBDJLLI21UUDJJPYAVNXn/AMeElb4Z6hJCbINBPa3BN8f3AWO4jdt46suFOVGWboASQKAOx0PWdN17Tkv9Fvre+snJVZ4HDoSDgjI9DV2R1ijeSRgqICzMegA6mvnL4W65q9v8TYNNj1TwgsGsNHqVzY6RbXELeV9k/dlPNULtI8tmUEvn0AbH0RfXH2SyuLgqXEMbSbQcZwM4oAydL8VaZqdzBDam7AuATbyy2kscU4wW+SRlCtlQWGDyASOK8y8Q+K/H8Wv6nb6HYzXUMF5cR2ytZkJKoSIqpbHQZlIbI3FcZPSud+Evi3XfGHxaW5/tqCPRZhc3x02G8a4YAQwKqPnCqgM5I2gZZXznAI+jKAPJYNc8X31p4R0/7eNLvtUub5JLm4sVd2hiDtExjO0KWUKT0+leq2qSx2sKXEommVAryhdu9gOWx2yecVx3i7/ko/gL/rpff+k5ra8ZeIIvDOhS6jNGZAjBQo7kmgDcoryJPjTYzW8ZjsZFmkZgAzDCgHvVq7+MOn29zaJ9kkaOckZ3DK8UAep0V45D8aIrv+0hbWQUwNsjLnOW568+xrItvjVdrpyyzLZyOJZlbCkEhVBXHPck0Ae9UV4v4o+Mgs7ZTYxRRP5aM3mjJLEA8YPTms7wv8a5rm6uU1BEkRdxTauMelAHvNFeHXnxtdrFJbS0hVmXcS/IQbsevPSsXUfjlffaIRAYEjxyVTOc9M0AfRdFfNZ+N2pGCJmuYllZELERfKDvIPHXpVzT/jPfllWWeNlLMHZ0Ax12gfUUAfRFFfPVj8cr8wp50FtJxGQyqQWLE7s8/SusHxdjja3kntUMDyFHCn5gdpYAc+1AHrNFeW2nxesZrb7Q9nIsbLlEDAtn3qf/AIWvYMh2WshcMV+8MZC5oA9Lory66+LdlbC3L2rHcUWTB+6SM5rU0L4l6bq18sCQSRq5VUZiOcnA4oA72isHx3rcnhzwnqGrQokklsqsFcEg5cL2+tedaz8brOwj0/y7F5ZZgpkUHoDjpQB7HRXkC/GW2TX5obiBF01YPMVh98NkAAnOOp7Cs69+OPlQalHDp267UMLU/wAORnG7nnBxnGKAPcKK+ZNU+MXiGaKN3ngtSRHJH5EeBjfht27OeB2rqdN+Ns1xseTT1+zRjbK3RmIH3xz0yOmO9AHuVFfKWhfF3V7PXrvUHZXinZXNuRldpJHHORjmus8Q/HaWXTzb6PafZ9RDjfJJhl24zwPXp1oA+garte2yyyRNPGJI08x13cqvqfbivi7xJ8RfEOt63DcXupuEtmPlLGoQAcZ6deg61g3XiG9lv2aS5kBVCoIc4wc8Hn3oA+5U17SpLGS8TULZrSL78okG1fqfwNQz+JtEt1gabVLRFn/1ZMg+f6V8R3fiK5bSl0+Kc/ZmCeYAT1A5/mc1HceIP9DhW3Eu0M5OGJ2hgARz9KAPuGLxNost1JbxanavNHy6q4JXjPP4UyLxVoU0M8sWrWbxwAGVhKCEBzjP1wfyr4Zh1yeMmRLhyfLwq5PUYA5+nrUVrrBVm3zPhuCASOB0Pv1NAH3ZL4p0KG1guZNWs1gnIEUhlGHOccevNTza9pUN7FaS6hbJdS48uJpAGbPTA/EV8Cf2jJKI45bhxHECEZicDnPQe9T3GryNJEzTuXVUbdubGcduc0AfdmmeKdE1S+ls9P1K2nuYzhkRwT+HrW1XxL8KdVFh470lWuSXafyzjOMEAAH15NfZ+r3RstKu7oYzDEzjPsKALdIxCjLHAr5P0/48+JIbK+F1NbzTykeQTGAYvXHY/jmqd38fPFX9mQwxXNsJlfLTCEb2HOQ38OPoBQB9e0HgV8eXX7QHjA39q8U1ksaqoaMQ/LIc9+c/kRXM6h8VPFF/d3rS6s4FyNkihAFA4OBxx0oA+5y6hC5YbRzmlRldAyEFT0Ir4Wg+Jmvw+Fp9BS9drKUkMSBvCnOQD1wc1f8ABfxO1Pw/rUU0d08luzgzQtzvQdhnoetAH23RXhUf7Qmn3M1yLbTJfKSPcrO44bA4PPPOelcbqf7ROvS29xFZWlhBKSRHIY2O0fTd1oA+p6K+Qp/j54tkggRZrWN4z8zpEMycZ+bJP6YqjJ8a/FtxqIun1IW4MLALHEmxc46AgmgD7KZgqlmOABkk1Tn1Wwt7ZLme7gjgdtiyM4Ck+mfwNfClz4+1uZ7+OPU7gQXhzIX6sOMduOR2rJTXrtbaOJZbh3jOeXJH4D1oA/Qdry2WdYWnjEr8qhbk02G/tZ5JkhuI3eE4kCtkoff0r4GfxZqzQYa8mJG35ucjB9aqWvibVbI3Jtrq4hNxkyPuJ3g9uaAP0IS4heHzUkVo/wC8DxUgYcc9elfn/pnivULax+xy3dw9tvDeWHPPvnrXT2/xG1S61LRraLULjyopY4ljYcAbxxkDJ60AfbVFQ2LmSzgdvvFAT9cVNQAUUUUAFFFFABRRRQAUUUUAFcX8X7LVr/wRJF4dtUutVS9s5oIpPuFkuY3y2P4RtyfYGu0rM8S2+p3Wh3cOg30dhqjJmCeWISIrDnDKex6H0zmgDxjwpbePdH8V+G9P8X23hyDTrvWbu+U2cztcNLJHPIQoJ+4C5HTIG3mveJESWN45FDo4KspGQQeorw/wd4YvdK+IGm6j43s9Vv8AW3YW9tqskyvE0wjm8x0VGxHGY9igMAzYBxkGvcqAPH/AdzrNt8YNY0gabDaeGraGaK0EVgsSoqfZ9gDhAcHfJj5iDt6DbXsFeD/D2+e7+P2vyxXTzW7m8TaJi2MGBV3R7sqFMcoyVUfMME7hXvFAHE+Lv+Sj+Av+ul9/6TmtPx94ZXxd4cl0l7g2ySurGRVyRg545FY/iW4huviD4AmtZo5omlvsPGwZTi3IPIru6APBLj9nuNnUR69MkYyFxESRnrn5uafF+z3AfN+0a9PIN2Yv3Z+UY/3vWveKKAPA4P2dreHka/cBmfLBYjhhz1+ati8+AHh2dl8q5niRVI28nnHBzu9a9kooA8K0j4BQR6i7avqZu7RBiJcNuPHfJ45+tP1H9n7T/JjOm6rPDIitvyp/eHtzu4xz+de5UUAeK6R8ANGtZ0lvL+a5QJtMRUgE56/e4rpofg74OjhaL+z3KMCDmVs/nXolFAHAwfCTwhDbNCunEgkMS0jE5+tVJvgv4OlWMGymypJJ85uc+vNek0UAePaj8B9Cur0zQ3ctvHxiNE6Y687u9ZVz+z9C8DlNclNz/DI0ZHf/AHvTivdqKAPnqP8AZ+vIlQQeICqFkLKUYcfxd+D6Uv8Awz/eLcZi17ZCMkDDE5x1619CUUAfPcfwBv2D/aNeR2AxGQrZ+pOa0vCfwWv9H1ez1C51hJ3t3Q7CrBcA5OK9yooA5z4iaNceIfBeqaXZSCO4uY1VGIyAQwPT8K+YpvhB43NykYt1xCH2TLkBsYx24z2r7AooA+PNL+EXjd7Z7mayVGiyv2eXOX9xwamX4P8AjmCKwljXzDcA+ZG+cwZI+9X17RQB8wWf7PmvXkGdV1W1EiJiMAvj1APHrXOS/Cjx5btcQLZ+akO6NHjziRQcZHHfrX2FRQB8m3/wJ8R2fh1dRs3Wa+dQJLQbg654OO38q5jwx8MPFevauLWezeCJ8q88oIVMDuRz2r7ZpAAOgAoA+btJ/ZtmaSR9V12OMkYCwRGXIPqWIxXSR/s9aINOjge/lM64zN5X3uc9N1e3UUAeOt8APDBEGJJ1MbBnIJG/H/AuK00+CPhFRMhtpfJkH3RIykfiDmvT6KAPKE+BPhNbKSAxzFmPyvvPyjPpnmmD4C+EQkW2ObehJZt7HdnGeM8dK9aooA8of4D+DnvxMbafytm0x+e3J9c5/SoV+AfhHFwrxTsJCTGRKy+X6DGea9dooA850f4OeEtLFo0NpIZ7eRZRKZGyWByD19hXoVzBHc28kEy7o5FKsPUGpKKAPO7r4N+C7hbdW0vaIPu7ZCM/X1qRfhB4LF4LkaSu/bt27ztx/u9K9AooA4T/AIVP4N+zzQ/2PEFlBDEH5hn0PUVdsPhx4UsbVYIdFtGRW3gyxh2z/vEZrrqKAPP9f+EXhDW9RivLnTVieP8Ahtz5Snp2XA7Vz3iz4CeGdT0ySPRkbT77BKSl2dc9gRnpXsNFAHy5pn7NWrFWN/rVnG2cDyVZsj8cV1Np+zfpMTwvcazNMVGHHkYDH/vqveqKAPFrX9nfwrHdzSXElzPC4+SLcy7Dx33c9/zrUs/gT4MhgZJbOaRmbO4zNwPTr+teq0UAcMPhV4P/AHGdIjPksGXJzkj19fxrdXwj4eWVZBommhl4H+ip/hW5RQBiJ4T8PokirounbXOT/oyf4VUv/Anhm+hSKfRrIKhBBSFVP5gV01FAHMr4D8MLdR3A0WxEka7B+5XGPcYwajj+H/hiK8a6j0i1WYv5mQgwD7DtXVUUAIiKihVAAFLRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVW1S0F/pl3ZmRohcQvFvTqu5SMj3Gas0UAeYaL8LrjT9I0qOLxDc2ep6fczXEdzaQxso8yMRlQsisMbRnp1Jr0q1jeK2hjmmaeRECtKwALkDliAAAT14GKlooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK5n4j+Ibjwv4SudSsYrWW6EsNvELqUxwq8sqxhnYAkKpfJ9h2oA6aivOfh14/l1a6vNI8T3OgrrlvdLbx/wBk3LSw3O6LzQUDfMMLkHtlT9K9GoAKKKKACiiigAooooAKKKKACoPtKfa/s/O/G6p6ynkSTX1iBbciZPbr0oA1aKKKACiiigAooooAKKKKACiiigAopsjrGhd2CqOpNHmINvzD5unvQA6imLKjOyhgWX7w9KUOpTcGBX1oAdRRTWdV+8wHGaAHUUKQwBByDRQAUUUUAFFFFABRRRQAUUUUAFFFR3My29vLM/3I1Ln6AZoAkorktP8AHOn3Xgax8UOkqWd0iMFC7mBY4FXZ/FVlDrmjaWVkM+qRGWE44ChS3P5UAdBRWXZ6zDdeINR0lARPZRQyuT0Ik34x9Nh/OqOneKrS/wDCk+uwowt4opJNrcE7QeP0oA6Kivndf2n9GMcbHR7gZ5f5z8o/755p8v7T2iKwEek3DDALEuRjnn+GgD6ForwEftN+HNqlrC7BI9D1z06elOP7TfhnzZALK8MQGVfacn8McUAe+UV88RftP6KWcS6RcLz8mHJyvqfl4rd8HfH/AEbxN4hsNJgsJ4pryURIzEkDJAHb3oA9qoprOquik8scCnUAFFFZlxrVvb6LLqcwcW8RYMFGTw+zp9aANOisbVvEFtpmsaZp06v5t+WEZA4BBUc/99CpLfWoZvEM+kqjedFD5xbtjOMUAatFFFABRRRQAUUUUAFFFFABRRRQAVzXxGg8P3HhC8XxgcaGjxS3GVZlwkisu4KCSu4DPHTOeK6WmTRRzwvFMiyRSKVdHAKsDwQR3FAHgXg2LRNY+Inh+88B+B7XTdGtWa7l1YwiGWaJ4po1MacHZvDAk9flI4r6Ark7bwJpen67bapo7XNhIk3mTxJM7RTrsdVTaxIRVMhIVcAenTHWUAFFFFABXH/Fbxg/gfwjNrEdr9qdZEjEecdT1rsKhu7W3vITFeQRTxE52SoGXP0NAHzW/wC0vcF2EegHgAcyA4Pcn2qH/hpe/KMF0NCwb727IC/TPXOa+ik8NaIk0kq6Rp++TG4/Z05x+FKPDmiLnbpGnDJycWyf4UAfNGp/tJa45jk0/S7eCMKQwmUvk8c8Efl71PZftJ6yLQrc6JFNPgkSxcIfwzX0j/wjui7dv9kadjnj7Mn+FJb+HdFt4Vii0qwCKMAfZ06flQB88v8AtIamto5Ph1xJxtkwdo47j61i237QevpcpPcaRHJOIlVtkZA3Acnr+lfU50fTSm06dZlfTyFx/Ksf+x9NXxIAun2gUx5I8hMZx9OKAPBm/aQ1jYEXw9ifvlTj8s0Wv7R2tKcXXh0uR/zzQgn3xk19I/2Ppm8t/Z1nuPU+QuT+lOXStOVtwsLQN6iFc/yoA+Z4f2jfECMBc6DGe3yoy5Ptk0z/AIaJ8TNdF00SFrboI/Jfd+efWvpltI01yC2n2bEHIzAv+FKdJ07BH2C1A9oV/wAKAPmzUP2itfi0uNl8OmC4DDfNLG3lEZ7emfrWK/7SviczuUsdNEZXCoY2JDfXd0xmvqu/0bTr+1+zXllby2+Q3ltGCuR04rFl+H/haXG7RbPh9/EYHOCPy56UAfNI/aT8Vlo2+zaUVBO4LCwz6Dl6sW/7Rvi6V5Sun6fIgOB5cDHb9fmr6VbwT4baJIzothtRDGMQKDg9ecdferlt4c0W2V1t9KsY1cgsFgUZx+FAHzEf2hvGZkjI0myGQRt+zv8AN7j5u3Strwv8dvFmp+I9Osr3R7eK2ubhIWP2aRSAzAcEtjvX0Wmj6amMafacEkHyV4ycnHFTfYbTKn7LBlTlf3Y4+lAHKfGRinwz11lzkRKeP99a+Ttf8aXl3qfgWU2F/EulJBiNn5utpU5Xjvjjr1r6y+MX/JNdc/65L3x/y0WvnHxiv/FVfCVSc/JZD0/ijoAyrDx9cwfFnxFrbaXqT/bbaSM2YbMkWYgu48Y4xnpXJab4nvLb4ZajpCrdkz3tvL9sDEpGFD/Kfc7vXtXqOlMB+0P4yaItt+xT8dz/AKOK880kH/hQWt54B1ayx+UtAD9Z8ZXtzofgSAW1/CdLAzIzHF3+8zleOfTvUmu+Nbq6+J91qzwX0EU6KklqSd+PLAxjHqAela3ioH/hD/g9k8bFHB/6b0ni1T/w0Bcq+TyvTrjyKAJv2f8A4g3fhe+1FZ7DUdXjeJAiQZbytu72PXP6V7hH8bg2fM8Ia4hAyf3TH+S15j+xtka/rwJ/5ZRZ9/v19YUAeQL8bYSBnwtrgycH9w/Hv9ylHxsgL4HhjW9v97yH/wDiK9eooA8fb4324zjwvrjY64t3/wDiK88+K/xZbXvA2safDo+qWjvcxlZ3RlWMBlOCdo5OD+dfUdeL/tCoR8JfE5LDBv4SBjH8cdAHzL8OPGGo6F4z02/eW7uoopCz28ZJMg2EYA59f0rtNG+I7W/jPx1qL2momLU0uPJiCsWtyyMBuGOMZ9sVxnwUVn+K3hxVBOZm4/7ZtXrWgD/i6fxeYkYEN72/6ZvQB55b+OrsfCS40MLfm7N8sy3nPlqoH3S2MfhmtbWPiVcXNz8O5IYtQiOlxRi53Aj7SQUyV456H161XgXH7N17z9/Wo/w/dmt7xRtN58Eht/5doAeOpzFQBZ8N/Esv8eJtVuhfjTZ3KR2rRsWj3JtAKhcjk55FfRfxD8Rw6D4GvtWa3luIzAcRp8rHKkjqOK8T8MorftaaurKpG6Q4I/6YmvobxBDHNod9HMiOhgfh1BH3TQB8i2XxdhtvhbYeF/7JuZJrYRj7T5g2NtIPTGRmtC6+OEE3ijwzqa6FdhdKtzE8XmrmU7CuQccdc12miadZN+zppc7WVsLhhDukMSluo6nGTW1cWFm3xD8AQtpdrHG1qS58pdsp8l8Hpz+NAHDab+0Ha2vivWNWPh2+Zb6G3hEXmqCpj8zk8d9/6Vl+GvjbBp/gS90OTRbyWSWOVPORxtQOCORj3r3jR9H01vih4ljfTrNo1srJlVoEwCTPnHHfArmfAmmWB+EmtyLaWpm8m4DSeSpPCk9cUAfE7sVUKT90cEdKjLnPOeeQf8aGI2KD/dGB+HeojntQBL5mCOQR7UgkPHzAHPXFR89qM+g70AS+Yexxiun+G+troHjTSdVkikljtblJmjT7zBWBwPc1yWeQOM13fwUjEnxP8Mo6hkbUIQQwBBG8ZFAH0PeftH2f2q1I8LallcvtaQK3II6EVKP2lbMyAHwrqQGCT++Xg/lXtV7pGmvfWksmnWjyAldxhUnGD7dKs/2Npec/2bZZ9fIX/CgDwpv2lrQEZ8KakozjmZevp0rndU+PdvdeE7jS/wDhHL5GmZv3plXAJlL+n4V9LnRtMJ506yPOf9QvX8q4nXtJsP8AhW2oMLG08wPIQ3krn/Xn29KAPF/E3x3g1TXdD1KLw9exmwZzseVcyZKng44+7+tdZ8MfivD4t+K6xw6Pc2zX1o0fzyA7Cvzknj/ZxXX+PNL01fG3g5fsNoI5JZNyiFQGO6PqMVqaTYWlt8WLvyLO2h26ZlfLjVf+WmM8Dr2oA76iiigAooooAKKKKACiiigAooooAKKKKACiiigAoorkPiPe65Z2Wmt4ZE8l+b2EtBHDuWaLevmIzFSE+Usckr068YIB19FeL6RrXjq/Hh/TNQ1CXR77ULy4Vp5LFGfZHapIQEYAYEpkUHHIUcnqfY7VJIrWGOeYzzIgV5SoXewHLYHAyecCgCWiiigAooooAKpmyJ1MXfmcBduzFXDwMmuC1n4madpmpXNr9hvriOBijTxJlCw6gd+PXpQB3tFedt8VNPdcWul6lcTH7sSIAW/E4FKvxFvyRu8F64itjBMkHOf+B0Aeh0V5x/wtOJI3Nz4f1aCVSB5bBCT+RIqSP4miaESW3hzVphnDAbBt/NqAPQ6KpaJqCarpVtfRxvEs6Bwj43L7GrtABRRRQAUUUUAY3jHRm8Q+Gr7SknEDXKBRIV3bcMD0yPSvMNY+D13qGt+DrxdViRNDWEP+5JMnllTx83GdvvXtFFAHj1p8Iri1+I+t+Jv7Tikj1C3kiWHySCjNGE67uenpXPab8Cr60+GV/wCHH1GF7m5nhuBIYuAUD5GN3+1619BUUAeD6v8ABXUL7Q/BFl/aUPmaAAJW8riTEm7j5uP1puq/BXUr/wCKEviUajAlu20iMxZPEWzH3vxr3qigDxz4IfCS5+Huo6jc3epR3guFRQqwlMFd3P3j/er2OuU1f4heGNI1KWw1HU/JuovvqIJWx+KqR2rPf4s+DQpMeqtIwONq2k3/AMRQB3dFcGvxY8IFtp1KRT72k3T1+5Un/C1vBeQP7ZOT0/0Sf/4igDuK4j4v+FLrxd4Ev9G0tkiubiWJ9zdDtcE9/QU5fij4OaVYxrHzscAfZpv57K6DRPEGl67539lXa3HkkB8Ky7c9OoFAHzn8PPgR4j8OePdM1S4ntzZ2jlzICMtlCMAbsjk4rutM+GOqW/jjxxq0rx+RrMVwlvgjP7xWAzz7ivZ6KAPneP4N66PhFc+GWkg+2y6gtyCCNu0Lj1rQ1z4U63d3Xw6eEwuugQxx3OWA5Ux8rz/sn1r3iigDyLSfh1qdl8c7zxezxHTp95xkbgTGV9fX2r1LVxu0q8HHML9f901bpsiLJGyOMqwII9RQB4H4XfzP2cLE5IKiJcjvjHfv1rodbiWXxn8NgyeYDB90nAP7hzXo8Hh3SrfR10qGzRdPXBEIJwMfjmrMulWUstjLJbqZLFt1u2TmM7Sv8mI5oA5vR/8AkqniX/rwsf5z1y/gQk/CnX1PaO4AH/bM16hHYW0eoT3yRAXUyJHJJk5ZVztH4bj+dVbbRLS30u5sET9xcKyyDpkMMH9KAPzUdDsQEcjA9e1Q+TnB78duma+yvEXg/wCDHhSVdO16OKC6AB2tJcFsYz/CSO4qLTNB+BuqRyrai1dg3zEy3CkcZ7kUAfHRjwfxweKTyyFH90Yz7V9f3fhj4GW7kXE1sOCMebcHBz14NOvPD/wJtkguZzaiORQExLcncPUgH3oA+QBFz6j0ru/gqiJ8UvDGeHGoQj6/OK+gl8MfAqYHyZLZR944luOn4mtfwtonwes/FVguhSW/9sCVJbZBJOTvz8pGeOuOtAHtzIrMrEAleh9KWiigAridZXPw31AZJ+eXtk/68121UptMtJtOksXizayZLJuPOW3HnOepzQBw3jxlPivwW4JwZzjj1aOtK1JHxbugB8p0gEnOefOrob3RLO9ksZLiPdLZOHhbJGCCD/QVMumWq6u2prHi8aHyC+Tym7djHTrQBdooooAKKKKACiiigAooooAKKKKACiiigAoorJ8V65beGvDt/rF8rNbWcfmOFxnGcd/r1oA1qK5TwH4tbxQl4slvZpJalczafeC8tXDZwFmCqC42ncuOMr611dAHE+Lv+Sj+Av8Arpff+k5rtq4nxd/yUfwF/wBdL7/0nNdtQAUUUUAFFFFADJ8CF9xwMHNU9BgS30i0ijGFSMKOPSpNVkMNhK4xkY69OoqzGuxFXAGB2oAdRRRQAUjfdP0paD0NAGfoKlNNjRwA6ZVgOma0KqaZu+ztu/vnH0q3QAUUUUAFFFFABRRRQAUUUUAIxCjJOBQ/3G+lUtY02HVbL7NcFhH5iSZU4OVYMP1FXG+WM89B3oAzNDtLX+y0KRAiY+bIWHLucZY+p4Faaxqn3VAqro+TpluT3QHHHFXKACmGJCMFRj0p9FAEP2WAxmMxJsIwVxwaqWenWllfySWdvHC0kaq5RMbgCcZ/M1o1Duxd7cjlOn50ATUUUUAFFFFABRRRQAUUUUAFFFFAHGy+BvDWuaxqGq6to1peXc7iNpJ4w3CDaMZ9hVG7+DvgO6lLyeHLJf8AZRdqj8BXa6YhSCQE5zNIfzc1boA8zPwN8AlmP9irz23nAoPwO8BEJ/xJgCpzkSHLfX1r0yigDg0+EXgNbcQnwzp7AHIZowW/Oo4vhn4R0S+sL3TdFtIbuO8jkSXbypznivQKoauxUWeO9zGP1oAv0UUUABAIIPINAGBgcAUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZHi2/n0rw3qF/aT2ME1tEZVe+JEIxz8xHIB6ZH5HpWvXH/FfRdT1/wZNYaElu+om6tZYxcY8seXcRuSw7qApJHU9BQBynwj8U+N/GVtpWo3z+Hf7D2lp7ixlaSaVwpHlspACHcQSR/dwODXc/EPVpdC8FatqdvaxXcltDvEMqFkbkDkDkjnPHpXB+DfCPj/Q/GH26/wBQ0B9Lv7tZr+DTYGhPy27RrgNxtyEJHUnn1r1PV5JItKvZISRKkLshHUEKcUAeNfCm7vfGnjTUtUe/uLG00poRFaaeZYLOcbrlG3RMcMWAikzjI+Uete4V5P8AAK68T3el3M3il9RnE1raTw3F2XAdnRi6qrIuMfLnGQcjB4r1igDifF3/ACUfwF/10vv/AEnNdtXE+Lv+Sj+Av+ul9/6Tmu2oAKKKKACiiigCpqrBbCUlSw44H1FWlztG4AHviqmrfNZMgVWLkABunXP9KuUAFFFFABQehooPQ0AVNKJa0DEg5JPFW6q6cc25HOQxBGKtUAFFFFABRRRQAUUUUAFFFFABVXU2K2ExXrj+tWqpa0SulzlSAcDqM9xQBYtYhBbxxAABBjAqWiigAooooAKpSsqapGWIBZMA569au1QuP+Qva+6tj8qAL9FFFABRRRQAUUUUAFFFFABQTgEntRUN42y0nbrhGP6UARaYS1uzHvI5H03HFW6p6O3maTZvjG+JWx9RmrlABRRRQAVV1FVaOJnGdkiuOccirVVdTO20ZgCdpzQBaooHQUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUyePzoZIyzpvUruQ4YZHUHsafRQBy/gbwtceGYblLrWb3VC+2OI3EjtsjUsVzvZiZDvO58gHC4VQAK6iiq2qG5XTbttPVWvBC5gDdDJtO0H2zigDkvF3/ACUfwF/10vv/AEnNdXqJZIo5VcqI3DHHcHjH615NpcHjm4tvC2tXulSalf6bdXe+CeZLWVopIdik5GOGLdugFen6pZTa14fa2leXT7idEZjE+WhYEMQGHXkYz3oAhjnmbxTJF5zG3WP/AFeBjOPXrVXT76cabqd3dykiSXbEFGfLyAoH580y58L3MtraiPWLmK8i377lfvPuIz346cVZ/wCEbRb2B4ru4js41Aa2ViFdgc7j+n5UAV7qa/k0G0gScLeO+yR1AJ2KSCRn8KnnuLpvFlvGJytnFH80YUYdmBHJ68cVHb+F9st20+oXMol3iIbsGEM25sH60j+G7g6E1kuqzreNKJftgHzZyDjGenHrQAmkm5u5Lqa4uRKs1wDDGQB5SqCpxgc8jPPrXTVgL4e26vY3i3kojto2RoP4ZSedx565rfoAKKKKACg9KKKAM7RLmK4iuREwZobh4pPZxjIqnbaheSa5eRt5ZsliLwEHlsYBJ49cis5/Cd3a6rf3mi61PZJeSGaS3ZPMjEh+8wGRgnj8qtz+GA8dkkF9cQ+QCshU8yqSWI9vmwfwxQAyHUr6Xw3LLv238zFIyVGIixO36496m1G+vlWwNpINwYfaFYD5geP5+lL/AGDMPEJvlv3+wsFJsyuV3r0YHPHftVW28LXMemXdpNrFzM8u0RTMPniAbcBnPPNAGrHc3MmvTQ7lW1hjHy92YgHP4c03w/c3N0l3LdODG8xa3XABWLAwD753VQl8N3TWlt5erTJfxn95dbcmQHqMZqf+wp01WCa31GaKwSJUa0AzuYEkNuzx1GeO1AG9WTaapJJeap50apZ2mArg/MxAO/I9OBir99HPNaSx2swgmYYWQru2/hxmsC40HVClilprCRKq7b3dbbzdDjODu+U4z69aAJ49Vvv+EfFxJbxf2iGwYUYlfvZ4P+5zUl3rMsculLDbq63hXcS2NgOP8arR6DqC63c3Laqh098tBai3w0LmPZnfu5HU4x3qrB4a1dNM8qbXVlv42QwXLWvEYXOAV3c54zz2oA3LfUHl1S9gMSrbW6KfMzyW5yMemMfnUBvWutDuJrhFiIdgADn5Q+FP4jB/GsyXQNcEUH2XW7eK4fm/lNkGFz2+Vd3ycfWpE0DVft00cuqwvozhFFp9l+fAUZ+fd3Iz0oA6iiiigAooooAKxtVuIo/EOiwSOVebzti/3tqgnmtmsLxZ4fGuwWxiuWtL21kEkFwq7thyCQRkZBxg0Aaep3YsbGW5KNIIxnavU84rMu9eaO10t4LcyS3zoApOAqEjcfwBqGz0jXDPF/a2tQXdspJaKOz8rfwQMncfX9Khi8N3/wBnvIp9WEmARYMINpteDgn5vnPQ9ulAGx/aJOtCzCAw7DmXPSTrsx/u81Ha6qZG1IzQlI7NiARzvAzz+lZDeHta/suJI9djTVDP5txdC0+WUbCmNm7jgjnPUZp8nh7VBPAsGsqtkUSO6ge23mYKADht3y557HrQBqWmpyS6ZZzyQgXFxj92pyBzzz9Oa1GIVSx6AZrD0rRry11KSa61BZ7ONj9kt1h2GFSMEFsnf+QrT1WCe50+eG1mEEzqVWQru2/hQBmR+J7F9En1TZcLbxMUClBuc4GAoz3zgZxVmbWreFdOMkcwN7jau0ZjBUtl+eBxjjPJFYS+G9VbXZEfUYR4awHWxEHz7+cYfPAGBxjmqA8MeJ5LDVGuNZtnvmzFYMLUAQReaHAb5vmOFxnigDr/AO17b+3P7KxJ9q8rzs7fl2/X14qLTtYtdZsLyW0WTyYy0e91wH+XOR7c4rlLnw14tSws5rPXrZdaMpN1cG0Gwo2MgJu7YOOe9TyeGvEltqsaaJrkFno/lgSwzWvnFm3fNtO4bcj64oA7HTAo061Cfd8pcfTFWaZDGIoUjUkqihRnrxT6ACiiigArP1+dLXRry4l/1cMTSNj0Aya0KxvGemS614T1fTbdgs93ayQxsezMpANAFnVNUg0nTPtt7uEQKqdg3HLEAfqahudfs7e6063fzTNf4MSqvQHufQciuP8ACnhbxhBaQweJvEkV9bxxMqxC2CuHIIVmfcd2CQcY7VNH4W8Tf2Tevc65BPrQ+WwufswUW6gYAK7vmzgE9KAOzt9Tt59SubKPcZLdVZ2x8uTngH1GOfqKqJ4hsn0q71DEqwWrMsgK/NlTjgZrl7/wp4kMGnJp+uwwzyNI2qzfZvluS4UEqm75eAccnGalTwpraa+23WIV0BgjPafZgXkZYwmN+7gEjPSgDo5vEFpFBpshSYnUGRYkCjcN2OW54AyM1Y/tWD+2/wCy9shn8nzt+BsxnG3OevfGOlcfbeFNfay1Jb/WY57uNHXSnW32fZtw43Hd8/IX0xj3rT0LQtZsrXTpb3UYp9R88zX8iw7Vm/dlAAM8fwnv0oA62iiigAooooAKKKKACiiigAooooAKhvLqCytJrq8mjgtoEMkksjBVRQMkknoAKmrz/wCO6St8M9ReAWRaCe1uG+3HEG2O4jdvMHUrhTlRkkcAEkCgDstF1fTtc0+O/wBGvbe+spCQs9vIHRiDggEccEVer5x+Fmt6xa/EuDTIb/wbHa6w0epXNho0U8TCH7J+7ZBIirtb92xAO/J6Yzj3/X5LKHQ7+TVnZNPWFzcMpbITHzY2/N09OaALqSJJny3VsddpzXi/iHxh48g1/U7bQ7CS8igvLiO3X7GQsqhIiqlsdBulIYEbiuMnpUPwc8SS6/8AELVrey8K2elabp0dxHJeW8DWnmZuCkKmLd83yxPliuQwZQF53e4UAeTW+v8Ai+/tPCVit7Hpl/qlzfI91c2IdmhiDtG3l5XBZQp7fSvVLVJY7WFLiUTTqgEkgXYHbHJ284yecVx3i7/ko/gL/rpff+k5rsbm5htUD3EixqTtBbuaAJaKyx4g0o38tj9vg+1xLveLd8yj1NQReK9Elt3ni1GB41JBIPpQBt0VhyeLNDigjmk1KBEkICknqT0qUeJdHa5+zjUIDLt37c9vX9KANeiudXxr4dbfjVbfCNtJzxn0roUdZEDoQykZBHegBaKKKACiiigAooooAKKKKACiiigAorO8Q6xaaBpFxqWoF1tYAC5Rdx5OOn41xMnxl8JJYJctczhmIXyTF84J9RmgD0eivMp/jV4UiMZEty0bDlhF09qqW3xx8OzXNyCk62sa5jl25L8enagD1iivGW+Pmhixdls7hrzzNkcQHysOOS3br6VP/wALx0qW8sra0sZ5XkQGbnHlvx8o4+bqfTpQB6/RSKQygqcg96WgAooooAKKKKACiiigAopsjrGhd2CqOSTXPaz428PaOyrf6nBGxG7bnJC/3j7UAdHRXL6f470HUNa/sy0u/MuT93C/K3GeDXQ313BYWc11dyCK3hQvI56Ko6mgCeiuAHxd8G/2e942qqqL0RlIdvoO9Fz8XvBdtBbSyauhE+MKqksmf7w7UAd/RXng+Mngg6i1odaiAClhMQfLOOwPrViP4seD5LOa4TVkIibaU2neTjPA70Ad3RWT4X8QWHibSY9R0p3e2ckAuu08Ejp+Fa1ABRRRQAUUUUAFFFFABRRTPNj2s28bV6nPSgBysGzjscUtU7rU7K0SJ7m5jjWX7hY/e+lVR4j0c6wNKGoW51EjIt93zkYz0+lAGtRRRQAUUUUAFFFFABRRRQAUUUUAFcV8YbPVb7wPLH4ftFvNUS9s5oIX+4zJcxv82P4QFyfYGu1rM8SQapc6HdxaBew2WqFM2880XmIGHOGX0PQntnNAHi/hK38eaR4r8OWHi7T/AA/bafdazd3yvaTlpzLJHcSFVBP3BvI6cDFe1+INLi1vQ7/S7iSWKG8heB3iOHUMMZU9jXjng7w1fab8QdM1Hx1bavfa4zC3tdTkkRoDOI5vMaNY2IjjMYRRvCsxAOMg49zoA8f+BM+itr/jO10ax1G3mtLlYp5729a5M+JrgbhuA25cSMcZyX65zXsFeOfAvVDfeLfHcTW1hB5d38pt4FjZx59yPmIPzcBW5xy5PfJ9joA4nxd/yUfwF/10vv8A0nNHxhstRv8AwPdQ6Om+73owXvgHnFReJp4rn4heAJbeWOWJpL7DowYH/RyOoru6APkSHw740Vv7VTTJWjKeW0R4LDpyM5qWTwV49kjgi/s8RwsWkjIcYBIxgjOR0719bUUAfILeCfHc2LOXTm+Ugl/MAC4Hrnmrx8N+Prjc9ppRVABGMyBePoTnvX1gQCMEZFFAHyUnw48e2VpH5VorbyZXXzFyrZIA6+hzXtvwc1m6/s6Xw7rw8jWtMIR4mP3lOcFT/EOO2a9IrlfGHg+LXJY7+wuZNM1uEERX0A+bHHysOjDgdc4oA6qivL1s/ipZ7kivtHv0ONrzt5bL+AjOalRvikuQ8Ggv1+b7SR9P+WdAHpdFeZef8UAMm00NiDyFuT/8bp51H4lLHn+xtKLAHOLo9c/7lAHaeJ9dtfD2kz394w2xoWCbsFsDOBXn1p8aNJmV3ktygA3AB+cY7nFUdQ8GeK/HmpRSeLJobDSI3ci1gk3kg446Djj1q/d/A3wvNGqwieA/xFZGO4emN30oAe3xo0T+zIbiOB2uJSo8jfggN33Yxx6VS1T42WVoG8uzUspA2tJ94k9iKYfgHoH2hXW8ulhH/LIZxn67sitSy+CnhSBn+0QS3SkAKskjfKQc5B3UAcy3xzP9t29t9ltYraRh5jOWYxgrnOQcVb8BfFO+8R67b2G2H94oLHawwcnI59gK7OD4VeDIQcaHA5IwS5Zs/ma3NO8K6HpsiyWOlWcDr0dIgG+uepoA5/46P5fwp8QEKzHykACjJJ8xK+Mbsag1ysU1nL58jDau0546V+gd3awXkDQ3cMc0LdY5FDKfqD1qifD+jNOszaTp5mX7rm3TcPocUAfBs1rq8yNssLreibmCxnHXGenHWmw2WqR27yJpV35b4TIjbbnpwcV99ppOnIXKWFopcYYiFRke/FOGmWAgEAsrYQg5EYiXaD64xQB8GQaRrpiEK6PeiSRgyN5LDGPwqa30TxE+oMq6PetPEfMbMLg8fhX3obeElT5UeV+78o4+lKIow7OEXc3U45NAHJfCjxCviLwXYXL4W6jQRzx55VwASCOo612FeI+Pfh/4p03XLjVfhzdfZorthLcWqzGMeZnllXocjAxx0rlYY/jVZtIwgvpvmyv72Nu3uaAPpiivnPTdY+MdvPELvTb+SNQQw8uA/Q9eaVvHvxRtmb7Vo1wMkAAwxcc89PUcUAfRdZfifWYPD+hXmp3XMdvGW29NxxwPxPFeCzfFPx/DJPv0VwA4IUomQAOR07+tYPiDVviJ8Q3TQ/skyWxYF1AVFYZ4LEY4GPegDqk/aJALTSaIpgGP3Ymw+T7nj9KztQ/aC1Se7nTTtLtYYMFUMrlmHvkEDPSs/wD4Zz1qSEmXU7VZCBhVY4B79q1dD/Zxfyi+sa0yTZOFt13KR9TigDyu6+IOualZzQahqlxcxyNvEXA+b8vSueiu57y5Kww3Nw5AUKqsx3Y6dOBmvrfRPgn4N0wxu2nfaZ06vI7cn6ZxXZ6d4W0HTX32Oj2EDkht6QKGz65xmgD5l+FFvr978R9Lv5bC5gtSZAXaM7QNh68V9KePbG81LwVrVlpyCS9ntXjiUkAFiMDk9K3IYY4V2wxpGvoowKfQB8h/8KK8ZuYo5ordEZCu7zFbaffDVGfgR41eZ4SsO1PmV/MTBwMf3q+wKKAPjv8A4UL418oSGKAuG+ZTKnb/AIFRP8EfHdvcRosMTiU7TKsyccem70r7EooA8W+Cem6h4C1Gfwz4jKJLeqJ7R942sE4ZepGcuK9ia7tlba1xCD6FxWP4w8LWPiiwWG6LwXMR3293CxWWB+xVgQfwzg4FebS/A+4kk8xvG+uF8dWOc/X5qAPZUljf7jq30Oaf1HFeMj4Pa1Ap+zfEDXVYkEbeMcdPvUz/AIVb4xiQeT8QNWLjIwznH86APaaa7rGpZ2CqBkknFeLt8LPGHl5X4ha15vcGQhfw5qwnws8TXMLQ3/xA1cRlcEKobP4k5xQB5z8U/jNrY8V3Nt4YvXgsbYhFaEBvNxzu5B9cfhXNX/xw8X3c0Jju2tzHs3LEvDYXByCM5J5r6T8MfDPwn4Z04Qtp9ncyHiS4u0Dlz/wLOPoK0IfCXgyKV5E0bRN79SYIz/MUAfI118QPFd5ObyF78NIpjd0Qnfnr275qvbat4xhV7SK11JIrlhIYfJbbIcY3dP5V9ow6V4dgjEcNjpUcYOQqxRgA+uMVdzp26Ns2m6PhDlcr9PSgD4lvdM8Xa5Iq/wBk36vbxBR+7YDC/XvXZfBLwZ4nj8fadrGp2FwtlEziRp+DkoQOOvUivq4XVqOlxAP+Bij7Zbf8/EP/AH2KAJ6KajrIoaNlZT3U5FOoAKKKKACiiigAooooAKKKKACiiigApk8STwyRSrujkUqy+oPBFPooA57wv4N0LwuSdEsmgJQRAyXEkxRB0VPMZto4HC4BwPQVsapafb9Mu7TzGi+0QvF5i9U3KRke4zVmigDzLQvha1loumQTa9fWmo2FzNcQ3OneWu3zEEZUCRHGNoz06k16RaxNBbQxPLJM0aBTLJjc5AxuOABk9eABUtFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRSFgCR6DNAC0UikMAR0NLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGfreiaXr1otrrenWeoWyuJFiuoVlUMAQGwwIzgnn3rD/4Vt4I/wChR0D/AMF8X/xNdZRQByf/AArbwR/0KOgf+C+L/wCJo/4Vt4I/6FHQP/BfF/8AE1f8R+KLHw/faRa36XG7U5zbxSImURgjOS7E8DarevSs3w/8QtC1mN2E5s/3UFxGLsqhlimVmideT94Ixx1G05AoAf8A8K28Ef8AQo6B/wCC+L/4mj/hW3gj/oUdA/8ABfF/8TXVRyJLGskbK8bgMrKcgg9CDTqAKek6XYaNYR2Wk2VvZWcZJSC3jEaLk5OFHHJJNXKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDlfG3hWTxNeaFILyKCHTLs3TxtCXM2Y3jKZDDaNsjc884rkj8HLU6U1sdUf7Ulva2lrdrGySWqW0bpC6FXBEg8wktnDdNuDXq9FAEdtEYbeKIu0hRApdsZbA6nFSUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Subtypes can be identified based on their responsiveness to chemical stimuli such as capsaicin, their activity during eupneic breathing, and their response to sustained lung inflation. Three broad classes of airway afferent nerves have been identified. A) Bronchopulmonary C-fibers are relatively unresponsive to mechanical stimulation but are activated by noxious chemical stimuli such as capsaicin, acid, hypertonic saline and inflammatory mediators including bradykinin and serotonin (5-HT). B) and C) Airway mechanoreceptors are exquisitely sensitive to the dynamic and sustained mechanical forces put upon the lung during respiration. Subtypes of airway mechanoreceptors can be identified based on their adaptation to sustained lung inflation. Activation of airway C-fibers and rapidly adapting mechanoreceptors reflexly increases airway parasympathetic nerve activity and regulates airway defensive reflexes such as cough. By contrast, activation of slowly adapting mechanoreceptors reflexly reduces airway parasympathetic nerve activity and may play only a modulatory role in cough. Slowly adapting receptors also play a primary role in regulating respiratory pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ho, CY, Gu, O, Lin, YS, Lee, LY. Sensitivity of vagal afferent endings to chemical irritants in the rat lung. Respir Physiol 2001; 127:113. Copyright &copy; 2001 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17346=[""].join("\n");
var outline_f16_60_17346=null;
var title_f16_60_17347="Polidocanol: Patient drug information";
var content_f16_60_17347=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Polidocanol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/6/110?source=see_link\">",
"     see \"Polidocanol: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10437705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Asclera&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10454824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692126",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat varicose veins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10453885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2832868",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to polidocanol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703723",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have blood clots.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10453887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10454827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10453889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10454826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10453886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10454828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10453890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15568 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-8B216F4EAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17347=[""].join("\n");
var outline_f16_60_17347=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10437705\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10454824\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10453885\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10453887\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10454827\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10453889\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10454826\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10453886\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10454828\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10453890\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/6/110?source=related_link\">",
"      Polidocanol: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_60_17348="Adapalene: Drug information";
var content_f16_60_17348=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Adapalene: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?2/34/2596?source=see_link\">",
"    see \"Adapalene: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/14/15587?source=see_link\">",
"    see \"Adapalene: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Differin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F130550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Differin&reg;;",
"     </li>",
"     <li>",
"      Differin&reg; XP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F130576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Acne Products;",
"     </li>",
"     <li>",
"      Topical Skin Product, Acne",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F130552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acne: Topical: Apply once daily at bedtime",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F130565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/14/15587?source=see_link\">",
"      see \"Adapalene: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F130553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F130537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical: 0.1% (45 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Differin&reg;: 0.1% (45 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical: 0.1% (45 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Differin&reg;: 0.1% (45 g); 0.3% (45 g) [ethanol free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lotion, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Differin&reg;: 0.1% (59 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F130525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes lotion",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13376045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For external use only. Apply a thin film at night to clean/dry skin; avoid contact with abraded, eczematous, or sunburned skin, mucous membranes, eyes, mouth and angles of the nose. Moisturizers may be used if necessary; avoid alpha hydroxy or glycolic acid-containing products.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F130538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of acne vulgaris",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F130574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Dermatologic: Dryness (&le;45%), scaling (&le;44%), erythema (&le;38%), burning/stinging (&le;29%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%: Dermatologic: Skin discomfort (1% to 6%), desquamation (2%), pruritus (&le;2%), skin irritation (1% to 2%), sunburn (1% to 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &le;1% (Limited to important or life-threatening): Acne flares, angioedema (gel), application site pain (gel), conjunctivitis, contact dermatitis, dermatitis, eczema, eyelid edema, facial edema (gel), lip swelling (gel), rash (cream/gel), skin discoloration",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F130541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to adapalene or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F130529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: Use is associated with increased susceptibility/sensitivity to UV light; avoid sunlamps or excessive sunlight exposure. Daily sunscreen use and other protective measures recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin irritation: Certain cutaneous signs and symptoms such as erythema, dryness, scaling, burning, or pruritus may occur during treatment; these are most likely to occur during the first 2-4 weeks and will usually lessen with continued use. Depending on the severity of irritation, reduce the frequency or discontinue use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For external use only; avoid contact with abraded, eczematous, or sunburned skin, mucous membranes, eyes, mouth, and angles of the nose. Wax depilation is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6217581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): Retinoic Acid Derivatives may diminish the therapeutic effect of Contraceptives (Progestins). Retinoic Acid Derivatives may decrease the serum concentration of Contraceptives (Progestins).  Management: Two forms of effective contraception should be used in patients receiving retinoic acid derivatives.  Particularly, microdosed progesterone-only preparations may be inadequately effective.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the adverse/toxic effect of Retinoic Acid Derivatives.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the adverse/toxic effect of Retinoid-like Compounds.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin A: May enhance the adverse/toxic effect of Retinoid-like Compounds.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F130534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F130543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects were observed in animal reproduction studies. Retinoids may cause harm when administered during pregnancy. A case report described maternal use of adapalene 1 month prior to pregnancy and through 13 weeks gestation; cerebral and ocular malformations were reported in the exposed fetus which resulted in termination of pregnancy (Autret, 1997). In clinical trials, women of childbearing potential were required to have a negative pregnancy test prior to therapy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F130555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F130542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Adapalene External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (45 g): $235.87",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Differin External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (45 g): $433.14",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Adapalene External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (45 g): $196.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Differin External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (45 g): $433.14",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3% (45 g): $301.98",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lotion",
"     </b>",
"     (Differin External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (59 mL): $301.98",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F130544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aclear (HK);",
"     </li>",
"     <li>",
"      Aclene (KP);",
"     </li>",
"     <li>",
"      Acnelene (PK);",
"     </li>",
"     <li>",
"      Acure (TW);",
"     </li>",
"     <li>",
"      Adaferin (CR, DO, GR, GT, HN, IN, MX, NI, PA, SV);",
"     </li>",
"     <li>",
"      Adaferin Gel (IL);",
"     </li>",
"     <li>",
"      Beautyface (TW);",
"     </li>",
"     <li>",
"      Butipalen (KP);",
"     </li>",
"     <li>",
"      Differin (AR, AU, BR, CL, CN, CO, EE, FI, HK, MY, NL, NO, NZ, PE, PH, PL, PT, PY, RU, SG, TH, TR, TW, UY, VE, ZA);",
"     </li>",
"     <li>",
"      Differin Gel (AT, BE, CH, DE, GB, IE, IL, IT, SE);",
"     </li>",
"     <li>",
"      Differine (CZ, ES, FR);",
"     </li>",
"     <li>",
"      Doulishu (TW);",
"     </li>",
"     <li>",
"      Easy Acne (TW);",
"     </li>",
"     <li>",
"      Evalen (ID);",
"     </li>",
"     <li>",
"      Klenzit (PH);",
"     </li>",
"     <li>",
"      Klenzit-MS (PH);",
"     </li>",
"     <li>",
"      Panalene (AR);",
"     </li>",
"     <li>",
"      Redap (DK);",
"     </li>",
"     <li>",
"      Rozac (IN);",
"     </li>",
"     <li>",
"      T3ADA (MY);",
"     </li>",
"     <li>",
"      Tifforly Gel (HK);",
"     </li>",
"     <li>",
"      Zudenina (CO);",
"     </li>",
"     <li>",
"      Zudenina F (CO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F130528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Retinoid-like compound which is a modulator of cellular differentiation, keratinization, and inflammatory processes, all of which represent important features in the pathology of acne vulgaris",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F130540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset: 8-12 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Topical: Minimal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Bile",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9352 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-5450C57513-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17348=[""].join("\n");
var outline_f16_60_17348=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130549\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130550\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130576\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130552\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130565\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130553\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130537\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130525\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13376045\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130538\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130574\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130541\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130529\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298686\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6217581\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130534\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130543\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130555\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130542\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130544\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130528\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130540\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9352\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9352|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?2/34/2596?source=related_link\">",
"      Adapalene: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/14/15587?source=related_link\">",
"      Adapalene: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_60_17349="Vinblastine: Patient drug information";
var content_f16_60_17349=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Vinblastine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     see \"Vinblastine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/50/7975?source=see_link\">",
"     see \"Vinblastine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F16369039\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Vinblastine Sulphate Injection",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700620",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is given as a shot into a vein only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700794",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause tissue damage if the drug leaks from the vein. Tell your nurse if you have any redness, burning, pain, swelling, or leaking of fluid where the drug is going into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692149",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be used for some health problems that are not cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703129",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to vinblastine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703158",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an infection or an unsafe low white blood cell count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun. Keep protecting yourself from sunburn for at least 5 days after care.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697022",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use birth control that you can trust.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is best not to breast-feed.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698222",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698237",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth and lip irritation. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697916",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bone pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698176",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       May not be able to get pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699056",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shortness of breath.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad jaw pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698558",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Some side effects may happen up to 2 weeks after the shot. Report them to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11530 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-88.81.100.162-2094B74F85-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17349=[""].join("\n");
var outline_f16_60_17349=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16369039\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025143\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025145\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025144\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025149\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025150\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025152\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025147\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025154\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=related_link\">",
"      Vinblastine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/50/7975?source=related_link\">",
"      Vinblastine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_60_17350="Aripiprazole: Patient drug information";
var content_f16_60_17350=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aripiprazole: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"     see \"Aripiprazole: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/35/7737?source=see_link\">",
"     see \"Aripiprazole: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Abilify Discmelt&reg;;",
"     </li>",
"     <li>",
"      Abilify Maintena&trade;;",
"     </li>",
"     <li>",
"      Abilify&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9490633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Abilify&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019657\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692053",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat schizophrenia. It may take 6 weeks to see the full effect.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691952",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat manic low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691959",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat mood problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bold or forceful actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Tourette's syndrome.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691741",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat autism.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701545",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aripiprazole or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019663\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a family history of high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697269",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high cholesterol, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697271",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high triglycerides, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697320",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Parkinson's disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have PKU, talk with your doctor. Some products have phenylalanine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are overweight, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698139",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood sugar. This most often goes back to normal when drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More trips to the bathroom, more thirst, or weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705488",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral-disintegrating tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not push the tablet out of the foil when opening. Use dry hands to take it from the foil. Place on your tongue and let it melt. Water is not needed. Do not swallow it whole. Do not chew, break, or crush it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699556",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699438",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (solution) in a refrigerator. Throw away any part not used after 6 months.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use oral-disintegrating tablet right after opening. Throw away any part of opened pouch that is not used.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10978 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-1A4E1675F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17350=[""].join("\n");
var outline_f16_60_17350=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136801\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9490633\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019657\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019659\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019658\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019663\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019664\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019666\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019661\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019662\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019667\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019668\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=related_link\">",
"      Aripiprazole: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/35/7737?source=related_link\">",
"      Aripiprazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_60_17351="Intraductal papilloma as a mammographic density";
var content_f16_60_17351=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Intraductal papilloma as a mammographic density",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 464px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The mammogram of the left breast using spot craniocaudal projection (A)&nbsp;and a spot lateral view (B) reveal a single, isolated dilated duct (ringed in yellow). An intraductal mass is not obvious, and&nbsp;was identified on the ultrasound.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Priscilla J Slanetz, MD, MPH, FACR.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17351=[""].join("\n");
var outline_f16_60_17351=null;
var title_f16_60_17352="Pathophysiologic pathways involved in emesis";
var content_f16_60_17352=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PALC%2F87723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PALC%2F87723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 507px\">",
"   <div class=\"ttl\">",
"    Pathophysiologic pathways involved in emesis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 487px; height: 707px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCALDAecDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAqCa8toH2T3EMbYztdwp/Wue1zU5bm5ktLWVobeL5ZpUOGZu6g9gO5HOeOMc4ceqaTbFohGjheWIPT3rgq4+MJcsdTphh3JXZ6GCGUFSCD0Ipa460dbdPteiP8oOZLYn5X9eOx9/59K6mxu4r60juICSjjoeoPcH3B4rehiFV9TKpTcCxRRRXQZhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVTVbr7Fp084++q4QHux4H6kVbrnPFU+64s7QYwSZX9Rjhfzy35VjiKnsqbkaUo880jnLtJX+yadak+fcuFLHkj1Y/QZNd5p1hb6fZpbWsYWJRg8cse5PqTXL+FYftPiG9umGUt0EaZ6ZbqR9AP8Ax6uyrky+klD2j3f5GuJneXL2OM1zTv7BuBqOnrtsWYLPCOkZJwGA9Pbt/Kxot2tpqQUH/RbwjHPCyY4P49Prtrp7mCO5t5YJ0DxSqUdT3BGCK87topYoLyxd28+ykKh+h45VvywazxMfq9RVYbf1+ZdJ+1i4SPSKKraZdC9062ugNvnRq+PQkdKs16id1dHHsFFFFMAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoqKe4ht13Tyxxj1dgKzpfEekRnDX8P/ATn+VAGtRWTF4j0mU4S+iz/tZH86lutc021QNNeQgHoFbcT+AoA0aK5xvGejqcebKfcRmn2/i/R53C/aGQnu6ECgDoKKjgminjEkMiyIejKcipKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACisbW9a+xSC1s4xcXzDIQn5UHqx/p39utc5eGeUM+sajKT1EUbbEHtgdfxzXJWxkKTtuzanQlPU7qR1jQvIyqqjJZjgCuKurlNQ125uIGDwoqxI46MBySPxLViGXRVcOY4SwP3iMn860Le/tGOISuPQGvMxGO9vFRtZHXSw/s3fc3PBBRYdRjBHnC53sO+Cowf0P5V01edtcS6bepqNkN2OJI8/fTuPr6Gu9sbuG+tIrm2ffFIMqf6H37V34CvGdPk6o5sTTcZc3Rk9cTriCDxXPgfLcW6OfcjK/yUV21cf4vITXrFgOTA4P5iqzBfuG+1gw38SxreD33+H4M9VeRPykYD9MVtVy3ge6BF9ZMf3kcnmqP9lhj+YP5iuprbCzU6MWuxnWjyzaCiiitzMKKKKACiiigAooooAKKKKACiisjVfEWnaZlZ5w8o/wCWcfzN/wDWoA16K811/wCJLWNv58doyQl1jU+U8zszHCgIgJJJI4ANYbfEjUn5MGtJ7LoF5/8AGqAPZiQBknArA1XxVptgxjWT7RMP4IucfU9K8ovfG9zfMYruPxC0WPujRbxQfqBFSWetaeH3SWOvn/uBXp/9o0Adle+K9Wu2ItES2TtgZP5mqEkmr3PM19Pz23kCqsHiTTRj/QfEAH/YAv8A/wCM1YfxRpgGBZeIf/Cfv/8A4zQA0QXsQLLeTAj/AGzUEWt6y9w9vFfz+WvBOcnP1pk/imw2kCy8Qf8Aghvv/jNZGj+ILON3eSx17JYnjQ709/aKgDo00uW5bfcSPK56l2JNWP7FjVclKhtfFumqBusvEP8A4T9//wDGank8X6YU4svEX/hP3/8A8ZoAoX1nHbwuwXBAqno1l5kYLjqc0zWPEtlPCypZeIPx0K+H/tGl0vxJYxIA1j4g/DQb4/8AtGgDoE0qLbytQz6ZGASFwaF8XaaFA+xeIf8Awn7/AP8AjNQXXivTmjO2x8Q5/wCwBfj/ANo0AZ8l3e2N2sWnXMkLEZbaeoqwo1adtz31yT6+YayV1yyN40psdf5wP+QFe/8Axmtm18UacoG6y8Q/+CC+P/tGgC5b6lrun4Zbp5UH8MvzfzrpdD8YQXbiDUVFtMeA2fkP+FcnceKdNZCBZeIf/Cfv/wD4zXLa3rlpKu2Gx14FiBzod6OO/WKgD3V9SsYzh7u3B95BU8M8U67oZUkHqrA14INTsjEB9j8Qf+CK+/8AjNNTVooG320HiOJx3XRL4f8AtKgD6BorxXTPiTeWF1bw3SapJHNIIk+26Xcwgseg8x4wAfqa9T0HX7PWI/3LbJwPmif7w+nqKANeiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKp6verp2nT3TjOxflX+8x4UfiSBVyuZ8ZyFn0y2zhXmMjD1Cjp+bD8qyr1PZ03JF0480kjHaZtPsmnmzLqF0dzEDJJPYfyArQ0zwms4W511mmlb5vs6sQiexI+8f0+vWmadELzxbGX5S1hMir23cAfzJ/KtPxldvbaZHEhK/aZRExH93BJ/PGPxrzaNOChKvU1S2/z+bOqpKTkqcNLkZuvDsBMMcFs+0YxDbbx+YXH61lanYeHLxWeJZbC47SRQOo/FQMH+fvVVtRWygijtIlaR2VBnAyxOAPar89t4gRcvaQTKeSI5Bkfnj9KhYmVeLtBNel/1K9kqb1dvmcv9t/s26FreTwyxv8AclQ8N9QeQfY/rWnpes/2LO0kLCexlOZIlPKn+8vv7d6S7ntuU1Wyktz0/fREKfoT1qs2laJcLlFjXP8AdO3+VcKcqU+aGj/rudDSnG0tT0mwvLe/tluLOVZYW6Mv8iOx9jXG+J5zceLorcDCwwKM+7Ek/oFrP0nSItPuDLpd1NBI/DBZWIb6gkg0a/o2oLP/AGkl4zXOADvxtYDoDgfrXdiMW69Fx5fXsc9Oj7Ope4/VZG0K8i1O3yxhGXUfxp/Ev4j9QK9CtbiK7tori3cPDKodGHcEZFeSXGqHUbJ45UImUFHQ9j6Vf8E+IZtCt4rHUlZ7DGVdRloSevHde/qPftOBxcacnCWiew8RRckpLc9RoqOCaO4hSWB1kicbldTkEeoNSV7h54UUUUAFFFFABRRRQAVBe3cNlbPPcyCONRyTVC+8Q6ZZOUlukaQdUj+Y/pXDeINXOvagFhLi0i4VTxk9yaALOseJL3VnaGx3W9r0yPvN9T2qha6SuQZBuJ9avWUCxqAAM1pQp8woA5jxVZLFbaOVUD/ib2I/8jpXePFiuX8apiy0f/sMWP8A6UJXYSigDlvE2qweH9LvtWvEle2s4HnkWIAuVUZIAJAz+IrOXx/pSX2lWgt7wy6lpbatCSI0URKu4qzM4Ctj/gPqQOa0fHWi/wBv+G9S0rz/ALOL23e3M2zfs3qRnGRnGemRXHWnwh061vdPudNmtLJoNGl0qf7PYKhuXePYZ2IYc98HJPrQB3UXjbw3DY2VxqWt6XprXcC3EcV3fwKxQjqCHKsPdSR6E1l6D8RNM1TxNreiXslnp13YX32K3SW8XfeHaDlEIB7gYGa8q8VfCXXrfTL3RfDaTX41PTrDT7q7uIoUhQW7Lh1Yz+YnCAlRG4PY9x3eofCUXV5e3B1kL9o1+310D7JnZ5SkeVnfznP3u3oaAOwn8T6CL65sTremfbbZGee3+1x+ZEqjLFlzlQBySelR+HNY03V4pJNK1CzvY0bDNbTLKFJGRkqTjIIP0Nebn4LRWs935WqrNbu129v9ojuHltjcRlW2kXAiPXk+VkgYJ7jr/Cfgax8PeDo9Ct1iTfbCC6uLeEQtcNs2mQ4z8x9SSaAN+38Y+GXS7ZPEWjMtmM3JF7EfIGdvz/N8vPHOOank8W+HF0+C9fxBpC2U5ZYrg3sYjkKjLBW3YOBycdK4KH4X37+D9M8Oya/am00i5hu9OkXTSrq8bllE483bKuCQQAmTzmmD4OWs93aXGrajBfEazNrF5BJYgwXDSIFMaxs5CKMA87ie9AGmnxT8M3ja+lncpPJo8ipKv2u2jEyllXzI2eVVKAuASSvPHJIB6iTxHoFjqZ0681zS7fUAu42st3GkoGN2dhOcYBPToK4bXPhOb+08YWFnrUNppviKSCYxfYd720kTRkbWEigphCNu0EZHPGDs2XgXUtK1DxLJoXiGKztddnkupfMsfNuYJXTbmOXzAAAcEBkbHQdc0AWPF3xI0XSPBOreIdDu9O18ad5Qkgs75G+/IqDLLu2/ez05xXVa1qWn6RZNd6vfWlhaghTNdTLEgJ6DcxAzXkcnwQurnT9fh1DxXJc3esWdtay3MltLI26GVZPMPmTuSW2YwCFGeABxXfeO/CL+JbnQ760v1stR0a7+12zywefCxxgh49yk8dCGBFAFmXxR4bgWyebxBo8a3o3Wpa9jAuBnGY/m+bnjjPNTx+KfDo1H+z/7e0n7f5jQ/Zvtkfm71+8uzOdw7jGRXA+K/hJJ4k1ufVb7V7aS4vbSO1vreS3uVtptjZUqkV1GwHA+VmcZGeDUsfwiRbtJ/wC2RuTxOniMf6Lk4VceRkuTz/f/AENAG94a+JfhbxHo17qcGq2tpa2c5gmN5cRRlDkhWOHICtg7STzg1Lqfijw9Fb2lw+u6SsNyPMgc3kYWVQcFkOfmAPGRXJXPwcd9KFgniEpFbaw2sWLLbyI8TsWLJIyTKXHIwyGNhg888V4fhBp9rfaLc3rafc22mi5LWf2OR4pnlIO/99NKwIIz1OT6UAeh6Z4h0XUNRk06x1fTrnUIgTJaw3KPKgBwcoDkYJHat5YwRXmvw58BXPhnW5b1NZA0+SJgNLs4porbzGbcZNsk0uG7fJtFenLQBw/xNt82eigDrqtuP/Qqzbi3ktZxPbs0cqHIZeMVvfEUZt9B/wCwvb/+zU3U0Ug8UAdB4V8RxarAIbl1jvk4ZScb/cV0VeJxWpm1JjHn5B1HrXSWmt6tpWMsbmAdUk5P4HrQB6RRWXoWt2usQb4CVlX78TfeX/61alABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXKeOF8u50i4P3VkeLPuwBH/oFdXWX4m006ro09tGQs4xJCx7OpyPz6fQmsMTTdSlKKNKUuSabMHR51t/E8RkOFuoWjVv9oYIH5A10Ov6aNV054NwSUEPE5/hYdP6j8a4W1lXUrMRzbormJsEdGjdT+hBFdHpHiVUK2utMIJxwtweI5fqf4T9ePT0Hn4OvBxdGp1/qx016ck1OJy00W2R7DVojBKex6H3U9xW5YavqtgipIE1G2XADFtsoH16N+PPvXW3dpa6hbiO6hiuIjyA4DD6j/GsOTwlbISbC6urX0TdvT8jz+tNYKrQd6EtP6+QniIVFaoieLxNpkqbbky25bgpNEf5jI/WsfXLfwtf2UqpNHbSnpLZqwZW9SFHP41S8QrPoYUS3VveOwysIQrIR9OR+JIqroGtadeSOJYhFIOCjDBBqKmKqX9nVir+f/DlRox+KDZyVjLqdo48p5zjtKpwfof8a6GPX7u7QQ3MLqR64wa0dSlgdiYgAPSqFtEOrDmvIlNq8UdyjezFt7QSTNIygFueKv3OnhbcFgMGnQFVbJqW5uAybaIqPK2xNu+ha+HsskU9/YkkwJiVB/dJJBx9eD9c+tdrXnPg+/8AsviueCf5YrqNUjJ/vrk4/EE/kK9Gr6PL581COux5eJjaowooortMAoopGIVSWIAHJJ7UAQ3t1DZWz3Fy4jiQZJNeb6vr2oa9O0NoXtrLOAqnBYe5/pRr+qS+INSMUTEWMTYQf3v9o1esrRYYgFAFAGVBpKwp6tVG3AtL+RH4z8wroblxGDntWBNZPqFz5kg+UcAe3vQBrQ3iMQEOT7VsWeWwTWbp+nJEqjHStuEKgxQBieNj/oWj/wDYYsf/AEoSuykGa4vxqwNppGP+gxY/+lCV2rCgDOvk3QsO9MtH3Rj1qzcplTVC2bZIyH6igBIvEuhtq/8AZI1nTTqgOPsYuk87Ppszu/StrqK8n0Ow1/TPDZ8PReGY/t0Ms7wau00Bt/MbeUucEmTzMsMjZ6/NVOw8P+LrgRQgeILCwaWwF0lzrXmzuyu32mSORZWKRlSo2hgT2RaAPWrxo7a2muJ22wxIZHbGcKBknArP0/W9I1AW32TUrSR7jb5UfmgSMWiEoXYfmDeWQ+CM7ecYrzXU/Dni02jWVxDrmpaWralFBBb6uIpvnkH2V5pTKrSRhNwwWJGeVPaqng3xILjRJ9TsdWurXTLqApa2WqiGRIv7MSF/LImQLicHPzAkF8ZDHIB7NZXFvd2/nWc8VxDuZPMicOu5WKsMjuGBBHYginSE815BqOieOGsNsq61czGO9Fp9k1ZYDb3DXcrQyzHzB5kflGIBfn2hSNnpf/sDxZHqi6gL2/N4dZbcGv2a2+xG3Iz5JfZjzcHG3cPYUAeiJKTMV9KdpeqWmom7Wzm8w2k7W03ykbJAASvI54YcjjmvC9E0Px/HZ3iXlxq73BWAXMSXKqbjEymUwTNdOY2KbwMJCOR90gY9D+Hek6hpeg6/HNZ3llLd309xbRXV2LiYI0aBS0m98tkHqxx64oA9A30havEdX8LeN00HwwtreazNcf2eBqqpfvJMt35cYDA/aoFKjDjhypPJVyS1R6/a+L9Ks/EWoTPrTwx6LdSNfXF35AhlW0ODFHFdOud4yMxAqSTvOBQB7gzVBJKU5PSvHrbSvFclq08MPiIaPLPaSSWEusA3syCOXzmjm84iNWdoG2iReEbG3OC2Xwx4zu9Iu2mudYju4dKn/s+JNXIZbnz5WhWVlcCR1jMalmyp7k9aAPYftAYdaq30g8ps9K8v1rQPGU3iDWH0ddQUT283kXV3d7IoJPKwoiRLgqwLdN8KkZJ3HAFafw50LXbK11D/AISBtRG9ozDFeMG2EKdxVvtVwxB44LLjHA5oA9D04YjXPpWktZunsTEmeuOa0F6UAcn8SGxb6F/2F7f/ANmqjrd3sUheXPAHvUnxQmEdlozMcBdVgP8A6FWfYob27M7g7B90H+dAF3R7QxRAsMu3JPvWk8IK4YZqe1iGOlSTAAUAczdCXTLtbuzcxyKc8fyNeheHNYj1mwEq4WZeJE9D/hXn3iC4REIJHHWszQrnUrKf7XZu0QIxsIyGHuKAPaaK5PRPGENzIsGpxi1mPAf+Bj/SusByMjpQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBy/iXw013cG/0xlivcfvEJwsw9/Rvf8AP1HKtfiCU2mqwNDN3SVcZ+nqPcV6lUF5Z219CYry3inj67ZFDD6815+JwEKr54uzOmliXBWeqPPbYQRLmxuri2BOdsMpVSfcDip5Lm7Zdp1e72n0YA/mBmtm48D6TISbc3VrnnEMvH5NmqbeAY93Gq3mz0IXP54/pXH9TxUNIvT1Zv7ei9WjCl+ywB3aQySty0kjbmb6k8mubvrV9RvD/ZlvNPdDtCDkD3I6CvSrXwJpURBuJLu65ziWQAf+OgV0tnaW9lCIbSGOGIfwRqFH14p0srm5c1Rini4pWijxzTbKaC82XwuI7mPhopT93j8j9a3VX0FTeNJVPjBY4x8wtkDn33Mf5EVZtIN4GBk151ehy1nBdDqp1LwUmU9rYprAjrWjKgUkMOlZ95Iqqe1Yzhylxlcy4EeTxBpip977XER9A4J/QGvX6868D2n23X3uyMw2anB9ZGGAPyz+Yr0WvoMrpuNG76nm4uV52XQKKKK9I5Qrl/H+pm00oWsLYnujt47L3/wrp2ZUUs5CqOSScYrzXxPcpf8AiQmORJIo1CIVOR0yf1NADNEtBHEoxyetbyphcVW05QADWl5e7pQBmTWvmt7VPbWIQcir6RAU9sAUAQCNVFZt/cfZzuP3e9aEjVlXv7zIPNAGJ4ouvNg0fByDq9if/I6V6PuBFePeIJDb3Ok2zZ2nVrNl/wC/6cV6xG/FAGL4+1O40jwvdXNjtF67xWtuzDISWaVIkYjuAzg474rkdd+IWi+HvEMGgX1zNcX8RghmnZ4EO+TAUlN6u2cgny0IGecdu38TaTHr+hXemzSNEJ1GyVRkxOpDI4HcqwVvwrNn8LWU99FqV21wNUCx+fNZ3U9rHOydC8SSbWHs27jjkUAZvh3x3Z63qllZ2+nalDFfRTz2d3MsQiuEiZVZlAcuOXXG5RkHNS/E3W9Q0Tw3C+jpcG9ur61sleBYmeMSyqhZRKQhbBIXdxuYZ4yRy1n8N4YNYvpbrUWS1mtbmzgt7NZYxDHOwL48yWRVOFx8ioOScdMd3c6bpt1YWdlNbKbS0khmgjViojaFg0eMEdCq8dOOc0AY1r8QIIbNIm0zXbuaK5/swPIlur3F2pwUGHVdxAZywAjAB5HApl38UbCCJTHo2tXE6wXVxcQRxwh7Zbdwku/dKBkFhjaWz2zxWjd+H9FuLGe0ktWEM12b5ik8iOs5O4yK6sGQ5/ukYzWY2ieF9NNtaGGGCS5guNPiWW6ffcLMweZcs2XdioYty3HXrQBs+GPF9v4iuby3jsb+xntooZyl2qAvFMGMbrsduDsbg4YY5ArmPFXjy4bwzql/oWn6lHDazLFHqLJAYpmW4WJ1RC5c5+cAlAODg9DW9otrpo1K+l0c25vEjhsrry5/MaNYgxjRlydpAkb0Jzzniq48A6Q73W+G5EN1IZZbdbyYQFy4csIg+xSWAOQAevqcgHPX3xU0jS5WOoWd7aXguHtXs7iW2idWVFkJ3tKIsbZEPD5O7GKvP8V9KMC3NlpesXtn5VtI9xbpDtT7QQsSkNIGLFjt4BwevHNbt54G0K7mmmktZo7maf7S09vdTQyeZ5axkh0YMoKooIBAOORmoL/wjoVvY3kt6pS22QS3M9xdyH5bY743d2bPylckk84+bNAEMXxFtpCkEGi6zPqhlnifTo1hM0fk7DIxPm+WR+8jxhyTuGAecczqnxM1G80vxBdaNYXKWVsLGWzvkSI7o5vKYqys5YswcgYTjvg11F74G0jUA0rwSFpZZLjzoLqWJy0iqr4dHB2sFXK52nA4pj+BtK3OVsmSN4ooWhiuZo4mWLb5eY1YKSu1QDjOBjNAFHVPito2mQsupWd7Z363L2r2VzLbROrLGkhO9phFjbIhGHJO7GM1NpnxH06+gmuLCyv7q2ito7uSYGCKNEkVmXLSSKAcrtxngkdskW9Q8H2N7cT3EltLHdTT/aXnt7uaGXzDGsZIdHBUFEUEAgHHIpp8KaWbS9tb2zmmhvY4orhnuJWdxF/qyXLbtwPO4HOec5oAh0j4p6Xq1vAdJ0zU7+5mu5bJba2e2dvMjjEjHeJvKK7SDkOfTrxVmD4jaLfW0ckFvfl5o7WSCExKHn8+QxgIN3VXVg+cYxnkYNZ83gHRZLyyktpr+3iiuZbu4239yZrh3hEWTN5vmLgBe/OMd614vCWmJr/h+/gSGG00O1lgs7VIvuM+0bi+ecKCAMdWJzmgCx4Wu7z/AISHxDpN9L9oFlLFNBKVVT5MqkhDgAZVlcZ7jbnJyT1ZPy1h6BpA0+/1e+nuRc3mpTiR3CbAkaqFjjAyeABknPJZjxnA2XYAdaAOA+LH72x0eHPLapB/7NWlp0AjiUAYrJ+JDb30Yemp2/8ANq6G3XCigC0jBFqrd3IVCc1HdyvGhKqW9hXP311dSRtthMaju5oArSRtqmp+WeYYzlvc+ldPb2YWMALwKpeHLTy7dWYfO3zEnuTXSIg20Ac/qOnpLEfl5rS8C626zHSb1yWH+oZjzj+7/hUl0oANclqW+C7S4gO2WNgykeooA9hoqppF6uo6bb3SdJFBI9D3H51boAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDzHxwGtPGaSsP3c9upU+4JBH8vzqxaakiDdnnFdT4t8Px+ILFI/M8m5hJaGXGdpPUEeh4/IVxK+CfEiNtE+nlf7xlf8A+JrxMVhKvtXOmr3O+jWhycsiW91ReWJrKtxd69e/ZNNj3P1dycLGPVjXSWHgCSRw+sX25R1ithjP/Aj2/AfWu107T7XTbYW9jAkEQOdqjqfUnufc0qOWzm+aroh1MUkrQK/h/SYtF0yO0hO8jLSSEYLuep/z2AFaVFFe3GKirI4G23dhSMQqlmIAHJJ7Utcl8QNWa1slsbdsTXA+Yjsn/wBemI5nxRrs2t6g1vbOy2EZwADjefU/0qgls1tPG4BKHrjtU2i2XAJFdELMMoBAxQBJYfMoIrVTgVUtYxEoAqwx6YoAlzxUEkgzikmkKpWX9qBlK5yaAL8nNZF8su47K1UOVpTBvGTQB5r4tW4E2jSSqp26rZ8jr/rlr1GCQMowa43xxbgRaQcf8xayH/kdK6iRXt3ygyvp6UAaIaoppAqkk1T+2ZHygk+mKdHBJOwabhf7tAEcUX2qbzHHyDge9WhZx/3atRxAAAdKmC4oAqpaxjoo/KuG+J/hHUPEl94cOlKkbWM09wLhmAWCUQt5LEZyR5gTIXPGa9EOBTGkAoA8LbwJ4y0iPVl0ppnF1qcF3dPbTbJLwG1USsm2eFlHn7jtMiHHqODo3HhPxldadKz3+um8g0iBLRl1D7MTdC4mLb0Sd1ZhEYgSzOGHUk9Oi+LXj9/Bdrp62bad9tuWll230ojQwxIWcL8wy7HYij1b2qxd/ErTLe6Kx2Wo3Noq2ryX0KxmGNbkgRMcuGIJIztU4oAxL/w34lsr+6t4Rr+oeHI9SEkdvBrBW7lhNogyszyq+xZ9+VMi+oBHBhg8L+MptE106hd6p/aC6FHHpqxamUH23ZcA5KsuXG6EFmwrH5uSoI29X+JVtBY68ILPUIL3SLeWa7862WRbbbym4CVQ+8fMoV+R1K1X1X4u6LbarqGk2aST6jbmeGPEsGHnjjZymzzRIB8pG4qFJ43dKAMlNB8cjxo1xdXWq/YvODRyWsivH5Pk7fLZXu1UNuz83kMdwB3EdOj+F2na7YW+oR6/b36DdGIZr67aWabg7iyfaJ0Tt9xlBJPyqAKh0z4mwjRLa41vSb+zvpdPhvUhAiP2ouypthxK3Jd0ADEH51z3x6AJQRzxQA3ZTTGD2qTeKcCKAKklsjDlRVd7PByjEVqYBpCooAxmNxCf7wpy3mRh8qfetRowaryWyN1WgDgfHsiuNIZTn/iaW/8ANq6a2OQK5z4mWxhs9IkhUbhqkGB6/eq9peoLJ8rZVh1B7UAbjR5FVZ7YSDaw4q1HMCOaexUigCO2jWJAB2qVrgKMd6qXFwEU89KyYLtri4bb90HGaALt9eKqkswFcrqF8Z3KWymRzxx0/OumltI7j/WLuHvTorCKP7kYH0FAEXg3XJdFjW01E7rZ2LbgP9WT/SvSkZXVWQhlYZBHQivNNQsRJEwxzWz8P9UZkk0u4bLxfNET3XuPwoA7OiiigAooooAKKKKACiiigAooooA4XwpZ67rfhnStUn8WanFLeW0c7xx21ptUsoJAzCTjnuTWr/wj+sf9Dhq//gNZ/wDxmuQvrjXbH9n2yv8Awpc+Rq1lpcF0n7tJBIiKrOhDA9UDdOc4xXMad8ZLySx8R+NDHPc+FkntdM0rT1jCl7hlVpHeQIXABYLwG9lJoA9W/wCEf1j/AKHDV/8AwGs//jNH/CP6x/0OGr/+A1n/APGa4W6+Lms2ujre3XgTU7VUuZ4rme5S6S2ghjQMJywtjLsbJAzEMbTnFYbfEvxHNrXjadJLR9DsNBg1S3FldLui3wlw0TyWx37jgfvFwo5wfu0Aerf8I/rH/Q4av/4DWf8A8Zo/4R/WP+hw1f8A8BrP/wCM14ynxO1Xw74l8Xa5dJPqekW9ho0r2k9+UaHz4wGaFBHsZyWyQBGDjPtXZSfGEJqwsRomT/wlS+Gd32vBGRnz8bP/ABz2+9QB2n/CP6x/0OGr/wDgNZ//ABmj/hH9Y/6HDV//AAGs/wD4zXjfhj4rX3hrwXdS3QXXtQF7qU32e4vbg3IgikONoSCUBAARucoq469cdx4e+KV74i8XWGkaN4Ykns57C01Ge9a+RPs0M6bsmMrliDgYUnPt3AOs/wCEf1j/AKHDV/8AwGs//jNH/CP6x/0OGr/+A1n/APGawfGnxFufDHiu20yfRfL0yURL/a97LNFbGSR9ojVo4JBu7/OUHv3rG0n4wXWpeILzQYPCtxJrWntem/tIrre0SQKvlshKDf5rMFUcfU0Adv8A8I/rH/Q4av8A+A1n/wDGaP8AhH9Y/wChw1f/AMBrP/4zXkfif4veIrvQrd9Js7LRtWh1Wwtryymmm8+JZ9x8uVJrVQucAbk3Y5IJ4z1C/Fu9k8ZTaFa+Er+8SzvYbC/ntPOl+zu4y0gxBsMSnuzoxHIXFAHaf8I/rH/Q4av/AOA1n/8AGa5LW/Ct7d6vI1x4o1aR1AUMYbUcfQRVhD426hcHT0tvDNsDqU1/b2rNqZyHtOX3jyeAV6EE88Ed66LwJ4gHizw5Ya4IXg+3Reb5btuKnJBGeM8g84FAFLwM1y0WpwXly101pfzWySuiqxRSMZCgDPPpXXgYFcl4IP7/AMQ/9he4/mK6pmwKAFZ8U6J89apSyfNViAkrmgAv2xExB7Vz+mSGSeQn+9W1qLYhasHRuJJR6MaAOktznira1Qt2qyZsDmgDnfHZH2bSP+wvY/8Ao9K3dWvYLS2mmuJY4oIlMkkkjBVRQMlmJ4AA5JNcl48ugU0hAfmOrWRx/wBt1rY8ZaVc6r4I8RWVnF519eadcwQR7gu53iZVGSQBkkck4oAtw6npNtHavcanYR/a4mngL3CATRqu5nTJ+ZQvzEjgDmt63KSRJLEyvG6hlZTkEHoQfSvDk+GviTTbrTbq1k897G2u7axEUwRrKJ7WXYuSR83nS7MrnCxxnIwaZealqtn4307Tb+/1GbWG1GyKJb6yPLjtREhkSS2WXcTuEhLtGwIIO7oKAPeGdU61SOp28lxNbwzxPcQhTLGrgsgbO3cOozg4z1xXjepaH4vPhfSbe2XV7zWZw/22QarKXgYA+XhVuYUxycncegJDGtLSvCPja+h0yLXZtSjjY6aLzyNR8s7VhkFz8yPkZcpnb1JyM4yAD043Jdtqbnb+6ozU8dneS9QsY9zk/lXkOqeFfiDHb2tvaXGrC0hF3FEbW5ElxGftMhhkcm7gEn7ny8b2k6EMvJr2TQNQvbyXUIr2xe3itJlgink+U3WEUvIEx8q7iyjk5256YoAyNF0jR9amj8Q2kz3MskLWiz/Mo2LIdyhW6fOpycZOByQBTbX4a+F7Wwms4tOItpvJDobiU5ETb4wPm4CnsPp04rzK38K+OLXQ7+10W21vTroWWoq7SashiuJpJC1v9nRZmERGSS2I++ck1s+P9B8ZLrUCeEo9VeCIQyLe/wBqyv5j+aWlEiPdRooxwB5UoIbaAgAwAdZF8PfBepRXpgs47hZxPZ3ckV5IxlJc+akjB8swYEfMSU5Ax0qxdeDPDVnfvezPPaNeTFGj/tKaOCeWQbcGHeI2Zv8AdJJ561x9x4X8X6hfXwvrrWYrZY9Yktvs+rPDmV7pWswdkgOBHuwDwoGDjpW5460LVNb8FeHUmtr281KyurO6u4LS9+zTPsx5u1xIi7uWI+YDIyCDigB7fC/TEv8Aw+9rc3CWWjPJLBbzSPcMHKhVxJIxKooGdmMZCkYxz1D6XdL/AKu4Vh6MteeGx8bJeJZW9nrAtBrTXovJNSjYLZm2KrAcylyVkIyMFcgEE9aym8EeMovDpaDUPEbasvh2F1VtekYf2sMl85l2kdBg/uz7nmgD1F7e+jPMSuP9hv8AGqOoazb6VHHJqLPbrJKkCbkYlndgqgYB6kj6dTwCa5O/0fxm/iW8ltxqwka8uXF5/aYFm1m0LCKFIPM+WUMU+bYvILbznFaXh7QL99W8OWmrLqMw06yXUb2a8nedZL54xCqqxJX5AJmKpwCyN1OSAdWl2uAQwIPcVHpmsWepTX0VpN5kllP9muBtI2SbFfbyOfldTkZHP1rx2Dwf8Q1GovPLqbXhQ+YYZkSK7H2iNm8p2u38pzEHCkQxAbucEA1Xm8GeNrS0vG0iz1W0sbjV5rl7SS/828eI20KRu0iXcZOGRwV8704YYoA95zmggGvEZPD/AIru7SVp9S1038UemxQFdRNqWAkAui8aSlN/l5ySW55Uk1P4h0TxmNMn07SIdVuIBe3TW1z/AGtK08URSPygT9qiZ13GTl3crtHyEGgDtfiQg+y6GPXVrf8A9mqlqliwPn23yyLz9aNeS+Xwl4MTWc/2mt3Yi63MGPm7Dv5HB+bPI4rcmi6+lAGLp2oiaEZ4YcEHsamutTjgTLuB+NYmvwSWMjXVsQAfvKeh96j0zTnvvLnuzuzyF7CgB91qVxfEx2kbbTxvIwKvaZb3cCKCseO/BratLOOJAFUDHtVpYwtAEdqp2guOatZAHSoZZFRTk4FVLe8WaUqpyBQBedQymuallfStbt7yPgI4JHqO4/Kun/gzXNeIgChoA9XRg6KynKsMg0tZfhe4+0+H7GUnJ8sKfqOP6VqUAFFFFABRRRQAUUUUAFFFFAHM/DZVf4deHUdQyNp0IIIyCNg4rSt/DuiW+jSaPb6PpsWkyZD2SWqLA2Tk5jA2nP0rO+Gf/JPPDf8A2D4P/QBXS0AcyfAHg428cB8J+HzBG7SJH/ZsO1WYAMwG3AJCrk99o9KvXnhbw/e3C3F5oWlXE6wG1EktnG7CEggx5IzswSNvTBNcl8QPiDL4P8aaDZ3cVsPD9zbTT6hdOG324V440YEHG3fKoOR0Oc8c5/g74o32o6WP7W0G7n1qa7u0i07TETzI4INmWk82QLuHmIpweWPyigDuJPB3hmXUIb+Tw5oz30IQR3DWMRkQIAE2ttyNoAAx0wMU+Xwn4cm1X+1JdA0h9T81Z/tbWUZm8xfuvv253Dsc5FcLbfFKa9/tu6ttNuF0a3FjJaX/AJMcilLhYiA6eerknzOMAYHXkYOvdfFDSrWC7uptO1YadEl40N55cZju2tVdpUjHmbs4jfG9VB2nBoA3rjwZ4XuY447nw3os0cbO6LJYRMFZ+XIBXgt3PfvV/T9E0rTZ/O07TLG0m8lLfzILdI28pBhI8gfdUdB0Has3wp4rg8Q3V9ajTtQ067s0hleG8Ee5o5QxjcGN3GDtbgkEY5ArnLr4n2UjapDZ211BLp93DayyTC3kO57qODHkCdZlzvJDOqjHzfNwrAHW3fhfQLvWE1a70PSp9UQqVvJbSNplK/dIcjcMduaz7DwNo1rrviTVp4jfXOviNLxbtUkj8tE2CNV2j5MdQc571zXiv4hynwld6to9pf2GnwXttGur3IgFvLH9tihl2qXLgFWk+ZkUYBIIOK07z4k2kMOnSW+ha3eDUYLm7tRCkCmS3h8stN+8lXCsJVKg4YjsOMgG7D4O8MwaZcabB4d0aPTrhg81qljEIpGHQsgXBI9xRN4P8Mz3ttdzeHdGku7VUWCZ7GIvEE+4FYrlQuBjHTtXKD4yeFn17T9LjkmaS8a1RZDJCuxrhFaIGNpBKch0yVRlXPJGDhIfi/o0uiXWqrp2oC0gmjgO6azVgz5xvBn/AHONuT53l4yB14oA0L/w/oi6pEtvo+mxC1MjReXaouxpB+8ZcDgt0Yjr3qWGwtdLtreDTraC1tYRtSGCMIiDrgKOBzRo+oLq8S6gkbRJcDzFRnRyAenzRsyn6qxHvWgE82E57k0AcD4LnC3fiEZ/5i9x/MV1kko28V414f8AGdjpfjjXtA1ZZLGeXVZ2tZ5uIrjLAbQ3QN7H1HfivUTdoqcsKAHyTFpwg+tbFsP3YrAsMzStL2PA+ldDAMIKAK9+u6JhXM6S/l31xGx75rqbrlTXE3RmXV9sBwXGCcdqAOsgkB+6c0XkxWMk9qhsI/KiwzFj71X1qTZbH1IoA5DxJLJILK8aG5mittRtZXW3geZwizKWYIgLHAB6A12SePNFUf8AHvr/AP4IL/8A+M1W0SILGK1bqXy4/egDMufiNokYx5WuD66Hej+cVVrfxzpl8/7m315o84aRdBvnA9uITzUlhps2uXpGWS1Q4eQdT/sr7+/au+tLSGzt0hgRURBgADpQBzVl4w0O2TCWfiTJ6k+HdQJP/kCrR8d6Pj/j08R/+E5qH/xiulSs/W9Wt9KgDzktI33I1+8x/wAPegDGfx/oyKWe28RKo5JPh7UAB/5BrNm+K3hxeIY9blP+zol4B+sVZ2oXd7rEha6k8uDPywqcKPr60sFrbxgZYGgB8nxQ0+U/uoNajHtod6T/AOiqjPj+wk+//wAJD+Gh3w/lFVtZYE6FRT1njPRhQBkXXxI0Czlt47y61q3kuH8uFZdIvVMr/wB1QYuT7CrY8eaev3T4i/8ABHff/Ga4v4ysIrfwlfqR/oniG0djn+Algw9B1HNei0AUl+JNnF1j1xx/taDe/wDxqrEXxW0ReLi11xfcaLeY/wDRVS1HJDHIPmUUAXbb4l+Hbk7YF1yRu4TQb5iPyhq2PHmj9rTxH/4Tuof/ABiuYm0wbxJAxjccgqcEVqaT4lubGRbfVgZIugmHUfX1oA0/+E90j/n08R/+E7qH/wAYpD470c/8uniP/wAJzUP/AIxXRQyJMivGwZGGQQcgipR0oA4m/wDFuiTjd9k8Rq46MPDuoAj/AMgVlQ/EHSIJzDNDriyDnB0O9BI9ceVmvSZBuFcd41sSkCX8Q/eWx3HHdO4/r+FAHP8AiLxJZ+IJNEtdMtNZaVNShmczaRdwoqLnLF3jCgfU11si5WqGlXQmiGDkGtA9KAOd8Rw+ZZSADnBpvh/DWsf+6K09Sj3QuDWV4cOFdP7jlf1oA6ONeKZIcVOOEzVG8lCqSTigDD1u8bcIYj87naKuabbrbQqBye59a5i8vU/tdJMkomQTjgGuhg1CF0GGFAGw04CYzXO65KrIcGm3d+Bn5wB9axp7rzztjDOfbp+dAHqfw+ct4ZgB/hdgPzrpK5b4fXtvLoyWcfyXEGS6k9cnqPaupoAKKKKACiiigAooooAKKKKAOa+Gf/JPPDf/AGD4P/QBWrreuaToNslxrmqWOm27v5aS3lwkKs2CdoLEAnAJx7VlfDP/AJJ54b/7B8H/AKAKpfEK01KTUfCeoaXpdzqY0zU2uJ4LaSJJPLNtPHkea6KfmkXjNAF6e28La9e6dqcz6bqMl1bS2to5mWWO4iYq7qq5KyDManODjb25qO/8A+HL4P51lMjvcTXRkgvJ4ZN82PN+dHDbWwMpnacDjiuJh8NeKIpbm9s7e80mDUrq9u5bDT7mLfaB7IRR8FhG0hlTzOpUM2c9TWLN4f8AiE2h2kEMWqxQxXkhnQ6hK93cIYkCOc6gNgVt42rc4PDbO1AHpz/D/wANM7lbCSON4YYHhiu5o4WSHb5WY1cISuxQGIzgYzimzfDzwxNNeyS6c7i8S4jkjN1MYlE4ImMce/bGXBOWQKTk8151d6P8RjrXh1oU1N0tGsBcXhvNguIwV8/zoheGJWA3AhYpd3UPnFQz+HviF9k1CKwGtBGuIpGmvNQb7RcRb2LxoiXxjXqp3I9uSBtxQB7PYaNYWGoXV9aQeXdXMUUMr72O5IgwQYJwMbm6dc85rGuPAXh66vZbu8try7uJGVt11qFxN5e2ZJgIw8hEY8yOM4XAO0AjHFedx6B43ji0At/wkN9LCzCWG4uxbRIpnJHmPFflyyp0LeflQoI3bq9W0bULvVLC8mudPnsNtxNDArN+8ljRiqy4YDbuwSAc8EHPNAGaPAPh0Lcxi0ufs1xKs72v2+4+zhxMswZYd/lofMQN8qjuOhIM1n4J8P2Txta2BjESXEcSCeTZElwVMqou7aqsUU4AAHOMZOfN9C0jx1p1tDK1nrtwLTUbWd1uNTH2q+hCyrIpRruWEYLoxw8asR9wbVqzpWleMGvLO48S6f4iurJmu3FnYa0sMltI947xmVhPGJEEJRQoZgu0jbzwAdf4a8N+FbtLbVPDwvIooCLVTbX11AkhtiYAJIw6iTb5WzLhshRyRirKeAtDja4dTrH2icIslydZvDOVQsVQS+bvCZdjtBCknJFct4E8Ja7oOqaRcMb+KKW81V9Rga/MkCxyTyPblYt5QEghsoN3zHd6VX8c6b43uviFZXOhWt5FpkF3ZsZ4b9hFLAHXzw8bXSoCAWGPIcsMfMD0AOi0TT7bSbBNP02IQ20X7uNAScDPqckn3PJrfiQKgA6V5p8ONM1yw17V/wC2IdSNsSfKn1C7LyM288eWtxLGBjHzKI/TbXoE1yUwqjLHoKAPHdX8M2HiK08SwajbJPF/a9xkN1HI5U9QR6iuSt73XPABhi8RPcan4QLhY9QUb5rRT0WUDkr7/wD1lr0Xw9b3k8/iLbIqqdWuARjPcVpWkXl5sb2NHjdSpDDKuvcEGgDY0Ka1vbKC6sJop7SVQ0csTBlZfUEVtDgV45c+Hda+HF5NrPgWJ9Q0CRjJe+HyxynrJbnsf9n+fGPRfCPivSPFuix6lolyJYW4dG4khbujr2I//Vkc0Aat64WM1zFrF5+pSS9lG0Vp63eCOFueai0SArCu77x5NAGpFEdtZmuL+5rfjQbaqXtoJlIIoAztOwkIpXWTUb5bWHgDmVx/Cvp9TUV232WLag3NkKqj+JjwBXS6Hpy2Fsqsd0zfNI/95j1oA0dPtorO3SKFQqqMACrJNMSlwTQAO7BGKAFscAnAzXPN4d+1XL3OpXTyzP1CDCr7DPat8is3UdcsbElZZgZB/AnzNQAyPQtPj6wbz/tsTVgWFmowtrCB/uCufm8VSOf9FsWI9XbH8qhHiDUzz9mgA98/40AdP9gtGGDawEf7gqvNodhIP+PZV90JFYH/AAkWqIcm2tyPTB/xrQsfFUDsEvoXtm/vfeX/ABFAHnH7Q+iJp/w0utRgmlC2V3bTENggfvlXP/j1dtcRXNkwF3Hhezryp/Gsj9odY7z4KeJTHiVDDE4KHP3ZkbPHpjNd9psq3el2skhWUSwoxJ5DZUHNAHMq6sMqc06rmr6ULNWurMHyhy8Y/hHqKoqwZQR0NAC1BdwLPGQwzU9FAC+DdQktL86bO2YXyYs/wt6fjXcg8V5dqxNvdW88Zw6OGBH1r01DkCgCSqeqwLPaSRsMqylSPrVscVXvpAkDsxwAM0Aeb+GZjEEjc8DKZ9wcf0rq81y/hqMSW5d1BEjs4H1ORXSFsCgCrftiJvpWF4eb9/c4P/LU1oa1crDbsWYAAZNc54Wv4zLKrNhmcsAe4NAHfI2Y6xtQspbiTG9gncDvWlbyAqOeKuRqrCgDnotHiEWwIAKryeHoc5C11exR0xUUg9KAOZTQbcHJjBPvzTm0xIx8qgVv49qilxigDntKum0rxBazZ2oW2P7qeDXrNeQeIVC7XXqDmvWrNi9pAx6sik/lQBLRRRQAUUUUAFFFFABRRRQBzXwz/wCSeeG/+wfB/wCgCulrmvhn/wAk88N/9g+D/wBAFdLQAUUUUAcZ8V/E2qeFPDUF9odpBeX0t9BbLBMCRIHbBAwRhj0B6Z7Vx1v8bLIa5q890kP/AAjEdrbS6bcIVWW6eSR4my7usaqHjcZJUDYST2r1bVtJstXjtk1CHzltrmO7iG9l2yxtuRuCM4I6Hj1rIvvA3hu9leSXS445Ggit1a3keAxpHI0ieXsI2MHdjuXDc9aAObt/i/o95aRT6ZpWraiTBdXMqWhtn8lLd1WUl/O2N99SCjMCDxzxTdQ+Lei6VNeG9keVDdQwWse2G2yHtY7jJlmmVCMSDklDkhQrEbj1cPg/RoiGaK7uJPsk1j5l1fT3DmGZlaRC8jluSi85yMcYqtJ4B8OOpC2U0MhkjlE1veTwyoyQrApWRHDL+7RVIBAOOcnmgDFg+LWhXFhPfW1pqcthbWEWpXFysceyGGTzcbiX5YGJl2rkkkYyMka/gHx5pPjdL7+yd6S2TIJo2mgmwHBKndDJInODxuyMHIFX4vCWipHfo9q9wL+1jsro3VxJO00Kb9qsXYk48x+epzyTgYs6DoVnoUMkVjJfujkEi7v57sjHACmV2Kj2GKANSiiigDnLxTHqM6pjkg8+4qq6NHcxsxzuOKu6p8uqMfVQahm+YxjHfNAHJeC0DS+Ij/1F7n+a1f1i18yIlOHX5lPvVLwR/rPEQ/6i9z/St27HGaAMvS74TwA5w44I964Hxp4QurHV5PFPgSaOw17711ani31BepVx0DHnDep6g/MOjvt1ldvLbBzE/JAB4NVftct/KIo2KL/ET1oAyfBXiy38aTSRPG9nqVmcXlhMcSROOOPVc9/zxXpVnFsWvOvFfgFNY+z6poVydK8TWQza3yD73+xIP4kPuDj3GQdT4e+OTq95N4f8SWo0rxZaD99aMfkuFH/LWE/xKeuOce45oA75DimXLhIyacDiqOpSAJjPFAEOj2/23WfMcZithu+rnp+Q/nXWqtY3hKEppaTP9+4Yyn6Hp+mK3KABRTmYIpLEAAZJPajOBXN+NL8w6cLaM4kuDt/4D3/oPxoAyNb1+41KdrfTmaK1HBccM/8AgKq2mnpGMuMtT9OthFGCRzV2gBqoqjAAp2KKKADA9KY8SOMMoNPooA4T4tW1xD8NvEi2krLE1o5kjz8pA5PH4V6J8PtWg1TwnpLRZR1s4dyN1A2DB+lcZ8Vv+Sa+Jv8Arwm/9BNWvBSSQeFvD9zattmWwg+jDy14NAHqIAZSrDKkYINcV5Ztb66tf4Yn+X6HkVs23iO38vF1FNFKOqhdwP0IrGDvcXdxdSKUMrZC+g7UASUUEgDJ6VTZ7m8lMGnxGR+5HRfqaAKeoqb2/t7SH5ndwoxXqCLtAA7DFchpNrp+hP8AaNQu4WvmGMlvuewH9auS+K7YHFrBc3B/2IyB+ZwKAOjY4GTXHeLNWFzv0yxbc7/LM69EHp9TSXmpalqSlOLSJv4Y2y5+p6D8KTTtMit14UCgBNNtBbwKAMADAqWZwoJJ4qe4kWNSB2rmNW1F5ZDb2vMh6n0oApaozapfC2TJjBy+PT0q5NokTopQbHHQjjFW9F07yIu5duST1NbIt8DmgDE077XA3lyneB0atvzikeTSiHHOKz9Xn8m2cjsKALVne+fIwB4HFXfMHesDQvltFc/ef5j+NaDTrvC7uT2oAtSyYGapyTj1FWJV3RH3rnL6yu1dmglBB/hagCLVGN1cxwpyWYAAV69AnlwRp/dUL+QryzwbbSSeJbdb0JhcuuD1YDivVqACiiigAooooAKKKKACiiigDkLbwBptrbx29rqXiCCCNQkcUer3CqijoAA3AHpUv/CEWn/QY8Sf+Dm4/wDi66qigDlf+EItP+gx4k/8HNx/8XR/whFp/wBBjxJ/4Obj/wCLrqqKAOV/4Qi0/wCgx4k/8HNx/wDF0f8ACEWn/QY8Sf8Ag5uP/i66qigDlf8AhCLT/oMeJP8Awc3H/wAXR/whFp/0GPEn/g5uP/i66qigDlf+EItP+gx4k/8ABzcf/F0f8IRaf9BjxJ/4Obj/AOLrqqKAOV/4Qi0/6DHiT/wc3H/xdH/CEWn/AEGPEn/g5uP/AIuuqooA8o8ZeFY7C9tGh1fxDskUg7tVnJyD6lveqI0KAIC2ta/n/sKz/wDxVeheO7M3OimVB+8t23j6dD/T8q4S10wToGnkYk9gcUAafhuzs9JtpILKSZxLK00jzzNK7u3UlmJJrcIWRa5GXTprU+ZZyMcfwk5zVuy1sKBHcgxyD1oA2JbUMTXOatp7WkwuoF6feA7it5NTgb+MfnUvmRXMZ2kMPagDK0+8WSNSDxWZ458HWPjKxiJley1i0y9jqMBKy27/AFHVfUfyPNWL+za1dpbQEj+JP6inWN+WAKnp1HcUAYfgbxrfHVm8J+N4o7PxPAmYpVP7nUYx/wAtIjgc8cr9emCF6nW3ItpSP7p/lWL408Nab4z0oWuobobqE77S9iOJbaTsyn6gZHfH0I5Lw74s1C2upvCXjbbHr8UZNrdjiPUYx0ZT/f45H/1xQB7tp8YhsrdB0WNR+lWs1WsJBPZQyIchkBH5VKpycUAOYmuI8Tyeb4gSNySsUYAAGeTz/hXcNwK5+61LTbN5blNsty5K/LyxI4/AcUAZJkMSgyQzIn95kIFSggjI5FbOiam2rJcRzwovl4yAcgg/Ue1c6skds88bOAqSsq/QGgCzRTEaSRcx21w6+oiNJ5yB9j7o3/uupU/rQBJRRRQByvxW/wCSa+Jv+vCb/wBBNaPgr/kTdB/68Lf/ANFrWd8Vv+Sa+Jv+vCb/ANBNaPgr/kTdB/68Lf8A9FrQBs4oJwCT2ooYZUg96ALMGli5sftN1O0MRG4Bf7vqTWLJfS3o8ixBtbH+FI+GkH95j159Kv6jqMknh2e1ZQCjJBuB+8Cf8KraVEMbiKAJLLS448HYoPqBz+daSW6g9KTz1TANO88Y6igCZURRUVzdpChJIAqGSXPQ1UmgExy/NAGfd3c96+yDKIerd/wq1pmlrEM7eTySepq7awIuMAVpRooFABbwhBT3YUjyqo61mXuoRQqS7gfjQBauJ1VDiuO1a6n1KaS0teFHDue3tT9Q8RRYZYg0hx/CCag8OXkCjEhxM3LBuDmgCzawapHGsWYgoGNwBrX07T3WTfKxdz3NXLVlbBGCK0o9vGKAGNFtQZqhcqADWlcPgVkX0wVGJNAGdoLs3jCyVOznP0wa9VrzX4fW5ufEc91jKwxnn3PH+NelUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFfUbf7VYXEH/PRCo+tea6fJ1U8EHBr1KvM/EludM8QygDEUx8xPx6/rmgDSh2NgGku9Mt7kfMik/SseS8MUiNn92R+tXY9SVVzvoAYPD9sDkp+tWViiso8KcAdqz7vXVAxGdzHoBVaCG71Bt07FI/TuaAH3WrR+aVRWc/7IzWRetI8vmwW8sT+oHX6iuqgsoIFACqKfIsIHRaAOYttTKYW5Ro2/vY4NUfGfhzTvGOj/Zb0lJoz5ltdRHElvJ2ZT+XHf8AI11U8NvKCGAI9xWVPpyRNutpGjPoDxQBj/Cv4gTabdf8IZ44kWDXLUYtrpuIr6Hs6n+9jqPb2IHr0V5bOu5JomHqHBrw/wAceGR4j01IZmMN9bt5tpew8SQSDoR7cDI7/XBrO8BeK3vZptE8R28Vt4ksQBMu0bbhO0qcdDxn0z+AAPbNY1+3hVorZ1muMcKpyAfUnsK4vb5fygZLYzheWPqfcmpYXRsY6ewxStJ5c0cmAdrBsfQ5oA7LQLBrDTzlh58h3O3XBxgD8BiqxfTdD58sz3bc84Zz7+gFUbzxKPI2WcbeYR95xgL/AI1zryO7MzMzSMcs7dSaAPQdI1T+0Y3byWiKNtIJB7Z4I+tW7yygv7dorqMMp6Hup9Qe1cXo2srp0bpNGzIW3BlI6++cV2Nhere2sU0asqOMgMMGgDkxG1vcTWshLNC2AT3HY08kAZJwKl1whfEEmO8Klv1pNJ086oTPcZWzU4VRx5nv9KAOG+Lt9Gnw18SCNlZzZumOvXg/zrd8JNEnhjR4Y5A3l2cKc9eEAqL9oARWPwW8S+SEhXyY0G0Y+9Ki4/HOK7iy0y0bSLO3mt1HlwogGMMuFA69aAMSin6hZy6dJkEy2pP3j1T6/wCNMBBGR0oAp3Cl7PU0VSTHsm/I81Np7gwDFamhKhe8RgCW2kg9xgisZYjYX0tqc7FPyE917UAN1aXy4Cd+w+orHt59WnQFEQL2LZyfwrT1OFppIhjK7hmti0twFAAwKAOdSTUojmaIMv8AsnmtSzuvOT5lIPvW08KbMECqhtVBO0daAIvtCIOWAqCfVooVJL0640sS9WYfQ1FHocG7LJuPvzQBlzazcXTFLONm98YFNttEmum8y/kLZ/g7CungsEjGFUCrscKRjmgDEg0aGNMLEAPpST6FBKvMYz61umeNeBio/tUe7BIzQBk6fYS23yBmZe2a1v8AVx5NWI5EI7VBckMpHagDIub9dxGeRWHqd08pEceSWOAB3qfV7IbjJHKUb9K2PhzpInuJ7672ymFgsXHGe5/lQB1HhDR/7I0lFkH+ky/PKfQ9h+FblFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVh+LNG/tayBiwLmL5oye/qK3KKAPGBctGzwToSVJUqR0NIlrJOcR74092zXSeO9Ge1vDqNumYJT+8A/hb1+hrnobwgYoA0bHToLchj8z9ya0HuEiXgisM3b44NJBDeX8my1ieVj/dHSgC3c6hgnBqhJqDk8GuitvCDxxfaNYukt4V5ZVOT9M9P51pWU+h2LA22myOR/wAtHUEn3+Y0Aclbpf3JHkWs8n+6hNXhoetSLkWUg/3iB/M10snik3AYadDtVGKFph3HUAA/1qH/AISe9idIXhgkeTO1xlQuO5Hf9KAOebw3rjD/AI8z/wB/F/xrifiF8Otb1OK31DT7WW01/Tz5lncoAw942xnKn3/qQfT7rxNf2FtLczSQyJGpYoY8Z9hg08a3qM2JVuAgcbgioCAD25HNAHlHgjxV/wAJBp8ont2tNUs38i+s3BDQSjgjB5wcHH/1q6UXA71ifEK21TQ/EkXxB0GCK5vbZBHq1mqbft9qMZyOm9QMg4zwOuAD674d/wCEb8WaBZazpVvbz2N7GJI3CbT7ggdCDkEdiDQB575qeoFNEi55avTX8J6Kxz9iA+jt/jU1v4b0eBgyWEJI7uC386APPdDtV1DU0Uruhi+ZvQnsK9BhXYABwAKpWA+0Sy3G0KGcqqgYCqDgCk8R3n2DRrmVTiQrsT6nigDkZ5X1XXJkhJzcS+WpHZF6n8hXfQwpBCkUQ2xoAoA9BXJeBLL55rthwg8pP5sf5V15bnFAHl37SmJPhTe2fOby6tbfaOrZnQ4Hv8teiyThe9eaftAv52meE7HOftviSyhK56rlic+3Ar0CxtX1G5K7isCffYfyFAE7ywOhSR0IYYKk9RWGdPkgLC1lS4jHITPzgf1ru7e3itowkEaovoB1+vrRcQxTRlZ1VlHOT29we1AHI+H7aeR5HCbJJDgBweFUf1JxV/UNCkvbOV2AS6BDRjPoOhPv/hUtrK8biSJgwAZQXH3lzwfrwKvQakfOSO4jCbztV1ORn0PpQB5/FMRIYrhdkiHBB6g1s2sg2dRWx4j8Ox6mTPbkRXYHXs/1/wAa4u4XUNJl2XkLqB0bqD+NAHQSvxkGsu61L7OfmVj9ATUCaqjrgnFH2uNupBzQBLb65by5G8AjqD1FTHV4Ux84OemK5fVoLabVLbKLtJO7jqMVs2tpaRYMSKD7UAbltcGXnpUd9JKF/d9ajhdVHBpZJlI60AYN1dX8BL7VdR2Bwah0W5fULhp3ZlAOAnp9a1LyWPyyGIrn7MXMV9ObSCSSI/MSikhT70AdnHKEHJqG7vUjQ5IrCE2oTtsgtJ3b0CGtbTfCOpag6vqT/ZYOpUHLn/CgDJjS61u/FtYoWJ+83ZR6k16ho2nRaVp8VrDyF5Zu7N3NO0vTbXS7YQWcQjTue7H1J71coAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAbLGk0bRyqrowwVYZBFc1c+C9NlkLwtNBn+FSCP1rp6KAOZtvBunRPuleaYDszAD9KjvdUjtUNpo6JDGvBkVf5f41Z8X6rFZ2iwC4SNpW2ud2Cq4/TPSuXtriG4Um3kSRV4yhyPzoAZfXt6+pWyzSS3FuVbIZhhG7H+Yq1j5c++KAqOArcH36VK0bKjAj3FAGPYyLFqF7akHJcTKccYYev1FX/K3ypJ3UEfnj/CobxUglW46bTtc+qn/A4q/Z4aT1BFAGXr526dNtUtyowB7jNaVsoIZgOAOKpakpezmVRksMfrWrbqpt3kPHHP1oAzL65S1t5JpVZkUdFGSfavK9BuLv4beLoLWSWS38K+JZTJAkblUsbxufL4ONrDA/DsAa9PuAbnUokLfu4R5rLjqxyF/LBNU/F/hm18W+Hr3Rr4YjnT5ZAOYnHKuPcHn9O9AHX6Fqk0V4kNzM8sMp2guclW7c+h6V1leA/C/wAR3uoaXeaPrh2+JNCcW93z/rMcxzD1DAdfx7ivfVOVB9RQBgWC+RPcwn+CVvyJyP0Nc547ug01rbA8LmZh+g/rXT3HGsXIHQqh/HH/ANauGvz/AGl4tMY5QzLF+C9f60AdhoVv9j0m2iPDbdzfU8mrjmpSvp0qCfgUAeS/F6T7T47+G+njJL6lNd7R38mPP/s1e16ZbfZLKOI/fxlz6seteM6hGuq/tGeErVsEaZpd1fkHtvPlj9RXuFABVLWSfsDAdGZVb6FgDV2myIssbJIoZGGCD3oAxKZKpk2Rr993AX65zn8MZq+dMwf3dxIF9GAbH4/41PaWUduxcFnkIxvfrj0HYUAWqa6LIpV1DKeoIyKdRQBkXPhzSrhiz2case6ZX+VV/wDhEtJ7RSD6SGt+igDltQ8FadcIDbmSGdfuvu3D8RXPXPhPWbdj5Hlzr22vg/rXpVFAHlZ0jxDHwbFz9GB/rUkWheILg4+y+WD3dwK9QooA4jTPBLFxJq11vx/yyi4H4muxtLWCzhWK2iWKMdlFTUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVheJdSe22WtuxWWQFmYdVXpx7mt2uG8YXlva65meTYvkLlyPlXlup7UAU9q4IwCD1z3+tUjpVqF/dK0L9nibaR+X9avWs0c8YkixIh6MOhqyphIwwx9O1AGTawXdsnzTC5Xvv4b8D0rUt5ypAcEqex7VKLYNzG4KmoZLeVDgqfrQAl7AOQ4yj0+xX94R1wtWmjMliM/eHSorBDmRiOgxQBUcDJGM1aHyWGO7tUMMLSzbQO/NaU0KhVypIUcKKAMfT7JmlllfIDkEk+gqzcSomUjI56n1p1w80g2hGVB2ArPvrJLmIx3Cnae2aAPOfiVayeH9esPHelxPMLALBrMEPJmsmYZYj1U9M+3Za+hrG+tr7ToL+znSWzniWaKVT8rIwyGHtg5rjPDWmWkt3c2P2WI2Mtq8dzEVysiNxtYd8jd+tcN8N7y68L63q/wALLydpIrJzd6VcO2TJYuc+XnuyscH8ewoA9Le9AS91CTiPBdc/3QMD8/61y3hBTJrSzOMsqtIfqeP61o+LpwscOmwn5nw8uOy9hR4QgCyXcvYbYx/M/wBKAOzH3c1Uuuhqxu+UVXn6UAeOaMn9ofHrxbc9f7L0y0ss/wB3zMy4H5dq9c0XVnEi21224HhJD1z6H/GvKfg6P7Q1Tx9rZ5F3rstvG2fvRwqFU/qa72dME0Ad1RVHRbo3enxuxzIvyP8AUf5zV6gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuI8QRhtYvVcZD7QQe42j/AOvXb1yviu2aO7S7A/dOoRj/AHWHTP1z+lAHMjTLVceVGYmAxujYof0qxDA6HiaV19Hwf1p01xHbqGkZFBOBuPU1UuNWiyI7d/PlJwFiBYD3OKANRZfJjKp989T6VfsZ2ljIkwdtY1v5jqN6kE9jjP6Vov8A6Nbhf4260AaC3ELfIuMipUWMggcHvWDbsRMp96sTTsLoFTgUAakdusTMU781VurWWRi28/SnXMxRARVdb0g8mgCF7WcZ2kk/WqjWmpO/yLbqvq24mt2CcSEYNVL/AF60spGidZXlTgqFx+poAXSrK9t4JIzcAGVtzvGm1j7Z9K4zxb4Wl8R+PtAh8OzLp2raB/ptzqbLvWOKXcog2ceYZNjE5YbVBPO4A6934rvZspZRJbr03H5m/wAK5y3ltrDUtWXxbp0mreG9aSE3TGA3HkTRElTJGAWZGG3kA7SmTwcgASdtQs7O38SvqK6zoN5cG3mne2+zz2r+YYgxAJV494C8BSoIPIzjvvDEPl6Ur4wZWLn+Q/QCvIvM8HaXpQ8E+CVt5tV1L9/fXy2pt/8ARUm8zGWA3tg+WoXOOScYxXtVoI7W3tLZ3VXKhEViAWIHOB34BNAGj2ridT1C/wBVvNYa31T+xtB0gmKe7hjjkuLicIJHSPzAUVVUgZKsS2QMbST2ma8w8Xto2gpq1n4102K88Lavd/aLa7a2F0bO7kj8sqYsFsnBZXUE5ZlOOMgEfguyi8HWGiwaXeHUfC2tSGSC4uAoure4lUyhZSvysGAIyACGwOQRjtbkVyGhaVZSx6HpXhzRH0zQNLkS6ubuay+xS6hcJGUT90Qr997O4GSoAzzjs7rG2gC/4Rbm8j7ZV/zBH9K6Kua8J/8AHzdf7q/zNdLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVfUAWsLgKgdvLbCkZBOKsUUAeVxaTYFUZ7WKR8D5nG4/rWla2yogjjTZGOBjtVvVbQ2F+yAYjYloz2x6fhVGW6HnJCWJkYZCjsPWgC/CscRJB3MB1qvcOZGBNKDtgJPVjgVREwuH8qFxhT87A9PYe9AFy3UmUe1JKcyk+9WLRFRGbPQcVnTziO4jQnmTOB69KANq4IKQqTw64/GsyVWjLAjJHb1q3cvm2g9QKjdvMjyCNw6g0AV7S5YLvIwF4b/ZPv6fyq/qFhDrFoOQlyg+R/6H2rOaRrdvtCKC6DJU9GXup9iK2rq3/s+WKWAk2c2NhP8AATzj6elAHERq0UzwzJslQ7WU9jV68unsdLmuobOe8eJd/kW+PMcdwoJAJxnjPPStLxTZB4F1GAfvEwJcd19fwqnp8olhBFAHgPj/AOKXhnU7nQ9c0iS7g1zRrwMbaeAo80LHbLESMgcep9e5rc+E/j+7+Ivx+lvpw8WnWmnzrYWxP+qQsgLHtvbufoOgFZ/x7+Fn9oSyeIPDNr/p21pLy1iX/XADJkUD+LGcjv169ee/Y+jV/idqDMMlNJlZfY+bCP5E0AfSPxpuL6z+GWuXukXEltf2caXUM0f3lMciufwIUgjoQSDxXhl38X9L8enwJa668WmtZ6n9u1UvkQ/uEyhU9w5JG3k5GOeCforx3Zf2l4K1+xxk3OnzxAe7RsBX58+GNBv/ABNr1npGkQma8un2IOwHdiewAySfQUAfcnhH4k6F4y1m4sfDQvL2K3TfPeCAxwR9guWwxJ5wAOxPaunu2rD+H/g+w8C+FrbR9OAZl+e4nxhp5T95z/IDsABWtcNk0AbHhJf3l4/b5F/n/jXRVj+F4imnNIRzK5b8Bx/StigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKoa/cyWWhajdQYEsFtJKmRkblUkfqKAL9FcRo2n+KdQ0ixvH8WBGuII5io02LALKDjr71d/sTxP8A9Dd/5TIv8aAOjvLSG8h8u4QOvUeoPqD2rhbzTl07VbtF3neVZWc5JXH8s5rX/sTxP/0N3/lMi/xqpf8AhXX75QLjxXuK/dYabECPoc0AZOqXTRQKI/8AWyMIox/tHv8Ah1/ClsbOK0hWKBQAOrd2Pck0XHw91khZR4qklljO5N1jHwfzquvhjXQf+RpYEeunx8frQBrPIIwqdh1rGsN93qc842tBGTFE3r/eI/HjPtUGpeF9cktjEfFL5lYJxYxg8nrnNTW3hLWraBIYfFDLGo2gf2fH0/OgDcuMBI17Y4rPe8jiuo7dziST7nvWfreia/Z6Vd3a+Jy7W8DyhTYRgEqpOOvtT7QHU9CsJp/9fLFFKGUYIcgHI9OTQBrRwvdzJbR/flO36DufwFd1PaxT2bW0i5iK7fp6VDpumW+nofJUmRh80jnLH8au0AcpahleazuQGKkxuCPvD1/EVyVsjWGp3Fk54RvlPqOo/Su412PydUt7gfdlXy2+o5H6E/lXLeLovJ1K0u1HEimNvqOR/P8ASgCfTPm12P8A2Ymb+Q/rXIv4f8H/AA7+I934qm1S00ttVtHhezkbG5zIjNJGo5wdvPHB+uK3n1e30LTdZ169BNvY2u7AOC56hB7khQPcivmi/vrzV9TutV1aTzdRu23yt2UdkX0VRwB+PUk1y4rFLDxTtds97IMhqZzVlFS5Yx3e/ol5s+rdC8XeHvEkkkGj6tZ3sqrl4Ucb9vrtPOPfGK4H4H/C+H4f2F1eagEk1y7JVnBDCCEH5YwfU4BY+uB2yfCTNcWc0N/p7mLULRvPt5R1Vx0/A9CO4JFfXGn341nSdMvLRQRfwxzRjPGHUMOfoaWExSxEW7WaHxBkUsmqxhzc0ZLR2ttuiWabOarIj3NxHDH9+Rto9verbaTqJk2/Z/8AgW8ba3dH0lLEmWQiS4YY3Doo9BXWeAaMESwQJEgwqKFFPoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoormtc8Sz2+sDRtC0xtV1fyhPKhmEMFvGSQpllw20sQcKFZjgnGBmgDpaK5DR/F88moWFnrunQWZ1EH7DeWV59ss7kgFtgl2IQ5UEgFQCAcE4rB+MvxA1f4bpp2sppMWqeHJW+z3ioxjmt5DyrhuQVIyMEDkDn5uAD02srxZ/wAirrP/AF5Tf+gGuN8B/GjwT4z8uKx1VLO/f/lzv8QyE+iknax9lJNdl4s/5FXWf+vKb/0A0AHhP/kVdG/68of/AEAVq1leE/8AkVdG/wCvKH/0AVq0AFecw+KvEev+OvEujeGhpFra+H/Ijla/ikke6lkXfhSjr5SgDG4h+eQD0r0aua1nwN4e1jV5NTvbKQXssawzyW91NALiMdElWN1Eq9sOCMcdKAOXj8R+Lj8YG8Ite6D9iXTBq5mGmTeYY/P8vyf+PjG7HO/GM/w1U8IeIvEfinx7f2kE+i6h4X00tDdapbWEtsZLjB/cwkzuH2nbubGOw6g16EPDulf8JO3iEWv/ABOGs/7PNx5jf6jfv2bc7fvc5xn3rK8M/D/QPDH2ZdCTU7WC2z5Vt/a928C5zn900pQ9SeV689aANS40gybWWblDuUFep96gaKVThonB9lyK3qKAOQ8TW8zeGNXPlMALObk8fwGk8BaIItB0e5umV3FrEyIOi/IOT6mtvxZ/yKus/wDXlN/6AaPCf/Iq6N/15Q/+gCgDVorF/wCEs8Of2t/ZX9v6R/ae7Z9j+2R+du9Nm7dn2xWtc3ENtF5tzNHDHuVd8jBRliABk9ySAPc0AUPEUW/TS4+9C6yD6A8/oTXL+LYxNonmjrE6v/7L/Wuv1r/kD33/AFwf/wBBNYCxpeac0Mh+WRdv0yKAPIPjVcfZPAOk6fn95qd+ski56xxqXz/30sX5143Xs3xd0W78TeK00/TJbcf2Do7XzQOxDyLI+DsABBIEI4OPvD1rg7HwLrF9pmjXlqsDnV53htYNxEjbc7nORgKMHnP4V4WYxnUrWS2X9fmfq3BlXD4XL3KpNJyk9/TT8It/ecrX0v8ACp3XwP4K8w8iytQv+6YwF/TFfPviPRk0a1uJF1fS714GKSx2sj7kIB/vooYcHlcj9K+j/h7ZGDRfCtljH2azgUj02RD19wK2yqLjz38v1PN49rwqrD8n97/23uelUUUV65+dhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFBOBk9KACq2o39nplpJdald29paxjLzTyCNF+rE4FeXa38TtR8QatPoHwosItZvom2XWrzkjT7M/wC+P9Y3sv4buRT9M+DVjqF1HqfxG1S88XasPmC3TGO0hPpHCpxj65B64FAFi/8Ajl4KiuWtdKur7XrxesGkWclwfwbAU/garj4meLb/AJ0H4V+IJlPT+0riKwP4h84r03TdOstKtFtdMs7aztl+7FbxLGg+iqAKtUAeUjXPjBd4MHhDw3p+eovNSaXt/wBM6BD8a5zmS78AWoA4EUd05P13f0r1aigDyk6D8XpQFfxl4egz1aLSyxX6Bjg/jUHh6y1PS9U1nQfF/ime31zV7iO/tdYsoorf7UixJGYUDq6Bk8vJXGSH3Dvj12qup6bY6rZvaapZ217aP96G5iWRG+qsCDQB4nZeHdS0/wAEaB4FtfEVy/ixjZz5IiuE0Zbd1dpAqqvyZXYA5O4tjpurD+OWkeMPD/w11WfxT8T01GwnUW62B8PW0ZupGOVQMGyp43bhyNuRyK+gtG0TStDt2t9E0yx06BjuMdpbpCpPrhQBXP8AjP4eaF411Wwu/E0c99b2KnybFpSsG8nl2VcFjjA5OMDpycgH56+GPC+ueKb37J4d0q71CbjcIIyVT3Zuij3JFfVvw2+HXxG8K+E9RfxF4r8nTFsZf+JOMXWB5bfLvbiPH+xkV9BaXptjpNjHZ6XZ29laRjCQ28YjRfoBxVXxZ/yKus/9eU3/AKAaADwn/wAiro3/AF5Q/wDoArVrK8J/8iro3/XlD/6AK1aAOI+Ivj5PBN9oiXGnPdWd60pubhJdptIo9m6Xbg7wA+SARgAnnpUOm/FDRJdNlutSMtsVubyIR20Ut4fJt5mjadvKQ7EOAdzAKM4ycV0ms+HLHWNW06/vhI7WMc8Sw8GORZkCOHBHPA7EfjXBxfAzwrBpenWNu90FsBMkUk8NrdNskk3lSs8LpwehChsdSaAO3g8X6FcbjBfrIFv10wlY3INwyK6oDjnKup3D5eetZafEzwtJYWt7De3k1vdqZLdodNuZDMgXczIqxksqgjcQMKThsHioY/htpsWrx3kGo6nDbrexaibCIwrbtcRxrGHwI9wyqLlQwX0Ap6/Duxg0jQbLTdV1fTptFtHsbe9tpIvOaFwoZH3RspzsQ5CggqCCKAN2w8UaDqF5b2dlrWnT3lxAtzFbJcoZXiZdwcJndgg5zjpWxVLQ9MtdE0ax0vT0KWdlAlvCpOSEVQoye/Aq7QBleLP+RV1n/rym/wDQDXj1vr/jy48OaDomt+GYdL0bUmtLF9ZstUUskTlVwExuVnX5AwPyls9cV7D4s/5FXWf+vKb/ANANUNP0m01z4f6fpuoxmS1uLCFWCsVYfIpDKw5DAgEEcggEUAcLNdzp4zTwSvgN28L/AGFx9lBs/LZRMqC5A8zO3aen3+c7c1i33jTwlceDPFXw+1/xLbx6jbfbNNga9dgSikiEtIw2ll+VSSckpk8k16H/AMIz4n2/Z/8AhLYfs4Xyvtf9lr/aHl/3fP3+Xn38rrzivMPjXp/iObQIfBXw78GzXVnFGY7jUrmFDweWWNpersSWaTrknBzkgA84+Df7QVzpmnt4d8cyy3enPEYrfUDlpYMggLJ3dPf7w9xjH0voVzDd2ME9tLHNBIgdJI2DKwI4II6ivj2D9nb4jPC8lzpNraIilj5t7EeB/uM1eufBDwP8QPBV0kN1qWkT6DI2ZbJppGaPnlozswp74zg98HkAFV/Fi6T8edU1a4f/AEFLlbGYY3DyREqPwOuG3Nj2xWvefEHRtN+IeiS6QHm8NaXafY02IwbDj5nAbByPlzkc7T615Nqk/wBq1zWLnOfP1C6lB9mmcjr2xiq9fOVsVONSSXe/3f8ADH7PlmQ4arg6NSond01Frp7yevquZpPzNXxHo2meS1tpWtx6g95cLawRxQSowWRggLl1UBvmHC7u/I7/AFj4WiU387KoCwxhFwMAZP8A9avlXwBY/wBpePdCtzykUxu5PZYlLA/99+WPxr678LweVpvmsPmuGMn4dB+g/WvSy2P7pyta7PieNareOjRcnLkit7bvXol0sct4i0H4gfaZp/DfjKzEbMSlpqGmIVUZzgSJzx05U1yt1rvxi0Yk6hpGlXsQ+9LY2bXK/gBOkn/kM17VRXdOLktHb+vO58XUg5qyk16W/VNHg9v8ZdbiuhbXdnoJuu9tcTT2Ex5/uSIzD8uK34PizqC4+2eFGPr9j1BJfy3rHXqGoafZ6jbmDULS3u4D1jnjWRT+BGK4zUfhR4UuAxsLOfR5T0bTJ2gVf+2QPl/mprhqUcZHWlVT/wAUf1VvyPMq4fMI60ayflKP6xt+RTg+Lukn/j90bX7L132qTf8Aol3/AM/jWnbfFLwZMcSa9BZn/qIRyWf/AKOVa5DUvhf4gsstoutWmpxjpDqUXkSH/trGCv8A5DFcnq0ep6ErHxFot9p8S5zchPPt8epkjyFH+/trgq47MsNrUoqS7xb/AOC/wPNrZlm+E1rYdTXeDf5av8D6E0zVdP1WLzdLv7S9i/v28yyD81Jq5Xy6mmaJqQjvIbWxnJ5S5hVd31V15/I1qWU+saYQdJ8R6za46JJc/ak+m2YOAPpj8KypcT4du1WDi/v/AK+4wo8ZYWT5a0JRf3/5P8D6OorxTT/iN4rsSFvrTStYiH8UZezlx/4+rH/vkV02nfFzQXwus2up6NJ3a5tzJFn/AK6RF1A92K169DM8LiP4dRX+5/cz3cLnGCxX8Kqm+2z+52Z6LRWfo2taXrlt9o0bUbO/g/56W0yyAfUqTitCu49Iq6fqFpqKTPYzpMsMz28m08pIjFWUjsQR/I9CKtV88w6te+CfiZ4rv7BJLiybUz/aNgnWVHijlEsY/wCeiiTP+2vHXbj3zStRtNW0221DTZ0uLK5jEsMqHh1IyDWFHEQrOUYvWLs/68zmw+Lp4iU4wesXZrt/w/QtUUUVudIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUANkdIo2kkZURQWZmOAAOpJrxPUb/U/jVqlxpXh67l0/4fWkxhv9ShYrLqjAfNDDxxHzgt3z36G38Rb+++IXi8/Drw7cyW+l26rN4j1CE8pGfu2yn+8/f29QGFer6NpdloulWum6VbR2tjaxiOKGMYCqP89e55oAi8PaHpvhzSLfS9Es4rOwgGEiiGAPUnuSe5PJrRoooAKKKKACiiigAooooAKKKKACsrxZ/yKus/9eU3/oBrVqnrNo1/o99ZowRriCSEMegLKRn9aAOC8bWF3qPwTt4NP+2G4W2spdtnEJZWVGiZtqlW3EAE4Aycd+hzrzUvFUdl4gvba98T3VlZrbLYRppsUNxc+ZGod2D2xb5WJYhYsjB+U8LXTaZaeNrDTbSzRvDjrbwpCGPn5IVQM/pVr/iuP+pa/wDI9AHn/hfUPiBraWVrfXus6bH9rvle8GnIJHiSOJoMmW2QDLM4z5SbtpGMjIdpXiDxvNqWhNf/ANsk3NhbvcWlvprQpBMYN0hlaS1ZWG/qFnRgfl2k5rvv+K4/6lr/AMj0f8Vx/wBS1/5HoA82af4lQ+HTfDWNcmvl8OQ6p9mbSrf5r85322BCDjGAUHz55yOlWryy1dfiFZajcf2zYWMOr30Qk07SkfcjxwbGcCFyVcqymU9l+8MZrv8A/iuP+pa/8j0f8Vx/1LX/AJHoA8h0668baB4N0HTtHk19ViNxFfvPprK9rIuPKSPZZSl42y5LBHBIA3rwD163fji40rWru51W6sZrW1tDbrb6SzxzSvAhlIUwNMQHLYATKH7wIBWuv/4rj/qWv/I9H/Fcf9S1/wCR6AMvQr3Ur/4XatNrS6kLvyLpd1+ipI6hSAwAhhIU9t0at6iup8J/8iro3/XlD/6AKwNTtPG1/pt3Zu3hxFuIXhLDz8gMpGf1rqNGtGsNHsbN2DtbwRwlh0JVQM/pQBcooooAraoN2mXa5xmFxn/gJrmNN4jH0rptVbbpd43pC5/8dNczYcRj6UAfHlu5kjMjnLOzOx9yxJqWr3ifSZfDPiO+0m9Qw7J5GtWfgTQliUZT0PBAOOhBFVtOsrzWNTh0vSIxNfzHAH8MS95H9FHX36DJNfL1KM3WcEtWz93wWY4anltPEymuSMVf5Lb16WO1+FFxpmhrqnijxDcmz03zI9LjuPLdwuSGlJ2gkAnYuemVxX0boXjvwjrComj+I9HuDgARR3abx6fKTkflXP8AgvwZpkfhxvD9xAt1pcVobWVZB/ri/Lsf9onJyOhaviv4xfD+7+HXjK40qcvLYyfvrK4I/wBbETxn/aHQj1GehFfSUaapQUF0PxXMcZLHYqpiZfad/l0XyWh+jYORkdKK+Df2evDmq+KNf+xWnjm58NLGBItvb3Ekc9yvOfKXIUjg5OTj+6RX3Lo1h/ZemW9mbu7vDEu03F3J5ksnuzYGT9AK0OIu0UUUAFFFFAHHeIPhv4Y1qeS6aw+wag/LXmnubeVj6tt4f/gYYVwur/DjxNpQZ9Ju7bXrYciKfFtc49Aw/duenURiva6K48TgMPil++gn59fv3ODGZZhcarV4Jvv1+9anzNLqC2t8tjqtvc6Xft923vozEz/7hPyv9UJq7X0Fqmm2WrWUlnqlnb3lpIMPDcRiRG+oPFea658JkhDzeD9SewfqLG8LT2reyknfH+BKj+7XzWM4Xa97DS+T/wA/69T4/H8GtXlg5/KX+f8AmvmecXGkWE9yLprZEux0uYSYph9JFww/OtjTte8VaRj+zfEU9xEOkGqRi6T/AL7ysv5uaz9Va98P3KW3iiwk0uVztjmZg9tKfRJhxn/Zba3tU9eH7fHZdLkcnHye3+R859ZzLKZ+zcpQfZ7fJO6ZXNxqOoa/q+qarBZwy3skT7bV2ZSViWMk7gCCQi8c/U1qeDPEreBdUczknwxeSbrlP+fGUnmdf9gn747feH8WadIwDKQwBBGCD3pUM1r0sV9a6vfsxYbOsRQxjxl7t7rZNf1+J9FxuksayRsrowDKynIIPQg06vEfhn4rPha8t/D2qyE6FcOI9OuHP/HpITxAx7Rk4CHsfl6Fa9ur9GwuKp4ukqtJ6P8Aqx+sYLG0sdRVei7p/h5MKKKK6DrCiiigAooooAKKKKACiiigAooooAK474s+Lz4L8F3Wo20fn6pMy2mn2+Mma5kOEUDvjlseimuxryC9X/hN/wBoCC1b95o/gu2FxIP4WvphlM+u1BkehB9TQB1Xwk8Gf8IX4Sitbp/tGs3bm71O6Y7mmuH5Ylu4HQfTPUmu1oooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAo64wXR7wnvEy/mMf1rAtBiMVseJ2xo8i92dFH/fYP8AIGsiA4jFAEWq6ZYaram31Sytb23Jz5VzEsi/kwIrOsdI0vRoWh0fTrLT4WO5ktYFiUn1IUCtp24rNvCzKVj++3yr9TwKAOk8MQmPTPMYczOZPw6D9AK5b41/Du1+I/g2bT22R6nb5msLhv8AlnJj7pP91uh/A9QK7u2iWC3iiThY1Cj8BUlAHingT4Xad4h+DHhrTPFVhNZa1p6SrFdRHy7qzkEzn5XHvzg5FS+G38Wwy6vovjDxpaW2i6JOlqdYiVYLq7Z4kkWN3kyqEK6kkAsdw+bgk+zVwus6fd6P4g1G/TRjruhaoY5ru1jCPNBcIixiRUchXVkRAQDuBQEBsnABg+EvFRNjoetaXrk+r+H9Skgt7u0vZI5brTpZyFhO9MHBdlRlfJ+bIPBB9YrwrV7TWdE8IaNa+DfBV9Loei3FtcXi3jRxX1+sDBk2ImdxDKrEsASQAqnJr1LwJ400Txxoq6loF0JUB2zQv8ssD/3ZF6qf0PbNAHR0UUUAFFFFABRRVfUI7qWylSwnit7phiOWWIyqh9SoZc/mP6UAZni7WND0bRpZfE09rHYS/uzFOu/zif4FjwS5P90An2r56iijfX5rnQbK40jw6yYj0+6k8xy399V/5Yr/ALG5vovSvQH+D+p3eryapq/jKa/1BsgXElgu6NSfuoC5VF9lA981dT4SSkZl8V6ju/6Z20Cj8ipP614ma4bF4yPsaUYqPd7/AC00/P0Pnc7wmNx8HQoxio95av5aO3rv6HDUV36/CG148zxT4jcdx/oig/lb5H51Mnwj0jP73WNflHYG5Rcf98oK+fXC+K6zj+P+R8suC8Z1nH73/keaXdtDeWstvdRrLBKpV0YcMDXefCvxlNHcxeFvENw0lyFP9m3srZN1Go5jc/8APVB3/jHPUNWovwk8OgfvLjWpG/vHUpV/RSB+lTxfCfwjHPbzfY9ReSCRZozJq944V1OVbBlIyDyK9jKspxWAqX504vda/wBXPfyTI8ZldXm9onB7rX715nQeOE1Z/CGrjw3ctbayts72kixrIfMAyo2sCDnGOh614v4V+K+seMNU+HdhpeoJA72UuoeI3WJG+SElCpBU7Nzo33cHDrjFfQdcH4H+Ffh3wZ4j13WdJW5e51ct5sc7K0cSlyxSMBQQpJHBJ+6K+jPrDntD+M66ifDl/caE1t4d8Q6g+nafe/a983mB9imSHYAqswIyHbGORVDTvjjc3dto123hhEtNT1l9DjZdR3OswICsV8oDYSRk5yOeDxnp9G+EPh/SrzSmiudTm07SbqS90/TJpUa2tZnOdy4QOcHkBnYA1Qn+FPhLQdB037fq99aado+sf26txdXMMaiYsOJGKAbMgDHB560Act4h+Jx1y00vz7TVtLvbDxjFolxDpuq+WjuN3LP5WZYjjlCq59RUf/Ca+KbzS/iyNZc/2dos0scT6ff/AGa5tgoyqROIOc4++3I9DXR6Z8PfAmt3Vwmk+JJL+ZtcTxTIlrfQSlZju28KpIiO4+5/vVvXnws0m4n8VGPUtWt7XxKpGoWkUkRiLlceYm6Msrcn+LHqDxgA46w+L93Y20Wl2Ggyag9h4Ug197i91XEssYjjLKzeSdz4YndxuPYZ41IfjKNUn0q28O6Ebu5udGbXLkXV35CW0AyCu5Ucs2RgDAHI5GeNe3+EOgQXdzcJd6oXn8Pjw2wMseBbBFTePk/1mFHPT/Zrn9f+ElzYw6YvglvKurTSZNIN7dal5LyQsSdkiC2kDjJJypjb0IwCAD0D4a+Kv+E28EaX4i+x/YvtyO32fzfN2bXZfvYGfu56DrXTVzPw08LnwX4F0fw+1wLl7KIq8oXaGYsWbA9MscV01ABRRRQBHcTR21vLPO4SKJS7seiqBkmvLf2cYJLrwZqHie7QreeJdTudSfd1VC5VF+gCkj/erofjVqJ0r4TeLLpW2v8A2fLErejOuwH65YVpfDjTBo3w/wDDenBdpttOgjYYx83ljcfxOTQB0dFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGV4jiaaziCgnbIGP5GsaEFRgiutYAggjINUprCNjlPloAwZD8tM0yH7Rq9up+6hMh/Dp+uK2m0zd0K1PYaeLWZ5MgsV28dqAL1FFFABRRRQAV5h48+G9xJrLeLfh/dpo3i5OZARi21Fe6TqO5/vfn2I9PooA4L4cfEa38UzXGj6vaPovi2x+W80q4OG/34j/Gh65Ge3Ygnva4j4kfDyw8ZxQXcU0ml+IrL5rDVrb5ZoG64OMbk9VPqcYzWN8P/AIg3662PBvxDgj07xZGP3E6cW+qIB/rIjgDd6r+WOVUA9B17V7PQdHu9U1KQx2drGZJGCljj0AHJJOAB6mr45FcN8UtO17VIdEg0O0sbi0ivlur37ZOY4wIwWj3AAllEgViBydgHGSRz3wv8c/2x4rlsLjVbvVpb60F3FL9nNtDEqnokDKGVGDqVkLPv5BIK4oA9aooooAKKKKACiiigAooooAKwvH1/c6V4F8R6jYSeVeWmm3NxBJtDbHSJmU4IIOCBwRit2orq3hvLWa2u4Y57eZDHLFKoZHUjBVgeCCDgg0AfOMvjrx5pHwx8N+IL7XxqD+Jbq0tVePToIW05Tv3srMRG7vgYMm1Bg8AHjK+LF54vu/A99ZeLZriJLXxBaCz85rJriWCTeVFwkG5Ay7RjAUNnkHHH0wdF0o6N/ZB0yx/snZ5f2LyE8jZ/d8vG3HtiqMPg3wxBYGxg8OaLHZNKs5t0sYhGZF6PtC43DsetAHz54v8AEuq+A/iB8UdV0tn1DUrXS9NiFxcopOWEaGV1RVXIznAAGccY4rq7bXfHKaf4l/tLXZdL01dJTUtN1fURpzTq6hdwaKAurQsScHaSMgAk4z7P/Y2mfbbu8/s6y+13kYiuZ/IXzJ0AwFdsZYY4way4fAvhGC2nt4fC2gx28+3zYk06ELJtOV3ALg4PIz0oA4D9n3xtrvj3+2dS8QX0UElv5MC6NFAE8kGMN57MV3nzOSoztAz14x7FVGDSNNg1SbUoNPs49RmjEUt0kKrK6DGFZwMkDA4J7Cr1ABRRRQAUUUUAeWftPOw+CevQxEiW4e2hTHGSbiPj8ga9RjRY41SMBUUBVA7AV5Z+0/8AJ8F9ZuRybaa1m2/3sXEYx7da9VoAKKK5f4lTTw+ELg2txPbSPcWsXmwSGN1V7iNWww5GVYjj1oA6iiuV/wCEItP+gx4k/wDBzcf/ABdH/CEWn/QY8Sf+Dm4/+LoA6qivNtWj8F6PfPZat48urC8QAvBdeJ3ikUEZGVaQEZBBrbg8HafcQRzW+ueIZYZFDpImtXDKykZBBD8gjvQB11Fcjc+D9OtbeW4udd8QwwRIZJJJNbuFVFAyWJL4AA5zTLLwnpd9aQ3Vjr+v3NrMgkimh1yd0dTyGVg+CD6igDsaK4S40LRLfXLPR5fEHiMaldxSTxQDVrpiY0KhmJDYUZYDkjJPGa0f+EItP+gx4k/8HNx/8XQB1VFcr/whFp/0GPEn/g5uP/i6qab4a0bVIGm0zxJrd5CjtE0lvr08ih1OGUlXPIPUdqAO1orz+70nQLPxFYaFceIfEiarfxyS28H9q3Z3qnLHcDtGM9yPatb/AIQi0/6DHiT/AMHNx/8AF0AdVRXm0cHhN9WvNMbxbrcV9aXMVlLFPrVzFmeVd0calmAdmXkBSa3/APhCLT/oMeJP/Bzcf/F0AdVRXK/8IRaf9BjxJ/4Obj/4uj/hCLT/AKDHiT/wc3H/AMXQB1VFedeMPD40LRV1Cw1jxB9oivLRQJdVnkUhriNGBUtggqxHNei0AFFFFABRRRQAUUUUAFGBRRQAUUUUAFFFFABRRRQAUUUUAFcx8QvBOkeOtDOn6xEVkQ+Za3cXyzWsnZ0bseBx0OOa6eigDyTwR401fw34jg8DfEmRDqLjGla0Bti1NBxtYn7so4yO59yC2Z8RNItPDerW1j4e8M6g9pqlys99DpoeMX/DqLdZUz5SqxWRlOxCGcg/eB9P8b+EtI8aaDNpOvWwmt35RxxJC/Z42/hYev4HIJFef+BfFGseDfEdv4D+IU5naXK6LrjcJfIOkUhPSUcDnr7kgsAbvw31MaRaP4f1XUWurqxP+kTl91tZPI48uyEzndI6hgBnJxjOMqK9CryDxv4Il0Nb/V/D6aneGaWaWC3hPm/2XPMr77uGEgmRzIy5HVVLbRXa+CGv9K8HW0/irUHEjBZd1+ypLbhwuIZXzhmVmK7uM8cZ6gHVUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5/8AH+yN/wDBrxZCoJK2Zm4/6ZsJP/Za6rwjejU/Cei36kFbqygnBHT5o1b+tS+I9NXWfD2qaY+Nt7ay2x3DIw6Fefzrif2dtTOp/B3w4ZMie0iaykQ9UMTsgB/4Cqn8aAPR65X4nf8AIoSf9ftl/wClcNdVXK/E7/kUJP8Ar9sv/SuGgDqqKKKAPP8A4j+HtU1jxf4BvtOtfOtdL1J7i7fzFXykMZAOCQTz2GTXK3ug/EN/HM1xDPqOw69HcRXo1ECwTSwvzQNbeYCZPU+Xyedwr2qigDwnRvD3xDi8Sa3PdjXv7Gntr5dIt31pXeykYfuzMfMzJu/g+Z/L746i14T0Hxva6vpcnjGDxDqlmmm2UcS2GsiEWtwoHnm5Hnp5xLc7syDHGDXb+MvGsXhnxNptldM5t57C8vpI47UO7LboHOJDKoU46DY2fVetcf4h+NdtJ4U1mbQ9K1W21WPQ11mz+2RQ7HgkYIsvEh4VmGVODwcA0AXtKhvfFE3xB8T6YJPtc1vNoeiOkmxgsKuC6NwBvnLc5/gXniuNk8GfEpdLulivPEBuW8N2xTOusT/aqyDfgmXj5M5/gPucVc0P4pan4cutWuvGNzqt7pljothdtA8Fr9o82eXYW/dbUx8y4G7hQM/Nmu21n4xeGtHm1mG+S8jl0zUItNZWESCaaRSy7GZwoUBSSzlAO9AHG6n4c+Jtz40N3cajqyWBktJIG06SNo41VB50ckbXcS8tnJ8uUnqpHQ0dD8F+MfDfhTUNJ07Q9SlupNbaZrldckVGtmL4kiRLuJiwB+YO0ZYlSd5Hy9nafHDw7fw2jaZp+sX0txHdSeVbpAWj+zgGQEmUKTtII2lgR0PStXS/ilpet3NhbeHdL1fV7m6sU1Fo7dIYzbxOdo8wyyIucg8KSeM9KAPKIvBnxEMfhe71vTtY1PUNOs9Stnmt9ViiuVaQ/uGMvnq2OmSGYgDBz0Onqfhj4qnT4Yp7vU7zURpVtFZ3Fhqot4rS7VwZHuVLp52V77ZM8jHOa7Kx+OPhG98QnSYHvGYtcLHOqxusjQqWcCNXMoyAdpZAGIOM10Hw6+IOmePrae50aCeOCJVbdNPbOx3ZwCkUruh46OFP64APPW8IeOLbxlfahaJMkd34k0m6uZ7a7SIXFpFblLglQ4JTdj5CMnjANdP8LdK8R6ffXP8AwmVtrlzq5lnLamdUEmnyIXygjtxN8ny4A/dDGDzzXplFABRRRQByvxO/5FCT/r9sv/SuGuqrlfid/wAihJ/1+2X/AKVw11VABRRRQAUUUUAFFFFABRVLVtUstJtTcahcJDGOm48sfQDua891Hx5qmqO8fhu0EMAODczgZ/DPyj6cmolNR3OihhalbWK07vY9PpryKn3mArxqRtdmw114ju0f0hZgv6Ff5VkXuv39rqUGlXWo3tzJKnmK7/d28gjdkknOOv8AWnTbqSUbWubV8F7Gm6nNe3qe33Or2Fr/AMfF3ChxnBcVVtPE2kXsLS2l9DLGrFCVboR1FfNWoTyRX0KXFztMMzbTJk5zjIz74/Sq2tST6LI9zp8jfZZ/mdVPG71rStB0pOPY9XBZHHGYFYmnJ8zvp6OzXr1R9Lt4mgEHmfY77BGR+5OD9D0qSPxNpy2AuruZbZejLIeVJOAD+OK4fTpZZfD1pKx1kBoVbGxSvQdDjp+NeWarfzN4qv0uDOtlaOsjJIcknaCoP481nc8zLsF9cxCo/efTVjqljfBjaXUMoU4ba3Q1cIz3P4V8v+EDqGyaVxJCs0xnI5BJ7V2uneKda0uKdDeoySY2mYbjH9P/AK+a7IYSco83U4sc6WHxE6NOXMou1/68z2sccUteDT/ES+sJd8upuzseBIRg/Rf8BXd6d8QraFFj12J4picCSGMtGR688/lkVlWpex+JomhGdf4ItnfVz3jvwjpXjbw7Po+txFoHIeOVDiSCQfdkQ9mGf5g8E1saff2uo24uLG4jnhPG5Gz+B9DVmsgaadmeTfDrxZqugeIR4A+IExk1dATpWqsMJqkA6ZP/AD1UdR39zy0nxm8KavrVxBeWutR2Oji2aC9+0zlILVAS7zOmdkwZRsKOOPlII5NdV8SPBGn+OvDzaffM1vdRMJrK9j/1lrMPuup/mM8j3wRznwt8ZXuo3F74L8dxxxeLtNTEoI/d6jB0E6cYII+8P0HIAI0vh54otrh7Xw9HZanbxQWKSadc6gP3l/bxhEaYjqvzMvDYJBBx6d5XjnjiG/8ADniqR9KudVhutWid4r2C0S8ubu53kx2YLqUihRRuxhQRuJYEMT6P4QTXxpQl8VzWZ1GYh2gtEIjtxtA2Bjy5yCST3JA4AoA3KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAryX4Mf8STxn8RvCbfKlpqo1K2XsIrld4C+ykY/GvWq8j8Xn/hGPj34S13Oyy8QWsmiXR7eap8yEn3Y4UewNAHrlcr8Tv+RQk/6/bL/wBK4a6quV+J3/IoSf8AX7Zf+lcNAHQX+pWOnG2GoXttam5mW3gE8qp5srfdjXJ+Zjg4A5OKtVx3xJsdfvv+EW/4Rp7lfI161n1DybgQ5s13eaG+Yb15XKc59DXA+D/DXxBsfEXhe+1K41do11DURqqT6r50RtWH+j5jMhXqTjaNw74wKAPb6K8j+J2keNLzxnaXnhhNUurKOOOJrV737JZZ35eTfDdRy7gvGGjkFc5okPiu8+KnivQoNd1W40XQGnv4ngui0zy3MK+TbEyMFYRneyq7bcgbuOgB6x4w0XwvdTW+p+Kfs0TRRS2EU9xdNAoW4Gx4/vAEsOB39MVVk+GfhGSEwvpOYzpa6Lj7TN/x5qwcRff/ALwB3fe968c1DwB4+1fwZqOnanaajeSW95ZXNtLd6s6XV2EYmXMf2uWGM4Y42ugOAcZAxt33hv4iyeNRdW93r9royyWcljHFcpcNBEqjzIbhXvUV2z95isxbqG7EA9M1D4deFdRS+S90lZlvbSGxnDTyfPDEQY1+9wVIB3DB461nr4E8CxXd1o7QxtqV88epSRS6lM92zRfIk6s0hkUrkjepHJ6157png74hteaK2oXWvCKS41VdSxrj8Qlc2eAJeDu6FOQOGwKUeHvi1LoenJDe3dtqieG5bWaSa/R1+2faAVyA5BkMQIEmDgnk0Aeqr4C8Pm6trqa3vLq6t4ZoIprvUbm4dY5l2yLukkJII9enbFZt54I8E6Da2F1MP7GisYVsYbqPVZ7MiMtlYmkWRS43HgMTyaveB7S6tvD08X2DXNNvSuP+J1qX29mk2Abgwmk+XPb5c8/KK80Tw948/wCECmtBbeJx4y8yIz6i2uqbadRcqz+Svn4j/dg8eWnAI5zggHp9r4D0GyurmfT4tQsftLySSQ2eqXUEJdwQzCJJAgY5zkKCDgjBANWvDvhHRfD19fXumW83269CC4urq6muppAowoMkrM2AO2cV5bd+DPiFNH471G017WrbU5r+ZdGtJNRVrZrRnjO5VyfLfaHVckbc9BnNWdU0nxdHf+HLvw5pfiq2sLf7dFqFle64k80jy26pDLua5dWRXBIG4FSCQvOSAeqSa9psfiSHQHucavNbNeJB5bcxKwUtuxt6kDGc+1WdR1Kx0yKOTUr22s45ZFhR7iVYw7t91ASRlj2HU14HZeEviHbQ6PqVxpk+o61beGZrGY3GreXI9y10GCmZJA+fL5DBgOANwrOvPAHxC1fQNRh1m31S6W31ixv7C1l1TEhiAPnqha5kwQSMb5e2VIJxQB9HWmpWN5dXdtaXttPcWjBLiKKVWeFiMgOAcqSOcGrVeI6loHj+S61l7L+2U0iTVNOljsjqo+0yWKQ4niil8392+/GTvXcQTuOcmDTfCvxCubjw5Dqt3rEWkjUtRe4jTVytxb2TxgW0c0qSbpXDA8guRnrQB6X8Tv8AkUJP+v2y/wDSuGuqryTT7TxFYfArSrXxo07a/FdWq3LTzLM5/wBPTZudSQx2becn35r1ugAooooAKKKKACsDxb4ns/DloHn/AHtzIP3UCnBb3PoPel8YeIrfw5phuJMPcPlYYs/fb39h3rzCztrm9vG1fWWMt5KdyIw4Qdjjt7DtWU5292O534TCKovaVPh/MR4LvWrs6l4ikdy3+qtskADtx/CPbqep99BmyAiKFRRhVUYC/QdqHJdu5JNWYYMDJFTGNj1JS+7sVGjJxk1i6w9sl/bxTcSlTtb2z0rqWjXaQe9ebfE2drHVdHl3Hypd8TexyMGurDTUKqctjixkXWoSjHf/ACKXjfTmcNsIzIuVP+0On+feuU0HVRNbvY3hzG3yjd1Rq7+X/iYaMN3LIOtc5pnhi3/tKe/u3/ck7hH2z3z+NehisPKq4uO+zI4ez5ZZzU613B6pefkdr4M1908ONY3i6nJdW5McTLOVjePtz1GOnHoKyrqSytLm4uJcS3Ezb3UMSAQMDJJ9qy9b8RRW+Le3JVSPuRj5iPf0rmb65luDbv8AZphGh3SAnhv8+9TalhlrrL+vuOnC5XjM6rzxFNeypTf4dktL6/I6HWfFslpGAse0EZAHAx9f/rVzul6lqniXW4LC3kMCyt87ryyoOSc9uPpWDrt5JeXjSOCAegPb0FegfBXT8S3V86fM48tGP90dfzOPyrgq4yrUlyp2XkdeJynCYKfsqcbuO7et36bW+R6JaaJbadbCOyhVBjlurN7sepP1pVlMWUcBkPVWGQfqK31QFMYrK1K1wCwrAxjPoypbvdaLOdT0Bym3me1zlHXvx/nHavU/DGv2niHThc2h2uuBLET80ben09DXlFnK8UmeeKkhuZfDWrRazpyk2kh2XUC9MH/OR6Gp/hu/QjEUFiFb7XR9/J/oe11wHxZ8DS+KLO01XQJxYeLtIbz9MvRx83eJ/VG5BB457gkHt9PvYNRsobu0kEkEq7lYd/8A69WK3PCaadmcX8LPHEXjbQZJJoDZa3YSfZtTsH4e2nHB4/unBIP1HUGuS16413T/ABbJqerz6np9taaiJDeveKmnf2eOkKwhsyTScL8y7gxyDgAGT4q6Ff8AhfXk+JPg+Ay31qgj1mwTgX9oMZbH/PRAMg+g9sHrLlbD4geGdF13w/dxs8TjUNNnkBaNJdjJ+8TPONzArwQehBGaBGj4L8UW3ivRo9Rtre4s1leVEgutizfu22sWRWO0g8EHkdwK6CvEtH1jS/DHxCe+1bVbqRLi1mhnvdUt8STypICTbRqu6KBf3m5jiM/KfmILV7XHIksaSROrxuAyspyGB6EGgB1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXn3x48Pz6/8ADbUTp24arppXU7F0+8s0J3Db7ldwHua9BoIyMHpQBh+BvEMHizwhpGu2u0R31uspVTnY+MOn/AWDL+FUfid/yKEn/X7Zf+lcNcT8ICfB/jnxV8PZyUtY5Dq+jg9Dayn50X2R+Prurtvid/yKEn/X7Zf+lcNAHVUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHK/E7/kUJP8Ar9sv/SuGuqrlfid/yKEn/X7Zf+lcNdVQAUUUUAFRXdxFaW0txcOEhiUu7HsAOalrzv4r6o7pa6DaH99dMHl56LngH8Rn/gNTOXKrm+HoutUUF/SOae5fxJrU+s3in7NG2y1hboAOmR7dT6k+lXJHJOSTk8mkREt4I4IhiONQq/4/U9aZhmesoxtue42tlolsT26ZOa0QMJzUVlETjirUowKowm7soscPXB/F6wN14XM8a5e0lWXj06H+ea7yUfNmqeoWsd7ZzW86BopUKOvqCKGi4Oxwfh6UvYDPR1BNZPiS+eGLybfly2xR/tH/AAretLB9PSeNf9VGu1SeuK5myT+0fFNvA3Kp8/4k/wD1hXvVq3JSc0eLk2AjisdGnUXuxu36Lp89ESWOn2mj2outRPmTv8x3ck1m33ilZGKRQoI+wxVbx5ftLqzwRnCIdoFSeGdHjuYGe5VWibsUBPHoSMj8K8vD4eVd7n6Zj8xoZZh1Xrq7eiS/T0Rg6lIt3LvVAC3BC969y+H+kDTdBtV6koDn68n9SawNK0XSUAk+wx/KcKSgJJrs9NnEdukcA/dLwFx0p1cM4vc+Vx+fUcw5ZU6bibER5p9xEJI+lRx8gHHWracqRXKcLfU5i/t2R/l4FSWrLJE0Ew3xuNrL6itHUYNyk1jRAxyYzQ9Toi7o2PhzqbaLrk2g3chNvOd9sx6bv/rj9R716pXh+vxs1lDfW5K3Nm4dWHULn+hwfzr13w1qa6zodnfLjMqfOB2ccMPzBqabt7pw5hSvasuuj9f+CaZGRg9K8Sgx8G/iGICfL8A+Jrj90ScJpl8f4fQRvj6D2C8+21jeMvDen+LfDV/omrxCS0u4yhOOUb+F1/2lOCPpWx5hx/xG8F/2jqcuq20F3eS3UUNube1ZY5UkjL7JFmY4iTZLMj8NlW4GevUeChrNvp72GvWNnbSWhEdu9i5aB4cfIFLHfuUDadwGcAjrxyHwV8R6hs1DwR4qk3eJvDpETSsf+Py1P+qnHrwQD36Z5NWPG/ibXtG1FHS50y3CS5tdIjBnutTTIDMTwIVAJOcEDALMBkUAekUU2N1kRXjYMjAFWU5BB7inUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHk3x4sbjSU0X4g6RA0mo+Gp99widZ7J/lmT8AcjPT5jXS+Or+21X4fQahYSrNaXVxp80Mi9GRrqEg/ka7C5giureW3uY0lglQpJG4yrKRggjuCK+eNMuZvBsGt/DPVJHZLS9s7/Q5ZDnzrJ7yIlMnqUbI/wC+scCgD6Loork9S8ax22p39np+ia1rH9nlVvZrCKNkgZlDBPnkVnYKysVjDEAjuQKAOsorlPCnjjStfu9QsTd2NvqlpeXdsbH7WjzFIJmj83ZwwB256cZ6nrVtfGvhVrKa8XxLohtIZBFLOL+LZG5BIVm3YBwCcHng0AdBRWJpvi3w3qc0kOm+INIvJY4jO6W97HIyxjq5AY4Xkc9Ky9U+JHhPT7KxvW13TZ7K7uxZLcwXkTxRuVLEu27AAA59MjigDw/WvEl5He/EBrDxLqx8YWeviHQ9Mi1CWQyplcxi03FGjwXySnGOoxXV6z8SfHkF346k07T/AA89h4YVfMWRJ2ndmhDDAVtpAbOTkcD8a9H8H+PNH8ST3trHe6fFqNtd3Vv9jW8SSV44ZWj87bwQrBd3TAz1PWtG28X+Grq2luLbxDo81vE/lSSx3sTKj4LbSQ2AcKxx6A+lAHjd/wDG3VwPE0ml2+j3dpp8elmC6Te0UX2lAZZJSH5RGyMDbjueDTZ/jLr8WmarLHc+FZ1sdYayF4rrEs1ssQcyxRS3KiViSMBZehHXNet3XiDwpr6y6SviSwkleMTNFY6v5M4QAPuDROHVcYJIIBB54NVPBVx4H0qzuLfwrq2kyRz3e6do9SFzJLcy9N7s7Mztt4ySTjigDX8E6u+veE9K1WQsXu4FmJa2Nsef+mZdyv03N7EituoLW7trsSm0uIZxFI0MnlOG2Ov3lOOhHcdRVM6/o41v+xjq2n/2vt3fYftKefjGc+XndjHPTpQBp0Vza+N/DtxbSzaXrOmamYnhWRLO/gYp5siopJLgAZYdTk9FDEgGe58W6FGNVSDVdPurzS4ZJ7q0hvIfNiCAltwZwE6Yy5UDuRQBu0VyeueOtJ0zV9H0qO6sZ9U1C6igazF4gmhR0ZvMKDJI4Htz1rZ0XxBo2utcLomr6dqLW5AmFncpMYic4DbScZwevoaAMj4nf8ihJ/1+2X/pXDXVVyvxO/5FCT/r9sv/AErhrqqACiiigAJxXikV0dX8T6rq7HKbjHD9Og/8dH/j1epeMr86b4X1K5U4dYiqEdmb5QfzIryjQR5GlxRsoBZPOPqSzEfyVfzrGprJI9bL4csJVO+n6v8AQs3MpDEA1NZEsRk1nzyFpcVoWCkkVR2yWhv2YwtFwaIDtWo5jk0HLbUpzkjmo4mBYBjxUsqk1VchM+lI1STVjF1T95Y3hC4bczD6Zrzvw5MsHjKMvxuT/Gu3ku9yY7E81594htZbLUI7y2ViI2w2B265ruqVFOk6fzRrkmGdLGc83ZSi4v57HP8AikEa5KW7tXongu2E2nqMYIFed+I5EunW5jYEt1r1vwBpc8WlwPMpG6BXx6fKKrB1VCLuelxjRc6NFef6f8AkuAYkKRkqQpAxxW54SkDaeySsPOVySCcnHas7UrWTzV2jqacMWsiSQ/K69ff2rKvLmtqeDhYWhKFup1u4CponFZFndLdRB0+hHcGtGHpXKaONtya4QPGa528jKSZArpByhFYmprtJweKCqT1sQW5WVWjkGY3Uqw9iMVsfCG/eGfUtFnbLRMZYx+O1v/ZT+NYFu2GAJ6VNo1wNO+IWnXGf3dz+5fHqRtH67TWctJJmtWHtKU4eV/mj2Wiiiug+dPJvjfpV5pE2mfEXw9CZNW8PZ+2RLx9qsT/rUP8Auglh6fMeuK0vHul6f488H6bqthJbyaZOqzzytIITJatE4BL9jGZBKFbjdH2NeiyxpLG8cqK8bgqysMhgeoI7ivHfhMD4R8X+I/hnqP7zT0Dalovm/MHs5Gw8XPXaxIx3+c9KAN74R6jYWtmdBj1Fb66w96ssNs1vaSKz/MLUMfmRSRkrlQX4xkAejV5drsmuaR4xl8QeIZPC8GlW7fZtLe+1V7dYI2++20xEGVgP73A4GPmLenQyxzQpLC6yRSKGR0OQwPIIPcUAPooooAKKKKACiiigAooooAKKKKACiiigAooooAK8y+OPhOy1uw0LWZGMOoaNqdrLDKoyWR540dD7HIP1X3Nem1yvxO/5FCT/AK/bL/0rhoA6quMufCutW2s6vd+G/EUOnW2qyLPcQz6f9paOUIqF4W8xQpKouQyuMjOO1dnXK/EbxFc+G9GtLm1ksrYXF7Fay3t8pa3s0bOZZAGXIGAPvKMsMkCgDGm+GUM8aRTak3l/b9UvZPLh2swvVlUqG3cFBL97nO0cDtneH/hM2m3en3F5q0V3LZXFrKkhjuWd0gEgWNvOuZVHMmRsVQpzgc8cV4Z8Z3+h2F/dWJtNRcrrd756NMlu7f2nEnm+WJCvlgSs/O5wowHwTnWm8eaxrF3JY2Wp6TqDR39zZ22paWk8cUn/ABKpJwwRZ2DkP8vLMOMgBgCADprr4T211okOmy6kVjRdUVnitwrN9tkL/wB4/c4HOd2O3Sppfh7qk9xJqU2vWX9uG7tblJY9MKWyi3R0VTD5245EjZPmDtjAGK8/1H4v6j4d8D6JNba3ous340xbqUG3GJNoAMZle8BMowdwVZGyQSg6Vr2/iK70fWtaew+xq8moatcK19dPDArx29sy+YQwTbk8lgcdivJoA6o/DFJreKK71TcPt2p3kzQ2/ll/tqyqVU7jtKiXg852jgVQ0H4SfYLmwmvtVhvJLO4tZVdorl2eOASBY2865lUcyZGxVAOcDnjW+Hfj6DXdNtzqd9BNfXV9JZwC1tNsbskQkIDRzTowC5JcSbf4Thhg858UdVv7TxZrdjJrllaaddeGJjFZXKNm4kHm7hF+9VfMxgkhWO3Ax3oAva/8NNVv/EsmuS+I5rxYJLqa1spEl+XzYJIxECZ/KUDfwwiDYGCT1qjF8PNYj8FXE+oPFeeIE0S1sbC0s4VtltpID5kZZmkcO6y7SXyBhTheaoT/ABB8SeFtFFjcQ6XdPBaaZKl1FAY47aK4EqkyiSdVbaYQNxkjBLjOOlE3xY1xNGgup5PDtjJ9inuo5JWFxHqciTMiwW5hnZVkKgEqHlILAYOCaAPRvBfh7UvD7RW0t/HLpkVmqmNUG+e8d3ee4c7cgsWGACRyxPas4eApx4kN2NWi/so6t/bJtTZ/v/P8vZjz9+NnfGzdjjdiuUv/AIkarLr2oaWZNGBXUV07+yBGxv8AyXtkka4J8zAVC7ZPl4O0jIPWp4K8U+J9D8DaJbCPS76C18M2OqxpFbSLILZdiyxk+Yd0nl/MGAA3DG05oAseE/hTqs/hTQU8R6jb2l/YWFrax21vaY8hY7qG4dZGErCViYFXcNoGScGtmX4VTzadc6bLrkX9nrZ6jaWISw2yxfawwZpX8z97t3HAATPU5PNcL8U9YuvEGhrq1zHFFbXega9JYqikMbXNqInfJPzMBv4wMMB2NdofFXiB/ElzpOivptu8up38ZmvY57kKsEMDrhfOXGS5GAQo6gZzkAvx/De7i1NGi1q1/sxdTXVmtpNP3SvKIvLKmTzACnU425HTOKl8NeC/EHh3yYLPxFF9ha5gL20UMixW9vGr7o4VmknI3kxqQGVVUfKARzx1n8X9evdW0GFNP0y2jvrfT5jDcTQxNci4VTIYXluI2+XcVAWKTJXBIzXs2karZ6vbyz6dMZoYp5bZn2Mo8yNyjgZAyAykZGQccGgDD+J3/IoSf9ftl/6Vw11Vcr8Tv+RQk/6/bL/0rhrqqACiiigDg/jHceV4YhhBIM1woI9gCf54rlL9Ps0EDKB+4jETf7uAD+oB/Otv4xsJJ9Dtuu53JH4oP8aydUbO8+pzWH22e9hY2oQ87mOHzLW9pqkgGubjjZJfkG5c/dHUfSuk0llYAqc+3pWjNqmiNhQQKjk96lZsLVdj70jlQ1yAKyr/ACYJj/sn+VaMjZqlcLujdfUEUjWCscjGuUHtUN68MEryTHCFRn/P4VOWxGK2NF0m3u5VuNTjUwr8oSQZLN1xj+7g/jkduqrVlRjzPU6kr6vYqeF/CFi8x1bUtOt3tpIf3KyAPvYnO8rnHT19e1dzbQrCjFVIXGACKEtYLhxmIBeyj7n/AHz0z74rRFt5MOwgBe2K5KbqTbqTer6dEc9Wq5WU2369DlMq77ZACM4IIzWZNpxW4u4LcBliCspeQg/Nk4HY9K2tTiEU5YY2nms+6JSVLgZ2TDypQBnGBkN+AB/DNXKTTumb09Rvh2OSOKUSpsO/OMg549q6CLtXPW0ht7oenf0IrfjPcVvGXMYVlZ3LWfkNYuonO6tleVrH1JeuKszp7mPHJiT8aj8QOYl0+8ThoJgc/kR/6DTGystLrQM2lTZ+7CEf8SxX+pqKi907I/Ej3dGDorqcqwyD7U6szwxP9p8OaXMTkvbRkkeu0Z/WtOtk7q58xOPLJx7BXk3x9sp9LtNE8e6XGz6h4YuhNKqHBmtHwsyfkQfYbq9ZqtqVlb6lp11Y3sYltbqJ4JYz0ZGBDD8QTTJPOfibpdhrtno3iQXSfYWhW3iudu77ObiWEw3cecAFHWMtnGULDPY2PgZqtxeeD7eynsXgitolkt5/MEizxu8g6hVUOGRgVXIA24OCKzPgHKW8J6z4J1sR3Vz4bvZdMkSVQwmtiSYmKnjaVJAHoterW1vDa28dvaxRwwRqESONQqoo6AAcAUASUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcr8Tv+RQk/6/bL/wBK4a6quV+J3/IoSf8AX7Zf+lcNAHVVS1fVdO0Wya81i/tLC0UhTPdTLEgJ6DcxA5q7XP8AjfQ7/wAQaRHaaXrEukzLOsrSxiTEiDOY28uSNwDnqrqeBz2oAj1XxR4Vk0yNb7xLpcFpqEZ8mZdUWAyoTt3RyK4PXjcp696xZ9Z8M+BLyz0bTJraXVdV1GBJbabUzLdv5uE85jIzyOAqjr2AGQBWVovwkGn6Hc6fLrIuGm0u/wBN81rUnb9qmaUv80jMdu7GCxLdS1W4vhvd2+pI1vrcC6adStdUlgewLTPLDHGm0S+YAEIjBwVJBPBxxQB2et+JND0F4k1zWdM01pQWjW8ukhLgEAkbiM8kfmKrDxl4YNjc3o8R6KbK2kEU9wL6Ly4nPRWbdhSfQ1R8VeDU8QatLevdrFv0a80kIYd+37QYz5mcjoIyNvfd1HfEv/hxeE3D6P4hfTZJrbT7U+VC6BktRMCrGOVHw/mj7rKRsHJBxQB0l34o8IxNYahea5oKGWNjZ3Mt3CN6MQG8tyeQSoBwcEgelao1jTWOF1GzJ+0fZOJ1/wBfjPldfv4529a860X4SDT9DudPl1kXDTaXf6b5rWpO37VM0pf5pGY7d2MFiW6lqv6L4JmtfiM2pSK40m0tIWiViu24vvLMLThQSVKwqqc9dxx0zQB2Wo6/o+mX1tZalq2n2d5dcW8FxcpHJNzj5FJBbn0rjbr4t+Go7i3jhvrIr/a76VdtNeRR/ZQscreceT8hMOBnbnPtg2PF/gGbXtV1Oe31aK0tdWtYLO/iks/OkKROzKYX3jyyd7A5Vx0IAPNNj8A3S61BcSavbvp1vrj65Fb/AGI+aJHjlRkMnmYIzLuB2AjbjnOQAa1tq/hDQ1a9j1nSbSPXbj7Ws0l+gW7kKJHujLNg/KiDC8cepq9e3Gh+IY77QJb+1unmhkjubSC72y+XnY+djB1AJ2k8YJxXnmofBvz7e3SDWxkQXFrOksdysU0UtxJNtKQXMR48wqdzMCAOBXe+DfDUXhm21CGKVZftl9LeFhHtI3nhSSSWwABknmgChqXjbRNI8T6L4atrrTpLm4kkhmgS7RXso47eSXe0YyQuIwvOAN2c9js2niXQrx5UtNa0yd4o2mkWK7jYoihSzHB4ADoSegDr6iuKf4aXh1VXGuwDS476/wBQit/sB87zLqKZGDS+ZhgpmJHyA4ABJ4Il1L4cXDWekx6NrEFjPZ6LJoc0klj5qywuI9zKokXY+Y85JYfMeDQB1snirw9HqVtp8mvaSt/chGgtmvIxLKH+6VTOWz2wOaPDuseHr4TWXhzUdJuRZnbLb2E8b+QSTwyoflyQ3XuDXmC+Btf07xLYafpaPLog1Ky1G6vJ7eFQWghRCFcTmTB8sYQxcEn58de28AeD7zwrJdLLq0c9jIiJBYW0M0dvb7S2SiyzSlcggbVKqAv3c80AWPid/wAihJ/1+2X/AKVw11Vcr8Tv+RQk/wCv2y/9K4a6qgAooooA8w+KID+K/DyHoSAfxkFY+oHIPvWt8ThnxpoAPT5P/RlYJYm3RW6r8jfUcVgviZ9Dh1+5p+n6srRp8/41u2KrIRvGWx94cMPxrHiHzVs2HGK0KqF91lVR5bq49H+U/mKqyTMnEkMq+4G4fpmrhziq8md1IwiVnuYhw0gX/e4/nTBLE2SJEI/3qs5PTNN2r/dH5UjQ5aFI49W/frmGNyM4477a1p5jcMGMkkYyfuEE/iCCKdqagxNgDnqPWsa78y2jgOcjkHFctdXfMztpWlax1miT3I3LMVZV+7IpwW/CtuS5DR4cj61wunarsGDzWqusxOMZ5qYzsZ1cO5SvYvXwifPOf1rMMghR9p+ZSrLke+CPxBx+NNmvEbpj86iilcRXUygN5MLShW5B28/0rKrUsrmsaPu6kN0Y1b5FwQccdK2bCXdbpzyOKwJ3AumTO7axUkd+eD+launHbbge9dNF3tYyrx902kb5ao34ypqaN+KiuDlTXQccVZnPTLianXEZk0i9HZ1J/BBn+a0l2D5wVTyxwPb3p126/YJkQfKVEY/H5f60SXunTfVHpvw3mM3grTGPVVZPydh/SulrjfhPKJPB0Kj/AJZyyL+uf612VVT+FHg4tWrzXmwoooqznPI71R4W/aOsbkfJZeL9Ne3k7A3VvhlY/wDbPCj6165XlH7R0Uln4O03xPbITc+G9UttRG3qY94R1+hDDP0r1SCWOeGOaFg8Uih0YdCCMg0APooooAKKKKACiiigAooooAKKKKACiiigAooooAK5X4nf8ihJ/wBftl/6Vw11Vcr8Tv8AkUJP+v2y/wDSuGgDqqKKKACiivnLxn4fvprz4iLq3h/VtS8S3twjeHL+3tJJVhj2jyxHOoKwbGyWyyZ96APo2ivDkn+Kw1jxW0N/KYNFsLc2dlJpiGPUp2szv8ucgE7ZhuIBbJwuQDWFpPj3xj5+v2f2nxNq9zaaPZXBtk02C2vILqRx5uEa2zsHI/1cny8jP3qAPo6kZgqlmICgZJPAAr5/8Pa/8T9QvdNsL86zbW0muS28t8ulqH+xGEMjEyWyKAG/jMSZPBHauo0qfxZr/wCz7rH/AAkMd/H4nexvotosxFPKV8wIPKK4y4CjheQ3GDg0AemaRq2m61am60fULTULYOYzLazLKgYdRuUkZHpT9R1Gy0yBZ9SvLazhZ1jWS4lWNS7HCqCSBkngDvXzxf6j4+8LeAfC+l+GrXxP9vh0GC4LGwjkhEvGbZkW0d96jIw7x8Dli3VfGNh4m1m68StLoFziXUPD9xE0Gl7GlIjzOS6pukCNwdxbZ046UAfSFFeF6X4m+IreI9J0+9t9XCrr95DfOdJxCbEAeQRKI9m3r8ytn1PSsyw1T4wQ/DvSNZvLy8ur7ULxI7u0OkLBc6dAryqzbVikZi/7s58ltoAwrZJoA+h6K5H4WXeu3nhCCTxVOtxqayyKZRazWxdN3ylkliiOccZCAHGRXXUAFFFFAHK/E7/kUJP+v2y/9K4a6quV+J3/ACKEn/X7Zf8ApXDXVUAFFFFAHlnxUOzxbob9wFOPpJWBM2Ljd/DMocf7wGD+mK3/AIsceJtDI+9gf+hiufhIu9HsHJ2l4Y3VvQlQawXxyPocO/3NP0/Vj4cbxk1s2WMAjpWDCx8wiRdrqcMtasdzHbw+bPIsUQz8zd/YdyfpVvTcqab2NrI21UcEkkAkCua1bxWtvHmIx20bLlZbjlm91QZ/qK4zUfE015JmKKe5x0a5bao/4Ap4/OueeIjEUKLXxM9KmvrSEkSXUIx12uGx+WajXWNMPAvUye3lyf8AxNeWfbtTlbIaCJP7iwq2PxYE/rUhmv2HNxj6RqP6Vl9ZfRG3so+Z6ittNqcPn6ev2i3GRvHy5I9mwa818TXfi601uSWLQ7ttPChFjktWkRwP4iR0P4+lPttb1y0jEdtqlxGg6KuMD8MVoW/jfxNbuGa8iuQBgLNAv81AP603XhJWkjK1aLvG1vxOdTxvaswTUbK7s5wMHyzuH5NgitjTfENlqDBILpHkPRSCCfwPNdn4b8eDW5xp+r6bb/a3B8vB/dy+q4bOD6DJz9cAniK18EQW6za3oFrAZSQiwQhXkI6/cweMjk01Sg480XoEcznTl7OpDUwA115gRFYnripYNQkgaeOcArJGYjtIJG7jPtTLO78DRyBbW91nToTx5TbpY1/Bg5H4VrxQ+GLpt0HiS0UH5dkmIs/XcQaxlTUtLp/M6o46nL4018n+hlWcrSzOT/Hz+v8A9euitpAkYXNY06pDfCHTT9ohQ4eSGLzNw9VIagX0YYhpVjI7OjA/oDXTSslqwqNVNY6nSJcDpmkmuVVCWIArnzcFseRdWzZ/29v/AKFin73iw8yuTnAduVz7EcV0Kz2Zz8lieVm3M5GGft/dX0qG7fybHe3QTQj85VFNEu9wexrL8e3P2Tw7Aoba093CgIPPDbv/AGWlLYbVkerfB058KSj0un/9BWu6rgPg5lNF1CLJIS7P/oK/4V39Ol8CPEx3+8T9QooorQ5DnviJpS654D8Q6YUDm6sJ40H+2UO0/gcH8Kyfglqp1r4S+Fb123ObCOFm9Wj/AHZP1yhrt68p/ZmzD8L0sR/q7HUby2T/AHRMx/8AZjQB6tRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyvxO/wCRQk/6/bL/ANK4a6quV+J3/IoSf9ftl/6Vw0AdVRRRQAUUUUAco3iO3vrTxnDe2UH2XRHe2lFw5eO4T7NHMxcBCQuJCpADcDODnFU/DOr+CdGtTHosGl6UZruG0mhsrMwhrh4hIgwEUsNh3ByMbQSSMHEl94CS5vddli8QazaWutsWvbOEWxicmFYTgvCzrlEXo3Wpo/AGip4itdZYXMlxb2IsBE8g8p1ClBIy45k2M6buPlYjHTAAyP4leFHh806lLHETFseaznjWUSSCNHjLIN6FiBvXK8gk4rpra/guNNW+UTR27R+Z+/geJ1Xr8yOAyn2IBrgND+Dnh3RjELKSdUhnt54wttaRuvkzJKimVIFkdSyKDvZiR3zzXZaRo8tpp19bX2oXF9LeTzzPK5PyLIxxGgJO1VXCge2epNAGKPiV4XaztruK8vJYLmLz4Wi026kMkQVWMgCxklFDKGbopO0kHIqdfH/hptYXTEv5HuWlhgDraTNCJJUWSJTME8sFldSMtznHXisjWfhPoGraX4es53mB0OzWwtppILa4Zogqrh1mieMn5AchQc5xgEitGL4faTF5mya6UPfWeobU8tFWS1jijjVVVAFQiFcgDucYGAACl4r+Itlp+lawul+cNasbc3KW+oWFxAsiLIqMy71TeoLDlSeo9a72vLrP4J+HbWe9mW91NnurWS0diLdX2PIkhy6xB5GBQANIWOCa9RoAKKKKACiiigDlfid/yKEn/X7Zf+lcNdVXK/E7/kUJP+v2y/8ASuGuqoAKKKKAPLPi1/yMeh9uOv8AwMVx3gq6+2+CNLkJyVj8o+20lf5AV1/xdIHiHRs9Auf/AB8V5F8J9djj0+60ucSExlrhSozhcAEe3OB9WrmvabPosOv3FP8ArqzvbiRIVSSUb5idsUYPL/Xvt/XsO+OO1bXpZZ2S2kE9wPlaY4aNP9lB0P16dcetO1OTVNY1mfS9Nls4ZnthNK8m47IydoQY6ZHJ9j7mpbDwL4gXCpcaRj3WSsKrnU22LlXhTbiYttp8lxMZJS80zHLO5JJ/Gty20OUgEpiuksPCniO0UESaET7iWp5rHxOgwJNCH0EtTHD23MHjFtFHPnRmjHIqI2KqeSK0rnTvFMmf9I0YfRZazZfD3iZySbvSf++ZKHT7DjXvuNa1hB5IqNrSE9CKD4X8Sk/8felf98yUf8Iv4l/5+9K/75kqfZsv28e5ELPZLHNC5SWNg6OOqsDkEV0vj1IdTs9F1ELtlmifeo6KQQSB+JasAeGfEo/5e9J/75krZvdB8UP4X02CS40XEckhR8S7sFjn+n5CrjTfK0Y1KsfaQl2/yOSe0GcYFMbTkfqgrW/4RbxIf+XvSf8AvmSl/wCEW8SD/l60n/vmSs/Ys6PrMTEOjx4+4KcIbqBQILy5jVegSVhj9a2j4X8S/wDP3pP/AHzJTG8J+JG/5etJ/wC+ZKXsX0F9Yg9zIW71GPI+0iXnJ86NXY/8CIz+tbmjz3D2E168EkEcUgiea3YkDI7oTz7845HFRQeCPEtxOsMVzpRkb/Zk4Hqa7XS/C/ibT9M/s9W0F4WUq+4TZcnqTW1Gm1K8thTxUUrRZgpcg7Xk8oq/3Z4fuMe4K8Y/IY9Oa898f+IPt+q2dmiPGllJl94wS+R29Bj9a6uG1vtP1zVdMvRbNcWnll0gLBZUZSc89COxrnvH+kpNYrqEHMsAG5scvETgE+6nj8+yiuutBwWjumVSqxrK63PoD4TECHW0H8N2Tj/P0rv682+DshlGtv8A35kb891ek06XwI8fHq2Il8vyQUUUVocYV5V+zn8/hTxBcAALceIb+VV/uguBj9K9M1O8i07Tru9uDiG2ieZz6KoJP6CvOv2bLSS2+Dmhy3AxcXhnvJPfzJnYH/vnbQB6dRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyvxO/5FCT/r9sv/SuGuqrlfid/wAihJ/1+2X/AKVw0AdVRRRQAUUUUAFFecfHzXtb8O+Ahd+GL1bHU5b63tkmaJJAA77TkMrD9K890/4reMLLxrPceLtOudN0a20Ka8bSvs6iWWWHaryhiu4Kz7wvONoB96APomivnvxV8YfFN14TS90jw/caI7XNi0d7OspgnimPKK01uoLcqCVBGCWVjgZ6vxF8Xm0DxLa6VdaXZXYN3a2N49heTzGzlmHRibZYuGyADIGIAO0cgAHrNFfPvgH4nX2gxvD4gjuNTs7/AF/UraK5N40txCIvmCCJl5QAADD8Z6VY1/4u3mr+DtUhXTX0mfUfDlzq+mXdpfmWRETcv7zCIYn4yNpYZ4zmgD3qivCtK+K9xosF/Bdw3up3MC6LZ263F1GsTTXdtv3FxFujXIJZnaTJ6bele06RJqEtkraxa2lreZO6K1uWuIwM8Ydo0J4/2R+NAFyiiigAooooA5X4nf8AIoSf9ftl/wClcNdVXK/E7/kUJP8Ar9sv/SuGuqoAKKKKAPJ/i6f+Kk0gAnPlj/0OvG/AttHY+HZL2dFInLSsScZjjyAoPu24fXbXs/xdwuv6K3P3f/ZxXkutolholvYxgBmKW/BzuCAFzj3YIfxNcFeXK5M+lwr/AHEH5fqSfDZpJ/Gd/POcyy2e9j7mSvWLi6ksLJp4LG4vnXH7m3MYc+48xlXj615d8O12+MLgD/nwH/oyvV+kJGcZGKKXwo4a695o4OX4tW82i6Jq1vpF7DpmqahHZJcXs0USqrFw0mFZzhTGchtuc8Gt668UaIljFfS61pqWUzFY7hrpBG5HUBs4J+lcrafD37J4W8K6L/am/wDsLUVv/O+z48/a7ts27vl+/jOT06VRt/hlJZzJc2OsRrdpNduDNZ+ZHsuBgrs3jkdmB57jFbPlZhFTXQ7aXXdJiuILeXVLBJ7hUeGNrhA0iucKVGckE8DHU0yx8RaJf+d9h1jTbnyUMkvk3SP5ajqzYPA9zXL6H8MrDTNW0+8e4W7Sx01bGBbi3V2jlEpkE6s2QGBJAGOPWsqb4SzX8lxJrHiS5vZZrN7RpTG+8gyB1JLSsAARjaoVSOw5NTaPcvmn2O6XxPoDWTXi65pZtFcRtOLuPYHIyFLZxnHanXPiTQ7X7P8Aada0yEXC74fMuo181ScZXJ5HuKwr7wlqd6+i3M+r2I1DSJGa2dNPZYSrJsIeLzeTxkEMuPSsG7+FVxJoMOj2/iW5TT1t3ikgeNyjSNIXMgVJFHU42tuGB680Wj3BufRHTWPjWwl8Wazod7Ja2T2LwRwyS3Kg3TSpuwqkDkcDAJzntWp4s8babYXnhnRLWazvb65uWtp4Y7pfMtcjcGdBk9uhx1rjLv4Yy3V1qAfWlFjqDWbXEQtP3n+jIFG2Tfhd2CT8p9Prs3Pwre1/sxjriNYrqU2rrb/ZCJt0yAOplEmCOBg7AR79qSjZmUnO69ToIPEGiztdLBq+nSNaIXuAlyhMKjqXwflA7k1Gninw6y7hr+kkBlXIvI+rdB16ntXH23wpKWKWk+sh4bbTrnTrPy7TYyLNuy0vzkSEbugC+vWn33wqF1p19anWNv2nSrTTN/2XO3yCp34387tvTt6mptHuac0+x1v/AAkmlxzXiXt3bWQtrgWxe4uoQHcjcAMOSDgH5WCtx0p58SaCI7aVte0eG3uSwiuJr2NIn2/e2sTg4zzisKx+FEuqa158eq7UGtW+sOxtshfKQr5ed/U5zn9K2G+DN7Bo0ul2Xi64t7Ce6u7i4t0t3jSZZwAFby5kY7BnqxU916g3GCepEqso6WOo8Oa3ap44uPDVrbpNjS49T/tFZgwlDuVChQOnGQQxznpXUXA2vXH+A/h0fCesWl+dV+2eRosOj7Ps/l7vLct5mdxxnONvb1rs7uqaS2Jg23qeD/EHz7P4jahqsR/cr9mgkH1jJH8j+VWb6GGeKWNj+5lTccdkcbXH6j9a0fG9sLqXxrwN0K2cy+2F5/Qmuf0xZZIbaR23RyKYgvbJGB+uD+FdUV7Sg12/4c66D5JRZ6l8GkaKTXInxuVosgHI/jr0uvNfhDKJLzWiSdzpbsc+u1s/rXpVc1H4DkzBWxEvl+SCiiitTiPNf2htXl034Y39jZfNqWtyJpFpHnBd5jtI/wC+N9dz4b0qLQvD2maTb8w2NrFbIfUIoUH9K8ujk/4WH8clki/eeHfBSsu8H5ZtRkGCPfy1H4MPRq9ioAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuV+J3/IoSf8AX7Zf+lcNdVXK/E7/AJFCT/r9sv8A0rhoA6qiiigAqjq2rWWkR2z6hN5K3NzHaRHYzbpZG2ovAOMk9Tx61erlviJ4am8U6Zp1lDKIkh1O1u5mE0kLeXHIGYI6fMr46EEc9x1oA0JZNE8Q3N/pN1DbahJps0RuLe4t96xSFRJGfmGCcEEEZx7Grk+ladcX4vriwtJb0RNbi4eFWkETdU3EZ2nuOleUeIvAuoaCutaroDT3Gpvqlnc6OZJZ72ZX8tYJBM77mEZDSZJYhVwT0xWVc/DG8k8R3+l6bptmYYNN0yOLXL0ustvKss7yy2+I2DysTlvnTBZc5BxQB6xB4I8KW8F1Bb+GNDihuwFuI00+JVmAOQHAXDAHnnvTj4L8LG5iuD4a0QzxLGkchsItyLGAEAO3IChVx6YGOleVy/CLXGv/ABNK15ayy6lb6jDFeNcojSfaUdUWdFtPMZVLL1nYDaCq/wANdLP8Oxa+JLC+tNC8O6pYpaRQtb6g5j+zTq5Z7mP91IHkcEbmbaxMa/N6AHQ6tpvhTwZbX3ihPDunQXMCtJLcWdjEtw244b5sAkknnJ5rStfCXhu1W9W18P6RCt8pS7EdlGouFPUSYX5gfQ5rx+H4SeKH1DWrmeXQIG1DT5rWT7JtiSaRp45FdkjtkI4Rs72lbJ4bBNb2qfDfVLu38TW0dtogvNTlnlh8QGU/btjyBxbuphYBNv7rhyNoHydqAPRm8M6C8N3C+iaY0V4kcdyhtIys6xjbGrjHzBRwAeg6VJaWel+G9K8nTdPisrCNsi3sLQ4BZuojjX1OSQPUnjJry7w98JGR9Ni12z02fTYb+e7nsHljngIa3EalI0tYI1+YAldmMjdkk1BpvwhvtO0K0tbM6TBdtpVvaX8kbOoubmO5ilMjHZl/lRwGbnkDAHQA9rorybw18P8AX7D4ojxNeto0duXu/ONkqRNcLKcpuRbdWJGFJMksmTkjHSvWaACiiigDlfid/wAihJ/1+2X/AKVw11Vcr8Tv+RQk/wCv2y/9K4a6qgAooooA8t+MLCPV9EkIyBuJ98MteOa+/nalZx4+7EZW5/iZiD+iivZPjZH82jyf9dVJ/wC+P/r14tqOW8RXJ27QqRKB6fu1rzcV8TR9JhNcND5/mza+Hv8AyOl1/wBeA/8ARlepSn5K8u+H3/I6XP8A14D/ANGV6fJ0FaQ+FHJW/iMr4yacBSgVIFoII8UjAhSQCSB0HepcUUAeOWHxJ1i4ILWunySPZ3txLaRxuJdNaEMUE5LchsAdE68UReO/E0Wn+HLjVBoFjDrQeVLwrI0UKLEHCuC6/OzEgDdj6mvYSM1m6zo9rrEAhvTdiMZyLe7lg3AjBDeWy7h7HNXzLsZ8su54/efFnU4fDGmXyrYDUrize7ktmtSI2CysnyyNOpzhfuqrnqenToNX+Juutd3Ey2+mfYbG7sbLyTHJ5jpPGGJ378BgT/dx7evoul6fbabZW2n6bbrDbwqI4oYx0Hp712Ws2MslpatAu8p8hGfYVSas9DKSakrs8X8M+Ob7UvHc2iXbaf5O+byRYqtyPLToZJlmPlseflaIemc16fY2Ut9LtTKxA/M/9B71p2ujEASXpUp/zzU9fqf8K3bWLphVUAYCqMACkkpMrnstyWwtYrS1WKFdqj8yfU1JJUp4XFQyGttjnWruRnpVO5PNW3OBWfK2XxUM2gjzXXwPtfj3d0+y2/5+UcVw2iXM0OlQPsZoo3DZHYg11vja6+y3PjFARvuTZQr+KEn9Aa5aJxaaCIG4LHdXdhV7j9TdP3Uen/BxfK1bWYlbcqqoB9cMRXqleV/CPA8QayPVA3/j3/169UrkpK0bGOYu9dvyX5BXm3xe8a3ekraeF/CYFx4z1vMVnGOfssZyGuH9FUBsZ7gnkA1L8R/iRH4fvIfD/hu1/tvxlefLb6dEciHP/LSYj7iDrzgkeg5Enwt8AyeGTea14hu/7V8Yaphr++boo7QxD+FF4HGM4HQAAaHCbXw58IWfgfwlZ6LYsZGjBkuJ2+9PM3LyH6n8gAO1dNRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcr8Tv+RQk/6/bL/0rhrqq5X4nf8AIoSf9ftl/wClcNAHVUUUUAFcf8Ttb1DQdK0m50lZZJptXs7Z4YljLzRvIA0a+YQoLDjJIx6jrXYVBd2dteLEt5bwzrFIs0YlQNsdTlWGejA8g9RQB5jZ/EXULLX9fl8QWFxZaNbaja2jrdvCH05JbcMHbyi6urSFR9/I3j0xRJ8VNRit7m7l8MxRWdnZWd/deZqBEyR3MkixqieUQz4QEqWXk7c5HO1r03hDxDFJpUtxtk1XUfstxHa2x828ktnAdJPkJMY2BWc4AXjcMirWs+HfC1n4qTxJrlrbz6jdva2Fq9zbLMIJFZ/L8r5CyMxk5OcfKvTFAGI3xPmRZLl9Fi/s6Q6glm4vszSPZrIXEkXl/uwfLbBDMRlcgZxTD8Tr2CKeLUNFsrXUfJs7i1gF9NMtwtx5u1B5Vsz+YPJf5VjYf7VdyvhrQlvry9XRdMF5eI0dzOLSPzJ1IwVdsZYEdQc0X/hrQtRieLUNF0y6idI42Se0jcMkZJRSCOQpZsDtk460AeaaB8Stc13WLS8s9MtotK/sm7ubmznumSRJILkxMy5g3E/LgBtn3jkKRg2tR+KuqWkOliLwo9zd6hYf2nFb281xO3kYTA/dWz4kLMRg4TABLgnA7WLw34XaeKyTw7poOnL5kAOmKscPmlifKYptySCWCnIyN3UZrWVn4Y8aaVsudAsbqy0y7uLCKG+s4nWJoZDE3lqchVynGMcY4HSgDm5viTrMmovDp/heB7b+1I9IR7rUmgl857dZwXj8ltqgMA3JIPQGq9v8UZJElu5bRLaYWmBZzXRaFrhb2S2KIY7dpWYmM7cKd3yjYDk16HPpukWFrLcf2ZbiOF/tpEFnvfzETaHVEUs0gRQowC2AAOwqJ/DWgXVo8Uuh6ZJbzoQ8clmmHUuZCGUr3dmYg/xEnrQBQ+Hnio+L9DnvpLFrCe3u5rOWBi5w8bYJG9EfB4OGRSOhArqKpaRpOnaNZ/ZNHsLSwtQ27ybWFYkz67VAGeBV2gAooooA5X4nf8ihJ/1+2X/pXDXVVyvxO/5FCT/r9sv/AErhrqqACiiigDzX42Lmx0tuwkcfmB/hXh9yxk1rUWPaZkH0U4H6CvcvjXj+zNN9fOb/ANBrwvdv1G/f+9O5/wDHjXm4r4z6LBf7vD5/mb3w/wD+Ryuv+vAf+jK9LJzXmfgA/wDFZXX/AGDx/wCjK9JzzVw+FHNV/iMkWndRUYbAyTgU6eKZUR5EZI25HuKG7K5jUmqcXJnD67qupXHiPVrCyvry1WwtIZorexS3M90XLBnzONuxMAEDBznnoDSsPiIzyaBAlut7HfGzhlucSJJE9xtCs6LG0S/eB2+bnB4zXcazpWiatBEmoaVZX7x/d+1W6S7fpuBxWvoHg3RDcxapfaJpsl1EEEEklrGzx7SCpUkZGCBjHSinPndrHBDE1Kkvd0R51rHiDxGY0his7PTNQGo2cP2W6lmSV4pLgREnfb7dpJALxs4G4kHIAO3Nr9zbDUvP0WOU2Oow6SxOpFUe4lWArg+VkIDNgscHABAYsVXXa/8Ah3a3F7pcelabHBdXItLrydFY2sswbiOSVYvKLBj0Zsg+9dbDoujpp89gml6eNPuQPNt1t08qUBVUblxg/KqjnsoHYV02iuh0JzfU4NfGt1b3YsNO8O2P9pxm+W6DamVhT7KIWbbL5JLAicdVXBBBxyRJF8VRNqOhQ22nLLY6k9nE8itN5lq9wisiyDyPKBG5ePNDEHIFbd/4U8GXniPQ9OutNsTNY2l1NaaZ9jQ23ls8Ikk27NoYMIwMEH5jwe2j4itfCGj3J13W9GsFuLWE3J1A6Z5rxJDt5MioSpHy7RnJx8oO04fLF9CG5dTkpPiXqC6bot4vhsySawJGtIlnnmO2MHzC4ht5GX+HbhTkEk7Mc60fxA1D7XYxXfh2bSrW8t43WbUHmhfzGjLGJR5DR71IK7XdCcZAIrqbnSNA1G2/sW80SyuLK0CSLbT2ANuu7djZuXYTw2QuSMjOMjKReFvDkF7DeQaBpEV3DGIY50sow6IF2hQwXIULxgcY4pqyJfMzk/DvxBv7t/DMF3pZhs9TsrSVdQvZ5AZpJYQ5VTHb+UXByMFo8nO1QMV6GxrGh8M+H7bUIL+30PSob6CNYobiO0jWSNFXaqqwGQAoAAHQcVoyygDrSbLhFiXEmBVWMb3pGYyNTbmVreNUiGbiThB6e5qDZKx51cWaah8S/EAlRJreCO2+Rhld5j6n6Y/nW3c6NYyWxBtbaRB1XyxXF6v4wtfDHjrxFp8Ok6zrGoSpbMIrC1MmP3ZyWbjA5681jjVPiJrd7Jb2trY+FbWdS2+5YXVwB0yqj5QfY/nUy5k97HTRmuWyV2dx4Z8R6P4X8Sa/ea7f2unWIRsPKwUcOMKo6k+wyaJPGHi/4lk23w5tJND8PP8ALJ4j1GIh5F6H7NEeSevzH/x04rmvhZ8OdIb4g3kviTzPEV/DC0qz6j+8AfevIQ/KOpxnOO1fRQAUAAAAcACtaXwnHj7+1vJW0RyXw++H+i+B7SZdMSW41C5O+81G6bzLi6bOSXc9s9hx+OTXXUUVqcQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXK/E7/AJFCT/r9sv8A0rhrqq5X4nf8ihJ/1+2X/pXDQB1VFFFABRRRQB5PZfDfWdL1LXtS0rULaO91u4vY7gvI58q3md3ikhbblJELZKD5WPUggNXO6b8GtRg0po7uy0W7njubKcW1xcRta3Xks28usdlHsZlZgWIlJBwxOMn3qigDx8fDfWk1t7y0g8P2k/2me6TUQzyT7HgZEs2Ty1BgRio+9gqg+QE5rF0T4R+IbOLUftKaA9vcT2Nw+lLIqWl0YTL5iSCK1jVVbehH7tzlAG3AV71RQB5DqPw41O6muZ4NN8PWtpINOzokcz/Y5Vt3uS8LkQj5D56MP3ZyynK465Z+E2rrpghbT/DF0rDUFisZpZFttOa4nMkcsGIvvIpC4CoRtGGFe5UUAeLap8LdauL/AFx7YaR/xMNMubNr27kE9xLI9sYVYN9nEkILYLASuuM4XJJrc8P+BdS0z4jDXBbaSloysJpmkW4uXPlBB5ZNurxDI5HnMuBgKMk16bRQAUUUUAFFFFAHK/E7/kUJP+v2y/8ASuGuqrlfid/yKEn/AF+2X/pXDXVUAFFFFAHmvxmIb+xIj/FJIf8A0Af1rw1I2F1dZByZWyD9TXtfxcy+uaDH2ycD6sv+Fc9B4bsdStkmuYwsxA+YEgn64rzsRHmmfR4S0cPC/n+ZyPgJSPGV1nA/0Adf+ulenW1tLcti3RpD3boo/GuY0LSLbSfiFKkdsCn9mhiGJOf3uM816da3CNEBFtKjgAdvwrWELJJnJVleTaINN0eGPD3J8yYdP7o+g71qS28M0ZSZAy9qdbsu3nvXnHxJ1jxDD4v03SfD0+qBZ9NurkxactnvaVGiCFmuRtCDechTu5FapLY5ZyaO0OlW4kDRoQVbPXOfarod0GDyK810X4lzT6Xa3SWUF5aW6WMOoXZuDBIZrjaMxQlDuUM3dl7gZxU83xQthHLA2nTLq6XRsRamT5Dc/aDEsPmYzuYDzPu/c5oUbbCjOOyKUHgzxHBLpml2V1bLp1jfG7gvItQuIJTA1wJZIpIFXZKSMplmxhs4BznCt/hbr1tqeqXGpJorW9/ZTW0iWcy2qTSNNG6s2y1+UAK2d/m9cZwTVnxJ8Rb7VfCfiVtM0jUrC3SxvTbapELhDE8RIG5zEqKWwcbJHwRg4Nek+LdfuNGk0qzsrOK+vdTuTbwx3E/kRAiNpGLOFYjhDgBSSfzotJO5Nk3ocBpfw1v7LUNIvbnS/DFxJbQXFsyCNIvIDyI8cqFLdVeRNr8hI/vnGOct1H4UPc+FNJ0uBNKiuYdAn068mILeddOluEkztyyqYDgnBUBcDjAj8IeL9atdCj8m0u9Yuls2umtxOZU+a9liJBEbSkKoz8u7Krwmasp8RdUOrXN9LZWbaLa6O99cQQXTs6NHLKr7Q0CsX+QKUfYFIOenNahaLH6l8P7u8g1ELpGhWkVzFZLFp9rd7IIWge5Zj81qyMD5yna0RBJbPQE+heErafSPDOnWF4LNbi3iCOLOIRQg+iqAAB9APoOlef2fxLvbuCIDw6Yrme6t7e3+0TzwQSCVXbd5ktup+XZ8wCMMMCCelV7Pxzq+pa5+5t7KCxj027e5gN8NyTQXBiZo28k7/u/KDgENkgYwVqUlFHrL3GelRgPIfavNtN+JDMLQrpRuLNXsLW5uJbsLP51zHGy7YxGFcDzFycp/EQuBWl4S8baj4j1HTbW60uLTLfUrOa8tpIbvznKxSIjBwUXaTvBGCeOuKVmUpLodtNOlsfLQeZOeiDt7n0p9nb/emmbdM3U+nsPapEtoreMiMcnqT1NMifaDnpSK3Whw0U/leO/E6nutqR/37NZyztea608SM1vEpjDjoT3NUdYlubj4g+IbO1+VZEtjJIOoHln5R9a6qwWCzsBbhdrYxkjFYT1kehQ92miDwFIF+I14P+eluQP/ABw/0r1mvIPCZ8n4nRDjEsP/ALSz/SvX66aHwnn5mv3sX5IKKKK2POCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKq6pp1nq1hLY6nbRXVpLjzIZV3K2CCMj6gGrVFAHK/8K78If9C5pv8A35FH/Cu/CH/Quab/AN+RXVUUAcr/AMK78If9C5pv/fkUf8K78If9C5pv/fkV1VFAHK/8K78If9C5pv8A35FH/Cu/CH/Quab/AN+RXVUUAcr/AMK78If9C5pv/fkUf8K78If9C5pv/fkV1VFAHK/8K78If9C5pv8A35FH/Cu/CH/Quab/AN+RXVUUAcr/AMK78If9C5pv/fkUf8K78If9C5pv/fkV1VFAHK/8K78If9C5pv8A35FH/Cu/CH/Quab/AN+RXVUUAcr/AMK78If9C5pv/fkUf8K78If9C5pv/fkV1VFAHLw/D/wlDNFLF4e01ZInWRGEIyrA5BHuCAa6iiigAooooA8u+Kh/4qnQB6YP/j4qbSNNRbWKY7mZQCMn+lU/ie27xrpanlY7YSY/4E5/9lqxp73zQptQJD6E84riqfGz6GkmsPC3b9WEMSzfEc/KMNpGf/I1aWpxNaHzoPkkBA47+xqpEoHxGCpx/wAScYP/AG2rWv43eaJHwQ0ij9a1ZwRerLFrMXHTZIPvRnqP8RVPVdA0TXZo213R9N1F4gRGby1SbYD1xuBxnAraNpE8W10BX9fzqi0EsJIi3TxDsT8y/QnrT1RN1I5fW9U8EaZ4jtodRsbOPVbCOHy7j+y2cWcbsVj/AHwjKxKSCBlgK63+ydMJLtp9mXNwLst5C5M+Meb0+/jjd1x3rz7WvBn9seL9UvtU1Ka20i8tbWB7OMqn2gxPIxWUshIX5h9xwTlge1Yth8O9RjiuEmh0oh7K4tprq3u5Ip9VaV1ZXuH8o7CoB/56cnHA4p3IafY9Cm0bwcfEctrLpGknWdQtpZ5SbBC88IZFk3vt5BLoCCec9Dg1tato+l6za/ZNYsrW/tdwbybqFZUyOhwwIzXj+jfDXUbPU9PvZ7Hw35sMVxbhoo0je0DvE0c8bR26K8yFHI+SP7/BHJNDU/AGqWGiQImjaMQZtMtpLLT3keO+aO5VnuLg+UNuVzuO1yAWJLYAp6E6roeyTeFPDktp9km0XSntdgj8l7SMptDFwu3bjG4lsepz1py+FvDqfYmXRdNzZKUtSLSMfZ1PUR8fKDk9MV49qfwr1e7tbZQ2mLbrPdSf2THKi21qJSm3yWktpRldp5EanLnaV6Hen+H95/Z/iJ410m61S++yrazaiBclI0t4IpQzPEVDN5b/ADBCD8pK8bQaBZ9jtINK8H6JqVpY22i6XZ3d4zTwpBYou9ohy+VXAKhzgk5+Y471LDovh3VILO7GhWGxS80Hn6eEkjMh3OdrqGRmJJOQCT1ry/w98MNQ02fTLi80/QNQNpqFzOtvO42RRSrFjYVt1XcjozBRGg+bIIOauaJ8Ob+0h8P2ZvrFrKK1todbt43dvPe2O6LZwOCxw2QMqoHNFxpPsemN4d0L7da3o0bTfttqixwXH2VPMhRRgKjYyoA6AUtvp2n2lxbtbWVrCbeNooTHCq+UjEFlXA4BKgkDrgeleceCvAepeHvGMurajcxTKTcZuluI1kuBI+4CVBbB2I4xumfBHHBxXpKPPISYbSRl/vOQgP8AWpZcVpqW2kzwtVY1luZXWMhIF4aTuT3A/wAamjtZpB/pDLGp6pGeT9T/AIVZWARIFhO1R0Haiw+ZdDzTSbEQ/EbxQp+YILYgnngoTXU3sCGJuh4rH0xDJ8QPGJIwRFagfXyjV2eO7ERYOGGOlZVFZnXh3dbmFov7n4i6QxP31x/466/0r2avFEfZ4y8Pyn5T5yxn/vv/AOyr2utcPszDNF70H5fqwooorc8sKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPJfiK2fH9pznbaY+n+sNa1nehrZESNmxxkDisPx5h/iJtPQW3/tNjXR2AjFjEF+9iuGXxM+hVlRp37IqwDb8SAew0cf+jq2NXnVTFKOkbqx+gNZEGT8SSv/AFCMf+Rq2Ncg3WhVFG9iFA9STWz2POjvqa+75Mdqy/EGoTaT4U1fU7WH7Rc2dpNcxw8/vHRGYLxzyRirqwuqAK44HTFOtWKM0bjB6j3qiGtNDyrxXc6paeBxqcfjSTU57uGCaO1VIIRITPFkwtGquqYYqdxfhhk+rtS+IF3p1y+mpoRGtLey2jW1tNPdW/yQxzFlaO3aTlZlGPKHOckAZrvIvB/hy0knlsvD+kQvPgzeXZRr5uG3DdheeQDz3qa90HQ9Vimj1DR9NvI5pRPMlxapIHkChQ7BgcsFAGTzgAU7ohKS2Z5vqPxA1xIZZ4NBZIbeOxNxHd3H2eaKS6cIieWYj91jgkkcc47Vci8c6q9wNOXRLE6wkt3HKj6kYrcLbrGzMspiyxImTAKj+LOAM16JHoOjpbG3i0rT0gIiUxrbIFxEQYhjGPkIBX+7jjFVbrw7oeoxSWupaNpt3GZjcFJ7WOQNIRjeQR97AAz14paFKUu549f+M/EmtaF4ivtPjit9PVdOntcXZS4iEwhcIAIxnduOSW4zgZFbt98Q9VsLhtNn0ZJdbS9ktGht2nuISEhjm3B4oGkOVlUY8oc5yQBmvQr3w3os919rl0XTZbtY1iEr2qF9ikEJuIzgEAgdBgUXehaNq0U0Wo6Jpt3HNKJ5VuLaOQPIFCh2BHLbQBk84AFGge9umcXH42u7i21Ca50z7Db2NjDd3R1G5e2MTSxsVjKLEzZ3qFPHQ5AJwppaT4/k1G5h0+08LWyau+omw8ue5mgjX/RTcByZLdZBwpGDGPUZBFeljQdIis5bRNLsFtZolgkhW3QI8ajCoVxgqASADwBXNT/DrwxfNYxto2nxWdncNcfZIrSJYZ3MbRjzE24bAbI9CB6UaB7z6mHo/wASY7tbJV0RUvdREP2CL7QCLgmVo5sNs4EewuSAcqVPGcV6eXLHan4msSXwvpyavp2pRIY3023ktrSCMKsUIfaCyqBkHCheuAM8c1vwoFAHpQHmyMQbuWyfqaQwKOgKn2NWHkAHoKajB1B9aAuzzjT52g+KXiaCT7s8Ntsb1IjOR9cGuk3YQxMOV4rn5Ig/jPxNJ/FbvZzA+wjOf0JravkFxdMVJAQbRispnbQs0jj/ABORb3thcA4WC6Dfng/+yV7bXhfjFGSzIbnbOoz9Vb/CvbbCQzWVvITkvGrZ+oBqsO9ycyXuQfr+hPRRRXSeQFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHjvj47PiExAz/o3/tNq2dEidYIZ3dmIwcZ4rJ+JEfl+O4m6b7Td+jj+lbGkXaDT0QkA9K4ZfGz6OOtCFuyH+JvD+i6w8NzrGj6dqLxjYjXVqkxUHnA3A4FcfqXg/wt9ssQPCmiRxtcRq2NPhGcsBjhenNeg3JykYPQf4VkeI4RJYusThZQNyH0Ycg/mKcmzGlGNtUNh8BeDFhLN4S8PsffTYf/AImmS/D/AMGzJ8vhXQUPqunQj/2WtnT7yO+0+OZc7JVzjuD3H1ByKiV7gM3lI8kY7ng//XquYxVJXZlr8P8AwgEw3hTw+Tjr/ZsP/wATVGfwF4S+1p5XhbQclc7f7Phxx/wGumE85GPJlz/tYFVp38giV5EMuRlQei+1JyLjTV9jJi8D+Djhv+EU0DB4IOnQ8H0+7SS/DvwjLcDb4W0NVZeNunxDB/75roJnQL56EFG++B296fFcMgDD50PRl5ouLkW6Rz83w/8ACUUQ3+FdA3Dv/ZsIz/47VbTvAnhH+0JY5PC2gsvUBtPhOB1/u+9dRPOZfvZCjkk1Vtcm788HknBX0H+QKL6jUFyu6M268BeDlHHhTw+Oe2nQ/wDxNRWfgLweVYnwroLcnrp0J7/7tdNctuZR+Jqvp06tDnuM5HpTvqSoLl2ObvvBPhBMY8J6EMEE40yLpn/dqWfwP4PWJRH4T8PF24H/ABLof/ia6sqk0ZZfvLzVJVxeL/d2FgPQ5GaLsajF9DAj+HPg8YaXwzoZJ/6cIgPy21aX4feDRyPCmgH/ALh0P/xNdO0CzRYYZFY+p3Y0a0kuZjK9shG4KNzLk4B5PTmi7RKip6EVnomk6Nb3UGi6ZY6fFKhMiWlukQY4xkhQM1ZgOwkOOWUH9KqWF+2qOkcFvNFBJw0s2ASPQAE9a0dTiEjokZKsgzuH8ql6q5pFcr5Wcb47UGwYgciVD+jD+tepeFJDL4Y0l2OWNrFn/vkV5L40dxYujnJ81B9Rhv8A61eu+Gofs/h7TIT1S2jB+u0VdDdk5j/Bj6/oaVFFFdR4wUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeVfFeIReKNFuXBCOgjY+oD8j8mpfC6r5H7z74yOe1bXxe01rvw5HdxjL2cgY/7jcH9dtcfpOphYFm7yjd/wL+L9c1xVVadz6HCv2mGjbpodsyGW2YKeVzisxrDzAfMdmJ96s6bcSiEMfmQ8kYq0cpmRBuU8/Sk9SE3BtHH3F3N4XvVkcPJpk7gSAcmJv7w9vUV2MF15i5Rg49jXPaqkmqxyQLBmFuCTx+VRW1veWSqLhRMg/BsUk7Gs4Kau9zpZZHnkWFTtBGWI64q0lnAiYKqM9sVQ0fypN80Iwh4GetWbt382IJ94tjn6GrXdnLJO/Kilf2nkkeTxG5Cso6c9xV1oYQy8bGPGVOM/lS3gxatk5IU80y7yYkYcsp3UWsO7diTyIkILZY543HNRXMOfnj4lXofX2NFsftNwCDlFHHuasTDEmKBXadjLnn8yLC/fkGPoO9FpbJKxlcfIPlUDjd9addWoSB5I+HBYn3GTxVm1AUIo6Ko/lS66mjdo6FtFSGAhQBkYxWVO0r3iG3Qv5Qw2OAc9Rn8qtX0kuw7BtHqf6VZgjWOJQop7ma93UggvDyhyrDqp4NZ2vbbm1Fq2N1w6jaf7oIJP6Y/GpddbZp17InEqRMUYdQ2OMfjiqOkacEtFkuC0szgF3c7iT9TUt9DWEV8RsadCBIm0YRKh1O5EV0XXJjIwSPWrrAQW0Uf3cjH+NY+sOqwkAgA9z2pvRWFD3pczOQ8RbtT1TT7CHO+4l7e5Cr+WG/OvckRURUQYVRgAdhXkvw2sP7X8V3GqEH7LZjbFnuSNq/pk/XFeuVth42VzmzOa5o0l0X4sKKKK3PLCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCG7t4ru1mt7hQ8MqFHU9wRg14Vc6fNoGtzaTd8gP5kEh4DZ6fmOPqB7173XOeNvDMPiPTdnyx3kWWglPY/3T7H/AOvWNWHMrrc78BilQlyy+F/h5nNaNexm0x3xjBq1p98TNJGq7gD1z0rirK7ubO9ew1GNob+M7SG/5af/AF/fv9evSeGplO9nHJY1zJnrVaSSbN+NIwdxjZM/3elRX8e+ElWDL+oq6ZEK5BFZOoXIhkyp4P3h61bsjlhdvQraVN5N+y5wkikkf7Q71q2+Z7gy/wAC8L7+9c/dFo54J4oy8StubA6Agdq6OyuobiBXiYFT6Uo9i6qt7yEvf3myFTy559gKqXTSwgofm3cK2MYPvV9iiMX43Y5NV7754AMYL4xntyKbM4PZD9EQRw/if8KlmOZs/jVSMTWoxw6deBgj/GluZgLcspyzjC4ovpYHG8rkkjj7GWI65Y/jzUUEm0xv2KjNSQ+XMqhjkDnHrRNauoJjGVPO0/0oC6WjJpAJguCAMgmiWZUXAOTWLqF/Fp8SPciYKzhBsAPPp19jSRTXtyoNra/Z1b/lpMQzfgo4/M0rj9mJrMvntHYrlndleUDnaoORn6kCtaFfKi3y/JGgyc8VU062trGR9z+ZcNh3JOWJ9TXOeM/EzNO+k29qziQNBKMjfJuRfuc8YD5JI9O2SDzZer92JY1LxILjUreO0hknjkA2SoSAOQTkEfdClW3ZwdwxmsrxJfz3csWnWis93ckJsXqAeg/H+X1qxq9/b6TaokEUf2t1wiKM4yc/gmScL+VdV8PPCUmnt/a+r5bUpgSqN1iB6k/7R/SlGLm7I0lOOHp+0l8l3Z0XhHQ08P6JDZqQ0v35nH8Tnr+HYfStqiiu1Kysj5+c3OTlLdhRRRTJCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA57xb4VsvEduPOHk3aDEdwo5HsfUV5jcvqnhe7+y61CxQ/6u4TkMPY/wAX44P8q9vqtqFja6javbX0CTwN1Vxn8fY+9ZVKSlqtzuwuOlRXJPWP5eh5ZDrLSQh0YPGejryP/rfQ01pJbolidsY5LHsKsa74A1DS5nu/DUzSxdTbuRvA9OeGHsf1rn4tYjkuPJ1ZJbOeM4K7T5YP+0v3l/X6CuWUWnaR7MJQqR5qWv5/cbsA1Ibp4ow9v/CnRgtT2s6ktPafu5P+WkZHX8PWnw62IbZP3QaNuFlQhkJ+o/l1qwtvFcAT2zp5xHzf7VO3Yx5/5ka1uiPEsrPvBGR2FJH/AKXcgpzGh4Pqar6W3lwmG4xvB+6atS3tvaRks6oKrQwaabsWriNcAA81QiRUumUjgjI9s9apvq80mTBAQp6PIcCqj3N2zhzNbhuRgAmh6lQpytY2JrRgxeE4PXBp0E04cJIjY9e1Y66lepgbreT2JIqdddVB/pkXkf7ZOV/OgHCVtVcr+Ko1mgjjIzvuI8fUZP8AIGmx6xA0W6GYpGgUszjarIcgMCf4cqcHvjjjBqqmox6nfecpxbQk7CeN7d2+npWDcPdO1nboFgW1tTBPK4VklAKgEc8dGPzdN2MGoubRg7JMSRDMZ45r5NVlfdaocLjySiuZDyQcSMnPoAAKXUJ7awuRFZRNcXhRYIkI3FEGdqcDoM9Op7npUFtm4um0/wAL2YM8rFnkiTaOTkkegGep6dBjAr03wT4Mt9AUXV2VuNTYcydRHnqF/wAaqMXN2QVakMMuae/Rf1sZ/gfwW9rONX1/97qDHdHExyIj6n/a9ug/l39FFdcYKKsjw69edeXNMKKKKoxCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArI17w7pmuxbdQtldwMLKvyuv0P9DxWvRSaT0ZUJyg+aLszyjUvh5qmlyPceHb0zD/nk5COR6f3W/HFc8+qXOm3XlavYzWk4/ijXZn32ng/gQK94qC7tLe9hMV3BFPGeqyKGH61i6C+yejTzKT0rLm89meQQa2tx80NzBKSMbJT5bD8G4P4E1ehYKVa8AWc8hWG0L9Aev1ro9V+HGh3m5rZZrOQ8/umyv5HP6Yrnbj4bavaE/wBk6ujIezM0R/TNZ+zlHodcMTh57St6/wCaNKKGOcAvIDn3qwLG1A+8Pzrl28I+MIshUhm9y8bZ/wC+qenhLxhJywgj/wCBxj+Qp3f8po5Q6VF95sXlpZc7bmMN6bhmsmeeG2VkuXRoWHKS4UMPbdjP4VNF8PPENw2LzVoUjPULK7n8sAfrWrp/wtsIyrX99cXB6kRqIwf5mjllLZCeKowVpTv6I4F723inaLT1lud7fu4lzge2fvN9MD610mjeB9X1tll1ljp9mDkQgYc/Re31bmvTNH0HTNHTbp1nFCe74y5+rHmtOqjQ/mOSrmfSireb3/yM7RNGsdEtBb6dAsS/xN1Zz6k960aKK3SS0R5UpOT5pO7CiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Emesis is mediated centrally by two separate &ldquo;centers&rdquo;. The chemoreceptor trigger zone (CTZ) is localized to the area postrema in the floor of the fourth ventricle where chemosensitive nerve cell projections are bathed by cerebrospinal fluid that is in equilibrium with blood in the fenestrated local capillaries. Neural pathways project from the CTZ to the nucleus tractus solitarius and the reticular formation of the medulla oblongata, which is the location of the vomiting center (VC). The VC is a diffuse, interconnecting neural network that integrates emetogenic stimuli with parasympathetic and motor efferent activity to produce the vomiting reflex. It receives afferents from the cerebral cortex and higher brainstem, thalamus and hypothalamus, the vestibular system, and via the vagus and splanchnic nerves, the pharynx, gastrointestinal tract, serosae, and other thoracoabdominal organs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17352=[""].join("\n");
var outline_f16_60_17352=null;
var title_f16_60_17353="Dextromethorphan poisoning: Epidemiology, pharmacology and clinical features";
var content_f16_60_17353=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dextromethorphan poisoning: Epidemiology, pharmacology and clinical features",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/60/17353/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17353/contributors\">",
"     Chris Rosenbaum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17353/contributors\">",
"     Edward W Boyer, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/60/17353/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17353/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/60/17353/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17353/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/60/17353/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    (d-3-methoxy-N-methylmorphinan, DXM) is an over-the-counter cough suppressant that is commonly diverted for illicit recreational use [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/1\">",
"     1",
"    </a>",
"    ]. While structurally related to the opiate receptor agonist,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    (methylmorphine), DXM in overdose expresses a unique combination of euphoric, stimulant, and dissociative effects in older children and adolescents. Rarely, DXM poisoning is associated with profound coma and, in young children, respiratory depression that is responsive to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Because of the marked increase in misuse of this substance in adolescents, clinicians should have a thorough understanding of clinical presentations of this drug, its toxicity, and the principles of management [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/1,4-6\">",
"     1,4-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, pertinent pharmacology, and clinical features of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    poisoning will be reviewed here. The treatment of dextromethorphan poisoning is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2615?source=see_link\">",
"     \"Dextromethorphan poisoning: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Related issues such as methylenedioxymethamphetamine (MDMA) abuse, serotonin syndrome, anticholinergic poisoning,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    intoxication, phencyclidine (PCP) intoxication, ethanol intoxication, and a general approach to management of the poisoned patient are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=see_link\">",
"     \"MDMA (ecstasy) intoxication\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link\">",
"     \"Anticholinergic poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40935?source=see_link\">",
"     \"Ketamine poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link\">",
"     \"Phencyclidine (PCP) intoxication in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/5/2137?source=see_link\">",
"     \"Ethanol intoxication in children: Clinical features, evaluation, and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one million US youth and young adults (age 12 to 25 years) misuse OTC cough and cold medicines that contain",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    each year [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/7\">",
"     7",
"    </a>",
"    ]. Nonmedical use of dextromethorphan (DXM) results in about 6000 emergency department (ED) visits annually in the US [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/8\">",
"     8",
"    </a>",
"    ]. Children (age 12 to 20 years) account for almost 50 percent of ED visits. Coingestion of ethanol is frequently seen. Reports from other countries suggest that DXM abuse is prevalent outside of the US as well [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Initially introduced in tablet form during the late 1950s as the over-the-counter (OTC) cough suppressant Romilar&trade;, DXM has a long history of abuse. Because of diversion to recreational use, Romilar&trade; was removed from the OTC market in 1973 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Subsequently, pharmaceutical companies introduced liquid formulations that were designed to reduce abuse by creating an unpleasant taste if ingested in large amounts [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/12\">",
"     12",
"    </a>",
"    ]. Before geltabs became more widely available, it took approximately one bottle of cough syrup to achieve the desired effect [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    DXM abuse is known as \"going pharming,\" \"Dexing,\" \"Robodosing,\" or \"Robotripping\" among adolescent and adult users [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Myriad slang terms exist for DXM based on tablet appearance and their similarities with popular candies (",
"    <a class=\"graphic graphic_table graphicRef66199 \" href=\"UTD.htm?0/63/1019\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2006, Coricidin&trade;, Nyquil&trade;, and Robitussin&trade; formulations accounted for almost 66 percent of misuse among US persons between the ages of 12 to 25 years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/7\">",
"     7",
"    </a>",
"    ]. These cough medicines often combine DXM with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , antihistamines, or decongestants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/13,14,17-21\">",
"     13,14,17-21",
"    </a>",
"    ]. In order to extract DXM from unwanted products in combination cold preparations, abusers sometimes perform a two-phase acid base extraction technique using common household products (\"Agent Lemon\" technique) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/22\">",
"     22",
"    </a>",
"    ]. This technique was applied quantitatively to 295 mL of a combination cough and flu medication and found to markedly reduce the amount of acetaminophen and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    in the final product while yielding significant quantities of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/52/17221?source=see_link\">",
"     doxylamine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/23\">",
"     23",
"    </a>",
"    ]. Some DXM abusers prefer a single phase acid base extraction technique that results in a substance known as \"Crystal Dex\" [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    DXM may encourage initiation and progression of substance abuse in teenagers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/6\">",
"     6",
"    </a>",
"    ]. Some younger adolescents consider DXM to be a harmless and legal high [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/24\">",
"     24",
"    </a>",
"    ]. Because it is easily available and produces an intense effect, DXM may entice young users to experience broader and illicit substance abuse experiences [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/24\">",
"     24",
"    </a>",
"    ]. For example, among young adults who ever misused",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    , 82, 49, and 44 percent reported use of marijuana, inhalants, or hallucinogens (eg, lysergic acid diethylamide [LSD], phencyclidine [PCP], 3,4-methylenedioxymethamphetamine [ecstasy, MDMA]), respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    (DXM) is the D- isomer of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    synthetic analog,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/22/29029?source=see_link\">",
"     levorphanol",
"    </a>",
"    . DXM also contains an alkylated amine adjacent to a cyclohexane ring, a chemical structure that is seen in other dissociative agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    , phencyclidine [PCP]). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40935?source=see_link\">",
"     \"Ketamine poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link\">",
"     \"Phencyclidine (PCP) intoxication in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    (DXM) is marketed as a nonsedating and nonaddictive cough suppressant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Formulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are over 140 products that contain DXM available worldwide, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Combination cough syrups (concentration range 5 to 40 mg per 5 mL, often combined with antihistamine,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16101?source=see_link\">",
"       guaifenesin",
"      </a>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"       pseudoephedrine",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Sustained release cough syrup suspensions (eg, Delsym&trade;, 30 mg per 5 mL)",
"     </li>",
"     <li>",
"      Liquid filled capsules (15, 30 mg)",
"     </li>",
"     <li>",
"      Oral strips (7.5, 15 mg)",
"     </li>",
"     <li>",
"      Lozenges (5, 7.5, 10 mg)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Toxic dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    (DXM) toxicity occurs in a dose dependent fashion. Neurobehavioral effects typically begin 30 to 60 minutes post-ingestion and persist for up to six hours [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/25\">",
"     25",
"    </a>",
"    ]. The different stages of toxicity are often referred to as \"plateaus\" by users [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild stimulation (first \"plateau\"): 1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      (adult dose:100 to 200 mg).",
"     </li>",
"     <li>",
"      Euphoria and hallucinations (second \"plateau\"): 2.5 to 7.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      (adult dose: 200 to 400 mg).",
"     </li>",
"     <li>",
"      Dissociative \"out of body\" state (third \"plateau\"): 7.5 to 15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      (adult dose: 300 to 600 mg)",
"     </li>",
"     <li>",
"      Complete dissociation with unresponsiveness (fourth \"plateau\"): 15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      (adult dose: &gt;600 mg)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    DXM may produce a life-threatening serotonin syndrome when coingested with monoamine oxidase inhibitors or other serotonergic agents (eg, serotonin specific reuptake inhibitors,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    , cocaine) (",
"    <a class=\"graphic graphic_table graphicRef64604 \" href=\"UTD.htm?42/19/43324\">",
"     table 2",
"    </a>",
"    ), even in a regular daily dose. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    DXM cough and cold products frequently contain",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , antihistamines, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    that have significant toxic potential as well. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Common coingestants'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13114?source=see_link\">",
"     \"Management of acetaminophen (paracetamol) poisoning in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link\">",
"     \"Anticholinergic poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mechanism of action",
"    </span>",
"    &nbsp;&mdash;&nbsp;In regular daily dosing,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    's (DXM) antitussive effect derives from the binding of sigma opioid receptors in the medulla by the active metabolite, dextrorphan. Because of its stereochemistry, DXM and its metabolites do not bind the mu and delta opioid receptors, thus avoiding classic opioid toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/27\">",
"     27",
"    </a>",
"    ]. Dextrorphan also has serotonergic activity at the 5-hydroxytryptophan 2 receptor which explains why a regular dose of DXM can cause serotonin syndrome when coingested with other serotonin agonists (eg, monoamine oxidase inhibitors) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In overdose, the active metabolite, dextrorphan, inhibits N-methyl-d-aspartate (NMDA) receptors. This action results in neurobehavioral effects similar to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    and phencyclidine (PCP) including hallucinations, \"out of body\" sensation, and dissociation. DXM also inhibits adrenergic neurotransmitter reuptake in the peripheral and central nervous system resulting in tachycardia, hypertension, and diaphoresis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/6,31-33\">",
"     6,31-33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     KINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pharmacokinetics of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    (DXM) are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/6,27,34-37\">",
"     6,27,34-37",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      DXM is well absorbed with peak serum concentration occurring 2.5 hours after oral ingestion of a regular dose [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/6\">",
"       6",
"      </a>",
"      ]. Volume of distribution is estimated at 5 to 6.7",
"      <span class=\"nowrap\">",
"       L/kg.",
"      </span>",
"     </li>",
"     <li>",
"      DXM undergoes metabolism in the liver via cytochrome CYP2D6 to dextrorphan (primary active metabolite) and 3-methoxymorphinan [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/6,35,37\">",
"       6,35,37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Peak plasma concentration of the active metabolite, dextrorphan, is achieved at 1.6 hours.",
"     </li>",
"     <li>",
"      Average half-life of the parent compound in therapeutic use is approximately 3 hours in individuals who are rapid metabolizers and 30 hours in slow metabolizers [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/38\">",
"       38",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       Dextromethorphan",
"      </a>",
"      and its metabolites, dextrorphan and 3-methoxymorphinan, are almost exclusively renally excreted [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The neurobehavioral effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    are primarily mediated by the action of the metabolite, dextrorphan at the N-methyl-d-aspartate (NMDA) receptor. Individual response to DXM ingestion is strongly affected by the genetically determined activity of the CYP2D6 enzyme. Approximately 85 percent of the US population have high CYP2D6 activity and would be expected to rapidly develop high dextrorphan levels after overdose. Chronic abusers of DXM describe tachyphylaxis (need to increase dose to achieve desired effect over time) that may relate to induction of the CYP2D6 enzyme. Medications that inhibit cytochrome CYP2D6 (eg, monoamine oxidase inhibitors,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    ) increase dextromethorphan levels, decrease dextrorphan levels, and thus, alter the associated neurobehavioral effects [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Mechanism of action'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The emergency provider should suspect",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    ingestion in youth and young adults who have abrupt change in behavior associated with hallucinations, gait disturbance, and clinical findings of sympathetic stimulation. Infants and young children may have an acute onset of altered mental status ranging from coma to irritability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historical features of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    poisoning vary significantly by age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Youth and adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adolescents and young adults most frequently misuse",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    -containing cough and cold preparations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/7\">",
"     7",
"    </a>",
"    ]. These patients often arrive in the emergency department (ED) with altered mental status and may not provide a history. Witnesses of the ingestion or emergency medical services (EMS) personnel, who may have recovered containers at the scene, should be interviewed in this setting. Key information includes the specific dextromethorphan containing substance, amount ingested, time of ingestion, and coingestion of ethanol, serotonergic agents (especially ecstasy [3,4-methylenedioxymethamphetamine]),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other recreational drugs.",
"   </p>",
"   <p>",
"    Additional history should identify the likelihood of trauma (particularly head trauma) and rape. Often, EMS reports regarding the environment in which the patient was found and whether the patient was partially or fully undressed can assist in identifying physical or sexual assault.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    is ingested as part of a suicide attempt in up to 14 percent of ED visits in teenagers and young adults [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/8\">",
"     8",
"    </a>",
"    ]. Thus, direct questioning regarding suicidal intent should occur in all intentional dextromethorphan ingestions. If suicidal ideation is present, further mental health evaluation is indicated after the patient recovers from the intoxication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants and young children, who are intoxicated by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    , may present with an intercurrent viral illness and sudden change in behavior. Fever is variably present. The caretaker should be carefully questioned about the use of over-the-counter (OTC) medications including the exact name of the medication, the amount of medication being given, and the frequency of dosing. Although OTC cough and cold medications intended for use in children under two years of age have been removed from the US market, caregivers may still have supplies at home or may give liquid formulations intended for older children.",
"   </p>",
"   <p>",
"    Exploratory ingestions of OTC cough and cold medications occur frequently in young children. As a general rule, ingestion of an amount that is less than the estimated total daily dose for the child does not produce significant toxicity other than self limited lethargy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/39\">",
"     39",
"    </a>",
"    ]. In this circumstance, caretakers should also be questioned regarding medications in the house and asked to check the home for signs of other toxic exposures. The patient's or caretaker's pharmacy may provide valuable information regarding prescribed medications, the date of the most recent refill, and the total number of pills dispensed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;In overdose,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    produces several characteristic physical findings that may be variably present depending on the dose ingested (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Toxic dose'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neurobehavioral changes that include euphoria, hallucinations, inappropriate laughing, psychosis with dissociative features, agitation, and coma",
"     </li>",
"     <li>",
"      Tachycardia",
"     </li>",
"     <li>",
"      Dilated pupils",
"     </li>",
"     <li>",
"      Diaphoresis (in the absence of anticholinergic coingestion)",
"     </li>",
"     <li>",
"      \"Zombie-like\" ataxic gait",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Tachycardia is such a consistent finding that its absence should call in to question the diagnosis of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    intoxication.",
"   </p>",
"   <p>",
"    Agitation in association with severe",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    intoxication may also result in hyperthermia and metabolic acidosis with potential for rhabdomyolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/13,14,26,32,33\">",
"     13,14,26,32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    may precipitate the serotonin syndrome (altered mental status, seizures, autonomic instability,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    muscular hypertonicity) in overdose and when combined with monoamine oxidase inhibitors, serotonin specific reuptake inhibitors,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"     tramadol",
"    </a>",
"    , and other serotonergic agents [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/29,40\">",
"     29,40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nystagmus is sometimes seen, but this finding may also indicate serotonin syndrome, ethanol intoxication, anticonvulsant overdose,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    toxicity, or PCP exposure.",
"   </p>",
"   <p>",
"    Respiratory depression and apnea have occurred rarely in infants and young children [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/2,41\">",
"     2,41",
"    </a>",
"    ]. Dystonia responsive to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Chronic use",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rapidly progressive tolerance is frequently described by experienced",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    users [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/12,26,42,43\">",
"     12,26,42,43",
"    </a>",
"    ]. Repeated dextromethorphan use has also been associated with toxic psychosis and cognitive deterioration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/42,44,45\">",
"     42,44,45",
"    </a>",
"    ]. In addition, habitual use and craving may occur in susceptible individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/13,46\">",
"     13,46",
"    </a>",
"    ]. Abrupt cessation of dextromethorphan in these patients may result in dysphoria and intense craving [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/42-45\">",
"     42-45",
"    </a>",
"    ]. Because dextromethorphan is produced as the crystalline hydrobromide salt, bromism is a rare consequence that has also been observed in heavy chronic abusers of dextromethorphan [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Common coingestants",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    , over-the-counter cough formulations frequently contain other pharmaceutical agents such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/52/24390?source=see_link\">",
"     chlorpheniramine",
"    </a>",
"    or other antihistamines,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    whose toxicity may complicate dextromethorphan poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/48\">",
"     48",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coingestion of antihistamines with high H1 receptor antagonistic properties (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/52/24390?source=see_link\">",
"       chlorpheniramine",
"      </a>",
"      ) can cause features of anticholinergic poisoning such as tachycardia, hypertension, hyperthermia, flushing, warm and dry skin, and agitated delirium (",
"      <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"       table 3",
"      </a>",
"      ). Rarely, seizures and rhabdomyolysis may occur [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=see_link\">",
"       \"Anticholinergic poisoning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"       Pseudoephedrine",
"      </a>",
"      , an alpha1 adrenergic agonist, typically causes tachycardia or reflex bradycardia with hypertension. Headache, agitation, and hypertensive emergency may develop in patients with severe toxicity [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      is commonly present in cough and cold preparations. Although it rarely causes immediate symptoms, acetaminophen has high potential to cause severe delayed hepatotoxicity, hepatic failure, and death. It is imperative for the emergency provider to obtain an acetaminophen level in all patients with serious",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      exposure in order to detect this threat. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13114?source=see_link\">",
"       \"Management of acetaminophen (paracetamol) poisoning in children and adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25274?source=see_link\">",
"       \"Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are many causes of neurobehavioral changes with psychotic features that deserve consideration when evaluating the patient with suspected",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    poisoning (",
"    <a class=\"graphic graphic_table graphicRef52785 \" href=\"UTD.htm?24/61/25564\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef50275 \" href=\"UTD.htm?25/40/26251\">",
"     table 5",
"    </a>",
"    ). In the poisoned patient, it is especially important to consider hypoglycemia and potential traumatic brain injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4666?source=see_link\">",
"     \"Emergency department evaluation of acute onset psychosis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Toxicologic causes of ataxia, nystagmus, and mental status changes include ethanol (a common coingestant with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    ),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    , phencyclidine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    . In addition, Wernicke-Korsakoff syndrome, serotonin syndrome, and abstinence syndromes (eg, ethanol withdrawal) have findings that overlap significantly with dextromethorphan toxicity, but are more commonly seen in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=see_link\">",
"     \"Phencyclidine (PCP) intoxication in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44584?source=see_link\">",
"     \"Intoxication from LSD and other common hallucinogens\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/5/2137?source=see_link\">",
"     \"Ethanol intoxication in children: Clinical features, evaluation, and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20694?source=see_link\">",
"     \"Ethanol intoxication in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     LABORATORY STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Dextromethorphan testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    poisoning is usually diagnosed based on history and clinical findings. Commonly available rapid urine screens rely on immunoassay techniques that do not detect dextromethorphan [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/6\">",
"     6",
"    </a>",
"    ]. However, dextromethorphan will frequently cause a false positive for phencyclidine (PCP) on rapid tests that utilize liquid chromatography [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17353/abstract/50-52\">",
"     50-52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Quantitative and qualitative testing for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    is available from dedicated toxicology reference laboratories with methodology such as gas chromatography or mass spectroscopy. However, the results usually cannot be obtained in time to be useful for patient management. Thus, specific measurement of dextromethorphan in the blood or other fluids is typically performed only for forensic or other nonclinical purposes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Acetaminophen level",
"    </span>",
"    &nbsp;&mdash;&nbsp;A serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    level should be obtained in all patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    exposure, including asymptomatic patients, unless coingestion of acetaminophen can be reliable excluded. Serum acetaminophen should also be obtained in patients who ingested dextromethorphan with suicidal intent.",
"   </p>",
"   <p>",
"    The serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    concentration should be measured between 4 and 24 hours after an acute overdose of an immediate-release preparation and plotted on the modified Rumack-Matthew nomogram (",
"    <a class=\"graphic graphic_figure graphicRef83590 \" href=\"UTD.htm?24/56/25472\">",
"     figure 1",
"    </a>",
"    ) to determine the need for antidotal therapy with N-acetylcysteine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25274?source=see_link&amp;anchor=H24#H24\">",
"     \"Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis\", section on 'General approach and serum acetaminophen concentration'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22186?source=see_link&amp;anchor=H5085042#H5085042\">",
"     \"Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents\", section on 'Acetaminophen level'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further laboratory evaluation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    intoxication varies depending on the clinical findings. Other ancillary studies may be indicated in selected patients in whom ingestion of other toxic agents, trauma, or sexual assault are suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=see_link\">",
"     \"Evaluation of stupor and coma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=see_link\">",
"     \"Trauma management: Approach to the unstable child\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=see_link\">",
"     \"Evaluation and management of adult sexual assault victims\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest the following tests in patients with altered mental function and suspected",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     dextromethorphan",
"    </a>",
"    overdose:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bedside glucose determination, to exclude hypoglycemia as the cause of altered consciousness.",
"     </li>",
"     <li>",
"      Arterial or venous blood gas measurement and continuous pulse oximetry to evaluate the adequacy of ventilation in patients with serious and persistent central nervous system depression.",
"     </li>",
"     <li>",
"      Serum electrolyte determination to assess for electrolyte disturbance and to calculate the anion gap in the setting of likely coingestants or evidence for metabolic acidosis.",
"     </li>",
"     <li>",
"      Serum blood urea nitrogen and creatinine to identify patients with renal insufficiency who may have delayed elimination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      and its metabolites after overdose.",
"     </li>",
"     <li>",
"      Liver enzyme studies (Aspartate transferase [AST], Alanine transferase [ALT]), prothrombin time (PT), and partial thromboplastin time (PTT) to determine presence of liver injury and as baseline values in patients with possible",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      overdose.",
"     </li>",
"     <li>",
"      Serum creatine phosphokinase in patients with agitation, seizures, or likely serotonin syndrome to diagnose rhabdomyolysis. Urine tests that are supportive but not diagnostic for rhabdomyolysis include reddish brown discoloration, rapid urine dipstick that is positive for heme, and the presence of urine myoglobin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link&amp;anchor=H25330957#H25330957\">",
"       \"Clinical manifestations and diagnosis of rhabdomyolysis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serum ethanol level, to identify patients at a higher risk for coma with respiratory depression due to coingestion of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      and ethanol.",
"     </li>",
"     <li>",
"      A plasma salicylate level, especially in patients with altered mental status, tachypnea, tachycardia, vomiting, or evidence for an anion gap metabolic acidosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/28/19913?source=see_link\">",
"       \"Salicylate (aspirin) poisoning in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19098?source=see_link\">",
"       \"Salicylate poisoning in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rapid urine toxicology screen for drugs of abuse.",
"     </li>",
"     <li>",
"      Rapid urine pregnancy test in postmenarchal women.",
"     </li>",
"     <li>",
"      Electrocardiogram (EKG), to evaluate for drug-induced cardiac electrical dysfunction.",
"     </li>",
"     <li>",
"      Chest radiography, if the history or exam suggests the possibility of pulmonary aspiration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"     Dextromethorphan",
"    </a>",
"    (d-3-methoxy-N-methylmorphinan, DXM) is an over-the-counter cough suppressant that is commonly diverted for illicit recreational use among teenagers and young adults. While structurally related to the opiate receptor agonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    , DXM in overdose expresses a unique combination of euphoric, stimulant, and dissociative effects in older children and adolescents. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H9\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Pharmacology",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       Dextromethorphan",
"      </a>",
"      (DXM) toxicity occurs in a dose dependent fashion. Neurobehavioral effects typically begin 30 to 60 minutes post-ingestion and persist for up to six hours. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Toxic dose'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In overdose, the active metabolite, dextrorphan, inhibits N-methyl-d-aspartate (NMDA) receptors. This action results in neurobehavioral effects similar to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      and phencyclidine (PCP) including hallucinations, \"out of body\" sensation, and dissociation. DXM also inhibits adrenergic neurotransmitter reuptake in the peripheral and central nervous system resulting in tachycardia, hypertension, and diaphoresis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Mechanism of action'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Physical findings and diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In infants and children,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      poisoning may follow excessive dosing by a caregiver in attempts to treat an upper respiratory illness. Exploratory ingestions in young children and infants usually have minimal symptoms but have the potential to cause marked respiratory depression and apnea. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Children'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prominent clinical findings of DXM overdose in teenagers and adults consist of neurobehavioral changes (eg, euphoria, hallucinations, inappropriate laughing, psychosis with dissociative features, agitation, and coma), tachycardia, dilated pupils, diaphoresis, and \"zombie-like\" ataxic gait. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Toxic dose'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       Dextromethorphan",
"      </a>",
"      may precipitate the serotonin syndrome (altered mental status, seizures, autonomic instability, and muscular hypertonicity) alone in overdose and in regular daily dosing when inappropriately combined with monoamine oxidase inhibitors, serotonin specific reuptake inhibitors,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"       linezolid",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"       tramadol",
"      </a>",
"      , and other serotonergic agents. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"       \"Serotonin syndrome\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H13\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      With",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      poisoning, additional toxicity derives from the ingestion of other ingredients in common OTC cough and cold medications (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      , antihistamines, decongestants) and from the development of serotonin syndrome when DXM is ingested with other serotonergic agents. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Formulation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Common coingestants'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/46/18150?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      poisoning depends on recognition of the clinical presentation and exclusion of other causes for acute psychosis, especially hypoglycemia and hypoxia (",
"      <a class=\"graphic graphic_table graphicRef52785 \" href=\"UTD.htm?24/61/25564\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef50275 \" href=\"UTD.htm?25/40/26251\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     US Dept of Justice DEA Office of Diversion Control. Dextromethorphan, 2007. file://www.deadiversion.usdoj.gov/drugs_concern/dextro_m/dextro_m.htm (Accessed on January 29, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/2\">",
"      Shaul WL, Wandell M, Robertson WO. Dextromethorphan toxicity: reversal by naloxone. Pediatrics 1977; 59:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/3\">",
"      Schneider SM, Michelson EA, Boucek CD, Ilkhanipour K. Dextromethorphan poisoning reversed by naloxone. Am J Emerg Med 1991; 9:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/4\">",
"      Schwartz RH. Adolescent abuse of dextromethorphan. Clin Pediatr (Phila) 2005; 44:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/5\">",
"      Bryner JK, Wang UK, Hui JW, et al. Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004. Arch Pediatr Adolesc Med 2006; 160:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/6\">",
"      Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care 2004; 20:858.",
"     </a>",
"    </li>",
"    <li>",
"     Substance Abuse and Mental Health Services Administration. Office of Applied Studies. The NSDUH report: misuse of over-the-counter cough and cold medications among persons aged 12 to 25. file://www.oas.samhsa.gov/2k8/cough/cough.cfm (Accessed on December 16, 2008).",
"    </li>",
"    <li>",
"     Ball JK, Albright V. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Emergency department visits involving dextromethorphan. The New DAWN report 2006; 32:1. file://www.oas.samhsa.gov/DAWN/dextromethorphan.cfm (Accessed on December 16, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/9\">",
"      Abanades S, Peir&oacute; AM, Farr&eacute; M. [Club drugs: old medicines as new party drugs]. Med Clin (Barc) 2004; 123:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/10\">",
"      Chung H, Park M, Hahn E, et al. Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 2004; 1025:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/11\">",
"      Shulgin AT. Drugs of abuse in the future. Clin Toxicol 1975; 8:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/12\">",
"      Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med 1995; 13:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/13\">",
"      Banerji S, Anderson IB. Abuse of Coricidin HBP cough &amp; cold tablets: episodes recorded by a poison center. Am J Health Syst Pharm 2001; 58:1811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/14\">",
"      Kirages TJ, Sul&eacute; HP, Mycyk MB. Severe manifestations of coricidin intoxication. Am J Emerg Med 2003; 21:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/15\">",
"      Desai S, Aldea D, Daneels E, et al. Chronic addiction to dextromethorphan cough syrup: a case report. J Am Board Fam Med 2006; 19:320.",
"     </a>",
"    </li>",
"    <li>",
"     Department of Health and Human Services. Trouble in the medicine chest (I): Rx drug abuse growing. file://ncadi.samhsa.gov/govpubs/prevalert/v6/4.aspx (Accessed on January 29, 2008).",
"    </li>",
"    <li>",
"     Watson, W. Toxic exposure surveillance system dextromethorphan data. American Association of Poison Control Centers, Washington, DC 2003.",
"    </li>",
"    <li>",
"     Drug Abuse Warning Network. Emergency department visits involving dextromethorphan, 2006 file://www.oas.samhsa.gov (Accessed on January 29, 2008).",
"    </li>",
"    <li>",
"     National Survey on Drug Use and Health. Misuse of Over-the-Counter Cough and Cold Medications among Persons Aged 12 to 25, 2008. file://www.oas.samhsa.gov (Accessed on January 29, 2008).",
"    </li>",
"    <li>",
"     Boyer, EW. 2003 Poisoning Data: Massachusetts Poison Control Center, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/21\">",
"      Simone, K, Bottei, E, Siegel, E, et al. Coricidin abuse in Ohio teens and young adults. J Toxicol Clin Toxicol 2000; 38:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/22\">",
"      Hendrickson RG, Cloutier RL. \"Crystal dex:\" free-base dextromethorphan. J Emerg Med 2007; 32:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/23\">",
"      Hendrickson RG. \"DXemon juice:\" analytical evaluation of an extraction process for the purification and freebasing of dextromethorphan from cold preparations. J Med Toxicol 2008; 4:309.",
"     </a>",
"    </li>",
"    <li>",
"     O'Brien, M. Emerging trends in drug use. Community Epidemiology Working Group Annual Conference. National Institutes on Drug Abuse. Atlanta 2003.",
"    </li>",
"    <li>",
"     Boyer E. Dissociative agents: Phencyclidine, ketamine, and dextromethorphan. In: Haddad adn Winchester's Clinical Management of Poisoning and Drug Overdose, 4th, Shannon MW, Borron SW, Burns MJ.  (Eds), Saunders, Philadelphia 2007. p.776.",
"    </li>",
"    <li>",
"     White, W. DXM FAQ, 1995. file://www.erowid.org (Accessed on January 29, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/27\">",
"      Siu A, Drachtman R. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain. CNS Drug Rev 2007; 13:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/28\">",
"      Kim HS, Park IS, Lim HK, Choi HS. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice. Arch Pharm Res 1999; 22:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/29\">",
"      Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care 2007; 23:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/30\">",
"      Kamei J, Mori T, Igarashi H, Kasuya Y. Serotonin release in nucleus of the solitary tract and its modulation by antitussive drugs. Res Commun Chem Pathol Pharmacol 1992; 76:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/31\">",
"      Steinmiller CL, Maisonneuve IM, Glick SD. Effects of dextromethorphan on dopamine release in the nucleus accumbens: Interactions with morphine. Pharmacol Biochem Behav 2003; 74:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/32\">",
"      Graudins A, Fern RP. Acute dystonia in a child associated with therapeutic ingestion of a dextromethorphan containing cough and cold syrup. J Toxicol Clin Toxicol 1996; 34:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/33\">",
"      Warden CR, Diekema DS, Robertson WO. Dystonic reaction associated with dextromethorphan ingestion in a toddler. Pediatr Emerg Care 1997; 13:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/34\">",
"      Barnhart JW, Massad EN. Determination of dextromethorphan in serum by gas chromatography. J Chromatogr 1979; 163:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/35\">",
"      Silvasti M, Karttunen P, Tukiainen H, et al. Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers. Int J Clin Pharmacol Ther Toxicol 1987; 25:493.",
"     </a>",
"    </li>",
"    <li>",
"     Baselt R, Cravey R. Disposition of Toxic Drugs and Chemicals in Man, Yearbook, Chicago 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/37\">",
"      Schadel M, Wu D, Otton SV, et al. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol 1995; 15:263.",
"     </a>",
"    </li>",
"    <li>",
"     Pharmacokinetic data. In: Goodman &amp; Gilman's The Pharmacologic Basis of Therapeutics, 11th, Brunton LL, Lazo JS, Parker KL.  (Eds), McGraw HIll, New York 2006. p.1816.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/39\">",
"      LoVecchio F, Pizon A, Matesick L, O'Patry S. Accidental dextromethorphan ingestions in children less than 5 years old. J Med Toxicol 2008; 4:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/40\">",
"      Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf 1998; 19:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/41\">",
"      Henretig FM. Special considerations in the poisoned pediatric patient. Emerg Med Clin North Am 1994; 12:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/42\">",
"      Hinsberger A, Sharma V, Mazmanian D. Cognitive deterioration from long-term abuse of dextromethorphan: a case report. J Psychiatry Neurosci 1994; 19:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/43\">",
"      Fleming PM. Dependence on dextromethorphan hydrobromide. Br Med J (Clin Res Ed) 1986; 293:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/44\">",
"      Dodds, A. Toxic psychosis due to dextromethorphan. Med J Aust 1967; 2:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/45\">",
"      Schadel M, Sellers EM. Psychosis with Vicks Formula 44-D abuse. CMAJ 1992; 147:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/46\">",
"      Nicholson KL, Hayes BA, Balster RL. Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys. Psychopharmacology (Berl) 1999; 146:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/47\">",
"      Ng YY, Lin WL, Chen TW, et al. Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. Am J Nephrol 1992; 12:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/48\">",
"      Helfer J, Kim OM. Psychoactive abuse potential of Robitussin-DM. Am J Psychiatry 1990; 147:672.",
"     </a>",
"    </li>",
"    <li>",
"     Tomassoni AJ, Weisman RS. Antihistamines and decongestants. In: Goldfrank's Toxicologic Emergencies, 8th, Flomenbaum NE, Goldfrank LR, Hoffman RS, et al.  (Eds), McGraw-HIll, New York 2006. p.791.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/50\">",
"      Darboe MN, Keenan GR Jr, Richards TK. The abuse of dextromethorphan-based cough syrup: a pilot study of the community of Waynesboro, Pennsylvania. Adolescence 1996; 31:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/51\">",
"      Schier J. Avoid unfavorable consequences: dextromethorpan can bring about a false-positive phencyclidine urine drug screen. J Emerg Med 2000; 18:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17353/abstract/52\">",
"      Williams JF, Kokotailo PK. Abuse of proprietary (over-the-counter) drugs. Adolesc Med Clin 2006; 17:733.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6488 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-6EBEB1F6CE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17353=[""].join("\n");
var outline_f16_60_17353=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Formulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Toxic dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      KINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Youth and adults",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Chronic use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Common coingestants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      LABORATORY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Dextromethorphan testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Acetaminophen level",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Pharmacology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Physical findings and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6488\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6488|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/56/25472\" title=\"figure 1\">",
"      Acetaminophen poisoning nomogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6488|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/63/1019\" title=\"table 1\">",
"      Dextromethorphan-DXM street names",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/19/43324\" title=\"table 2\">",
"      Serotonin syndrome drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/6/44140\" title=\"table 3\">",
"      Poisoning syndromes - toxidromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/61/25564\" title=\"table 4\">",
"      Organic psychosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/40/26251\" title=\"table 5\">",
"      Drug psychosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25274?source=related_link\">",
"      Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/19/43319?source=related_link\">",
"      Anticholinergic poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=related_link\">",
"      Approach to the child with occult toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22186?source=related_link\">",
"      Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2615?source=related_link\">",
"      Dextromethorphan poisoning: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/35/4666?source=related_link\">",
"      Emergency department evaluation of acute onset psychosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20694?source=related_link\">",
"      Ethanol intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/5/2137?source=related_link\">",
"      Ethanol intoxication in children: Clinical features, evaluation, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=related_link\">",
"      Evaluation and management of adult sexual assault victims",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=related_link\">",
"      Evaluation of stupor and coma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44584?source=related_link\">",
"      Intoxication from LSD and other common hallucinogens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40935?source=related_link\">",
"      Ketamine poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21560?source=related_link\">",
"      MDMA (ecstasy) intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13114?source=related_link\">",
"      Management of acetaminophen (paracetamol) poisoning in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/35/570?source=related_link\">",
"      Phencyclidine (PCP) intoxication in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/28/19913?source=related_link\">",
"      Salicylate (aspirin) poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19098?source=related_link\">",
"      Salicylate poisoning in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=related_link\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=related_link\">",
"      Trauma management: Approach to the unstable child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_60_17354="Hemiplegic migraine";
var content_f16_60_17354=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hemiplegic migraine",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/60/17354/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17354/contributors\">",
"     David F Black, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17354/contributors\">",
"     Carrie Elizabeth Robertson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/60/17354/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17354/contributors\">",
"     Jerry W Swanson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/60/17354/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/60/17354/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/60/17354/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1732684\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hallmark of hemiplegic migraine is unilateral weakness that accompanies a migraine headache attack. The weakness is a manifestation of motor aura and occurs with other forms of aura that impair vision, speech, or sensation. This form of migraine with aura may occur either in families or only in one individual (sporadic).",
"   </p>",
"   <p>",
"    This topic will review the pathophysiology, clinical features, diagnosis, and management of familial and sporadic hemiplegic migraine. Other aspects of migraine are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=see_link\">",
"     \"Pathophysiology, clinical features, and diagnosis of migraine in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/44/44743?source=see_link\">",
"     \"Basilar-type migraine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15496?source=see_link\">",
"     \"Migrainous vertigo\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H81875659\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary feature that separates hemiplegic migraine from other types of migraine with aura is the presence of motor weakness as a manifestation of aura in at least some attacks. Migraine auras most often manifest as visual disturbances, but can also involve sensory, verbal, and rarely motor disturbances. Thus, hemiplegic migraine is an uncommon subtype of migraine with aura. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link&amp;anchor=H203275055#H203275055\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\", section on 'Migraine aura'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemiplegic migraine may be familial or sporadic, as discussed in the following section.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1735110\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY AND GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The weakness that characterizes hemiplegic migraine is a manifestation of motor aura. The aura of hemiplegic migraine is most probably caused by cortical spreading depression, a self-propagating wave of neuronal and glial depolarization that spreads across the cerebral cortex. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link&amp;anchor=H130649634#H130649634\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\", section on 'Cortical spreading depression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H81876416\">",
"    <span class=\"h2\">",
"     Familial hemiplegic migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first three types of familial hemiplegic migraine account for some, but not all, of the patients who have familial hemiplegic migraine (see",
"    <a class=\"local\" href=\"#H166228438\">",
"     'Additional types'",
"    </a>",
"    below). They are channelopathies numbered according to the gene involved:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      FHM1 is caused by mutations in the CACNA1A gene",
"     </li>",
"     <li>",
"      FHM2 is caused by mutations in the ATP1A2 gene",
"     </li>",
"     <li>",
"      FHM3 is caused by mutations in the SCN1A gene",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because these types of familial hemiplegic migraine are transmitted in an autosomal dominant pattern, the child of a parent with familial hemiplegic migraine has a 50 percent chance of inheriting the mutation, though the penetrance of these mutations is variable.",
"   </p>",
"   <p>",
"    Each mutation lowers the susceptibility to cortical spreading depression, which most researchers agree initiates the aura of migraine and may initiate the migraine itself in these individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link&amp;anchor=H130649634#H130649634\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\", section on 'Cortical spreading depression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H81875837\">",
"    <span class=\"h3\">",
"     FHM1",
"    </span>",
"    &nbsp;&mdash;&nbsp;FHM1 is associated with mutations in the CACNA1A gene on chromosome 19p13 that encodes the alpha-1A subunit of the",
"    <span class=\"nowrap\">",
"     P/Q",
"    </span>",
"    type calcium channel [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. The estimated penetrance of CACNA1A mutations ranges from 67 to 89 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,6,7\">",
"     3,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to FHM1, CACNA1A gene mutations have been implicated in spinocerebellar ataxia type 6, episodic ataxia type 2, and benign paroxysmal torticollis of infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/1,8,9\">",
"     1,8,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29242?source=see_link&amp;anchor=H10#H10\">",
"     \"The spinocerebellar ataxias\", section on 'SCA6'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37433?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of the hereditary ataxias\", section on 'Episodic ataxias'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/26/8616?source=see_link&amp;anchor=H7#H7\">",
"     \"Acquired torticollis in children\", section on 'Benign paroxysmal torticollis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H81875844\">",
"    <span class=\"h3\">",
"     FHM2",
"    </span>",
"    &nbsp;&mdash;&nbsp;FHM2 is associated with mutations in the ATP1A2 gene on chromosome 1q23 that encodes a catalytic subunit of a",
"    <span class=\"nowrap\">",
"     sodium/potassium",
"    </span>",
"    ATPase [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/5,10\">",
"     5,10",
"    </a>",
"    ]. The estimated penetrance of ATP1A2 mutations ranges from 63 to 87 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6,7,11\">",
"     6,7,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to FHM2, ATP1A2 mutations have been associated with basilar-type migraine, benign familial infantile convulsions, and alternating hemiplegia of childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/44/44743?source=see_link\">",
"     \"Basilar-type migraine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=see_link&amp;anchor=H15#H15\">",
"     \"Benign partial epilepsies of childhood\", section on 'Benign partial epilepsies in infancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H81875851\">",
"    <span class=\"h3\">",
"     FHM3",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mutation in the SCN1A gene on chromosome 2q24 that encodes the transmembrane alpha subunit of the brain sodium channel has been described in several familial hemiplegic migraine pedigrees [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/15-19\">",
"     15-19",
"    </a>",
"    ]. The estimated penetrance of SCN1A mutations is 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6,15-19\">",
"     6,15-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to FHM3, mutations in the SCN1A gene have been linked to a number of epilepsy syndromes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33769?source=see_link&amp;anchor=H6#H6\">",
"     \"Epilepsy syndromes in children\", section on 'Severe myoclonic epilepsy of infancy (Dravet syndrome)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=see_link&amp;anchor=H6#H6\">",
"     \"Febrile seizures\", section on 'Genetic susceptibility'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H166228438\">",
"    <span class=\"h3\">",
"     Additional types",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in the PRRT2 gene, initially recognized as a cause of several paroxysmal disorders, including episodic (or paroxysmal) kinesigenic dyskinesia 1, benign familial infantile epilepsy, and familial infantile convulsions with paroxysmal choreoathetosis, was identified in 2012 as a cause of familial hemiplegic migraine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Thus, PRRT2 gene mutations are associated with a high degree of phenotypic variability within and between families. The same PRRT2 gene mutation may present with different episodic disorders, even within the same family. In addition, some patients with PRRT2 mutations have mixed phenotypes that combine features of several of these disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/21,23\">",
"     21,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While not an ion channel gene, PRRT2 encodes a protein that interacts with the synaptosomal-associated protein SNAP25 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/24\">",
"     24",
"    </a>",
"    ], which may play a role in regulating voltage-gated calcium channels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The known types of familial hemiplegic migraine account for only a small proportion of cases. The best available evidence comes from a 2007 Danish population-based study that included 44 families with FHM [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/7\">",
"     7",
"    </a>",
"    ]. Mutations in the CACNA1A or ATP1A2 genes were found in only 14 percent of families, and no SCN1A mutations were detected. In another study that examined 101 patients with hemiplegic migraine and no known mutation in CACNA1A, ATP1A2, and SCN1A, mutations in the PRRT2 gene were found in 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/21\">",
"     21",
"    </a>",
"    ]. Therefore, it is likely that there are additional types of familial hemiplegic migraine caused by mutations in genes other than CACNA1A, ATP1A2, and SCN1A and PRRT2.",
"   </p>",
"   <p>",
"    In addition to the four established familial hemiplegic migraine genes, mutations in the SLC4A4 gene that encodes for the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    cotransporter, a known cause of proximal renal tubular acidosis (RTA) with ocular abnormalities, have been associated with familial forms of migraine in a few patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/27\">",
"     27",
"    </a>",
"    ]. The phenotype appears to be variable, and includes familial hemiplegic migraine with proximal RTA and typical migraine with or without aura. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18120?source=see_link&amp;anchor=H4#H4\">",
"     \"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis\", section on 'Proximal (type 2) RTA'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H81876444\">",
"    <span class=\"h2\">",
"     Sporadic hemiplegic migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are the first member of their family to have hemiplegic migraine are classified as having sporadic hemiplegic migraine. Some cases of sporadic hemiplegic migraine are caused by one of the genetic mutations that cause familial hemiplegic migraine, due to either de novo mutations or inheritance from an asymptomatic parent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In population- and clinic-based studies, mutations in the CACNA1A and the ATP1A2 genes have been identified in 10 to 20 percent of patients with sporadic hemiplegic migraine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6,29,30\">",
"     6,29,30",
"    </a>",
"    ]. However, in patients with severe sporadic hemiplegic migraine associated with additional neurologic manifestations, the frequency of these mutations may be much higher [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One patient with sporadic hemiplegic migraine with seizures and ataxia was found to have a mutation in the SLC1A3 gene that encodes the glutamate transporter EAAT1 causing neuronal hyperexcitability [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1732712\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemiplegic migraine is a rare disorder. In a population study from Denmark, the estimated prevalence of hemiplegic migraine is 0.01 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/32\">",
"     32",
"    </a>",
"    ]. The familial and sporadic versions occur with equal prevalence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33\">",
"     33",
"    </a>",
"    ]. The average age of onset is 12 to 17 years (range 1 to 51 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,33\">",
"     3,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Like other forms of migraine, women have a higher prevalence of hemiplegic migraine, with female to male ratios ranging from 2.5:1 to 4.3:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1732719\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemiplegic migraine is characterized by migraine attacks with motor weakness during the aura phase. Attacks may variously include severe headache, scintillating scotoma, visual field defect, numbness, paresthesia, unilateral weakness, aphasia, fever, lethargy, coma, and seizures. The symptoms can last for hours to days, or rarely weeks, but most resolve completely. The clinical symptoms of sporadic hemiplegic migraine are indistinguishable from those of familial hemiplegic migraine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/36\">",
"     36",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181715005\">",
"    <span class=\"h2\">",
"     Auras",
"    </span>",
"    &nbsp;&mdash;&nbsp;Motor aura is the hallmark of hemiplegic migraine, but it is never the only type of aura present during a hemiplegic migraine attack [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,33,35\">",
"     3,33,35",
"    </a>",
"    ]. Two or more auras are always experienced. Each one tends to evolve over 20 to 30 minutes and may take hours to gradually improve, typically beginning with a visual aura, and followed successively by sensory, motor, aphasic, and basilar-type symptoms, usually in that order [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33\">",
"     33",
"    </a>",
"    ]. The aura symptoms associated with basilar-type migraine (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/44/44743?source=see_link\">",
"     \"Basilar-type migraine\"",
"    </a>",
"    ) include vertigo, dysarthria, ataxia, bilateral visual, sensory or motor symptoms, hyperacusia, tinnitus, and diminished consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33,35,37\">",
"     33,35,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Motor symptoms most often start in the hand and gradually spread up into the arm and then the face [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ]. The unilateral features of hemiplegic migraine may switch sides between or during attacks. However, bilateral motor signs occur in up to one-third of patients with familial hemiplegic migraine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3\">",
"     3",
"    </a>",
"    ], affecting both sides either in succession or simultaneously. The degree of motor weakness can vary from mild to severe [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a minority, motor weakness or other aura symptoms can develop acutely (ie, in less than five minutes) and may mimic a stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33,35\">",
"     33,35",
"    </a>",
"    ]. The auras of hemiplegic migraine are often prolonged, with 41 to 58 percent of patients have auras lasting &gt;60 minutes and 2 to 8 percent have auras lasting &ge;24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,33,35,38\">",
"     3,33,35,38",
"    </a>",
"    ]. In unusual cases, reversible hemiplegia can last up to four weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181715012\">",
"    <span class=\"h2\">",
"     Headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with hemiplegic migraine have headache with each attack [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33,35\">",
"     33,35",
"    </a>",
"    ]. The headache usually occurs during the aura, most often after the development of visual disturbances, but may occur before the aura. The headache can be bilateral or unilateral, and unilateral headache may be contralateral or ipsilateral to the aura symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/11,39,40\">",
"     11,39,40",
"    </a>",
"    ]. The severity of headache ranges from mild to excruciating.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91544380\">",
"    <span class=\"h2\">",
"     Severe attacks",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to attacks with visual, sensory, motor, aphasic, and basilar-type auras, some patients with hemiplegic migraine have more severe attacks accompanied by encephalopathy or coma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ]. Severe attacks affect a variable proportion of patients in different reports, ranging from 1 percent in a population-based study of patients with familial hemiplegic migraine from Denmark [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33\">",
"     33",
"    </a>",
"    ] to 33 percent in a study of patients with mutations in CACNA1A (ie, FHM1) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3\">",
"     3",
"    </a>",
"    ]. The encephalopathy can manifest as confusion, agitation, delusions, somnolence, or deep coma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/11,41-43\">",
"     11,41-43",
"    </a>",
"    ]. Seizures, fever, meningismus, cerebrospinal fluid pleocytosis, cerebral edema or cerebral infarction can also occur with severe attacks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ]. The aura symptoms of severe attacks, including hemiplegia and impaired consciousness, can be prolonged and last days to months before completely resolving [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,44-47\">",
"     3,44-47",
"    </a>",
"    ]. In rare instances, severe attacks can lead to permanent brain injury, cerebral infarction, cerebral atrophy, cognitive decline, or death [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/48-52\">",
"     48-52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181714998\">",
"    <span class=\"h2\">",
"     Attack frequency and triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mean frequency of attacks is three per year. However, the attack frequency is quite variable and ranges from a few per lifetime to 250 per year [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/53\">",
"     53",
"    </a>",
"    ]. In many patients, the frequency of attacks falls after age 50 years, and hemiplegic attacks can evolve into more typical migraine attacks without hemiparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,34\">",
"     3,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Though most attacks occur without one, reported triggers of hemiplegic migraine attacks include acute stress, bright light, intense emotions, too little or too much sleep, exertion, and mild head trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/34,53-56\">",
"     34,53-56",
"    </a>",
"    ]. Some attacks have been triggered by conventional angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100609674\">",
"    <span class=\"h2\">",
"     Neurologic signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination during an attack may reveal the presence of a Babinski sign or unilateral hyperreflexia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/34\">",
"     34",
"    </a>",
"    ]. Motor and sensory findings more often involve the upper than the lower limbs [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In between attacks, most patients have a normal neurologic examination [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33\">",
"     33",
"    </a>",
"    ], but a majority of patients with FHM1 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,57\">",
"     3,57",
"    </a>",
"    ] and a minority with FHM2 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/11,44,58\">",
"     11,44,58",
"    </a>",
"    ] have cerebellar findings, including gaze-evoked nystagmus, dysarthria, or gait or limb ataxia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100609932\">",
"    <span class=\"h2\">",
"     Epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epilepsy with seizures occurring independent of hemiplegic migraine attacks has been reported in 7 percent of patients with familial hemiplegic migraine in a Danish population study [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/33\">",
"     33",
"    </a>",
"    ]. However, epilepsy occurs at higher rates in some families with FHM2 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/14,59\">",
"     14,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100609711\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;During attacks of hemiplegic migraine, brain imaging is usually normal, whether by CT or MRI (including T1, T2, FLAIR, and diffusion sequences). In a minority, however, CT or MRI may reveal edema, swelling of the cortical ribbon, and cortical or meningeal enhancement contralateral to the hemiparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/31,60,61\">",
"     31,60,61",
"    </a>",
"    ]. In addition, a number of studies have demonstrated hyperperfusion on MR perfusion-weighted imaging or single photon emission computed tomography (SPECT), in some cases with vasodilation on noninvasive or conventional angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/45,49,62-66\">",
"     45,49,62-66",
"    </a>",
"    ]. Other reports have found hypoperfusion without infarction, in some cases accompanied by vasoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/67-70\">",
"     67-70",
"    </a>",
"    ]. These differences may be related in part to the timing of the imaging studies, as there is evidence to suggest that migraine aura is initially associated with transient hypoperfusion followed by hyperperfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/66,70,71\">",
"     66,70,71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cerebellar atrophy is frequently observed in patients with FHM1 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/46,57\">",
"     46,57",
"    </a>",
"    ]. In severe cases of hemiplegic migraine, brain MRI may reveal cortical hemispheric atrophy and cortical laminar necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/49,72\">",
"     49,72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95562561\">",
"    <span class=\"h2\">",
"     Other comorbid headache types",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared with the general population, evidence from Danish population studies suggests that individuals with familial and sporadic hemiplegic migraine have an increased risk for typical migraine with aura but no increased risk for migraine without aura [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report from a tertiary headache referral center observed the co-occurrence in 10 patients of hemiplegic migraine and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/75\">",
"     75",
"    </a>",
"    ]. Both SUNCT and SUNA are rare types of headache that are classified as trigeminal autonomic cephalgias, a group of primary headache disorders characterized by unilateral trigeminal distribution pain that occurs in association with ipsilateral cranial autonomic features (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28648?source=see_link\">",
"     \"SUNCT and SUNA headache syndromes: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27174?source=see_link\">",
"     \"Pathophysiology of the trigeminal autonomic cephalalgias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H166227735\">",
"    <span class=\"h2\">",
"     Genotype-phenotype correlations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three types of familial hemiplegic migraine cannot be reliably distinguished on the basis of clinical features alone. In addition, sporadic hemiplegic migraine cannot be reliably distinguished from the familial type except for the lack of family history. The phenotype of hemiplegic migraine may change within an individual, and often family members suffer different symptoms though they share identical mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/39\">",
"     39",
"    </a>",
"    ]. However, there are differences in the range of phenotypic expression of the three known genetic mutations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      FHM1 is caused by mutations in the CACNA1A gene (see",
"      <a class=\"local\" href=\"#H81875837\">",
"       'FHM1'",
"      </a>",
"      above). About half of the families with FHM1 have cerebellar involvement, including gaze-evoked nystagmus, ataxia, and vermian atrophy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/1-5\">",
"       1-5",
"      </a>",
"      ]. In addition, some families have severe attacks with coma, prolonged hemiplegia or both, with full recovery. Transient cerebral edema and cerebral atrophy are uncommon clinical features. Neuronal impairment in the superior cerebellar vermis has been suggested by metabolic alterations found on magnetic resonance spectroscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/76\">",
"       76",
"      </a>",
"      ]. Co-occurrence of familial hemiplegic migraine with childhood epilepsy and cerebellar ataxia in a single family with a CACNA1A mutation has also been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/77\">",
"       77",
"      </a>",
"      ]. A severe phenotype is associated with the S218L mutation of FHM1, in which mild head trauma may lead to attacks with prolonged hemiplegia, coma, cerebral edema or even death [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/47,48,78\">",
"       47,48,78",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      FHM2 is caused by mutations in the ATP1A2 gene (see",
"      <a class=\"local\" href=\"#H81875844\">",
"       'FHM2'",
"      </a>",
"      above). The clinical features of FHM2 are less well defined than for FHM1, but different ATP1A2 mutations have been linked to different phenotypes, including frequent and long lasting hemiplegia, recurrent coma, or seizures with mental retardation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/5,10,11\">",
"       5,10,11",
"      </a>",
"      ]. Cerebellar involvement also been described in some patients with FHM2 [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/11,44,79\">",
"       11,44,79",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      FHM3 is caused by mutations in the SCN1A gene (see",
"      <a class=\"local\" href=\"#H81875851\">",
"       'FHM3'",
"      </a>",
"      above). Only a few families with this genotype have been reported, and the phenotype includes epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/15-17\">",
"       15-17",
"      </a>",
"      ]. In two unrelated families with FHM3, a novel phenotype called elicited repetitive daily blindness has been described, consisting of repetitive stereotyped spells of blindness, usually bilateral, lasting up to 30 seconds followed by instantaneous recovery [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/18,80\">",
"       18,80",
"      </a>",
"      ]. The visual loss can occur spontaneously or can be triggered by eye rubbing, sudden changes of light, or sudden standing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1732726\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of hemiplegic migraine remains clinical, and genetic testing is not necessary for all patients. The key features for the diagnosis (see",
"    <a class=\"local\" href=\"#H1734585\">",
"     'Diagnostic criteria'",
"    </a>",
"    below) are the occurrence of episodic, reversible motor weakness as a manifestation of migraine aura in conjunction with at least one other kind of aura (visual, sensory, aphasic, or basilar-type). Since motor aura is a necessary feature for the diagnosis, the clinician must establish as clearly as possible whether the patient actually experienced motor weakness as an aura symptom. Although seemingly straightforward, this determination is often challenging because patients may confuse or misinterpret ataxia or numbness as weakness.",
"   </p>",
"   <p>",
"    A thorough family history is essential to distinguish familial from sporadic hemiplegic migraine. In some cases, the diagnosis will change from sporadic to familial hemiplegic migraine over time if a family member develops hemiplegic migraine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In cases where the diagnosis is uncertain, investigations including brain imaging (eg, brain MRI or CT), neurovascular studies (eg, MRA, CT, or ultrasound) electroencephalography, and spinal fluid analysis may be helpful to exclude other causes of weakness such as stroke and seizure (see",
"    <a class=\"local\" href=\"#H1734634\">",
"     'Differential diagnosis'",
"    </a>",
"    below), especially if the attacks are of recent onset, include prolonged symptoms, or do not have a family history of similar spells.",
"   </p>",
"   <p>",
"    Genetic testing for mutations involving the genes that cause familial hemiplegic migraine (CACNA1A, ATP1A2, SCN1A, and PRRT2) may be most useful for patients with early onset severe sporadic hemiplegic migraine associated with nystagmus, seizures, or other atypical neurologic manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6,28\">",
"     6,28",
"    </a>",
"    ]. In addition, genetic testing may be helpful for cases of familial hemiplegic migraine when the attack severity or permanent neurologic manifestations diverge from those of affected relatives. However, the yield of genetic testing is low in patients with adult onset hemiplegic migraine, particularly when there are no associated permanent neurologic features. (See",
"    <a class=\"local\" href=\"#H1735110\">",
"     'Pathophysiology and genetics'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1734585\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic criteria according to the International Headache Society for familial hemiplegic migraine and sporadic hemiplegic migraine are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/82\">",
"     82",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A) At least two attacks fulfilling criteria B and C",
"     </li>",
"     <li>",
"      B) Aura consisting of fully reversible motor weakness and at least one of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fully reversible visual symptoms including positive features (eg, flickering lights, spots, or lines)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      negative features (eg, loss of vision)",
"     </li>",
"     <li>",
"      Fully reversible sensory symptoms including positive features (eg, pins and needles)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      negative features (eg, numbness)",
"     </li>",
"     <li>",
"      Fully reversible dysphasic speech disturbance",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      C) At least two of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      At least one aura symptom develops gradually over &ge;5 minutes",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      different aura symptoms occur in succession over &ge;5 minutes",
"     </li>",
"     <li>",
"      Each aura symptom lasts &ge;5 minutes and &lt;24 hours",
"     </li>",
"     <li>",
"      Headache fulfilling criteria for migraine without aura begins during the aura or follows onset of aura within 60 minutes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      D) For familial",
"      <strong>",
"      </strong>",
"      hemiplegic migraine, at least one first or second-degree relative has attacks fulfilling criteria A to E; for sporadic",
"      <strong>",
"      </strong>",
"      hemiplegic migraine, no first or second-degree relative has attacks fulfilling criteria A to E",
"     </li>",
"     <li>",
"      E) Not attributed to another disorder",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While these criteria require fully reversible aura symptoms, it is accepted that permanent neurologic deficits occur in occasional patients with hemiplegic migraine. (See",
"    <a class=\"local\" href=\"#H91544380\">",
"     'Severe attacks'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1734634\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of hemiplegic migraine primarily concerns cerebrovascular disease (eg, transient ischemic attack and ischemic or hemorrhagic stroke), seizure with postictal paralysis, other forms of migraine, and tumor. Other entities that may mimic hemiplegic migraine include the syndrome of stroke-like migraine attacks after radiation therapy, the syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis (HaNDL), alternating hemiplegia of childhood, central nervous system infections, certain hereditary and metabolic disorders, and Sturge-Weber syndrome.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The symptoms of TIA and hemiplegic migraine are fully reversible, and neuroimaging is often unrevealing in both conditions. However, both a TIA and an ischemic stroke typically have a sudden onset of symptoms rather than a gradual progressive spread of one aura symptom after another. Ischemic events are also less likely to have positive symptoms such as visual scintillations or paresthesia, and are less likely to have migrainous symptoms such as nausea, vomiting, photophobia, and phonophobia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36439?source=see_link\">",
"       \"Differential diagnosis of transient ischemic attack and stroke\"",
"      </a>",
"      ). An exception might be brain ischemia caused by cervical artery dissection, which can have both a progressive spread of symptoms and some migrainous features [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/83-85\">",
"       83-85",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/30/10730?source=see_link\">",
"       \"Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Brain tumors typically cause progressive rather than transient neurologic symptoms and are clearly differentiated from hemiplegic migraine by neuroimaging findings of one or more mass lesions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Epilepsy with hemiparesis attributed to postictal (Todd) paralysis is usually distinguished from hemiplegic migraine by paroxysmal symptoms at seizure onset such as limb jerking, head turning and loss of consciousness, and by the presence of postictal confusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The syndrome of stroke-like migraine attacks after radiation therapy (SMART) may include discrete spells of unilateral headache, hemiparesis, hemisensory, visual and speech impairments that may or may not resolve. SMART should be differentiated from hemiplegic migraine by the history of previous cerebral irradiation and characteristic imaging findings of thick cortical gyral enhancement [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/86-88\">",
"       86-88",
"      </a>",
"      ]. Patients with SMART syndrome are unlikely to have a family history of hemiplegic migraine and are more likely to have associated seizures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis (HaNDL), like hemiplegic migraine, may present with episodic headache, hemiparesis, and aphasia, and may have ictal regional blood flow abnormalities or be triggered by angiography. Unlike hemiplegic migraine, HaNDL has no family history and is monophasic with resolution in three months. Spinal fluid lymphocytosis is required for the diagnosis of HaNDL, but it has occasionally been found in patients with familial hemiplegic migraine [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,34,89-91\">",
"       3,34,89-91",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27894?source=see_link\">",
"       \"Syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis (HaNDL)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Alternating hemiplegia of childhood is a rare condition caused by mutations in the ATP1A2 gene and is allelic with FHM2 (see",
"      <a class=\"local\" href=\"#H81875844\">",
"       'FHM2'",
"      </a>",
"      above). It is characterized by periodic episodes of hemiplegia or quadriplegia beginning in infancy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/12,92\">",
"       12,92",
"      </a>",
"      ]. Associated symptoms include dystonia, paroxysmal eye movements (eg, nystagmus), seizures, cognitive impairment, and ataxia, which help to distinguish it from hemiplegic migraine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Central nervous system infection (meningitis, encephalitis, abscess) can cause headache and hemiparesis, but clinical signs (eg, rash, fever, nuchal rigidity), cerebrospinal fluid analysis (eg, pleocytosis), and neuroimaging findings (eg, meningeal enhancement or parenchymal lesion) usually point to the correct diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The symptomatology of certain inherited disorders such as MELAS [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/93\">",
"       93",
"      </a>",
"      ], CADASIL, and hereditary hemorrhagic telangiectasia [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/94\">",
"       94",
"      </a>",
"      ] can include recurrent migraine-like headaches and neurologic deficits. They are distinguished from hemiplegic migraine on the basis of their clinical features, neuroimaging abnormalities, and genetics. MELAS is notable for maternal inheritance and is caused by mutations involving mitochondrial transfer RNA; CADASIL is caused by NOTCH3 mutations; hereditary hemorrhagic telangiectasia is associated with vascular malformations of the central nervous system. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link&amp;anchor=H10#H10\">",
"       \"Mitochondrial myopathies: Clinical features and diagnosis\", section on 'MELAS'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11530?source=see_link\">",
"       \"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=see_link\">",
"       \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Some metabolic disturbances including ornithine transcarbamylase deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/95\">",
"       95",
"      </a>",
"      ] and homocystinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/96\">",
"       96",
"      </a>",
"      ] can occasionally present with headache and stroke-like attacks but are rarely confused with hemiplegic migraine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sturge-Weber syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=see_link\">",
"       \"Sturge-Weber syndrome\"",
"      </a>",
"      ) is a rare congenital vascular disorder characterized by facial capillary malformation (port wine stain) and associated capillary-venous malformations affecting the brain and eye. While it is not ordinarily confused with hemiplegic migraine, there are case reports of patients with Sturge-Weber syndrome who develop attacks of headache and stroke-like events with paroxysmal hemiparesis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/97,98\">",
"       97,98",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1732770\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe attacks of hemiplegic migraine (see",
"    <a class=\"local\" href=\"#H91544380\">",
"     'Severe attacks'",
"    </a>",
"    above) may require hospital care due to fever, depressed consciousness or seizures. These problems are treated in the same manner as they are for patients without hemiplegic migraine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ]. Otherwise, management generally involves pharmacologic treatment with abortive and preventive medications.",
"   </p>",
"   <p>",
"    Conventional contrast cerebral angiography should be avoided if possible, as it is a known trigger of hemiplegic migraine attacks. (See",
"    <a class=\"local\" href=\"#H181714998\">",
"     'Attack frequency and triggers'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H977692\">",
"    <span class=\"h2\">",
"     Abortive and preventive medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the possible exception of agents that may theoretically cause or exacerbate ischemia (see",
"    <a class=\"local\" href=\"#H625410\">",
"     'Drugs of concern'",
"    </a>",
"    below), patients with hemiplegic migraine may be treated with the same abortive and preventive medications that are used for patients who have typical migraine typical aura. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21194?source=see_link\">",
"     \"Acute treatment of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/56/42889?source=see_link\">",
"     \"Preventive treatment of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18490?source=see_link\">",
"     \"Management of migraine headache in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no randomized controlled trials of therapy specifically for hemiplegic migraine. However, there is limited evidence from case reports and small series regarding the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34484?source=see_link\">",
"     flunarizine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    for the treatment of hemiplegic migraine:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       Verapamil",
"      </a>",
"      has been used as a prophylactic and abortive agent for hemiplegic migraine. However, the evidence is limited to studies involving a small number of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/40,51,55\">",
"       40,51,55",
"      </a>",
"      ]. In one report of four patients with sporadic hemiplegic migraine, treatment with oral verapamil (120 mg one to three times a day) was associated with complete resolution of attacks within the first month in two patients, and a &ge;50 percent reduction in attack frequency and severity in a third patient [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/40\">",
"       40",
"      </a>",
"      ]. A fourth patient initially improved with intravenous verapamil (5 mg given over five minutes) followed by oral verapamil (120 mg daily). However, verapamil was discontinued for this patient due to side effects, and the frequency of hemiplegic migraine attacks gradually returned to pretreatment baseline. In contrast, other investigators have reported little or no improvement in hemiplegic migraine despite treatment with verapamil [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"       6",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      Hemiplegic migraine may respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34484?source=see_link\">",
"       flunarizine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/19,99,100\">",
"       19,99,100",
"      </a>",
"      ]. In one study that included 13 children with hemiplegic migraine, flunarizine (2.5 to 10 mg daily) treatment was associated with a &ge;50 percent reduction in attack frequency in 11 (85 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/100\">",
"       100",
"      </a>",
"      ]. Flunarizine is unavailable in the United States.",
"     </li>",
"     <li>",
"      Nonrandomized studies suggest that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"       acetazolamide",
"      </a>",
"      is effective in channelopathies such as hypokalemic periodic paralysis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9193?source=see_link&amp;anchor=H13#H13\">",
"       \"Hypokalemic periodic paralysis\", section on 'Preventive treatment'",
"      </a>",
"      ) and episodic ataxia type 2 (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37433?source=see_link&amp;anchor=H19#H19\">",
"       \"Overview of the hereditary ataxias\", section on 'Episodic ataxias'",
"      </a>",
"      ); the latter is allelic with FHM1 (see",
"      <a class=\"local\" href=\"#H81875837\">",
"       'FHM1'",
"      </a>",
"      above). The utility of acetazolamide for these conditions prompted its use as a preventive medication for familial hemiplegic migraine. In several case reports, treatment with acetazolamide (250 mg twice a day) was associated with improvement in hemiplegic migraine [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/4,101,102\">",
"       4,101,102",
"      </a>",
"      ]. Acetazolamide may act through changes in the local pH around defective ion channels.",
"     </li>",
"     <li>",
"      In a case series of 47 patients who had migraine with aura,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      was reported as beneficial in a majority, including the 2 patients who had hemiplegic migraine [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/103\">",
"       103",
"      </a>",
"      ]. In a prospective open-label study of 59 patients who had migraine with aura, including 8 with motor aura, lamotrigine (25 to 300 mg daily) was associated with a reduction in migraine aura intensity and migraine attack frequency compared with baseline [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/104\">",
"       104",
"      </a>",
"      ]. However, an earlier randomized controlled trial with 77 patients who had migraine with and without typical aura did not demonstrate any benefit of lamotrigine for migraine prophylaxis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/105\">",
"       105",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The use of triptans for hemiplegic migraine is controversial (see",
"      <a class=\"local\" href=\"#H625410\">",
"       'Drugs of concern'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Intranasal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      given at attack onset was associated with a reproducible decrease in the intensity and duration of aura in 5 of 11 patients with familial hemiplegic migraine [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/106\">",
"       106",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one patient with possible sporadic hemiplegic migraine and another with what was termed \"complicated migraine\" without hemiplegia, intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      (0.4 mg) was associated with resolution of the aura-like symptoms but not the headache pain within two minutes [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/107\">",
"       107",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest initial therapy with either oral sustained-release",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34484?source=see_link\">",
"     flunarizine",
"    </a>",
"    (where available) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    for patients with hemiplegic migraine who desire pharmacologic therapy because the attacks are frequent, prolonged, or debilitating. Sustained-release verapamil is started at 120 mg once daily and increased to 120 mg twice daily (total 240 mg daily). The dose can be further titrated up to 120 mg daily three times a day (total 360 mg daily) for most patients if needed. However, we suggest a maximum verapamil dose of 120 mg daily for small or elderly patients. The usual starting dose of flunarizine is 2.5 to 5 mg given once daily (in the evening), and the dose can be further titrated up to 10 mg per day as needed. Acetazolamide is given at 250 mg twice a day (total 500 mg daily).",
"   </p>",
"   <p>",
"    For adult patients with hemiplegic migraine who do not improve with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34484?source=see_link\">",
"     flunarizine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    , and particularly for patients who have persistent aura symptoms that predominate over headache, we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , despite the lack of benefit in a single small randomized controlled trial. Lamotrigine is started at 25 mg daily with slow titration in 25 mg steps weekly or biweekly up to 100 mg per day if needed. Of concern, a benign rash may develop in up to 10 percent of patients during the initial one to two months of lamotrigine therapy and necessitates discontinuation of the drug; the risk of developing a life-threatening rash such as Stevens-Johnson syndrome is approximately 1 in 1000 adults. This risk is increased dramatically in children, leading to the recommendation that the drug not be used in patients under the age of 16 years.",
"   </p>",
"   <p>",
"    Since hemiplegic migraine is a subset of migraine with aura, certain preventive medications commonly used to treat typical migraine with aura (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    , or valproic acid) may be beneficial, and we suggest them as alternatives if",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34484?source=see_link\">",
"     flunarizine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    are ineffective or intolerable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/56/42889?source=see_link\">",
"     \"Preventive treatment of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18490?source=see_link&amp;anchor=H14#H14\">",
"     \"Management of migraine headache in children\", section on 'Prophylactic treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625410\">",
"    <span class=\"h2\">",
"     Drugs of concern",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sympathomimetics such as triptans and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/20/23877?source=see_link\">",
"     ergotamine",
"    </a>",
"    derivatives are felt to be contraindicated in hemiplegic migraine because of the potential for cerebral vasoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ]. This theoretical risk is based primarily on the relatively outdated vascular theory of migraine (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link&amp;anchor=H130649627#H130649627\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\", section on 'Traditional theories of migraine'",
"    </a>",
"    ) and some have argued that the contraindication for triptans should be reconsidered [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6,108\">",
"     6,108",
"    </a>",
"    ]. Patients with hemiplegic migraine were excluded from the larger randomized controlled trials that evaluated triptans for migraine because of historical concerns regarding vasoconstriction. However, the limited available evidence suggests that triptans do not increase the risk of ischemic events when used for individuals with hemiplegic migraine.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective series of 76 patients with hemiplegic migraine, triptans appeared to be beneficial for the treatment of the headache phase [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/109\">",
"       109",
"      </a>",
"      ]. There were no ischemic strokes or permanent neurologic complications reported, although one patient had a prolonged attack of hemiplegic migraine that persisted for several months following triptan treatment.",
"     </li>",
"     <li>",
"      In a retrospective series of 13 patients with basilar-type migraine, hemiplegic migraine, and prolonged aura exposed to triptans, there was no increased risk of adverse events [",
"      <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/108\">",
"       108",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some headache specialists also avoid beta blockers as preventive therapy for patients who have hemiplegic migraine, basilar-type migraine, or migraine with prolonged aura [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/110\">",
"     110",
"    </a>",
"    ]. The concern is that beta blockers may potentially limit compensatory vasodilatory capacitance of cerebral vessels. There is anecdotal evidence that beta blockers may lead to aura prolongation or ischemia in patients with hemiplegic migraine [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/111,112\">",
"     111,112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one reported case, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/20/16710?source=see_link\">",
"     nimodipine",
"    </a>",
"    possibly provoked a seizure during a prolonged attack of hemiplegic migraine in a patient with FHM2 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although data are scant and conflicting, we suggest",
"    <strong>",
"     not",
"    </strong>",
"    using beta blockers, triptans, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/20/23877?source=see_link\">",
"     ergotamine",
"    </a>",
"    derivatives to treat patients with hemiplegic migraine because of theoretical concerns and anecdotal evidence that these medications may lead to ischemia. However, some experts do use triptans to treat headache associated with hemiplegic migraine attacks, with the exception of patients with severe attacks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181715735\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In nearly all patients with hemiplegic migraine, the aura symptoms eventually resolve completely, though they may be prolonged. However, in rare cases, hemiplegic migraine leads to permanent neurologic deficits, cerebral infarction, cognitive decline, or death [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/48-52,72\">",
"     48-52,72",
"    </a>",
"    ]. Most such patients have phenotypes characterized by early onset of hemiplegic migraine with severe attacks (see",
"    <a class=\"local\" href=\"#H91544380\">",
"     'Severe attacks'",
"    </a>",
"    above), recurrent coma, or seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In many patients, the frequency of attacks falls after age 50 years, and hemiplegic attacks can evolve into more typical migraine attacks without hemiparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/60/17354/abstract/3,34\">",
"     3,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9630101\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary feature that separates hemiplegic migraine from other types of migraine with aura is the presence of motor weakness as a manifestation of aura in at least some attacks. (See",
"      <a class=\"local\" href=\"#H81875659\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The aura of hemiplegic migraine is probably caused by cortical spreading depression, a self-propagating wave of neuronal and glial depolarization that spreads across the cerebral cortex. (See",
"      <a class=\"local\" href=\"#H1735110\">",
"       'Pathophysiology and genetics'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The first three types of familial hemiplegic migraine are channelopathies numbered according to the gene involved. FHM1 is caused by mutations in the CACNA1A gene, FHM2 by mutations in the ATP1A2 gene, and FHM3 by mutations in the SCN1A gene. Mutations in the PRRT2 gene also cause some cases of familial hemiplegic migraine. The known types of familial hemiplegic migraine account for only a small proportion of cases. (See",
"      <a class=\"local\" href=\"#H81876416\">",
"       'Familial hemiplegic migraine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who are the first member of their family to have hemiplegic migraine are classified as having sporadic hemiplegic migraine. Some cases of sporadic hemiplegic migraine are caused by one of the genetic mutations that cause familial hemiplegic migraine, due to either de novo mutations or inheritance from an asymptomatic parent. (See",
"      <a class=\"local\" href=\"#H81876444\">",
"       'Sporadic hemiplegic migraine'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemiplegic migraine is a rare disorder. (See",
"      <a class=\"local\" href=\"#H1732712\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to motor weakness during the aura phase, which is typically unilateral, the manifestations of hemiplegic migraine attacks may variously include severe headache, scintillating scotoma, visual field defect, numbness, paresthesia, aphasia, fever, lethargy, coma, and seizures. The symptoms can last for hours to days, or rarely weeks, but most resolve completely. (See",
"      <a class=\"local\" href=\"#H1732719\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of hemiplegic migraine remains clinical. While formal diagnostic criteria require fully reversible aura symptoms, permanent neurologic deficits develop in occasional patients with hemiplegic migraine. The differential diagnosis of hemiplegic migraine primarily concerns cerebrovascular disease (eg, transient ischemic attack and ischemic or hemorrhagic stroke) and tumor. (See",
"      <a class=\"local\" href=\"#H1732726\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with severe attacks of hemiplegic migraine (see",
"      <a class=\"local\" href=\"#H91544380\">",
"       'Severe attacks'",
"      </a>",
"      above) may require hospital care to treat fever, depressed consciousness or seizures. (See",
"      <a class=\"local\" href=\"#H1732770\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      With the possible exception of agents that may theoretically cause or exacerbate ischemia (see",
"      <a class=\"local\" href=\"#H625410\">",
"       'Drugs of concern'",
"      </a>",
"      above), patients with hemiplegic migraine may be treated with the same abortive and preventive medications that are used for patients who have typical migraine with aura. For patients with hemiplegic migraine who desire pharmacologic therapy because the attacks are frequent, prolonged, or debilitating, we suggest initial treatment with either oral sustained-release",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/43/34484?source=see_link\">",
"       flunarizine",
"      </a>",
"      (where available) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"       acetazolamide",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For adult patients with hemiplegic migraine who do not improve with verapamil, flunarizine, or acetazolamide, and particularly for patients who have persistent aura symptoms that predominate over headache, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      25 mg daily with slow titration in 25 mg steps weekly or biweekly up to 100 mg per day as needed to reduce the aura symptoms and headache (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Lamotrigine should be discontinued if a rash develops. (See",
"      <a class=\"local\" href=\"#H977692\">",
"       'Abortive and preventive medications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with hemiplegic migraine, we suggest",
"      <strong>",
"       not",
"      </strong>",
"      using beta blockers, triptans, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/20/23877?source=see_link\">",
"       ergotamine",
"      </a>",
"      derivatives because of theoretical concerns and anecdotal evidence that these medications may predispose to prolonged aura or ischemia. (See",
"      <a class=\"local\" href=\"#H625410\">",
"       'Drugs of concern'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/1\">",
"      Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/2\">",
"      Terwindt GM, Ophoff RA, Haan J, et al. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group. Neurology 1998; 50:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/3\">",
"      Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001; 345:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/4\">",
"      Kors EE, Haan J, Giffin NJ, et al. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol 2003; 60:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/5\">",
"      Jen JC, Kim GW, Dudding KA, Baloh RW. No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Arch Neurol 2004; 61:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/6\">",
"      Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011; 10:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/7\">",
"      Thomsen LL, Kirchmann M, Bjornsson A, et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain 2007; 130:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/8\">",
"      Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol 2002; 44:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/9\">",
"      Alonso I, Barros J, Tuna A, et al. Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family. Arch Neurol 2003; 60:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/10\">",
"      De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/11\">",
"      Jurkat-Rott K, Freilinger T, Dreier JP, et al. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology 2004; 62:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/12\">",
"      Bassi MT, Bresolin N, Tonelli A, et al. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet 2004; 41:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/13\">",
"      Ambrosini A, D'Onofrio M, Grieco GS, et al. Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology 2005; 65:1826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/14\">",
"      Vanmolkot KR, Kors EE, Hottenga JJ, et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003; 54:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/15\">",
"      Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005; 366:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/16\">",
"      Vanmolkot KR, Babini E, de Vries B, et al. The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online. Hum Mutat 2007; 28:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/17\">",
"      Castro MJ, Stam AH, Lemos C, et al. First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. Cephalalgia 2009; 29:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/18\">",
"      Vahedi K, Depienne C, Le Fort D, et al. Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology 2009; 72:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/19\">",
"      De Cunto A, Bensa M, Tonelli A. A case of familial hemiplegic migraine associated with a novel ATP1A2 gene mutation. Pediatr Neurol 2012; 47:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/20\">",
"      Dale RC, Gardiner A, Antony J, Houlden H. Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol 2012; 54:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/21\">",
"      Riant F, Roze E, Barbance C, et al. PRRT2 mutations cause hemiplegic migraine. Neurology 2012; 79:2122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/22\">",
"      Marini C, Conti V, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 2012; 79:2109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/23\">",
"      Cloarec R, Bruneau N, Rudolf G, et al. PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 2012; 79:2097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/24\">",
"      Lee HY, Huang Y, Bruneau N, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012; 1:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/25\">",
"      Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005; 122:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/26\">",
"      Jarvis SE, Zamponi GW. Masters or slaves? Vesicle release machinery and the regulation of presynaptic calcium channels. Cell Calcium 2005; 37:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/27\">",
"      Suzuki M, Van Paesschen W, Stalmans I, et al. Defective membrane expression of the Na(+)-HCO(3)(-) cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci U S A 2010; 107:15963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/28\">",
"      Riant F, Ducros A, Ploton C, et al. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology 2010; 75:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/29\">",
"      de Vries B, Freilinger T, Vanmolkot KR, et al. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology 2007; 69:2170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/30\">",
"      Thomsen LL, Oestergaard E, Bjornsson A, et al. Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia 2008; 28:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/31\">",
"      Jen JC, Wan J, Palos TP, et al. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005; 65:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/32\">",
"      Lykke Thomsen L, Kirchmann Eriksen M, Faerch Romer S, et al. An epidemiological survey of hemiplegic migraine. Cephalalgia 2002; 22:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/33\">",
"      Thomsen LL, Eriksen MK, Roemer SF, et al. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/34\">",
"      BRADSHAW P, PARSONS M. HEMIPLEGIC MIGRAINE, A CLINICAL STUDY. Q J Med 1965; 34:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/35\">",
"      Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 2003; 60:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/36\">",
"      Thomsen LL, Olesen J. Sporadic hemiplegic migraine. Cephalalgia 2004; 24:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/37\">",
"      Haan J, Terwindt GM, Ophoff RA, et al. Is familial hemiplegic migraine a hereditary form of basilar migraine? Cephalalgia 1995; 15:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/38\">",
"      Terwindt GM, Ophoff RA, Haan J, et al. Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19.DMG RG. Cephalalgia 1996; 16:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/39\">",
"      Ahmed MA, Reid E, Cooke A, et al. Familial hemiplegic migraine in the west of Scotland: a clinical and genetic study of seven families. J Neurol Neurosurg Psychiatry 1996; 61:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/40\">",
"      Yu W, Horowitz SH. Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 2003; 60:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/41\">",
"      Fitzsimons RB, Wolfenden WH. Migraine coma. Meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. Brain 1985; 108 ( Pt 3):555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/42\">",
"      M&uuml;nte TF, M&uuml;ller-Vahl H. Familial migraine coma: a case study. J Neurol 1990; 237:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/43\">",
"      Spacey SD, Vanmolkot KR, Murphy C, et al. Familial hemiplegic migraine presenting as recurrent encephalopathy in a Native Indian family. Headache 2005; 45:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/44\">",
"      Spadaro M, Ursu S, Lehmann-Horn F, et al. A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 2004; 5:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/45\">",
"      Oberndorfer S, W&ouml;ber C, Nasel C, et al. Familial hemiplegic migraine: follow-up findings of diffusion-weighted magnetic resonance imaging (MRI), perfusion-MRI and [99mTc] HMPAO-SPECT in a patient with prolonged hemiplegic aura. Cephalalgia 2004; 24:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/46\">",
"      Vahedi K, Denier C, Ducros A, et al. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology 2000; 55:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/47\">",
"      Debiais S, Hommet C, Bonnaud I, et al. The FHM1 mutation S218L: a severe clinical phenotype? A case report and review of the literature. Cephalalgia 2009; 29:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/48\">",
"      Kors EE, Terwindt GM, Vermeulen FL, et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 2001; 49:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/49\">",
"      Hayashi R, Tachikawa H, Watanabe R, et al. Familial hemiplegic migraine with irreversible brain damage. Intern Med 1998; 37:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/50\">",
"      Vanmolkot KR, Stroink H, Koenderink JB, et al. Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann Neurol 2006; 59:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/51\">",
"      Knierim E, Leisle L, Wagner C, et al. Recurrent stroke due to a novel voltage sensor mutation in Cav2.1 responds to verapamil. Stroke 2011; 42:e14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/52\">",
"      Dodick D, Roarke M. Familial hemiplegic migraine: permanent attack-related neurologic deficits. Headache 2007; 47:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/53\">",
"      Terwindt G, Kors E, Haan J, et al. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch Neurol 2002; 59:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/54\">",
"      WHITTY CW. Familial hemiplegic migraine. J Neurol Neurosurg Psychiatry 1953; 16:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/55\">",
"      Razavi M, Razavi B, Fattal D, et al. Hemiplegic migraine induced by exertion. Arch Neurol 2000; 57:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/56\">",
"      Hansen JM, Hauge AW, Ashina M, Olesen J. Trigger factors for familial hemiplegic migraine. Cephalalgia 2011; 31:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/57\">",
"      Elliott MA, Peroutka SJ, Welch S, May EF. Familial hemiplegic migraine, nystagmus, and cerebellar atrophy. Ann Neurol 1996; 39:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/58\">",
"      Fernandez DM, Hand CK, Sweeney BJ, Parfrey NA. A novel ATP1A2 gene mutation in an Irish familial hemiplegic migraine kindred. Headache 2008; 48:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/59\">",
"      Terwindt GM, Ophoff RA, Lindhout D, et al. Partial cosegregation of familial hemiplegic migraine and a benign familial infantile epileptic syndrome. Epilepsia 1997; 38:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/60\">",
"      Cha YH, Millett D, Kane M, et al. Adult-onset hemiplegic migraine with cortical enhancement and oedema. Cephalalgia 2007; 27:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/61\">",
"      Dreier JP, Jurkat-Rott K, Petzold GC, et al. Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology 2005; 64:2145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/62\">",
"      Lindahl AJ, Allder S, Jefferson D, et al. Prolonged hemiplegic migraine associated with unilateral hyperperfusion on perfusion weighted magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002; 73:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/63\">",
"      Barbour PJ, Castaldo JE, Shoemaker EI. Hemiplegic migraine during pregnancy: unusual magnetic resonance appearance with SPECT scan correlation. Headache 2001; 41:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/64\">",
"      Masuzaki M, Utsunomiya H, Yasumoto S, Mitsudome A. A case of hemiplegic migraine in childhood: transient unilateral hyperperfusion revealed by perfusion MR imaging and MR angiography. AJNR Am J Neuroradiol 2001; 22:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/65\">",
"      Hsu DA, Stafstrom CE, Rowley HA, et al. Hemiplegic migraine: hyperperfusion and abortive therapy with intravenous verapamil. Brain Dev 2008; 30:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/66\">",
"      Iizuka T, Takahashi Y, Sato M, et al. Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. J Neurol Neurosurg Psychiatry 2012; 83:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/67\">",
"      Gonzalez-Alegre P, Tippin J. Prolonged cortical electrical depression and diffuse vasospasm without ischemia in a case of severe hemiplegic migraine during pregnancy. Headache 2003; 43:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/68\">",
"      Pierelli F, Pauri F, Cupini LM, et al. Transcranial Doppler sonography in familial hemiplegic migraine. Cephalalgia 1991; 11:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/69\">",
"      Prodan CI, Holland NR, Lenaerts ME, Parke JT. Magnetic resonance angiogram evidence of vasospasm in familial hemiplegic migraine. J Child Neurol 2002; 17:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/70\">",
"      Hansen JM, Schytz HW, Larsen VA, et al. Hemiplegic migraine aura begins with cerebral hypoperfusion: imaging in the acute phase. Headache 2011; 51:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/71\">",
"      Mourand I, Menjot de Champfleur N, Carra-Dalli&egrave;re C, et al. Perfusion-weighted MR imaging in persistent hemiplegic migraine. Neuroradiology 2012; 54:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/72\">",
"      Black DF, Kung S, Sola CL, et al. Familial hemiplegic migraine, neuropsychiatric symptoms, and Erdheim-Chester disease. Headache 2004; 44:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/73\">",
"      Thomsen LL, Olesen J, Russell MB. Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol 2003; 10:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/74\">",
"      Thomsen LL, Ostergaard E, Romer SF, et al. Sporadic hemiplegic migraine is an aetiologically heterogeneous disorder. Cephalalgia 2003; 23:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/75\">",
"      Lambru G, Nesbitt A, Shanahan P, Matharu MS. Coexistence of hemiplegic migraine with SUNCT or SUNA: a case series. Cephalalgia 2012; 32:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/76\">",
"      Dichgans M, Herzog J, Freilinger T, et al. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology 2005; 64:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/77\">",
"      Kors EE, Melberg A, Vanmolkot KR, et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 2004; 63:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/78\">",
"      Stam AH, Luijckx GJ, Poll-Th&eacute; BT, et al. Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation. J Neurol Neurosurg Psychiatry 2009; 80:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/79\">",
"      Grimaldi D, Tonon C, Cevoli S, et al. Clinical and neuroimaging evidence of interictal cerebellar dysfunction in FHM2. Cephalalgia 2010; 30:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/80\">",
"      Le Fort D, Safran AB, Picard F, et al. Elicited repetitive daily blindness: a new familial disorder related to migraine and epilepsy. Neurology 2004; 63:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/81\">",
"      Stam AH, Louter MA, Haan J, et al. A long-term follow-up study of 18 patients with sporadic hemiplegic migraine. Cephalalgia 2011; 31:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/82\">",
"      Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/83\">",
"      Silverman IE, Wityk RJ. Transient migraine-like symptoms with internal carotid artery dissection. Clin Neurol Neurosurg 1998; 100:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/84\">",
"      Mirza Z, Hayward P, Hulbert D. Spontaneous carotid artery dissection presenting as migraine--a diagnosis not to be missed. J Accid Emerg Med 1998; 15:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/85\">",
"      Haraguchi K, Toyama K, Ito T, et al. A case of posterior cerebral artery dissection presenting with migraine-like headache and visual field defect: usefulness of fast imaging employing steady-state acquisition (FIESTA) for diagnosis. J Stroke Cerebrovasc Dis 2012; 21:906.e5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/86\">",
"      Bartleson JD, Krecke KN, O'Neill BP, Brown PD. Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro Oncol 2003; 5:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/87\">",
"      Black DF, Bartleson JD, Bell ML, Lachance DH. SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia 2006; 26:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/88\">",
"      Kerklaan JP, Lycklama &aacute; Nijeholt GJ, Wiggenraad RG, et al. SMART syndrome: a late reversible complication after radiation therapy for brain tumours. J Neurol 2011; 258:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/89\">",
"      Berg MJ, Williams LS. The transient syndrome of headache with neurologic deficits and CSF lymphocytosis. Neurology 1995; 45:1648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/90\">",
"      Fuentes B, Diez Tejedor E, Pascual J, et al. Cerebral blood flow changes in pseudomigraine with pleocytosis analyzed by single photon emission computed tomography. A spreading depression mechanism? Cephalalgia 1998; 18:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/91\">",
"      De Benedittis G, Ferrari Da Passano C, Granata G, Lorenzetti A. CBF changes during headache-free periods and spontaneous/induced attacks in migraine with and without aura: a TCD and SPECT comparison study. J Neurosurg Sci 1999; 43:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/92\">",
"      Bourgeois M, Aicardi J, Gouti&egrave;res F. Alternating hemiplegia of childhood. J Pediatr 1993; 122:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/93\">",
"      Koo B, Becker LE, Chuang S, et al. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 1993; 34:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/94\">",
"      Steele JG, Nath PU, Burn J, Porteous ME. An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 1993; 33:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/95\">",
"      de Grauw TJ, Smit LM, Brockstedt M, et al. Acute hemiparesis as the presenting sign in a heterozygote for ornithine transcarbamylase deficiency. Neuropediatrics 1990; 21:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/96\">",
"      Silva GS, Almeida CM, F&eacute;lix EP, et al. [Cerebral venous thrombosis and homocystinuria: case report]. Arq Neuropsiquiatr 2001; 59:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/97\">",
"      Dora B, Balkan S. Sporadic hemiplegic migraine and Sturge-Weber syndrome. Headache 2001; 41:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/98\">",
"      Jung A, Raman A, Rowland Hill C. Acute hemiparesis in Sturge-Weber syndrome. Pract Neurol 2009; 9:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/99\">",
"      Tobita M, Hino M, Ichikawa N, et al. A case of hemiplegic migraine treated with flunarizine. Headache 1987; 27:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/100\">",
"      Peer Mohamed B, Goadsby PJ, Prabhakar P. Safety and efficacy of flunarizine in childhood migraine: 11 years' experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol 2012; 54:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/101\">",
"      Athwal BS, Lennox GG. Acetazolamide responsiveness in familial hemiplegic migraine. Ann Neurol 1996; 40:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/102\">",
"      Battistini S, Stenirri S, Piatti M, et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 1999; 53:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/103\">",
"      Pascual J, Caminero AB, Mateos V, et al. Preventing disturbing migraine aura with lamotrigine: an open study. Headache 2004; 44:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/104\">",
"      Lampl C, Katsarava Z, Diener HC, Limmroth V. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 2005; 76:1730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/105\">",
"      Steiner TJ, Findley LJ, Yuen AW. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997; 17:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/106\">",
"      Kaube H, Herzog J, K&auml;ufer T, et al. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000; 55:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/107\">",
"      Centonze V, Brucoli C, Macinagrossa G, et al. Non-familial hemiplegic migraine responsive to naloxone. Cephalalgia 1983; 3:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/108\">",
"      Klapper J, Mathew N, Nett R. Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 2001; 41:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/109\">",
"      Artto V, Nissil&auml; M, Wessman M, et al. Treatment of hemiplegic migraine with triptans. Eur J Neurol 2007; 14:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/110\">",
"      Evans RW, Lipton RB. Topics in migraine management: a survey of headache specialists highlights some controversies. Neurol Clin 2001; 19:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/111\">",
"      Prendes JL. Considerations on the use of propranolol in complicated migraine. Headache 1980; 20:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/112\">",
"      Gilbert GJ. An occurrence of complicated migraine during propranolol therapy. Headache 1982; 22:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/60/17354/abstract/113\">",
"      Mj&aring;set C, Russell MB. Intravenous nimodipine worsening prolonged attack of familial hemiplegic migraine. J Headache Pain 2008; 9:381.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14112 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-422ACB6E1F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17354=[""].join("\n");
var outline_f16_60_17354=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9630101\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1732684\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H81875659\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1735110\">",
"      PATHOPHYSIOLOGY AND GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H81876416\">",
"      Familial hemiplegic migraine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H81875837\">",
"      - FHM1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H81875844\">",
"      - FHM2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H81875851\">",
"      - FHM3",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H166228438\">",
"      - Additional types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H81876444\">",
"      Sporadic hemiplegic migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1732712\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1732719\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H181715005\">",
"      Auras",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H181715012\">",
"      Headache",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91544380\">",
"      Severe attacks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H181714998\">",
"      Attack frequency and triggers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H100609674\">",
"      Neurologic signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H100609932\">",
"      Epilepsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H100609711\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95562561\">",
"      Other comorbid headache types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H166227735\">",
"      Genotype-phenotype correlations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1732726\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1734585\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1734634\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1732770\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H977692\">",
"      Abortive and preventive medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H625410\">",
"      Drugs of concern",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H181715735\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9630101\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/26/8616?source=related_link\">",
"      Acquired torticollis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21194?source=related_link\">",
"      Acute treatment of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/44/44743?source=related_link\">",
"      Basilar-type migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=related_link\">",
"      Benign partial epilepsies of childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11530?source=related_link\">",
"      Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36439?source=related_link\">",
"      Differential diagnosis of transient ischemic attack and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33769?source=related_link\">",
"      Epilepsy syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18120?source=related_link\">",
"      Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=related_link\">",
"      Febrile seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31226?source=related_link\">",
"      Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/62/9193?source=related_link\">",
"      Hypokalemic periodic paralysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/3/18490?source=related_link\">",
"      Management of migraine headache in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15496?source=related_link\">",
"      Migrainous vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=related_link\">",
"      Mitochondrial myopathies: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37433?source=related_link\">",
"      Overview of the hereditary ataxias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/34/27174?source=related_link\">",
"      Pathophysiology of the trigeminal autonomic cephalalgias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of migraine in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=related_link\">",
"      Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/56/42889?source=related_link\">",
"      Preventive treatment of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28648?source=related_link\">",
"      SUNCT and SUNA headache syndromes: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/30/10730?source=related_link\">",
"      Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=related_link\">",
"      Sturge-Weber syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27894?source=related_link\">",
"      Syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis (HaNDL)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29242?source=related_link\">",
"      The spinocerebellar ataxias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_60_17355="SJS TEN therapies";
var content_f16_60_17355=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of reported treatments for SJS and TEN",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Treatment",
"       </td>",
"       <td class=\"subtitle1\">",
"        Observations in SJS",
"       </td>",
"       <td class=\"subtitle1\">",
"        Observations in TEN",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic corticosteroids (short term, high dose)",
"       </td>",
"       <td>",
"        Results mixed: possible benefit, possible harm",
"       </td>",
"       <td>",
"        Possible harm due to increased rates of sepsis and impaired re-epithelialization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravenous immunoglobulin",
"       </td>",
"       <td>",
"        <p>",
"         Possible benefit",
"        </p>",
"        <p>",
"         No significant evidence of harm",
"        </p>",
"       </td>",
"       <td>",
"        Possible benefit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclosporine",
"       </td>",
"       <td>",
"        Possible benefit",
"       </td>",
"       <td>",
"        Possible benefit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasmapheresis",
"       </td>",
"       <td>",
"        No data",
"       </td>",
"       <td>",
"        <p>",
"         Possible benefit",
"        </p>",
"        <p>",
"         No evidence of harm",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thalidomide",
"       </td>",
"       <td>",
"        No data",
"       </td>",
"       <td>",
"        <p>",
"         Harmful",
"        </p>",
"        <p>",
"         Contraindicated",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17355=[""].join("\n");
var outline_f16_60_17355=null;
var title_f16_60_17356="Variants hereditary hemochromatosis";
var content_f16_60_17356=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F56329&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F56329&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Genetic causes of hemochromatosis, iron overload, and hyperferritinemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Inheritance",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical characteristics",
"       </td>",
"       <td class=\"subtitle1\">",
"        Genetic defect(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        I",
"       </td>",
"       <td rowspan=\"2\">",
"        AR",
"       </td>",
"       <td>",
"        Low penetrance,&nbsp;clinical onset&nbsp;in adults",
"       </td>",
"       <td rowspan=\"2\">",
"        HFE protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Classical hereditary hemochromatosis",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        II",
"       </td>",
"       <td rowspan=\"2\">",
"        AR",
"       </td>",
"       <td rowspan=\"2\">",
"        Rapid iron loading, full penetrance, and early onset of hypogonadism and cardiac complications. Liver disease less prominent. Also termed \"",
"        <strong>",
"         juvenile hemochromatosis",
"        </strong>",
"        .\" Onset in children or young adult.",
"       </td>",
"       <td>",
"        Hemojuvelin (IIA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepcidin (IIB)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        III",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"       <td>",
"        Rare condition described in only eight families to date. Clinically similar to classical HH, but with onset in young adults.",
"       </td>",
"       <td>",
"        Transferrin receptor 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"       <td>",
"        Variable disorder. Families with loss-of-function mutations&nbsp;have high ferritin levels, increased macrophage iron, reduced transferrin saturation, mild anemia and minimal hepatic iron deposition (\"Ferroportin disease\"). Other families with gain-of-function mutations&nbsp;have findings similar to classical HH.",
"       </td>",
"       <td>",
"        Ferroportin 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        V",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"       <td>",
"        Found in four of seven members in a single Japanese family.",
"       </td>",
"       <td>",
"        H-ferritin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VI",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"       <td>",
"        High levels of ferritin in association with bilateral congenital cataract; no iron deposition. Also termed \"",
"        <strong>",
"         hereditary hyperferritinemia-cataract syndrome",
"        </strong>",
"        .\" Other mutations may lead to \"Benign hyperferritinemia\" without other manifestations.",
"       </td>",
"       <td>",
"        L-ferritin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AR: autosomal recessive; AD: autosomal dominant.",
"    </div>",
"    <div class=\"reference\">",
"     Compiled from multiple sources. See text for details and references.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17356=[""].join("\n");
var outline_f16_60_17356=null;
var title_f16_60_17357="Maternal age-related Down syndrome risk at 3 gestational ages";
var content_f16_60_17357=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75423&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75423&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Maternal age-related Down syndrome risk at three gestational ages",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" rowspan=\"2\">",
"       Maternal age (completed years)",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"3\">",
"       Down syndrome risk (1:n) at:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Term*",
"      </td>",
"      <td class=\"subtitle2\">",
"       16 weeks",
"      </td>",
"      <td class=\"subtitle2\">",
"       10 weeks",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       20",
"      </td>",
"      <td>",
"       1477",
"      </td>",
"      <td>",
"       1211",
"      </td>",
"      <td>",
"       1152",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       21",
"      </td>",
"      <td>",
"       1461",
"      </td>",
"      <td>",
"       1184",
"      </td>",
"      <td>",
"       1125",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       22",
"      </td>",
"      <td>",
"       1441",
"      </td>",
"      <td>",
"       1168",
"      </td>",
"      <td>",
"       1110",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       23",
"      </td>",
"      <td>",
"       1415",
"      </td>",
"      <td>",
"       1147",
"      </td>",
"      <td>",
"       1090",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       24",
"      </td>",
"      <td>",
"       1382",
"      </td>",
"      <td>",
"       1120",
"      </td>",
"      <td>",
"       1064",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       25",
"      </td>",
"      <td>",
"       1340",
"      </td>",
"      <td>",
"       1085",
"      </td>",
"      <td>",
"       1032",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       26",
"      </td>",
"      <td>",
"       1287",
"      </td>",
"      <td>",
"       1029",
"      </td>",
"      <td>",
"       978",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       27",
"      </td>",
"      <td>",
"       1221",
"      </td>",
"      <td>",
"       977",
"      </td>",
"      <td>",
"       928",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       28",
"      </td>",
"      <td>",
"       1141",
"      </td>",
"      <td>",
"       901",
"      </td>",
"      <td>",
"       856",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       29",
"      </td>",
"      <td>",
"       1047",
"      </td>",
"      <td>",
"       827",
"      </td>",
"      <td>",
"       775",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       30",
"      </td>",
"      <td>",
"       939",
"      </td>",
"      <td>",
"       733",
"      </td>",
"      <td>",
"       686",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       31",
"      </td>",
"      <td>",
"       821",
"      </td>",
"      <td>",
"       632",
"      </td>",
"      <td>",
"       591",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       32",
"      </td>",
"      <td>",
"       696",
"      </td>",
"      <td>",
"       536",
"      </td>",
"      <td>",
"       494",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       33",
"      </td>",
"      <td>",
"       572",
"      </td>",
"      <td>",
"       435",
"      </td>",
"      <td>",
"       401",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       34",
"      </td>",
"      <td>",
"       456",
"      </td>",
"      <td>",
"       346",
"      </td>",
"      <td>",
"       315",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       35",
"      </td>",
"      <td>",
"       353",
"      </td>",
"      <td>",
"       265",
"      </td>",
"      <td>",
"       240",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       36",
"      </td>",
"      <td>",
"       267",
"      </td>",
"      <td>",
"       197",
"      </td>",
"      <td>",
"       179",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       37",
"      </td>",
"      <td>",
"       199",
"      </td>",
"      <td>",
"       147",
"      </td>",
"      <td>",
"       131",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       38",
"      </td>",
"      <td>",
"       148",
"      </td>",
"      <td>",
"       108",
"      </td>",
"      <td>",
"       96",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       39",
"      </td>",
"      <td>",
"       111",
"      </td>",
"      <td>",
"       80",
"      </td>",
"      <td>",
"       71",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       40",
"      </td>",
"      <td>",
"       85",
"      </td>",
"      <td>",
"       60",
"      </td>",
"      <td>",
"       53",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       41",
"      </td>",
"      <td>",
"       67",
"      </td>",
"      <td>",
"       47",
"      </td>",
"      <td>",
"       41",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       42",
"      </td>",
"      <td>",
"       54",
"      </td>",
"      <td>",
"       38",
"      </td>",
"      <td>",
"       32",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       43",
"      </td>",
"      <td>",
"       45",
"      </td>",
"      <td>",
"       31",
"      </td>",
"      <td>",
"       27",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       44",
"      </td>",
"      <td>",
"       39",
"      </td>",
"      <td>",
"       26",
"      </td>",
"      <td>",
"       22",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       45",
"      </td>",
"      <td>",
"       35",
"      </td>",
"      <td>",
"       23",
"      </td>",
"      <td>",
"       19",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Based on Risk = 1/((1 + exp",
"     <sup>",
"      (7.330-4.211)",
"     </sup>",
"     /(1 + exp",
"     <sup>",
"      (-0.282x(age-37.23))",
"     </sup>",
"     )) from Morris JK, et al. J Med Screen 2002; 9:2.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Rodeck, CH, Whittle, MJ. Fetal Medicine: Basic Science and Clinical Practice, 2nd ed, Elsevier 2009. Copyright &copy; 2009. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17357=[""].join("\n");
var outline_f16_60_17357=null;
var title_f16_60_17358="Abdominl stab wound management algorithm";
var content_f16_60_17358=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Management of abdominal stab wounds",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 302px; background-image: url(data:image/gif;base64,R0lGODlhdwEuAdUAAP///4CAgAAAAMDAwEBAQIiIiERERLu7uyIiImZmZt3d3ZmZmRERETMzM+7u7szMzFVVVXd3d6qqqt/f339/fz8/P+Dg4CAgIPDw8NDQ0JCQkM/Pz3BwcL+/vxAQELCwsG9vb6CgoDAwMGBgYFBQUFdXV19fX/n5+efn50tLSy8vLwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAB3AS4BAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaaiIQSqq6ytrq+wsbKztLW2t7i5qxynvUoBIwPCw8TFxsfIycrLzM3Oz9DRAxoEvtZGAQHXbwPV29vZ323d4tfh5Wrk6L3n62fq7qXtWgcCWPVRBQZr9QIHX/DijZo3xQEEAQgj4NN3BN8Sh0P8KWFooACTikIkVmlgEUxAgaEISmnQwAGAAw0gVlHZhKETjFkY/PPoDaQokVAeCDA5ZOE+/wMNECY4aU9BUAEQFCAUUJKlv3pBGTwAUGDpT4tVET5IsHTBgq4SDSA0YJIpwgUAIiydKoSrAARGE1KtKEBBlY82PeF8cgBBEZ8ADOyrpwAfhH1FlEpweqDePwMJdP6jWECykQQNAnf0VwCBAwccAQjA6leAhCMSIUAA8EBm55l3a+b9tNeJTrs97VEGoLSwPQRohTwQe5axwwQJFvidq1k5kQIMEPqF6Q+5kAJDJTrvLCABz4z/gAsxsMClFbyzN9V2QtIuSsAYextGDAAzAAcCFhi3Vz+ygKmHaWYZb6alNV0E4HX2GQIWabecEAwEBx4AqrHGGX2xpQfKek0oQP8cAwrpdhWBvvF2FAQHRIdAfvu1NZRbDYyY1X/EIeDXV/mFNVZZ/yjnQHRMfSfaP3EJgKB5GWqolzZKeoFek5ZwCKUUT045iZRWPlFllpBgySUTW37ZiJd6wHTHg1OEKeYiZMbBkmZdIEkFRwhYl6Zsa0bSJhxvmqmFnFRw1dGdeVKyZ08r5hdYogasyIBdWSEwVX519rWUiUJRZWOQiaKJUaeTHoWWW4pW1GiRESglFKqaIkQSQhIo9U89oEFnJ5V4FurIoRCiJQEDge3zVXiVSZXWakhBiKBhQykgVWcK/Kgff0T4iQCCo1EF7BD2AWVXha0d4BK4rsGllEUJ7GP/3a1o4qqrJLyqupSHFjlUEY7SDUkiUQAkepZLwPVZgAOkZjdrXdDlC5N4gZWHGMPkuSQRQyn2poWa7xbCKwARVlsvfxW1xtaEHGNlDwRDDQHwtEI2txMADRhsoGIGwknhapIVkNnNFoqL2MSIAbXaxblmrMjGlr4Fp70mZ6oRjitiipACK4Om9BAVFVmnaNI9Jt10HbHaWnesSjwZYhJolAXGRguycZztZqG2GYCeV3Tbh7ydRVYyeTE3Gc6etgXbeP+h95qEF97H4WImrvgejH/p+ON5RB5IfEulbMfklN9hOSB+6jQyHZx3XsfnXQCVqT5VKXBQkA+cSKGrDkAl/4BU+AZn8eZ3m244k3YYgPN/r1FVEswF6Kzy8Rw5FthQZkInYR2l+y4H6lxQ53BbS5F9UAMLkNrdcdAPyvAd1VsPB/ZbYJQ21Yjp3LKm8ufmYmAI9pG++m6wrwVx2TLP6/IzI7QMcFr3wxFazsc7/g3Cf1nwEyf258A1QBALEtwEBSuYhgumZ4McPIMHZwPCEJZhhHkpoQnHgEKbqHCFYQgAAbJBwxra8IY4zKEOd8jDHvrwh0AMohCzMYLewXAOAxiiEpe4RFUw8YlQ5GEIjpixFlLxilGwIha3yAQtcvGLR/AiGMcoBDGSEYxmPCMX06hGTlgginBUohPjSMcfWv+gjYEYwAXqyMc++nGIFxgAHgHxwmsQQJCDJEMEdiY6QunqkEmoh2fqg6FEQsEBDIJZ/tz1SEQ25C0vqqQl+QIizxRpKAsA0qCMUEhrQBIJ9RhWuk4SnY6Nsglc+QfKeCMVA2wyCa30xSs/6aE67YMBFknl/G5pBIf4i0VBMcDoihDMXgyzmXXRiQAMsLu6MPMh/NmlEcR5hGqe4pp/8SZXjokVBizzm/aTWl1qNE0imNMU6CQCYQg0mFpOD55OMuKU8gnQN5CgewLwpJUsgFCBFvQMIUDomi7QPV48FA4MXYpDZzOC7in0om2gKEI0sKYPdA+kceDAUjKwJgwshQT/KIWDSQXggUKJYKQxfYNLBTCCQqlUACzNqRtuOsU8DYCmQn1DAARwx0LxNKlu0OO7SFBUqLLBooXSQFOtytWuevWrnbCANMZK1rKa9axbfVcKKsDWtrr1rXCNq1znSte6wlUFGyBDAC6gi7769a+A/ese2wYCRHQgrywEnk3Y+InCHuKwelUsSBjrCccaArKJTQ9lO2HZQmBWDJs9mmQL1VlCfDaGo41HaDdh2ar8EgzReecUTguG1SLCtplorZHIENst0PYLts3g7wirst0Kp3sWUctRjrQUBJwmKAeRQOzG4rqlRMABNTqNWgwQnQQc5FnJqkpHfuuFdgBwlUfA/8jfqiBcK6zXCBp5b2IyNwTcYkK3r7UQsNRikaDApir7OIppEOBOqHDsZdHFpDv5e2AFfMU7DHAngYdA3i6Ydyj1qCdqYHOF9lZBvkQAsRIaCQD7XgK/Q6juUhzA4OhKAICZCcpUdJIZ/Oykt70NigQYHNu0reYgB9lkhblw4V5FalLKSRd25kUcsohGVCdJ1Ki6YrPrEDhIswuS7Yx1ZFIpJcmg8rKOtlk7sxhLCLszsSVQLISDWCS2/MXkf6JzABrD7D9CIHCZMxOdb5lGwSzOVo+TpU1vCmHIWyjyV0R2LNEMTb2T8UytREMajvlqW23JjJ8UhMnkMa8AzoMMo/8jgKyZJIsI19LXkDjdvLCkTHr1Te2adLsUqUSnAXC+3Vmo4iqm3Jkt090mpBKCXVdpV9A78bEQoEsERGvBvF3Bl9I0Aun+XEdmypHX1BKmtE0HDTndSwD5pF0aU/+DYPSN7wHshB3y5Xl6aq5EaZfA4Db4t9mIBS3wIDMERkdkJuo9Dacz6SBLp7hAEQDbc/bhrPIcTwjk83dGBKedl8VMNBQXl6QZ5O4wylpM81ZCvfnha3xHFmua47XTAI6uqTWZRwBwTtKm87Uqq/zUB3T3jF40NYlojed1GTNZOs7AeFMi5IFwdhaMXjc8GH0SSAeE0rHAdFFW7uNfivofpn7/hacDwuuRKAEFxk72spv97GhPu9rXzvazmyDfqNUs1rmEggnY/e54z7ve9873vvv973s/wclnA3arFn5xcwerBRP/jcMn1fGQY7zi0QB5PVQ+ppd3uuQnb4bMe27znB+8FJyzbIvgx/T/Ed8/+30UBiH0b9rOH+mTAJPeFPt26H2C5y+6sdmTGgC/Ws2vrK0EZ716aE23GEpWM3sk1L4uixTCAqzehN0/tPcPGn4EoNPoWyFBeUZIvqF14oDmpzds0G8Abqpg/YJinwhSaUDsYtdyKoc/5Sqj/u6GZH4jPD9aCXBrq+cE7QdQ7zcEEMB92/cy3ncEneGA+jd+O9F//0UAE+RHBF8hW78AeqGnb1TQfNAhfAywMw0YICnGAMiHfIiBTESgfBcHgu5EBAlnFwngFwkofTEoBQUIT72HXDqBevmjehzDYSdxFKHBHK0hJNrWEdJWADdIBLcnf63yFkSoexzYgbV1hVfwYlGwfVLwIxpIZFqIhRY2hvJghmT4bGg4EGuYhl3XhiEBh25IBTsYB3XITHeoVHI4hzq4h0vCh4snd4CoBnsVWIZ4iIgYWIM1iGggVmf1iM2QUJA4icmQVowoCtRyiVeUiZp4RJzYiSv0iaAYQqI4ihVUiqbIP6iYinGQRH/0in8kALA4izz0VTJEi7gYRbKYi7y4VP+26IeFsIrBqEbRZyEa1kXASAjCqIxKIEkmMUsO1GmaRIfJOAjLaI3NCEqUxEEpknAOcEoxp0pJkIfu9QirGEvV0U+3M4CFk0sU0iy9lF/YUI2CcI31mI3FNEssqEy+40zdox/RdIwlRo+BYI8FiY/axE2GZmid4xDkRAQPWQTk+GHmiI/1sU0loy1h+C4OUSTzJB0COZFUYJCAcI7epBTqaEttJJJTQJJ/4JK3dFPdY4mWMFNL0VOIEFEVBVU/hRAXwAk7tRQfkAhBiRBDmVQ2KQBYpQkyiRAYoAhNKQBPCVXdc5TqsRQisAg9uVHwRABLMZUatBRLeQg2SZBUpAH/CMGVkbAUH3UIbMlVGYAQZtkHBwWTe+CVNdVVHpBQn4CWMMUIS/WXXEUCeekJcUlSjHCYXhUCgukJHhBUjPCYXmUBiPkJY6kIl8mKmrmZnFl9vfiZQUSTS/BGoDlEojmPpRlHp3kKu5iarmlDgRQFevSaPhSbTNCatKlEtvkNdtkIBKUE94QFv1kEvRkHw2kKxbkIx1lOaskGy5kRhfCco5CciiCd9tScayCd1OkG1hkK24kI3SkEwXkF2hmdbekL33kI4QkA47kETQcA5XmbVQgH6+kJ6akFIgYGy2kBIVCZ8KBtcfNJWMAQifJw8Hme8HUZS7EZ8zmgQZN7S1Cf/53Aic3VoP/2Jh/GYcIlK1FQoEJCUBjwARwgUjXxnwx5BuYhjUIQn0OQcFORIg1ioVbwnkwgoZxAoWjBfUyAoSMpo1mgoiuqUEnklQglAsNADQe3flF2KdAYML9hegywGP60pKOBL0OBJOfDohAiOMbzZLumFloBjqyzTY8WAVYqL0qmclKoOt1RBDa6CThqISrWFP6QIzMXGDuyZVNxZP0Ckqo2Hg0iKqpyAF9xP5RSg1DKpQz0ShgwAnv5ejS1CiJQEwCakfjQpAj0gA+4j+7EgkWQgS6xABc3BFrKodJXGu2EcQgIjw9QPIRxG0MAqg/aSLMkGEShpG+qCXGKqP+fVg8M6hCsBmquNmpDk2fYoqENUmn8xx/WcWrOQXqiin/olAHU0FBDYKLrp3z2gKn48CMosQDdtH+iOi8u0YBayjFcqjwSQRjc4R3PtD2AGgGoJGDwA6ik1xdwsn8HWg4UCpLiI27U8hTM+moA6yLkhm4r5zH6Qnr+UKjWphHeCj7346YICgAielMlSqknyoJVoSm0hED1oWcZCR0/Yj4I8j7vea41+KIsKBEJB38L8JDmkUp9k2oouzMhg2cBgjm4WrHISZwSUj8QF7CN8TIDJ6wuInEZCDMygzUxGnPLIbAKYBRNazyYhgTPiQGeZKLNFXPSURQrgmsgey4QN6X/KYIQyfO19Up8pOqzEaGgaJsRXfMjtOORa5tn8aO2Y5OmWbGmFqGvuZoJcYqAXQER/mA1NEdmOpc5P/encFJw+iIWI1i1p8ct+LevUIAxPEoG5woIgYsJ94kGJNaMOZgE66m5oQsFnfsHn3sJqVsGK0J9RdAA8kixsomdarC6ftC6lvC6gnC6uJsGutsHvFsJvhsIwHuXbgudhFC8lHC8nru81OQBiVi9rOAB0isA1ru9soC9/AoK66m1lDi+xQCWwEm+xSCJ6DsM5nsN0Mu60hsP77sO80u88esO9fu9n+C8pJC/4uC/esC/0+k7AJwHAoyJBAy+90u/CUwJVmN1/wfsnQ1cBMHmeghFhPiSSXgatw1oBKk0Fg9QqUdAKinxbsUFK0YQwaBQwO5rBMZ3HSqIBKQHHRbBbxnWwVBYIAYBric6winDFVNxPjPCpW2bJSxsDZ8IfkXQdLOnPPxmaTg8BJWbpEtwKxCAIOfzwEegwp9wxOh5fxAoww+CD/z2FQoQxbFKHN4hwpehOQTKjim8wOjgxb2QxAHKxA/ixFSGxkUAGqnSw22MgFgMx7ZrJXTMmi6MgjB8HSu4SjPcMU88sW2GIQcgTffBEfo6IBPLFXbBQErAxfY5wfpkhB3BEEmIgc0VHJF8kUuRIhymYslSqXJCwmzxTBEqx/rbOf8w6YVbKLtKUMJcAMoTKsqcIMw3SsybYMxwisyaoMy6ysyZ4MyCC82YIM2gS82XYM2uS8C5mZu7CSWHbAq5OUevuZp5Ec7qw5II7FXqLMHsPJeKg87W084r/IvMJM++Q89dbM+3hM96AakAHdACPdAEXdAGfdAIXdA/qzj6vAb+TAcPLQi0a2Ub6XFTsopVMTQaPAkRHQiiEzjUeNETEWELBKGO0NGBoDMVkjRoAaZ4hgQNrQYYzSAS1jRSeNJ5IbIdM3wFsgQxnQYz/SOISqu+PIw2wRDahjAr4h3jCM/PnASairb3GqCIgNIpvYIDqJLzKNJQvRwrUhk6W9TMeNT/iDFzdItlMO3U09zV0hdAriKQhmDVmPDTaCDXbmDXUaLW11wKeF0JdH0Gfe3Qn+CKrknOs7jX/UsbM9TNsxjYXODYQE0ben3XiD3Af/i8lb3OnRDTkI2fC73Zk90GnS03n80JnJ3Z7gzaxova9XzZHM3a++zakjDaWEDbZWDbiSZDiw0JrriLuExI2eDboNDb2WCV2dw9P/kIR9U9VfUISSkAzc0Jcdk9lXkJS3WTazmTklCUUhkKj4oQkHkJ040Q0c0IdSkAyS0JRCoAWRkK553emfDd5nwIaIkQOAkvYikK9f1Um1CX7Q0J423cvC2UopBR0M0J9Z2ZkemUlfCo/6QgUvMdCRkl4I7QUf89CQcVvJFg4Z5AUe3rCBEV2m2AliKuByal4JZQRJTAUL89CHEZ3qDgUhSOCSFQ4moA35Rw4aIgAh+OCRgQ4YkA45PQ4pIg5J155EhuVIwdRW1J2EvORz7r5E8eRERuhVNeQ0Cue4t95UE0Q9iw5VwORV4+jmAe5js05mKAm1P+zVRn42K41V2Cde2HQnbtvDsoEu28HnMOz3Ve5XBuCHju5qJn0RrD5wbs5xIp6Gr457si54r+hmTQ52+eN6OV545uBZt7QoaOQSZtBXYOPNE1BnaW24xOFJMEjWzgEjRK6Gn9BB4iHWiR6YNOJSHQ4yGGyv/S0REeBqhe8OmES8RfMOqLnujptDWovgarvoHKzh7HUxUPIOuZxX4IIQIcgKCZ+MidXoHZTgW+3mY9bSELemdHcRoDxE34wQBiUX5AshpAYhrBxk139jr6ECRiUcMvHejpJEspiRZserl9OxX9LjXl0yhnmjn6kErXkRl8SgR6LnkX2GYhEhSScnvAwtKa0SiZ9COLIWVWaAXX3T0EoAHhfe15rGkD8yFUqg9H0SxLQaexNCODwfFFTOreDuz69WvOcrVuZmNa4WuuNep6ZmD+JUkXuQBpo34YWUaVLlmE0Sj6mEzuZKuE4Rb+MRW1OjwPsEvOMhzqh8oOoOpk0TH/EUKsxN7UTuCwLpJhN0MrQ7DTwOItHrupl6Z7CY3QBBBUJG8/FcH2EDIoUs+QiuGrFiJwxzT3Mz/ss8OlsLwTMnZgX+8v13U717FbR29ndmZjVvMAdsZgKxLqSl/qr0pdC0kv+xKry4Gv2vOuMDGu2xY/+6APEnAj3dMuDW8bLwPxwOoXaoFMSU369yET4NP7BIiGH48QHjACIZBWeZ/wcLL7BbB/PDschcsfM6yQ3bN+3Z74hPtmjP8fkqQTwOJa535cCm8kOuHVBeZrMrb5bn01n1/2uUGDGMmxUf+3J9pIO2sR7/OQCwMEEYBEoCg0AICCAaAQIAqAB+ORtFoD/4HrFpDlfpOIhkMpeBwEyUbC+igyFldDNJlAMMhw8L6r5f8DBARINDLA0qwWEJIK9Oba3ugAHp0UEpAcBBbQktyqIJj0uAgG/ky3vJIgBAUhpgQaGAQcGgRkET4FayMyGRJlBdgAVgUkHmoFDBQAah/ckCIEohxkJfu4Uq3Qlp2YDmQdoyq3CnSrDFjFkYsey56KXhOW6vAYWYWx/MCyTRXQn+Kg0aVAYDAABxAIWtSuibQkCBWeSsJP4pUBpf4gSrKAFYI4kwoUZPNN0BJxRUgm3KQxgUJvCZ9cIVXxFMU/zWjmNEXN1xWbNnWaYhiU6LU9QIsmJYpU6RaNTXVCwP/3ZSbUifpO4bSqs5wQn1ivbt0zVCwgsKjOllWLdq3Ttnz+NVi2p6pVpm/V/kyLly/bo3v72gW89WlgmnWh3jXcVO9ix2H/Pi6rGGphyXwQMx58OWhjzn3vUrZKNvHmyp9NZVYagEAW169hx5Y9m3Zt27JbYzON2tS8fYNtEvkl6OOVaE+qJFGAgIkca4L7Crg9nXp11xcwWh1gnXt376+z5+Ot1PeX0GD/WYkQpxEXV8MgJKGVbAtpzaC/5+duYXz/mnsNgClAW5aBCRcAYCEOgJYUhEiQJpBhowCYGkBGgoNgiiNBTZwQZCrxItuCky0k6OmLCOJjJoEEmrPCgAj/k/jHAAc4qoMNTRBI4DgzvvLPxx+BRMoAJjg6AAAorkBACIcmvOISABgQghOpmqBiQgWciIJFKOMoEcEomixPNz5sGtGK5S5kEJ9vlhlywRZj9KaICR2gpYAaF7wxxWLM2w3IPwFdS8goRpzDAQYNEsBIRZQABoFxOIGJON8UVUIZVgRxYtFFxPTrNy7MlEIULhSpokNW4KSkiBUZSQBPVitVIqEEyAAx0FtxfWvQgxCZgyMy1kBwUycujGARBsBMg0orKDVynlGFBYDRI0L8VESNJkyOixdrdRJOkBoyAoE6odhGgWBjtQJa0XJt193/wHik0ALOVejGTSdRaBGO3t6BkBUjmqt0HgcXqZTRePokEz1W4pBUkytOzdSKLZ0LN99kyECHAXSNpEaXbo16V+SRK2IXqiYXO49kT1du2WXI8CrHFiNTBs7PQE1+WecfcyZZ5Zd73llo1IIW+WeXix5aaceSdvfolpteWmq8os716ZWrnlprsVjTz+uvb8vtqNbALrs7sbdO+7PtzG7b7PC4YNvtuW2DW+278c5b77357tvvvwEPXPDBCS/c8MMRT1zxxRlv3PHHIY9c8skpr9zyyzHPXPPNOe/c889BD1300Ukv3fTTUU9d9XeDAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CT: computed tomography; DL: diagnostic laparoscopy; DPL: diagnostic peritoneal lavage; GIB: gastrointestinal bleed; LWE: local wound exploration; SE: serial examination; US: ultrasound.",
"     <br>",
"      * Clinical indications (and potential caveats) for emergent laparotomy include:",
"      <br>",
"       -",
"       <strong>",
"        Hemodynamic instability",
"       </strong>",
"       (hemothorax/ pneumothorax/ hemopericardium may be alternative or contributory cause)",
"       <br>",
"        -",
"        <strong>",
"         Peritonal signs",
"        </strong>",
"        (can be insensitive, especially early after injury)",
"        <br>",
"         -",
"         <strong>",
"          Implement-in-situ",
"         </strong>",
"         (patients with severe co-morbidities or pregnancy should not undergo laparotomy if it can be avoided)",
"         <br>",
"          -",
"          <strong>",
"           Evisceration",
"          </strong>",
"          (up to one-third do not have intraperitoneal injury)",
"          <br>",
"           -",
"           <strong>",
"            GIB especially for LUQ wounds",
"           </strong>",
"           (uncommon cause for laparotomy).",
"           <br>",
"            &bull; Generally reserved for use when sites of entry put diaphragm at risk.",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Isenhour, JL, Marx, J. Advances in abdominal trauma. Emergency Clinics of North America 2007; 25:713. Copyright &copy; 2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17358=[""].join("\n");
var outline_f16_60_17358=null;
var title_f16_60_17359="Umbilical hernia in a patient with Beckwith-Wiedemann syndrome";
var content_f16_60_17359=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F81489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F81489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Umbilical hernia in a patient with Beckwith-Wiedemann syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 344px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_60_17359=[""].join("\n");
var outline_f16_60_17359=null;
